<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="/resources/spdi-openaccess-jats.xsl"?>
<!DOCTYPE response [
	
<!ENTITY % article SYSTEM "http://jats.nlm.nih.gov/archiving/1.2/JATS-archivearticle1.dtd">
<!ENTITY % book-part-wrapper SYSTEM "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
	]><response><apiMessage>This XML was provided by Springer Nature</apiMessage><query>doi:10.1007/s11357-017-0002-y</query><apiKey>87ba7cb21f89ce78154df796840621f4</apiKey><result><total>1</total><start>1</start><pageLength>2</pageLength><recordsDisplayed>1</recordsDisplayed></result><records><article dtd-version="1.2" article-type="review-article" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="publisher-id">11357</journal-id><journal-id journal-id-type="doi">10.1007/11357.1574-4647</journal-id><journal-title-group><journal-title>GeroScience</journal-title><journal-subtitle>Official Journal of the American Aging Association (AGE)</journal-subtitle><abbrev-journal-title abbrev-type="publisher">GeroScience</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2509-2715</issn><issn pub-type="epub">2509-2723</issn><publisher><publisher-name>Springer International Publishing</publisher-name><publisher-loc>Cham</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">s11357-017-0002-y</article-id><article-id pub-id-type="manuscript">2</article-id><article-id pub-id-type="doi">10.1007/s11357-017-0002-y</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">The Oxygen Paradox, the French Paradox, and age-related diseases</article-title></title-group><contrib-group><contrib contrib-type="author" id="Au1"><name><surname>Davies</surname><given-names>Joanna M. S.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" id="Au2"><name><surname>Cillard</surname><given-names>Josiane</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" id="Au3"><name><surname>Friguet</surname><given-names>Bertrand</given-names></name><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" id="Au4"><name><surname>Cadenas</surname><given-names>Enrique</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff6">6</xref><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author" id="Au5"><name><surname>Cadet</surname><given-names>Jean</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author" id="Au6"><name><surname>Cayce</surname><given-names>Rachael</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au7"><name><surname>Fishmann</surname><given-names>Andrew</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au8"><name><surname>Liao</surname><given-names>David</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au9"><name><surname>Bulteau</surname><given-names>Anne-Laure</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author" id="Au10"><name><surname>Derbré</surname><given-names>Frédéric</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author" id="Au11"><name><surname>Rébillard</surname><given-names>Amélie</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author" id="Au12"><name><surname>Burstein</surname><given-names>Steven</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au13"><name><surname>Hirsch</surname><given-names>Etienne</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author" id="Au14"><name><surname>Kloner</surname><given-names>Robert A.</given-names></name><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author" id="Au15"><name><surname>Jakowec</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author" id="Au16"><name><surname>Petzinger</surname><given-names>Giselle</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author" id="Au17"><name><surname>Sauce</surname><given-names>Delphine</given-names></name><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author" id="Au18"><name><surname>Sennlaub</surname><given-names>Florian</given-names></name><xref ref-type="aff" rid="Aff15">15</xref></contrib><contrib contrib-type="author" id="Au19"><name><surname>Limon</surname><given-names>Isabelle</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" id="Au20"><name><surname>Ursini</surname><given-names>Fulvio</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author" id="Au21"><name><surname>Maiorino</surname><given-names>Matilde</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author" id="Au22"><name><surname>Economides</surname><given-names>Christina</given-names></name><xref ref-type="aff" rid="Aff17">17</xref></contrib><contrib contrib-type="author" id="Au23"><name><surname>Pike</surname><given-names>Christian J.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff18">18</xref></contrib><contrib contrib-type="author" id="Au24"><name><surname>Cohen</surname><given-names>Pinchas</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff19">19</xref></contrib><contrib contrib-type="author" id="Au25"><name><surname>Salvayre</surname><given-names>Anne Negre</given-names></name><xref ref-type="aff" rid="Aff20">20</xref></contrib><contrib contrib-type="author" id="Au26"><name><surname>Halliday</surname><given-names>Matthew R.</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author" id="Au27"><name><surname>Lundquist</surname><given-names>Adam J.</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author" id="Au28"><name><surname>Jakowec</surname><given-names>Nicolaus A.</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author" id="Au29"><name><surname>Mechta-Grigoriou</surname><given-names>Fatima</given-names></name><xref ref-type="aff" rid="Aff21">21</xref></contrib><contrib contrib-type="author" id="Au30"><name><surname>Mericskay</surname><given-names>Mathias</given-names></name><xref ref-type="aff" rid="Aff22">22</xref></contrib><contrib contrib-type="author" id="Au31"><name><surname>Mariani</surname><given-names>Jean</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" id="Au32"><name><surname>Li</surname><given-names>Zhenlin</given-names></name><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" id="Au33"><name><surname>Huang</surname><given-names>David</given-names></name><xref ref-type="aff" rid="Aff23">23</xref></contrib><contrib contrib-type="author" id="Au34"><name><surname>Grant</surname><given-names>Ellsworth</given-names></name><xref ref-type="aff" rid="Aff24">24</xref></contrib><contrib contrib-type="author" id="Au35"><name><surname>Forman</surname><given-names>Henry J.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" id="Au36"><name><surname>Finch</surname><given-names>Caleb E.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff17">17</xref><xref ref-type="aff" rid="Aff25">25</xref></contrib><contrib contrib-type="author" id="Au37"><name><surname>Sun</surname><given-names>Patrick Y.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff25">25</xref></contrib><contrib contrib-type="author" id="Au38"><name><surname>Pomatto</surname><given-names>Laura C. D.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff25">25</xref></contrib><contrib contrib-type="author" id="Au39"><name><surname>Agbulut</surname><given-names>Onnik</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" id="Au40"><name><surname>Warburton</surname><given-names>David</given-names></name><xref ref-type="aff" rid="Aff26">26</xref><xref ref-type="aff" rid="Aff27">27</xref></contrib><contrib contrib-type="author" id="Au41"><name><surname>Neri</surname><given-names>Christian</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" id="Au42"><name><surname>Rouis</surname><given-names>Mustapha</given-names></name><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" id="Au43"><name><surname>Cillard</surname><given-names>Pierre</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" id="Au44"><name><surname>Capeau</surname><given-names>Jacqueline</given-names></name><xref ref-type="aff" rid="Aff28">28</xref></contrib><contrib contrib-type="author" id="Au45"><name><surname>Rosenbaum</surname><given-names>Jean</given-names></name><xref ref-type="aff" rid="Aff29">29</xref></contrib><contrib contrib-type="author" corresp="yes" id="Au46"><name><surname>Davies</surname><given-names>Kelvin J. A.</given-names></name><address><email>kelvin@usc.edu</email></address><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff7">7</xref><xref ref-type="aff" rid="Aff25">25</xref><xref ref-type="corresp" rid="IDs113570170002y_cor46">az</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0428 6296</institution-id><institution-id institution-id-type="GRID">grid.413117.1</institution-id><institution content-type="org-name">The Medical Group, Internal Medicine, Rheumatology &amp; Osteoporosis, Dermatology, Pulmonology, Ophthalmology, and Cardiology; the Hospital of the Good Samaritan</institution></institution-wrap><addr-line content-type="postcode">90017</addr-line><addr-line content-type="city">Los Angeles</addr-line><addr-line content-type="state">CA</addr-line><country country="US">USA</country></aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2156 6853</institution-id><institution-id institution-id-type="GRID">grid.42505.36</institution-id><institution content-type="org-division">Leonard Davis School of Gerontology of the Ethel Percy Andrus Gerontology Center</institution><institution content-type="org-name">University of Southern California</institution></institution-wrap><addr-line content-type="postcode">90089-0191</addr-line><addr-line content-type="city">Los Angeles</addr-line><addr-line content-type="state">CA</addr-line><country country="US">USA</country></aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2191 9284</institution-id><institution-id institution-id-type="GRID">grid.410368.8</institution-id><institution content-type="org-division">Lab de Biologie Cellulaire et Végétale, Faculté de Pharmacie</institution><institution content-type="org-name">Université de Rennes</institution></institution-wrap><addr-line content-type="postcode">35043</addr-line><addr-line content-type="city">Rennes Cedex</addr-line><country country="FR">France</country></aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 1955 3500</institution-id><institution-id institution-id-type="GRID">grid.5805.8</institution-id><institution content-type="org-division">Institut de Biologie Paris-Seine (IBPS), UMR CNRS 8256, Biological Adaptation and Ageing</institution><institution content-type="org-name">Sorbonne Universités, UPMC Univ Paris 06</institution></institution-wrap><addr-line content-type="postcode">75005</addr-line><addr-line content-type="city">Paris</addr-line><country country="FR">France</country></aff><aff id="Aff5"><label>5</label><institution-wrap><institution content-type="org-name">INSERM ERL U1164</institution></institution-wrap><addr-line content-type="postcode">75005</addr-line><addr-line content-type="city">Paris</addr-line><country country="FR">France</country></aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2156 6853</institution-id><institution-id institution-id-type="GRID">grid.42505.36</institution-id><institution content-type="org-division">School of Pharmacy</institution><institution content-type="org-name">University of Southern California</institution></institution-wrap><addr-line content-type="postcode">90089-9121</addr-line><addr-line content-type="city">Los Angeles</addr-line><addr-line content-type="state">CA</addr-line><country country="US">USA</country></aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2156 6853</institution-id><institution-id institution-id-type="GRID">grid.42505.36</institution-id><institution content-type="org-division">Department of Biochemistry &amp; Molecular Medicine, Keck School of Medicine of USC</institution><institution content-type="org-name">University of Southern California</institution></institution-wrap><addr-line content-type="postcode">90033</addr-line><addr-line content-type="city">Los Angeles</addr-line><addr-line content-type="state">CA</addr-line><country country="US">USA</country></aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9064 6198</institution-id><institution-id institution-id-type="GRID">grid.86715.3d</institution-id><institution content-type="org-division">Département de Médecine nucléaire et Radiobiologie, Faculté de médecine et des sciences de la santé</institution><institution content-type="org-name">Université de Sherbrooke</institution></institution-wrap><addr-line content-type="postcode">J1H 5N4</addr-line><addr-line content-type="city">Sherbrooke</addr-line><addr-line content-type="state">Québec</addr-line><country country="CA">Canada</country></aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2112 9282</institution-id><institution-id institution-id-type="GRID">grid.4444.0</institution-id><institution content-type="org-name">Institut de Génomique Fonctionnelle de Lyon,ENS de Lyon, CNRS</institution></institution-wrap><addr-line content-type="postcode">69364</addr-line><addr-line content-type="city">Lyon Cedex 07</addr-line><country country="FR">France</country></aff><aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2152 2279</institution-id><institution-id institution-id-type="GRID">grid.11619.3e</institution-id><institution content-type="org-division">Laboratory for Movement, Sport and Health Sciences-EA 1274, M2S</institution><institution content-type="org-name">Université de Rennes 2-ENS</institution></institution-wrap><addr-line content-type="street">Bruz</addr-line><addr-line content-type="postcode">35170</addr-line><addr-line content-type="city">Rennes</addr-line><country country="FR">France</country></aff><aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 1955 3500</institution-id><institution-id institution-id-type="GRID">grid.5805.8</institution-id><institution content-type="org-division">INSERM UMR 1127-CNRS UMR 7225, Institut du cerveau et de la moelle épinière-ICM Thérapeutique Expérimentale de la Maladie de Parkinson</institution><institution content-type="org-name">Université Pierre et Marie Curie</institution></institution-wrap><addr-line content-type="postcode">75651</addr-line><addr-line content-type="city">Paris Cedex 13</addr-line><country country="FR">France</country></aff><aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0452 8371</institution-id><institution-id institution-id-type="GRID">grid.280933.3</institution-id><institution content-type="org-name">Huntington Medical Research Institutes</institution></institution-wrap><addr-line content-type="postcode">91105</addr-line><addr-line content-type="city">Pasadena</addr-line><addr-line content-type="state">CA</addr-line><country country="US">USA</country></aff><aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2156 6853</institution-id><institution-id institution-id-type="GRID">grid.42505.36</institution-id><institution content-type="org-division">Department of Neurology, Keck School of Medicine</institution><institution content-type="org-name">University of Southern California</institution></institution-wrap><addr-line content-type="postcode">90033</addr-line><addr-line content-type="city">Los Angeles</addr-line><addr-line content-type="state">CA</addr-line><country country="US">USA</country></aff><aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 1955 3500</institution-id><institution-id institution-id-type="GRID">grid.5805.8</institution-id><institution content-type="org-division">Chronic infections and Immune ageing, INSERM U1135, Hopital Pitie-Salpetriere</institution><institution content-type="org-name">Pierre et Marie Curie University</institution></institution-wrap><addr-line content-type="postcode">75013</addr-line><addr-line content-type="city">Paris</addr-line><country country="FR">France</country></aff><aff id="Aff15"><label>15</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9373 1902</institution-id><institution-id institution-id-type="GRID">grid.418241.a</institution-id><institution content-type="org-name">INSERM Equipe 14 Institut de la Vision</institution></institution-wrap><addr-line content-type="postcode">75012</addr-line><addr-line content-type="city">Paris</addr-line><country country="FR">France</country></aff><aff id="Aff16"><label>16</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1757 3470</institution-id><institution-id institution-id-type="GRID">grid.5608.b</institution-id><institution content-type="org-division">Department of Molecular Medicine</institution><institution content-type="org-name">University of Padova</institution></institution-wrap><addr-line content-type="postcode">35121</addr-line><addr-line content-type="city">Padova</addr-line><country country="IT">Italy</country></aff><aff id="Aff17"><label>17</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0428 6296</institution-id><institution-id institution-id-type="GRID">grid.413117.1</institution-id><institution content-type="org-name">Los Angeles Cardiology Associates, Hospital of the Good Samaritan</institution></institution-wrap><addr-line content-type="postcode">90017</addr-line><addr-line content-type="city">Los Angeles</addr-line><addr-line content-type="state">CA</addr-line><country country="US">USA</country></aff><aff id="Aff18"><label>18</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2156 6853</institution-id><institution-id institution-id-type="GRID">grid.42505.36</institution-id><institution content-type="org-division">Division of Neurobiology, Department of Biological Sciences of the Dornsife College of Letters, Arts, and Sciences</institution><institution content-type="org-name">University of Southern California</institution></institution-wrap><addr-line content-type="postcode">90089-0191</addr-line><addr-line content-type="city">Los Angeles</addr-line><addr-line content-type="state">CA</addr-line><country country="US">USA</country></aff><aff id="Aff19"><label>19</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2156 6853</institution-id><institution-id institution-id-type="GRID">grid.42505.36</institution-id><institution content-type="org-division">Keck School of Medicine of USC</institution><institution content-type="org-name">University of Southern California</institution></institution-wrap><addr-line content-type="postcode">90033</addr-line><addr-line content-type="city">Los Angeles</addr-line><addr-line content-type="state">CA</addr-line><country country="US">USA</country></aff><aff id="Aff20"><label>20</label><institution-wrap><institution content-type="org-name">Lipid peroxidation, Signalling and Vascular Diseases INSERM U1048</institution></institution-wrap><addr-line content-type="postcode">31432</addr-line><addr-line content-type="city">Toulouse Cedex 4</addr-line><country country="FR">France</country></aff><aff id="Aff21"><label>21</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0639 6384</institution-id><institution-id institution-id-type="GRID">grid.418596.7</institution-id><institution content-type="org-division">Stress and Cancer Laboratory</institution><institution content-type="org-name">Institut Curie-Inserm U830</institution></institution-wrap><addr-line content-type="postcode">75248</addr-line><addr-line content-type="city">Paris Cedex 05</addr-line><country country="FR">France</country></aff><aff id="Aff22"><label>22</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2171 2558</institution-id><institution-id institution-id-type="GRID">grid.5842.b</institution-id><institution content-type="org-division">Laboratoire de Signalisation et Physiopathologie Cardiovasculaire-Inserm UMR-S 1180, Faculté de Pharmacie</institution><institution content-type="org-name">Université Paris-Sud</institution></institution-wrap><addr-line content-type="street">92296 Châtenay-Malabry</addr-line><addr-line content-type="city">Paris</addr-line><country country="FR">France</country></aff><aff id="Aff23"><label>23</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0428 6296</institution-id><institution-id institution-id-type="GRID">grid.413117.1</institution-id><institution content-type="org-division">Department of Radiation Oncology</institution><institution content-type="org-name">Hospital of the Good Samaritan</institution></institution-wrap><addr-line content-type="postcode">90017</addr-line><addr-line content-type="city">Los Angeles</addr-line><addr-line content-type="state">CA</addr-line><country country="US">USA</country></aff><aff id="Aff24"><label>24</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0428 6296</institution-id><institution-id institution-id-type="GRID">grid.413117.1</institution-id><institution content-type="org-division">Department of Oncology &amp; Hematology</institution><institution content-type="org-name">Hospital of the Good Samaritan</institution></institution-wrap><addr-line content-type="postcode">90017</addr-line><addr-line content-type="city">Los Angeles</addr-line><addr-line content-type="state">CA</addr-line><country country="US">USA</country></aff><aff id="Aff25"><label>25</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2156 6853</institution-id><institution-id institution-id-type="GRID">grid.42505.36</institution-id><institution content-type="org-division">Division of Molecular &amp; Computational Biology, Department of Biological Sciences of the Dornsife College of Letters, Arts, and Sciences</institution><institution content-type="org-name">University of Southern California</institution></institution-wrap><addr-line content-type="postcode">90089-0191</addr-line><addr-line content-type="city">Los Angeles</addr-line><addr-line content-type="state">CA</addr-line><country country="US">USA</country></aff><aff id="Aff26"><label>26</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2153 6013</institution-id><institution-id institution-id-type="GRID">grid.239546.f</institution-id><institution content-type="org-name">Children’s Hospital of Los Angeles, Developmental Biology, Regenerative Medicine and Stem Cell Therapeutics program and the Center for Environmental Impact on Global Health Across the Lifespan at The Saban Research Institute</institution></institution-wrap><addr-line content-type="postcode">90027</addr-line><addr-line content-type="city">Los Angeles</addr-line><addr-line content-type="state">CA</addr-line><country country="US">USA</country></aff><aff id="Aff27"><label>27</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2156 6853</institution-id><institution-id institution-id-type="GRID">grid.42505.36</institution-id><institution content-type="org-division">Department of Pediatrics, Keck School of Medicine of USC</institution><institution content-type="org-name">University of Southern California</institution></institution-wrap><addr-line content-type="postcode">90033</addr-line><addr-line content-type="city">Los Angeles</addr-line><addr-line content-type="state">CA</addr-line><country country="US">USA</country></aff><aff id="Aff28"><label>28</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 1955 3500</institution-id><institution-id institution-id-type="GRID">grid.5805.8</institution-id><institution content-type="org-division">DR Saint-Antoine UMR_S938, UPMC, Inserm Faculté de Médecine</institution><institution content-type="org-name">Université Pierre et Marie Curie</institution></institution-wrap><addr-line content-type="postcode">75012</addr-line><addr-line content-type="city">Paris</addr-line><country country="FR">France</country></aff><aff id="Aff29"><label>29</label><institution-wrap><institution content-type="org-name">Scientific Service of the Embassy of France in the USA, Consulate General of France in Los Angeles</institution></institution-wrap><addr-line content-type="postcode">90025</addr-line><addr-line content-type="city">Los Angeles</addr-line><addr-line content-type="state">CA</addr-line><country country="US">USA</country></aff></contrib-group><author-notes><corresp id="IDs113570170002y_cor46"><label>az</label><email>kelvin@usc.edu</email></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>21</day><month>12</month><year>2017</year></pub-date><pub-date date-type="pub" publication-format="print"><month>12</month><year>2017</year></pub-date><volume>39</volume><issue seq="3">5-6</issue><fpage>499</fpage><lpage>550</lpage><history><date date-type="registration"><day>9</day><month>11</month><year>2017</year></date><date date-type="received"><day>7</day><month>11</month><year>2017</year></date><date date-type="accepted"><day>9</day><month>11</month><year>2017</year></date><date date-type="online"><day>21</day><month>12</month><year>2017</year></date></history><permissions><copyright-statement content-type="compact">© The Author(s) 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>The Author(s)</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p></license></permissions><abstract xml:lang="en" id="Abs1"><title>Abstract</title><p id="Par1">A paradox is a seemingly absurd or impossible concept, proposition, or theory that is often difficult to understand or explain, sometimes apparently self-contradictory, and yet ultimately correct or true. How is it possible, for example, that oxygen “a toxic environmental poison” could be also indispensable for life (Beckman and Ames Physiol Rev 78(2):547–81, <xref ref-type="bibr" rid="CR24">1998</xref>; Stadtman and Berlett Chem Res Toxicol 10(5):485–94, <xref ref-type="bibr" rid="CR365">1997</xref>)?: the so-called Oxygen Paradox (Davies and Ursini <xref ref-type="bibr" rid="CR80">1995</xref>; Davies Biochem Soc Symp 61:1–31, <xref ref-type="bibr" rid="CR78">1995</xref>). How can French people apparently disregard the rule that high dietary intakes of cholesterol and saturated fats (e.g., cheese and paté) will result in an early death from cardiovascular diseases (Renaud and de Lorgeril Lancet 339(8808):1523–6, <xref ref-type="bibr" rid="CR317">1992</xref>; Catalgol et al. Front Pharmacol 3:141, <xref ref-type="bibr" rid="CR55">2012</xref>; Eisenberg et al. Nat Med 22(12):1428–1438, <xref ref-type="bibr" rid="CR94">2016</xref>)?: the so-called, French Paradox. Doubtless, the truth is not a duality and epistemological bias probably generates apparently self-contradictory conclusions. Perhaps nowhere in biology are there so many apparently contradictory views, and even experimental results, affecting human physiology and pathology as in the fields of free radicals and oxidative stress, antioxidants, foods and drinks, and dietary recommendations; this is particularly true when issues such as disease-susceptibility or avoidance, “healthspan,” “lifespan,” and ageing are involved. Consider, for example, the apparently paradoxical observation that treatment with low doses of a substance that is toxic at high concentrations may actually induce transient adaptations that protect against a subsequent exposure to the same (or similar) toxin. This particular paradox is now mechanistically explained as “Adaptive Homeostasis” (Davies Mol Asp Med 49:1–7, <xref ref-type="bibr" rid="CR79">2016</xref>; Pomatto et al. <xref ref-type="bibr" rid="CR297">2017a</xref>; Lomeli et al. Clin Sci (Lond) 131(21):2573–2599, <xref ref-type="bibr" rid="CR232">2017</xref>; Pomatto and Davies <xref ref-type="bibr" rid="CR296">2017</xref>)<bold>;</bold> the non-damaging process by which an apparent toxicant can activate biological signal transduction pathways to increase expression of protective genes, by mechanisms that are completely different from those by which the same agent induces toxicity at high concentrations. In this review, we explore the influences and effects of paradoxes such as the Oxygen Paradox and the French Paradox on the etiology, progression, and outcomes of many of the major human age-related diseases, as well as the basic biological phenomenon of ageing itself.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Oxidative stress</kwd><kwd>Oxygen Paradox</kwd><kwd>Age-related diseases</kwd><kwd>French Paradox</kwd><kwd>Ageing</kwd><kwd>Proteostasis</kwd><kwd>Adaptive Homeostasis</kwd><kwd>Healthspan</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution>National Science Foundation</institution><institution-id institution-id-type="doi" vocab="open-funder-registry">http://dx.doi.org/10.13039/100000001</institution-id></institution-wrap></funding-source><award-id award-type="FundRef grant">#DGE-1418060</award-id><principal-award-recipient><name><surname>Pomatto</surname><given-names>Laura C. D.</given-names></name></principal-award-recipient></award-group><award-group><funding-source><institution-wrap><institution>National Institute of Environmental Health Sciences</institution><institution-id institution-id-type="doi" vocab="open-funder-registry">http://dx.doi.org/10.13039/100000066</institution-id></institution-wrap></funding-source><award-id award-type="FundRef grant">#ES023864</award-id><award-id award-type="FundRef grant">#R01ES020812</award-id><award-id award-type="FundRef grant">#D43ES022862</award-id><award-id award-type="FundRef grant">#ES003598</award-id><principal-award-recipient><name><surname>Forman</surname><given-names>Henry J.</given-names></name></principal-award-recipient><principal-award-recipient><name><surname>Cohen</surname><given-names>Pinchas</given-names></name></principal-award-recipient><principal-award-recipient><name><surname>Warburton</surname><given-names>David</given-names></name></principal-award-recipient><principal-award-recipient><name><surname>Davies</surname><given-names>Kelvin J. A.</given-names></name></principal-award-recipient></award-group><award-group><funding-source><institution-wrap><institution>Institut National de la Santé et de la Recherche Médicale</institution><institution-id institution-id-type="doi" vocab="open-funder-registry">http://dx.doi.org/10.13039/501100001677</institution-id></institution-wrap></funding-source></award-group><award-group><funding-source><institution-wrap><institution>National Institute on Aging</institution><institution-id institution-id-type="doi" vocab="open-funder-registry">http://dx.doi.org/10.13039/100000049</institution-id></institution-wrap></funding-source><award-id award-type="FundRef grant"># AG-040753</award-id><award-id award-type="FundRef grant"># AG058068</award-id><award-id award-type="FundRef grant"># P01AG034906</award-id><award-id award-type="FundRef grant"># R01AG034430</award-id><award-id award-type="FundRef grant"># AG052374</award-id><award-id award-type="FundRef grant"># AG052374</award-id><principal-award-recipient><name><surname>Finch</surname><given-names>Caleb E.</given-names></name></principal-award-recipient><principal-award-recipient><name><surname>Cohen</surname><given-names>Pinchas</given-names></name></principal-award-recipient><principal-award-recipient><name><surname>Cohen</surname><given-names>Pinchas</given-names></name></principal-award-recipient><principal-award-recipient><name><surname>Davies</surname><given-names>Kelvin J. A.</given-names></name></principal-award-recipient><principal-award-recipient><name><surname>Sun</surname><given-names>Patrick Y.</given-names></name></principal-award-recipient></award-group><award-group><funding-source><institution-wrap><institution>Agence Nationale de la Recherche</institution><institution-id institution-id-type="doi" vocab="open-funder-registry">http://dx.doi.org/10.13039/501100001665</institution-id></institution-wrap></funding-source></award-group><award-group><funding-source><institution-wrap><institution>Université Pierre et Marie Curie</institution><institution-id institution-id-type="doi" vocab="open-funder-registry">http://dx.doi.org/10.13039/501100005737</institution-id></institution-wrap></funding-source></award-group><award-group><funding-source><institution-wrap><institution>Université Toulouse III - Paul Sabatier</institution><institution-id institution-id-type="doi" vocab="open-funder-registry">http://dx.doi.org/10.13039/501100009160</institution-id></institution-wrap></funding-source></award-group><award-group><funding-source><institution-wrap><institution>Conseil Régional de Bretagne</institution><institution-id institution-id-type="doi" vocab="open-funder-registry">http://dx.doi.org/10.13039/501100004584</institution-id></institution-wrap></funding-source></award-group><award-group><funding-source><institution-wrap><institution>Ligue Contre le Cancer</institution><institution-id institution-id-type="doi" vocab="open-funder-registry">http://dx.doi.org/10.13039/501100004099</institution-id></institution-wrap></funding-source></award-group><award-group><funding-source><institution-wrap><institution>Fondation de France</institution><institution-id institution-id-type="doi" vocab="open-funder-registry">http://dx.doi.org/10.13039/501100004431</institution-id></institution-wrap></funding-source></award-group><award-group><funding-source><institution-wrap><institution>Centre National de la Recherche Scientifique</institution><institution-id institution-id-type="doi" vocab="open-funder-registry">http://dx.doi.org/10.13039/501100004794</institution-id></institution-wrap></funding-source></award-group><award-group><funding-source><institution-wrap><institution>Assistance Publique - Hôpitaux de Paris</institution><institution-id institution-id-type="doi" vocab="open-funder-registry">http://dx.doi.org/10.13039/501100002738</institution-id></institution-wrap></funding-source></award-group><award-group><funding-source><institution-wrap><institution>U.S. Department of Defense</institution><institution-id institution-id-type="doi" vocab="open-funder-registry">http://dx.doi.org/10.13039/100000005</institution-id></institution-wrap></funding-source><award-id award-type="FundRef grant">DOD-PC160353U</award-id><principal-award-recipient><name><surname>Cohen</surname><given-names>Pinchas</given-names></name></principal-award-recipient></award-group><award-group><funding-source><institution-wrap><institution>American Foundation for Aging Research</institution><institution-id institution-id-type="doi" vocab="open-funder-registry">http://dx.doi.org/10.13039/100005366</institution-id></institution-wrap></funding-source></award-group><award-group><funding-source><institution-wrap><institution>Don Roberto Gonzalez and Family Foundation</institution></institution-wrap></funding-source></award-group><award-group><funding-source><institution-wrap><institution>National Parkinson Foundation</institution><institution-id institution-id-type="doi" vocab="open-funder-registry">http://dx.doi.org/10.13039/100001262</institution-id></institution-wrap></funding-source></award-group><award-group><funding-source><institution-wrap><institution>National Heart, Lung, and Blood Institute</institution><institution-id institution-id-type="doi" vocab="open-funder-registry">http://dx.doi.org/10.13039/100000050</institution-id></institution-wrap></funding-source><award-id award-type="FundRef grant">#U01HL122681</award-id><principal-award-recipient><name><surname>Warburton</surname><given-names>David</given-names></name></principal-award-recipient></award-group><award-group><funding-source><institution-wrap><institution>Pasadena Guild</institution></institution-wrap></funding-source></award-group><award-group><funding-source><institution-wrap><institution>Children's Hospital Los Angeles</institution><institution-id institution-id-type="doi" vocab="open-funder-registry">http://dx.doi.org/10.13039/100006459</institution-id></institution-wrap></funding-source></award-group><award-group><funding-source><institution-wrap><institution>the webb foundation</institution></institution-wrap></funding-source></award-group><award-group><funding-source><institution-wrap><institution>The Garland Foundation</institution></institution-wrap></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>publisher-imprint-name</meta-name><meta-value>Springer</meta-value></custom-meta><custom-meta><meta-name>volume-issue-count</meta-name><meta-value>6</meta-value></custom-meta><custom-meta><meta-name>issue-article-count</meta-name><meta-value>8</meta-value></custom-meta><custom-meta><meta-name>issue-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-pricelist-year</meta-name><meta-value>2017</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-holder</meta-name><meta-value>American Aging Association</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-year</meta-name><meta-value>2017</meta-value></custom-meta><custom-meta><meta-name>article-contains-esm</meta-name><meta-value>No</meta-value></custom-meta><custom-meta><meta-name>article-numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-year</meta-name><meta-value>2017</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-month</meta-name><meta-value>11</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-day</meta-name><meta-value>9</meta-value></custom-meta><custom-meta><meta-name>article-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>volume-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>journal-product</meta-name><meta-value>NonStandardArchiveJournal</meta-value></custom-meta><custom-meta><meta-name>numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-grants-type</meta-name><meta-value>OpenChoice</meta-value></custom-meta><custom-meta><meta-name>metadata-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>abstract-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodypdf-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodyhtml-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bibliography-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>esm-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>online-first</meta-name><meta-value>false</meta-value></custom-meta><custom-meta><meta-name>pdf-file-reference</meta-name><meta-value>BodyRef/PDF/11357_2017_Article_2.pdf</meta-value></custom-meta><custom-meta><meta-name>target-type</meta-name><meta-value>OnlinePDF</meta-value></custom-meta><custom-meta><meta-name>issue-online-date-year</meta-name><meta-value>2017</meta-value></custom-meta><custom-meta><meta-name>issue-online-date-month</meta-name><meta-value>12</meta-value></custom-meta><custom-meta><meta-name>issue-online-date-day</meta-name><meta-value>27</meta-value></custom-meta><custom-meta><meta-name>issue-print-date-year</meta-name><meta-value>2017</meta-value></custom-meta><custom-meta><meta-name>issue-print-date-month</meta-name><meta-value>12</meta-value></custom-meta><custom-meta><meta-name>issue-print-date-day</meta-name><meta-value>27</meta-value></custom-meta><custom-meta><meta-name>issue-type</meta-name><meta-value>Combined</meta-value></custom-meta><custom-meta><meta-name>article-type</meta-name><meta-value>ReviewPaper</meta-value></custom-meta><custom-meta><meta-name>journal-subject-primary</meta-name><meta-value>Life Sciences</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Cell Biology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Geriatrics/Gerontology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Molecular Medicine</meta-value></custom-meta><custom-meta><meta-name>journal-subject-collection</meta-name><meta-value>SC3</meta-value></custom-meta><custom-meta><meta-name>open-access</meta-name><meta-value>true</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p><underline>Outline</underline><list list-type="order"><list-item><p>Basic Aspects of the Oxygen Paradox and Aging</p></list-item><list-item><p>The Role of Adaptive Homeostasis in the Oxygen Paradox</p></list-item><list-item><p>Heart and Circulatory System</p></list-item><list-item><p>Myocardial Ischemia and Reperfusion Injury</p></list-item><list-item><p>Lung Injury, Oxygen, and Acute Respiratory Distress Syndrome (ARDS)</p></list-item><list-item><p>Liver and The French Paradox</p></list-item><list-item><p>Cancer and carcinogenesis</p></list-item><list-item><p>Neurological Disorders and Stroke</p></list-item><list-item><p>Joints and Inflammation</p></list-item><list-item><p>Bone and Macrophages</p></list-item><list-item><p>Role of oxidation in Skin Photoaging</p></list-item><list-item><p>Cataracts</p></list-item><list-item><p>Age-related Macular Degeneration</p></list-item><list-item><p>Conclusions</p></list-item><list-item><p>Acknowledgements</p></list-item><list-item><p>References</p></list-item></list></p><sec id="Sec1"><title>Basic aspects of the Oxygen Paradox, the French Paradox, and ageing</title><p id="Par2">Cellular homeostasis is constantly challenged by reactive oxygen and nitrogen species which are either generated endogenously during cellular metabolism (e.g., by mitochondria, NADPH oxidases, and cytochrome P450 reductases) or originate from exogenous sources including drugs, xenobiotics metals, and radiation. Reactive oxygen and nitrogen species alter a wide variety of macromolecules including proteins, lipids, sugars, DNA, and RNA. Depending on the severity of oxidatively generated damage, newly oxidized molecules are repaired or are eliminated by dedicated degradation systems. When production or clearance of reactive oxygen and nitrogen species is overwhelming or when repair/degrading systems for damaged molecules are impaired, oxidative stress occurs. Excessive amounts of (unrepaired) oxidant-induced cellular damage are associated with cancer, ageing, and numerous other pathologies such as Parkinson and Alzheimer diseases (Beckman and Ames <xref ref-type="bibr" rid="CR24">1998</xref>; Stadtman and Berlett <xref ref-type="bibr" rid="CR365">1997</xref>). Thus, the first paradox to be considered in this discussion is the “Oxygen Paradox”—the discovery that although oxygen is essential for multicellular eukaryotic life forms, its very chemical/physical nature ensures its conversion into oxygen radicals, and other reactive oxygen species, that cause damage to cells, organs, and organisms. In human terms, it would be very hard to live without oxygen, but it is also extremely hard to live with oxygen (Fig. <xref rid="Fig1" ref-type="fig">1</xref>) (Davies and Ursini <xref ref-type="bibr" rid="CR80">1995</xref>).<fig id="Fig1"><label>Fig. 1</label><caption xml:lang="en"><p>Sources of oxidative stress, cellular defenses, and compromised stress resistance with ageing. Upper (green background) panel—young cells—cells must cope with both internal and external sources of oxidative stress. Extracellular sources include smoke and partial combustion products (of all forms), pollution, radiation, environmental toxicants, and various dietary constituents. One internal source of oxidative stress arises from mitochondrial electron transport and respiration. Electron “leakage” from the electron transport chain to molecular oxygen generates superoxide (O<sub>2</sub><sup>·−</sup>) which is either dismutated into hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) via the mitochondrial manganese superoxide (MnSOD) or the cytosolic copper-zinc superoxide (CuZnSOD). Additionally, if the superoxide is not removed and/or an accumulation of hydrogen peroxide (above homeostatic levels) occurs, the likelihood of hydroxyl radical (HO<sup>·</sup>) generation increases, with consequent protein, lipid, and even DNA damage. To combat these potential sources of damage, mitochondria rely upon detoxification enzymes, such as glutathione peroxidase (GPx) and proteolytic enzymes, such as the mitochondrial Lon protease, which can remove oxidized proteins. Another prominent internal source of oxidative stress are peroxisomes, which can generate O<sub>2</sub><sup>·−</sup>, H<sub>2</sub>O<sub>2</sub> (and, thus, HO<sup>·</sup>) as a consequence of fatty-acid metabolism. Fortunately, the O<sub>2</sub><sup>·−</sup> can be dismutated by CuZnSOD. And the H<sub>2</sub>O<sub>2</sub> can be removed by catalase which is in extremely high concentration inside peroxisomes. The endoplasmic reticulum also contributes to cellular levels of reactive oxygen species, due to H<sub>2</sub>O<sub>2</sub> generation from protein folding and the formation of O<sub>2</sub><sup>·−</sup> by membrane-bound NADPH oxidase (NOX) enzymes. An additional safety mechanism the cell relies upon is the 20S proteasome. During periods of oxidative stress, the 19S regulatory caps of the 26 proteasome are sequestered away by HSP70 and ECM29, increasing the available pool of ATP-independent 20S proteasomes. These free 20S proteasomes can degrade oxidized proteins, thus preventing their aggregation and cross-linking and providing a pool of (undamaged) amino acids for the synthesis of additional protective enzymes. Overall, a combination of protective cellular mechanisms minimizes damage accumulation and help to maintain cellular homeostasis (depicted by the green background). Thus, in young cells and organisms generally, only a small amount of damage occurs and most of that is repaired. The green balls inside the mitochondria represent small amounts of mildly oxidatively damaged proteins, as do the orange colored balls in the cytoplasm. In both mitochondria and cytoplasm, the yellow star-bursts indicate severely damaged, aggregated and often cross-linked proteins. Lower (light red background) panel—old cells—with age, gradual damage accumulation can lead to less-than-optimal defense systems. As a result, background inflammation and oxidative stress can increase from both external and internal sources (symbolized by the red background). Additionally, the internal generation of O<sub>2</sub><sup>·−</sup> and H<sub>2</sub>O<sub>2</sub> may increase, but the enzymatic defenses, such as the mitochondrial Lon protease or superoxide dismutase may decrease in clearance efficiency, further exacerbating damage accumulation. Similarly, the defense enzymes necessary to protect against peroxisome and endoplasmic reticulum O<sub>2</sub><sup>·−</sup>and H<sub>2</sub>O<sub>2</sub> generation may decrease in efficiency with age, together leading to a cellular imbalance toward oxidative damage. Finally, the 20S proteasome must deal with more and more oxidized proteins (indicated by a great increase in green and orange balls, and yellow star-bursts compared with the upper panel of young cells), many of which aggregate and cross-link before they can be degraded. This results in proteasome becoming irreversibly bound to ‘clumps’ of damaged proteins that it cannot degrade. Proteasomes bound to such oxidized protein aggregates (sometimes called lipofuscin) become inactive, thus further decreasing clearance of damaged proteins and enabling ever-increasing protein aggregation</p></caption><graphic specific-use="web" mime-subtype="GIF" xlink:href="MediaObjects/11357_2017_2_Fig1_HTML.gif" id="MO1"/></fig></p><p id="Par3">The French paradox was proposed in 1992 based on epidemiological data from the French population (Renaud and de Lorgeril <xref ref-type="bibr" rid="CR317">1992</xref>). Diets with high intakes of dietary cholesterol and saturated fat were found to coincide with low rates of coronary heart disease and low risk of cardiac mortality in the French populace. These findings were counterintuitive and were aptly dubbed the “French Paradox.” However, in-depth research has provided new evidence as to why the “French Paradox,” which seemingly is harmful, may actually promote the health and longevity of the French people. For example, the high consumption of wine and cheese, both of which are often viewed in a negative light, may actually be beneficial. Due to wine’s high concentration of resveratrol (Catalgol et al. <xref ref-type="bibr" rid="CR55">2012</xref>), and the high prevalence of spermidine in cheese (Eisenberg et al. <xref ref-type="bibr" rid="CR94">2016</xref>), the French diet may actually contribute to the positive effects of the French Paradox. Clearly, much of what underlies the French Paradox is, in turn, caused by the “Oxygen Paradox” wherein oxidative stress is seen as an unavoidable consequence of aerobic life (Davies and Ursini <xref ref-type="bibr" rid="CR80">1995</xref>) and a major contributor to the initiation and/or progression of many age-related human diseases.</p><p id="Par4">The goal of this review is to explore new viewpoints that may help to explain how basic aspects of the Oxygen Paradox are impacted by the diet and environment and, in turn, affect the etiology and progression of age-related human diseases.</p></sec><sec id="Sec2"><title>The role of adaptive homeostasis in the Oxygen Paradox</title><p id="Par5">The third (apparent) paradox to be considered in this review is the seemingly paradoxical observation that treatment with low doses of a substance that is toxic at high concentrations may actually induce transient adaptations that protect against a subsequent exposure to the same (or similar) toxin. Thankfully, we can now mechanistically explain this particular ostensible paradox as the phenomenon of “Adaptive Homeostasis” (Eisenberg et al. <xref ref-type="bibr" rid="CR94">2016</xref>; Davies <xref ref-type="bibr" rid="CR79">2016</xref>; Pomatto et al. <xref ref-type="bibr" rid="CR297">2017a</xref>; Lomeli et al. <xref ref-type="bibr" rid="CR232">2017</xref>; Pomatto and Davies <xref ref-type="bibr" rid="CR296">2017</xref>),;the non-damaging process by which an apparent toxicant can activate biological signal transduction pathways to increase expression of protective genes, by mechanisms that are completely different from those by which the same agent induces toxicity at high concentrations. Adaptive pathways allow cells and organisms to cope with transient environmental and internal perturbations. It is now clear that resistance to multiple forms of stress is not a static property of cells, tissues, or organisms. Indeed, multiple protective systems demonstrate great transient plasticity in response to very small changes in reactive oxygen species, such as the superoxide anion radical (O<sub>2</sub><sup>·–</sup>) and hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>). The term Adaptive Homeostasis describes this important cellular capability. Single or repeated exposures to mild stress at younger ages are beneficial against higher, more toxic oxidant levels, indicating that rescue systems are actively induced in the young (Eisenberg et al. <xref ref-type="bibr" rid="CR94">2016</xref>; Davies <xref ref-type="bibr" rid="CR79">2016</xref>; Pomatto et al. <xref ref-type="bibr" rid="CR297">2017a</xref>; Lomeli et al. <xref ref-type="bibr" rid="CR232">2017</xref>; Pomatto and Davies <xref ref-type="bibr" rid="CR296">2017</xref>). Adaptive Homeostasis has been defined as follows: “The transient expansion or contraction of the homeostatic range in response to exposure to sub-toxic, non-damaging, signaling molecules or events, or the removal or cessation of such molecules or events.” This definition allows us to predict and explain the transient expansion of the homeostatic range that occurs upon exposure to nanomolar, even picomolar, levels of agents that would only be damaging or toxic in the millimolar range. Since a wide variety of diets, environmental conditions, and human activities (including exercise, a pro-oxidant activity) involve both mild stresses and positive health benefits, there is real hope that new strategies relying on adaptive homeostatic effects could be used as palliative or preventive agents in human beings (Rattan and Le Bourg <xref ref-type="bibr" rid="CR313">2014</xref>).</p><p id="Par6">The importance of adaptive homeostasis, and its decline with age, can be seen in two studies conducted in the fruit fly <italic>Drosophila melanogaster</italic>. Proteasome, a protease involved in the degradation of both normal ubiquitinylated proteins and mutated or damaged proteins, regulates a vast number of cellular functions (Bonet-Costa et al. <xref ref-type="bibr" rid="CR35">2016</xref>; Johnston-Carey et al. <xref ref-type="bibr" rid="CR170">2015</xref>). Impaired proteasome function promoted several “old-age” phenotypes and markedly reduced the lifespan of flies (Tsakiri et al. <xref ref-type="bibr" rid="CR388">2013a</xref>, <xref ref-type="bibr" rid="CR389">b</xref>; Pomatto et al. <xref ref-type="bibr" rid="CR298">2017b</xref>). Proteasome expression is regulated by the NFE2-related factor 2 (Nrf2)/Ketch-likeECH-associated protein 1 (Keap1) signaling pathway. This pathway and its constituent components (i.e., the Nrf2 ortholog, cap’-n’-collar isoform-C (CncC), and the Keap1 and Maf proteins) are conserved in <italic>Drosophila</italic> and appear to engage in similar regulatory interactions as in vertebrates (Sykiotis and Bohmann <xref ref-type="bibr" rid="CR376">2008</xref>). The Nrf2 pathway works well in young flies, where it induces proteasome expression and increased oxidative stress resistance. This important mechanism of adaptive homeostasis is severely abrogated in old age. Interestingly, inducible activation of Nrf2 in transgenic flies upregulated basal proteasome expression and activity, independently of age and conferred resistance to proteotoxic stress. Prolonged Nrf2 overexpression, however, reduced longevity indicating that excessive activation of the proteostasis pathways can be detrimental (Fig. <xref rid="Fig2" ref-type="fig">2</xref>) (Tsakiri et al. <xref ref-type="bibr" rid="CR389">2013b</xref>).<fig id="Fig2"><label>Fig. 2</label><caption xml:lang="en"><p>Adaptive homeostasis and nrf2 dependent stress responses decline with age. During cellular homeostasis in young organisms and tissue, nuclear factor (erythroid-derived 2)-like 2 (Nrf2), the master stress-responsive transcriptional activator, is retained in the cytosol bound to the Keap1-Cul3 complex, which contains a ubiquitin E3 ligase. In the absence of stress in young cells (top left panel) Nrf2 is polyubiquitinylated, tagging it for degradation by the ATP-dependent 26S Proteasome, and preventing Nrf2 translocation into the nucleus. Concurrently, as the Nrf2 protein undergoes rapid turnover, the <italic>nrf2</italic> gene is constantly transcribed and translated, and de novo Nrf2 is bound to Keap1-Cul3 complexes, enabling cells to have a constant supply of Nrf2. At the same time, cells retain sizeable pools of both 20S and 26S forms of the Proteasome for (different forms of) protein clearance. During periods of oxidative stress in young cells (top right panel), Nrf2 is released from the Keap1-Cul3 complex and phosphorylated, and then translocated into the nucleus. Once in the nucleus, Nrf2 binds to the antioxidant response element (ARE), also called the electrophile response element (EpRE), leading to the transcriptional upregulation of stress responsive enzymes, including the 20S Proteasome. With age, however (bottom left panel), the ability to mitigate damage declines, resulting in an overall increase in baseline inflammation (symbolized by the pink background). In addition, the pool of available Proteasomes (both 20S and 26S) is diminished, as a certain percentage become inactive after binding to indigestible protein aggregates. The inability to clear away all cellular damage promotes the accumulation of protein aggregates, thus further diminishing the available pool of Proteasome. During periods of acute stress in aged cells (indicated by the darker pink background in the bottom right panel), cellular limitations of the stress-response system become evident, as binding of Nrf2 to ARE/EpRE sequences diminishes. Decreased binding efficiency of Nrf2 to ARE/EpRE sequences may be due to Nrf2 competitors such as c-Myc and Bach1. The net result is significantly decreased ability to rapidly upregulate target stress-responsive genes, further promoting protein aggregation, diminished proteostasis, and ineffective adaptive homeostasis</p></caption><graphic specific-use="web" mime-subtype="GIF" xlink:href="MediaObjects/11357_2017_2_Fig2_HTML.gif" id="MO2"/></fig></p><p id="Par7">Another cellular stress-responsive protein is the mitochondrial Lon protease. Lon is a major regulator of mitochondria physiology, regulating and chaperoning imported proteins into the mitochondria and degrading unfolded, oxidized, and non-assembled proteins. Acute stressors such as heat shock and oxidative stress lead to its up-regulation (Ngo et al. <xref ref-type="bibr" rid="CR268">2013</xref>; Pinti et al. <xref ref-type="bibr" rid="CR291">2010</xref>, <xref ref-type="bibr" rid="CR292">2011</xref>, <xref ref-type="bibr" rid="CR294">2016</xref>). However, prolonged oxidative stress can cause Lon down-regulation (Pinti et al. <xref ref-type="bibr" rid="CR293">2015</xref>). A new study by Pomatto et al. (Pomatto et al. <xref ref-type="bibr" rid="CR299">2017c</xref>) showed that young female fruit flies (but not males or old flies) were capable of H<sub>2</sub>O<sub>2</sub> stress adaptation and increased Lon expression, whereas only young males were capable of paraquat stress adaptation and adaptive increase in Lon expression. These results suggest both an age- and sex-dependent threshold for transient oxidative stress adaptation, including increased Lon expression, that is beneficial for survival of a short stress, but costly for longevity. Thus, the balance of positive and negative effects of adaptive homeostasis on fitness traits could vary. Further investigation is necessary to determine what conditions/treatments might ultimately lead to beneficial therapeutic interventions for humans.</p><p id="Par8">A novel family of peptides, encoded within the mtDNA, has been shown to normalize mitochondrial function and to prevent metabolic deterioration, vascular disease, diabetes, and neurodegeneration, namely the mitochondrial-derived peptides, humanin (Yen et al. <xref ref-type="bibr" rid="CR429">2013</xref>), MOTS-c (Lee et al. <xref ref-type="bibr" rid="CR221">2016a</xref>), and SHLPs (Cobb et al. <xref ref-type="bibr" rid="CR66">2016</xref>). These mito-hormones hold promise as both diagnostic and therapeutic agents in human disease and their role in the paradox is being studied.</p><sec id="Sec3"><title>The aged proteome and decline of adaptive homeostasis in ageing</title><p id="Par9">Dysregulation of protein homeostasis and accumulation of oxidatively modified proteins by reactive oxygen/nitrogen species and various processes related to the formation of advanced glycated/lipid peroxidation end products (AGEs and ALEs) are hallmarks of the ageing process in different organs and tissues across different species (Stadtman and Berlett <xref ref-type="bibr" rid="CR365">1997</xref>; Baraibar and Friguet <xref ref-type="bibr" rid="CR18">2013</xref>). In addition, cellular protein maintenance systems, such as the proteasome system, are often themselves affected during ageing and upon oxidative stress, losing effectiveness over time (Baraibar and Friguet <xref ref-type="bibr" rid="CR18">2013</xref>). Thus, the accumulation of altered proteins during ageing is due to both an increased production of modified proteins and a decreased efficacy of the mechanisms responsible for their removal (Petropoulos and Friguet <xref ref-type="bibr" rid="CR283">2006</xref>).</p><p id="Par10">Among the many types of oxidative protein modifications described, carbonylation is one of the most prominent. Protein carbonylation is irreversible and often leads to loss of function or gain of toxic function of the targeted proteins (Baraibar and Friguet <xref ref-type="bibr" rid="CR18">2013</xref>). However, the key question, whether protein carbonylation is directly involved in ageing and age-related diseases, remains unanswered. In recent years, different studies have provided evidence that the oxi-proteome (the build-up of carbonylated proteins) during ageing and age-related diseases is composed of only a limited group of proteins (Baraibar and Friguet <xref ref-type="bibr" rid="CR18">2013</xref>), indicating that not all proteins have the same susceptibility for oxidation. For example, the replication and differentiation capability of adult muscle stem cells (satellite cells) is compromised with age, contributing to the development of sarcopenia. However, the molecular events related to satellite cells dysfunction during ageing are not completely understood.</p></sec><sec id="Sec4"><title>Decline of adaptive homeostasis in mitochondria</title><p id="Par11">Recent evidence indicates that expression of the Lon protease may be regulated by pro-oxidants in a manner consistent with the removal of oxidatively modified proteins (Ngo et al. <xref ref-type="bibr" rid="CR268">2013</xref>). An alternative or additional mode by which Lon may be inactivated or activated in response to pro-oxidants is through its own modification. While free radicals have long been viewed as damaging species, it is now recognized that, by virtue of their reversible nature, certain oxidative modifications to proteins may serve to regulate their function(s).</p><p id="Par12">At the interface between the body and the environment, the skin is directly exposed to numerous chemical oxidants and other air pollutants, all of which are potent inducers of reactive oxygen/nitrogen species (Mancebo and Wang <xref ref-type="bibr" rid="CR242">2015</xref>; Valacchi et al. <xref ref-type="bibr" rid="CR395">2012</xref>). An in vitro model using a direct exposure device for studying the cellular effects of five VOCs (hexane, toluene, acetaldehyde, formaldehyde, and acetone) at doses mimicking low-dose chronic environmental exposure on skin keratinocytes and skin explants assessed Lon protease activation and degradation of oxidatively modified proteins induced by VOCs exposure. Exposure of cells or skin explants to VOCS induced free radical production that mediated apoptosis due to DNA damage, mitochondrial membrane potential collapse, lipid peroxidation, and proteasome and Lon protease inactivation in keratinocytes and in human skin explants.</p><p id="Par13">It is well known that proteasome dysfunction is a consequence of oxidative stress and that proteasome inhibition induces mitochondrial dysfunction (Livnat-Levanon et al. <xref ref-type="bibr" rid="CR229">2014</xref>). In keratinocytes, exposed to mild air pollutants, no induction of Lon expression was observed, suggesting that the damage was so great that VOC induced irreparable injuries which did not allow induction of cellular defenses. Another example assessing the consequence of chronic oxidative stress relies upon the Parkinson Disease mouse model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) intoxication. Bulteau et al. showed that Lon protease expression increased in the ventral mesencephalon of intoxicated animals, concomitantly with the appearance of oxidized proteins and dopaminergic cell loss. In addition, they reported that Lon protease is inactivated by oxidants and is not able to cope with the accumulation of oxidized proteins produced in the mitochondria. In this case, even induction of increased Lon expression is not sufficient to overcome the oxidative insult.</p><p id="Par14">Taken together, these data underscore the importance of adaptive homeostasis. It is increasingly apparent that pro-oxidants do not simply cause damage, but can regulate protein function in a reversible fashion. Thus, critical factors that shift the balance from non-damaging and reversible signaling, to oxidative stress and irreversible loss are major threats to normal function and healthy ageing.</p></sec></sec><sec id="Sec5"><title>Heart and circulatory system</title><p id="Par15">The term cardiovascular disease (CVD) actually encompasses an array of diseases including coronary artery disease, hypertension, congestive heart failure, and stroke. Atherosclerosis that begins early in life and progresses gradually is a major cause of cardiovascular disease (Madamanchi et al. <xref ref-type="bibr" rid="CR236">2005</xref>).</p><sec id="Sec6"><title>Atherosclerosis</title><p id="Par16">The development of atherosclerosis is a complex process, involving the interaction of a variety of cells within the vessel wall, including endothelial cells, trans-differentiated vascular smooth muscle cells, and monocytes/macrophages. These two later cell types are believed to play a pivotal role in the development of the disease, mainly through the accumulation of oxidatively modified low-density lipoproteins (oxLDL, a proatherogenic particle detected in the intima of the arterial wall), and the production of inflammatory mediators, cytokines, and extracellular matrix-degrading enzymes (Glass and Witztum <xref ref-type="bibr" rid="CR132">2001</xref>). If left unchecked, will eventually lead to the formation of a lipid core of advanced atherosclerotic plaques (Tabas <xref ref-type="bibr" rid="CR379">2005</xref>).</p><p id="Par17">Fortunately, ATP-binding cassette (ABC) transporters maintain cellular cholesterol homeostasis and protect arteries from atherosclerosis (Schmitz et al. <xref ref-type="bibr" rid="CR347">2006</xref>). High-density lipoproteins (HDLs), lipoproteins-containing apolipoproteinA1 (apoA1), are the principal lipoproteins that play a major role in RCT.</p><p id="Par18">HDL particles and their apoA1, recovered from human atheroma, are extensively oxidized by myeloperoxidase (MPO) and are non-functional (Huang et al. <xref ref-type="bibr" rid="CR162">2014</xref>). In vitro oxidation of either apoA1 or HDL particles by MPO impairs their cholesterol acceptor function. In addition, oxindolyl alanine (2-OH-Trp) moiety at Tryptophan72 (Trp72) of apoA1 is selectively oxidized by MPO, is markedly enriched within human atheroma, and is functionally inactive, including inhibition of the ABCA1-dependent cholesterol acceptor activity of apoA1. OxTrp72-apoA1 recovered from human atheroma or plasma is lipid poor, virtually devoid of cholesterol acceptor activity and demonstrates both a potent pro-inflammatory activity on endothelial cells and an impaired HDL biogenesis activity in vivo. Elevated levels of the MPO-oxidized apoA1 form, oxTrp72-apoA1, in subjects are thus associated with increased cardiovascular disease risk, and may serve for monitoring a pro-atherogenic process in the artery wall. Their studies also reveal MPO-catalyzed oxidation of apoA1 as a potential therapeutic target for the treatment and prevention of atherosclerotic heart disease.</p><p id="Par19">Among the antioxidant systems, thioredoxin-1 (Trx-1), a 12-kDa highly conserved protein, has recently been recognized as a critical protective system against oxidative stress. Interestingly, this protein decreases dramatically with risk factors (Forstermann <xref ref-type="bibr" rid="CR112">2008</xref>). The C-terminal truncated form made up of 1–80 or 1–84 N-terminal amino acids (Trx-80), both cleaved by two alpha-secretases (ADAM-10 and ADAM-17) at the cell surface, possesses a cytokine like activity (Pekkari and Holmgren <xref ref-type="bibr" rid="CR280">2004</xref>). Macrophages have been reported to cleave Trx-1 to yield Trx-80 (Bizzarri et al. <xref ref-type="bibr" rid="CR32">2005</xref>).</p><p id="Par20">In atherosclerosis, Trx-1 polarized macrophages to the M2 anti-inflammatory phenotype and protected the ApoE2.Ki mouse against atherosclerosis (El Hadri et al. <xref ref-type="bibr" rid="CR95">2012</xref>). Conversely, Trx-80, oriented macrophages toward the M1-pro-inflammatory phenotype and enhanced atherosclerosis in the same animal model (Mahmood et al. <xref ref-type="bibr" rid="CR240">2013</xref>), promotes pro-inflammatory macrophages of the M1 phenotype and enhances atherosclerosis. Trx-80 also exerts angiogenic and mitogenic effects (Couchie et al. <xref ref-type="bibr" rid="CR71">2017</xref>). In addition, isolated perfused hearts adapted to ischemia and reperfusion by short cycles of ischemia and reperfusion (I/R), the protection is apparently afforded by the enhanced induction of Trx-1 (Turoczi et al. <xref ref-type="bibr" rid="CR392">2003</xref>). Further studies conducted in animal models suggest that Trx-1 has many beneficial functions in the heart including a protective role in cardiac hypertrophy (Matsushima et al. <xref ref-type="bibr" rid="CR248">2011</xref>; Yamamoto et al. <xref ref-type="bibr" rid="CR421">2003</xref>).</p><p id="Par21">Endothelial and vascular smooth muscle cells (VSMC) are involved in the vascular ageing and play a major role in CVD through the endothelial dysfunction and VSMC transdifferentiation/calcification. The senescent phenotypes associated with Lamin A/C alterations can be due to mutations in the lamin-encoding gene LMNA resulting in familial lipodystrophy FPLD2 associated with early atherosclerosis (Bidault et al. <xref ref-type="bibr" rid="CR29">2013</xref>), or treatment with some anti-HIV antiretroviral drug (ART), such as protease inhibitors (PI) (Lefèvre et al. <xref ref-type="bibr" rid="CR223">2010</xref>). These treatments are associated with increased cardiovascular risk in ageing HIV-infected ART-controlled patients and alter the processing of prelamin-A to lamin-A resulting in the accumulation of farnesylated prelamin-A leading to cell senescence. By comparing the endothelial function and senescence in primary human coronary endothelial cells culture issued from an old and a young individual, old subjects accumulated prelamin-A and exhibited endothelial dysfunction, oxidative stress, inflammation, and senescence. Most PIs induced the accumulation of farnesylated prelamin-A, as a result of their ability to inhibit the enzyme involved in the processing of prelamin-A to lamin-A, ZMPSTE24 as well as endothelial dysfunction, oxidative stress, inflammation, and senescence. Importantly, statin treatment prevented all those alterations; other classes of ART molecules, such as maraviroc or dolutegravir, entry or integrase inhibitors, respectively, were either not affecting vessels or able to decrease inflammation and senescence.</p><p id="Par22">Overexpressing mutant LMNA in primary human VSMC culture or treating them with PIs increased prelamin-A and decreased ZMPSTE24. Similar results were obtained in fibroblasts from LMNA-mutated lipodystrophic patients and peripheral blood mononuclear cells from PI-treated-HIV-infected patients. These alterations positively correlated with oxidative stress, inflammation, senescence, and calcification. ZMPSTE24 silencing in native VSMCs recapitulated the mutant LMNA- and PI-induced accumulation of farnesylated prelamin-A, oxidative stress, inflammation, senescence, and calcification. The farnesylation inhibitors pravastatin and the farnesyl-transferase inhibitor, FTI-277, or the antioxidant N-acetyl cysteine, partly restored ZMPSTE24 expression, and concomitantly decreased oxidative stress, inflammation, senescence, and calcification of PI-treated VSCMs. Thus, ZMPSTE24 down-regulation, resulting from LMNA mutations or PI treatments, should be considered as a major contributor in VSMC dysfunctions in early atherosclerosis. Statin and antioxidants could be of therapeutic interest in that setting.</p><p id="Par23">VSMC change of phenotype (i.e., their transdifferentiaton) contributes to the pathogenesis of age-related CVD such as atherosclerosis and post-angioplasty restenosis. Cyclic AMP, the production and degradation of which are catalyzed by adenylyl cyclases (AC) and phosphodiesterases (PDE), respectively, plays a key role in modulating VSMC phenotype. Additionally, transdifferentiation of VSMCs into inflammatory/migratory cells in vitro depends on de novo expression of the transmembrane AC isoform 8 (Clement et al. <xref ref-type="bibr" rid="CR65">2006</xref>). The pathological VSMCs in human atherosclerosis lesions have high AC8 levels (Gueguen et al. <xref ref-type="bibr" rid="CR136">2010</xref>).</p></sec><sec id="Sec7"><title>Stroke</title><p id="Par24">Age is a well-documented prominent non-modifiable risk factor for stroke, with arterial stiffness as a major independent determinant of increasing systolic and pulse pressure and a tissue biomarker of cardiovascular risk factors. It is becoming increasingly clear that VSMC plasticity significantly contributes to arterial stiffening in ageing (Lacolley et al. <xref ref-type="bibr" rid="CR205">2012</xref>; Sehgel et al. <xref ref-type="bibr" rid="CR349">2015</xref>). The process of phenotypic switching requires a specific pattern of transcriptional factors, in particular the SRF and myocardin, and microRNA expression whose mechanisms are now beginning to emerge. Using the conditional SMC-inactivation of SRF gene mouse model, SRF controls pressure-induced myogenic tone and vasoconstriction in mesenteric arteries via VSMC phenotypic modulation linked to changes in contractile protein gene expression (Galmiche et al. <xref ref-type="bibr" rid="CR121">2013</xref>). SRF-related decreases in vasomotor tone and cell-matrix attachment increase arterial elasticity in large arteries. By contrast, in mice with inducible SRF overexpression, the in vitro contractile response was significantly increased in all arteries. Using the knock-out (KO) mouse model of intermediate filament genes such as desmin and vimentin, they have shown that a lower distensibility and an increase of arterial wall viscosity in desmin KO mice (Lacolley et al. <xref ref-type="bibr" rid="CR204">2001</xref>), and vimentin ablation results in decreased arterial pressure and increased carotid wall stiffness (Langlois et al. <xref ref-type="bibr" rid="CR211">2017</xref>). They observed that several endothelial markers are up-regulated and content of several components of basement membrane such as laminin, fibronectin, and perlecan is increased in vimentin KO mice, suggesting a role of endothelial cells in vascular stiffness.</p></sec><sec id="Sec8"><title>Congestive heart failure</title><p id="Par25">As stated above, CVD also encompasses congestive heart failure, a morbid disorder whose prevalence strongly increases with the ageing of the world population and the spread of Western dietary pattern. Despite continuous progress in the therapy of heart failure, which is mainly based on the use of β-blockers, neurohormonal antagonists, and diuretics, morbidity and mortality remain high for this disease and the economical and societal costs keep rising. One major issue that is poorly addressed in current heart failure therapy is the severely depressed bioenergetics functions in the failing heart. Indeed, the failing heart is characterized by deficient mitochondrial functions leading to a decrease in high-energy phosphate metabolites levels (ATP, phosphocreatine) and an increase in oxidative stress. Nicotinamide adenine dinucleotide (NAD+) is a major hydride-transfer coenzyme in the process of glucose and fatty acids oxidation and a major electron donor to the mitochondrial electron transport chain allowing the synthesis of ATP. NAD(H) is the sole precursor of NADP(H) which has a dual role, either acting as the final donor of electrons in oxygen radical detoxification systems (glutathione, thioredoxin, etc.) or participating in the generation of superoxide by NADPH oxidases in oxidative burst reactions.</p><p id="Par26">Myocardial NAD+ level decreases in the failing heart of many different mouse models of heart failure (Mericskay <xref ref-type="bibr" rid="CR255">2016</xref>). This decrease parallels the down-regulation of the major NAD+ salvage pathway mediated by the NAMPT enzyme in most forms of heart failure (Hsu et al. <xref ref-type="bibr" rid="CR160">2014</xref>). Supplementation of food with NAD precursors can markedly improve cardiac functions while preserving cardiac energy metabolism and allowing the cardiac cells to cope with pathological changes to the redox state. These findings (Pillai et al. <xref ref-type="bibr" rid="CR290">2005</xref>; Yamamoto et al. <xref ref-type="bibr" rid="CR422">2014</xref>; Lee et al. <xref ref-type="bibr" rid="CR222">2016b</xref>) suggest that maintaining NAD levels in the heart constitute a new therapeutic avenue for the treatment of heart failure, a syndrome strongly associated with ageing.</p><p id="Par27">To address the issue of heart tissue injury, a new approach based on cardiac tissue engineering for heart failure treatment has been developed. The principle of tissue engineering mainly relies upon the promotion of cells growth on a bio-inspired scaffold that mimics both physical and chemical properties of cardiac tissues (Kitsara et al. <xref ref-type="bibr" rid="CR179">2016</xref>). To develop a new generation of cell therapy products made of cellularized biomaterials, robust differentiation protocols were developed to generate contractile human cardiomyocytes derived from pluripotent stem cells (Joanne et al. <xref ref-type="bibr" rid="CR169">2016</xref>). Different biomaterials composed of nanofibers from extracellular matrix components were developed (i.e., collagen, hyaluronic acid) or natural polymers (i.e., fibrin, chitosan) mimicking the alveolar and fibrous structure of the myocardium (Joanne et al. <xref ref-type="bibr" rid="CR169">2016</xref>; Bellamy et al. <xref ref-type="bibr" rid="CR25">2015</xref>; Fiamingo et al. <xref ref-type="bibr" rid="CR106">2016</xref>). Moreover, these biocompatible and biodegradable biomaterials could be seeded with human cardiomyocytes, enabling the development of functional cardiac-like tissue. Finally, engraftments of these cellularized biomaterials on the surface of the heart demonstrate integration and functionality of engineered tissues in animals (Joanne et al. <xref ref-type="bibr" rid="CR169">2016</xref>). In conclusion, combining cardiac cells with the biomaterials to control both biological and physical-chemical environments of the cells allows the development of new cell therapy products for cardiovascular diseases.</p><p id="Par28">Based on previous reports of a decreased ability to activate the Nrf2 pathway in animal studies (Zhang et al. <xref ref-type="bibr" rid="CR434">2012</xref>), it was hypothesized that the ability to activate Nrf2 would decline in primary human cells with age. Primary human bronchial epithelial (HBE) cells were obtained from six different male, non-smoking subjects (three from age 28–29 and three from ages 67–69). Three comparisons were made by randomly pairing one young with one old into groups. Cells of low passage were treated with or without 2 μM sulforaphane for 12 h, and the mRNAs of Nrf2-regulated antioxidant (phase II) genes were measured. Unstimulated expression of GCLC, GCLM, HO1, and NQO1 genes was the same in the young and old HBE. In contrast, sulforaphane-induced phase II gene expression of the young HBE cells was significantly greater than that in the older cells supporting our hypothesis. Western blot analysis showed an increase in Nrf2 accumulation within 1 h in cell nucleus after stimulation with sulforaphane in both young and old cells, suggesting that the difference in response occurs in the nucleus. Bach-1 and c-Myc which are Nrf2 suppressors were subsequently quantified at baseline and after stimulation. The results mimic what has been observed in several previously reported studies of animal organs.</p></sec></sec><sec id="Sec9"><title>Myocardial ischemia and reperfusion injury</title><p id="Par29">The management of myocardial infarction has evolved dramatically over the last 30 years. In the 1980s, reperfusion therapies were developed, first with thrombolytics, and now with primary percutaneous coronary interventions. It is well accepted that acute reperfusion with angioplasty, thrombectomy, and stenting is the current state-of-the-art treatments. Early reperfusion therapy with percutaneous coronary interventions (stents and/or balloon angioplasty) and/or thrombolytic therapy has reduced the size of myocardial infarctions and improved survival. However, despite falling door-to-balloon times, mortality rates have plateaued. According to the American Heart Association, about 15% of patients who experience a myocardial infarction in any given year will die of it. While 30-day mortality rates still were reported to be 7.8 to 11.4% in some analyses (Mozaffarian et al. <xref ref-type="bibr" rid="CR260">2015</xref>). Nearly a quarter of older patients suffering a myocardial infarction will suffer congestive heart failure after 1 year. Therefore there is an unmet need to further reduce structural and functional damage to the heart following a myocardial infarction.</p><p id="Par30">One approach is to further reduce myocardial infarction size. It is well recognized that the size of the myocardial infarction is a major determinant of outcome (Boden et al. <xref ref-type="bibr" rid="CR33">2013</xref>; Turer et al. <xref ref-type="bibr" rid="CR391">2005</xref>). The desired goal is to decrease the myocardial infarction size above and beyond reperfusion, by reducing reperfusion injury. In this review, we will describe the four basic types of reperfusion injury, potential mechanisms of reperfusion injury, attempts to reduce reperfusion injury by scavenging or inhibiting the formation of ROS, and new targets related to reperfusion injury.</p><p id="Par31">In the early seconds to minutes of reperfusion, following a coronary artery occlusion, there is a burst of reactive oxygen species (Zweier et al. <xref ref-type="bibr" rid="CR436">1987</xref>). These reactive oxygen species include O<sub>2</sub><sup>·–</sup> and H<sub>2</sub>O<sub>2</sub> that may contribute to membrane damage, increase cell membrane permeability, disrupt ion channels, and allow for calcium overload to the cell.</p><p id="Par32">There are four basic types of reperfusion injury: reperfusion arrhythmias, stunned myocardium, microvascular obstruction (no-reflow phenomenon), and lethal myocardial cell injury (which means that cells that are viable at the end of the ischemic period die because of reperfusion). Reperfusion arrhythmias include ventricular arrhythmias such as ventricular premature beats, runs of ventricular tachycardia, and ventricular fibrillation that may occur very early after reperfusion. These arrhythmias are rarely a major clinical problem and are treated pharmacologically if needed and usually subside over time (Kloner et al. <xref ref-type="bibr" rid="CR191">2011</xref>).</p><sec id="Sec10"><title>Stunned myocardium</title><p id="Par33">Stunned myocardium refers to previously ischemic viable myocardium that has been salvaged by reperfusion, in which there is prolonged, but transient post-ischemic contractile dysfunction (Braunwald and Kloner <xref ref-type="bibr" rid="CR43">1982</xref>). Early experimental studies showed that a brief 15-min coronary artery occlusion followed by reperfusion did not kill myocardial cells; rather these cells showed functional abnormalities and subtle ultrastructural abnormalities that resolved in a few days (Heyndrickx et al. <xref ref-type="bibr" rid="CR155">1975</xref>; Kloner et al. <xref ref-type="bibr" rid="CR190">1983</xref>). During the coronary artery occlusion, a regional wall motion abnormality was demonstrated within the zone of ischemia; however, following reperfusion and despite the fact that the reperfused myocardium was viable, persistent ventricular wall motion abnormalities persisted for several days (Heyndrickx et al. <xref ref-type="bibr" rid="CR155">1975</xref>; Kloner et al. <xref ref-type="bibr" rid="CR190">1983</xref>). Hence, the myocardium behaved as if it were stunned. Using ultrasonic crystals implanted into the wall of the left ventricle to track percent segment shortening, Przyklenk et al. (Przyklenk and Kloner <xref ref-type="bibr" rid="CR301">1986</xref>) showed that superoxide dismutase and catalase, given prior to, during occlusion and during reperfusion, improved the recovery of the segment shortening within the stunned segment. This finding and those of the Bolli group (Bolli <xref ref-type="bibr" rid="CR34">1988</xref>) showed that the mechanism of stunned myocardium involved reactive oxygen species and that a potential therapy for stunned myocardium was oxygen radical scavengers. Another theory regarding stunning was that calcium overload into the cells, due to increased permeability and damage to membranes caused by reactive oxygen species, then desensitized the contractile apparatus to calcium, preventing normal myofilament function. We observed that in similar experimental models that the calcium channel blocker, nifedipine, also improved the function of stunned myocardium (Przyklenk et al. <xref ref-type="bibr" rid="CR303">1989</xref>).</p><p id="Par34">Stunned myocardium has been described in patients and includes the following: gradual return of regional function following thrombolytic therapy for acute myocardial infarction; prolonged left ventricular regional wall motion abnormalities in patients with unstable angina, persistent left ventricular regional wall motion abnormalities following exercise-induced ischemia, and prolonged but reversible left ventricular dysfunction following cardiac surgery (Patel et al. <xref ref-type="bibr" rid="CR278">1988</xref>). Stunned myocardium does respond to inotropic stimulation (Arnold et al. <xref ref-type="bibr" rid="CR11">1985</xref>). In the setting of post myocardial infarction, stunning or post cardiac surgery stunning where heart failure is an issue, inotropes are often used to hold the patient over until the stunning recovers. Because stunning does eventually resolve, by definition, it can usually be managed in the clinical setting using general measures such as inotropes.</p></sec><sec id="Sec11"><title>No-reflow phenomenon</title><p id="Par35">The no-reflow phenomenon is the inability to reperfuse regions of the myocardium after re-establishing patency of an occluded epicardial coronary artery. The usual cause is microvascular obstruction. Experimental studies showed that following release of a 90-min or longer coronary artery occlusion in the canine model of myocardial infarction that the markers of flow do not perfuse portions of the subendo-and mid-myocardium, despite the fact that the epicardial infarct artery is patent (Kloner et al. <xref ref-type="bibr" rid="CR189">1974</xref>). These zones of no-reflow are characterized by anatomic evidence of microvascular obstruction. Ultrastructural analysis within the zone of no-reflow revealed localized swelling and protrusions of the endothelium that appear to block the lumen. It was also observed the no-reflow phenomenon in other species including rabbit and rat with as little as 30 min of coronary artery occlusion followed by reperfusion. There is evidence that no-reflow is a true form of reperfusion injury. It was observed that size of the no-reflow zone expands over the first few hours after reperfusion of an epicardial coronary artery, suggesting worsening microvascular damage during the phase of reperfusion (Reffelmann and Kloner <xref ref-type="bibr" rid="CR315">2002</xref>). In other experimental studies, we observed that no-reflow correlates with worsened left ventricular remodeling during the chronic phase of infarction. Ventricles with no-reflow are likely to demonstrate more thinning and stretching of the infarct wall and left ventricular dilatation (Reffelmann et al. <xref ref-type="bibr" rid="CR316">2003</xref>). The most likely explanation for this is that no-reflow inhibits the efflux of cellular debris from the necrotic core and limits entrance of those humoral factors and cells that are important to the healing phase such as macrophages and fibroblasts. Studies by Przyklenk and Kloner showed that oxygen radicals may play a role in the microvascular damage associated with no-reflow. Upon administration of superoxide dismutase and catalase, given just prior to reperfusion after a 2-h proximal coronary artery occlusion, improved regional myocardial blood flow measured with radioactive microspheres in the endo-, mid-, and epicardial layers of the myocardium. In addition, superoxide dismutase and catalase improved the ultrastructural appearance of the microvessels (Przyklenk and Kloner <xref ref-type="bibr" rid="CR302">1989</xref>). Of note, these benefits of the oxygen free radical scavengers were independent of any effect on myocardial infarct size, since these drugs did not reduce infarct size in our models. Other experimental therapies that have reduced the no-reflow phenomenon in our myocardial infarct models include therapeutic hypothermia, when administered either early, during the phase of ischemia, in which it also reduces myocardial infarct size (Hale et al. <xref ref-type="bibr" rid="CR140">2003</xref>); or when administered late, after reperfusion has already been established, in which case it reduces the no-reflow zone but has no effect on myocardial infarct size (Hale et al. <xref ref-type="bibr" rid="CR141">2013</xref>). Finally we recently observed that the mitochondrial targeted peptide, elamipretide, which is known to reduce the generation of reactive oxygen species from the mitochondria during stress, reduced the size of the no-reflow zone for any given risk zone in a rabbit model of coronary artery occlusion (Kloner et al. <xref ref-type="bibr" rid="CR192">2012</xref>).</p><p id="Par36">No-reflow has been documented in patients following reperfusion of the epicardial infarct related arteries. Perfusion defects within the myocardium have been observed by contrast enhanced magnetic resonance imaging, echocardiographic contrast injections, and nuclear studies (Kloner <xref ref-type="bibr" rid="CR188">2011</xref>). In the catheterization laboratory, low TIMI grades, long TIMI frame counts, and reduced myocardial blush grades and slow resolution of ST elevation on the ECG are other findings consistent with no-reflow (Rezkalla et al. <xref ref-type="bibr" rid="CR319">2010</xref>). Patients who demonstrate no-reflow after myocardial infarction also demonstrate more adverse left ventricular remodeling including a more dilated ventricle (Kloner <xref ref-type="bibr" rid="CR188">2011</xref>), which parallels the findings described in the experimental literature. Patients who demonstrate no-reflow following a myocardial infarction have worse survival rates than patients without no-reflow and this observation is independent of infarct size. No-reflow in humans may differ somewhat from that described in the experimental models as it also can involve micro-emboli of atherosclerotic and embolic debris released downstream into the microvasculature following coronary balloon inflation and/or stent deployment. While there is no standardized therapy for treating no-reflow in the catheterization laboratory, some of the strategies that have been employed include adenosine, verapamil, nitroprusside, systemic anticoagulation and platelet 2B-3A receptor blockers, aspiration thrombectomy, and distal protection filters (Kloner <xref ref-type="bibr" rid="CR188">2011</xref>).</p></sec><sec id="Sec12"><title>Lethal myocardial cell injury</title><p id="Par37">Lethal cell injury is the most important, but probably the most controversial, of the forms of reperfusion injury. Here, cells that are reversibly injured at the end of a period of ischemia become irreversibly injured by the act of reperfusion. Presumably reactive oxygen species generation, coupled with calcium overload lead to additional cellular damage at the time of reperfusion. If a drug or other therapy is administered at the time of reperfusion and the size of the myocardial infarction is reduced compared to reperfusion alone, then this finding would support the concept that reperfusion injury exists and that the adjunctive therapy was working by limiting reperfusion injury. While some studies suggest that drugs given at reperfusion can limit the size of a myocardial infarction (Yellon and Hausenloy <xref ref-type="bibr" rid="CR428">2007</xref>), other studies show contrary results. These studies have demonstrated that for an adjunctive therapy to limit myocardial infarct size, the drug or therapy had to be on-board during a substantial phase of ischemia or given before ischemia. Thus therapies such as hypothermia (Hale et al. <xref ref-type="bibr" rid="CR140">2003</xref>, <xref ref-type="bibr" rid="CR141">2013</xref>), remote ischemic conditioning (Przyklenk et al. <xref ref-type="bibr" rid="CR304">1993</xref>), calcium channel blockers (Lo et al. <xref ref-type="bibr" rid="CR230">1985</xref>), and beta blockers (Rasmussen et al. <xref ref-type="bibr" rid="CR312">1977</xref>) which reduced infarct size in some of these models needed to be present prior to or during the ischemic insult. Given only after reperfusion, they did not work. Hence, postconditioning did not reduce myocardial infarction size in these models (Dow and Kloner <xref ref-type="bibr" rid="CR89">2007</xref>). Similarly, superoxide dismutase and catalase, given at reperfusion, failed to reduce myocardial infarct size, but did reduce microvascular obstruction (Przyklenk and Kloner <xref ref-type="bibr" rid="CR302">1989</xref>). In general, clinical trials reducing infarct size by giving agents at reperfusion have been disappointing (Gerczuk and Kloner <xref ref-type="bibr" rid="CR128">2012</xref>). Recent clinical trials involving postconditioning and mitochondrial permeability pore blocking agents (cyclosporine) have been negative (Kloner et al. <xref ref-type="bibr" rid="CR193">2017</xref>). An older study, utilizing superoxide dismutase was negative (Flaherty et al. <xref ref-type="bibr" rid="CR110">1994</xref>). Some studies showing certain adjunctive agents when given during ischemia, but prior to reperfusion, reduced infarct size in clinical trials including adenosine, remote ischemic conditioning, successful hypothermia in patients with anterior infarcts, hyperoxemia, beta blockade, and others.</p><p id="Par38">In summary, there are several forms of reperfusion injury. Stunned myocardium and the no-reflow phenomenon are well documented in both preclinical experimental models and in patients. Therapies are available for both, but there is a clinical need to better develop systematic therapy for no-reflow. Such therapy has the potential to enhance healing after a myocardial infarction, reduce adverse left ventricular remodeling, reduce heart failure, and improve survival. The concept of lethal myocardial cell injury, due to reperfusion, remains somewhat controversial in our opinion. However, since there is time to administer agents to patients with infarcts prior to reperfusion therapy in the ambulance or emergency room, there is still the potential to reduce myocardial infarct size above and beyond reperfusion.</p></sec></sec><sec id="Sec13"><title>Lung injury, oxygen, and acute respiratory distress syndrome</title><p id="Par39">Oxygen and its potential for toxicity has compounded the management of acute lung injury and the acute respiratory distress syndrome (ARDS). Though there are multiple causes for ARDS, the ultimate insult is an injury to the endothelial barrier to the vasculature and leakage of protein-rich fluid into the alveoli. This results in severe hypoxemia and acute respiratory failure. Clinical studies over the past four decades have shown slow progress in the management of ARDS.</p><p id="Par40">In the 1970s, high fraction of inspired oxygen (FIO<sub>2</sub>), volume ventilation, and positive end expiratory pressure allowed for some improvement in maintaining normoxemia (Petty and Ashbaugh <xref ref-type="bibr" rid="CR284">1971</xref>). The addition of larger tidal volumes (10–15 cm<sup>3</sup>/kg), in the 1980s and early 1990s, became the standard of care in the ICU management. However, this approach was accompanied by severe life-threatening complications of barotrauma while attempting to find a ”safe” FIO<sub>2</sub> (Pierson <xref ref-type="bibr" rid="CR288">2013</xref>). Failure to lower FIO<sub>2</sub> usually resulted in worsening lung injury and increased mortality. At the turn of the twenty-first century, the ARDS network confirmed the value of lung protective ventilation with lower tidal volumes (5–6 cm<sup>3</sup>/kg) and airway pressures than in prior decades, resulting in improved survival (Brower et al. <xref ref-type="bibr" rid="CR45">2000</xref>).</p><p id="Par41">The avoidance of oxygen toxicity led to reliance on higher levels of positive end-expiratory pressure (PEEP). The reduction in tidal volume continues to persist and remains the oxygen paradox with some boundaries for clinicians but no simple solutions. Though numerous medications including steroids, non-steroidal anti-inflammatory agents, surfactants, and nitrous oxide have been tested. There is no approved medication for ARDS. The next area of study is moving from barotrauma to biotrauma. The one new area of drug research involves stabilizing the endothelial injury with interferon-β (IFN-β) (Traumakine) (Bellingan et al. <xref ref-type="bibr" rid="CR26">2014</xref>). The intravenous infusion stabilizes the injury by replacing the loss of CD 73 (5′Nucleatidase). Currently it is in stage 3 clinical trials in Europe and Japan and awaiting final approval.</p></sec><sec id="Sec14"><title>Liver and the French Paradox</title><p id="Par42">The liver plays a crucial role in overall human health and is necessary for proper immune function and lipid and carbohydrate metabolism (Rouiller <xref ref-type="bibr" rid="CR330">2013</xref>). Loss in hepatic homeostasis can result in debilitating conditions, one of the most prevalent being nonalcoholic fatty liver disease (NAFLD). NAFLD encompasses a broad spectrum of pathological conditions, ranging from steatosis at the early stages, to nonalcoholic steatohepatitis (NASH) and cirrhosis as the disease progresses. The early stages of the disease are characterized by the accumulation of triglycerides (TAG) in over 5% of hepatic cells, resulting in not only ectopic fat accumulation, but the negative repercussion of low-grade chronic inflammation resulting in tissue normally not accustomed to lipid accumulation (Fabbrini et al. <xref ref-type="bibr" rid="CR102">2010</xref>). Eventually, if not corrected, NAFLD can lead to liver failure (Musso et al. <xref ref-type="bibr" rid="CR262">2011</xref>) and/or hepatocellular carcinoma (Marrero et al. <xref ref-type="bibr" rid="CR244">2002</xref>).</p><p id="Par43">Currently, in the USA, over 30% of adults will develop NAFLD, with this percentage predicted to rise with age (Browning et al. <xref ref-type="bibr" rid="CR47">2004</xref>). The increase in disease prevalence is largely attributed to excess caloric consumption, largely resulting from calorie-dense westernized diets. In turn, excess caloric intake not only promotes NAFLD, but loss in blood glucose regulation. Hence, it is of little surprise that the rise in NAFLD coincides with the increasing development of the metabolic syndrome, which is a generalized term for metabolic abnormalities, including increased abdominal fat, insulin resistance, and high blood pressure and blood triglycerides (Alberti et al. <xref ref-type="bibr" rid="CR4">2005</xref>). NAFLD stems from hepatic TAG generation exceeding the rate of hepatic TAG catabolism (Birkenfeld and Shulman <xref ref-type="bibr" rid="CR30">2014</xref>). Indeed, as early as 3 days following consumption of high fat-diets can induce hepatic insulin resistance in mice and rats (Samuel et al. <xref ref-type="bibr" rid="CR338">2004</xref>). Thus, NAFLD has been aptly coined as the hepatic manifestation of the metabolic syndrome (Lebovics and Rubin <xref ref-type="bibr" rid="CR218">2011</xref>).</p><p id="Par44">Unless corrected, metabolic complications can increase the risk of developing type II diabetes mellitus (T2DM), predominantly characterized by loss in insulin sensitivity (insulin resistance), and is a disease strongly associated with NAFLD. Moreover, the prevalence of individuals with T2DM and NAFLD is almost double the amount found in age-matched healthy controls, ranging from 50 to 75% (Targher et al. <xref ref-type="bibr" rid="CR382">2007</xref>). Consequently, these individuals are at a greater risk for developing more advanced forms of NAFLD, and ultimately, increased risk of mortality (Ong et al. <xref ref-type="bibr" rid="CR273">2008</xref>).</p><p id="Par45">Paradoxically, the French diet, which is primarily known for its rich diet (i.e., foods high in saturated fats), which are known contributors of chronic conditions, including NAFLD and coronary artery disease, yet strikingly shows a relatively low prevalence in the French population (Gambini et al. <xref ref-type="bibr" rid="CR122">2015</xref>). This has been attributed to the relatively high consumption of red wine, characterized for its highly beneficial components, including polyphenols, which is the staple drink in the French diet. One of the most well-characterized components of red wine is resveratrol and has been linked to numerous beneficial health improvements (Yang and Lim <xref ref-type="bibr" rid="CR423">2014</xref>). Indeed, studies in mice fed a high fat diet supplemented with red wine showed improved glucose tolerance, insulin sensitivity, and decreased hepatic steatosis. Moreover, when the same animals were fed the “waste” product of the wine extraction, pomace, caused the greatest improvements in these markers (Rosenzweig et al. <xref ref-type="bibr" rid="CR326">2017</xref>). However, it is important to note that excess alcohol consumption can have detrimental effects, and individuals should practice moderation in the extent and type of alcohol that they consume.</p></sec><sec id="Sec15"><title>Cancer and carcinogenesis</title><p id="Par46">Among the main non-communicable diseases, cancer represents the leading cause of death worldwide, with approximately 8.2 million deaths and 14 million new cases in 2012 (Stewart and Wild <xref ref-type="bibr" rid="CR369">2014</xref>). Western populations are the most affected, especially in France and in the USA, with an age-standardized rate for all cancers higher than 300 cancers per 100,000 people in 2012 (Ferlay et al. <xref ref-type="bibr" rid="CR105">2015</xref>). When diagnosed, several therapies such as chemotherapy, radiation therapy, or surgery (or multiple forms of combination therapies) are used to treat cancer, depending on type, localization, and grade. In addition, patients’ diet and physical activity levels are known to modulate the efficiency of these anticancer treatments, but the molecular mechanisms remain unknown (Friedenreich et al. <xref ref-type="bibr" rid="CR118">2010</xref>; Davies et al. <xref ref-type="bibr" rid="CR81">2011</xref>). Oxidative stress is a key factor in both carcinogenesis and response to anticancer therapies, increasing the interest in reactive oxygen species-targeted therapies (Gorrini et al. <xref ref-type="bibr" rid="CR133">2013</xref>; Gentric et al. <xref ref-type="bibr" rid="CR127">2017</xref>; Batista et al. <xref ref-type="bibr" rid="CR20">2013</xref>; Costa et al. <xref ref-type="bibr" rid="CR70">2014</xref>). Among them, physical activity and antioxidant supplementation have progressively become recognized as key actors in preventing cancer development (Gueritat et al. <xref ref-type="bibr" rid="CR137">2014</xref>; Rebillard et al. <xref ref-type="bibr" rid="CR314">2013</xref>). We address new insights on the controversial role of reactive oxygen species in carcinogenesis and in responses to chemotherapy and/or adjuvant therapies. Moreover, we elaborate on the benefits of individualizing the treatment according to the tumor redox status.</p><sec id="Sec16"><title>The double face of reactive oxygen species in cancer</title><p id="Par47">Altered redox balance is an important hallmark of cancer. In 2009, Luo et al. added on the list of common cancer characteristics a new set of hallmarks called “Stress phenotype of cancer”. Among these are DNA damage, mitotic stress, metabolic stress, and oxidative stress, which are all sensitive to reactive oxygen species-mediated signaling (Luo et al. <xref ref-type="bibr" rid="CR235">2009</xref>). The levels of oxidatively damaged DNA (i.e., 8-oxo-7,8-dihydroguanine (8-oxoGua)), lipid peroxidation adducts [i.e., 4-hydroxy-2-nonenal (4-HNE) and malondialdehyde (MDA)] and/or protein carbonyls increase in blood samples, urine excretion, and tumor tissue of patients with breast, colorectal, lung, prostate, esophageal, and thyroid cancer (Sheridan et al. <xref ref-type="bibr" rid="CR355">2009</xref>; Crohns et al. <xref ref-type="bibr" rid="CR72">2009</xref>; Lagadu et al. <xref ref-type="bibr" rid="CR208">2010</xref>; Young et al. <xref ref-type="bibr" rid="CR431">2010</xref>; Kosova et al. <xref ref-type="bibr" rid="CR196">2014</xref>). Some studies also reported that the levels of oxidatively induced damage correlates with poorer survival or even with more advanced stages of the disease (Crohns et al. <xref ref-type="bibr" rid="CR72">2009</xref>; Dziaman et al. <xref ref-type="bibr" rid="CR92">2014</xref>). Accordingly, cancerous tissues have been found to produce elevated levels of H<sub>2</sub>O<sub>2</sub>, compared to adjacent normal tissues (Szatrowski and Nathan <xref ref-type="bibr" rid="CR378">1991</xref>). In the same way, polymorphisms in antioxidant genes are linked to increased cancer incidence (Freriksen et al. <xref ref-type="bibr" rid="CR117">2014</xref>). Finally, resistance to reactive oxygen species-producing chemotherapeutic agents is directly proportional to the cellular antioxidant capacity of the patients (Ramanathan et al. <xref ref-type="bibr" rid="CR310">2005</xref>).</p><p id="Par48">Reactive oxygen and nitrogen species, mainly produced by xanthine oxidase (XO), NADPH oxidases (NOX), nitric oxide synthase (NOS), and inducible nitric oxide synthase (iNOS) and mitochondria in cancer cells (Huang et al. <xref ref-type="bibr" rid="CR163">2015</xref>; Roy et al. <xref ref-type="bibr" rid="CR331">2015</xref>; Panieri and Santoro <xref ref-type="bibr" rid="CR277">2016</xref>), play a dual role in cancer, depending on the levels generated within the cell or in the microenvironment. Reactive oxygen species, particularly the hydroxyl radical (·OH) induce DNA mutations that might lead to tumor initiation and promotion by targeting tumor suppressor and pro-oncogenic genes (Higinbotham et al. <xref ref-type="bibr" rid="CR156">1992</xref>). Together, oxidatively generated DNA damage, coupled with a defective repair system, are widely accepted as important mutagenic factors involved in carcinogenesis (Loft and Poulsen <xref ref-type="bibr" rid="CR231">1996</xref>). The sustained presence of reactive oxygen species is associated with the development of metabolic perturbations that provide cancer cells with amino acids, lipids, and nucleotides to further boost their uncontrolled proliferation (Sainz et al. <xref ref-type="bibr" rid="CR335">2012</xref>). It is important to note, the amounts of intracellular reactive oxygen species are well controlled in cancer cells, depending on the stage: low-to-moderate reactive oxygen species levels are produced during malignancy transformation (Bostwick et al. <xref ref-type="bibr" rid="CR38">2000</xref>; Cullen et al. <xref ref-type="bibr" rid="CR74">2003</xref>; Sander et al. <xref ref-type="bibr" rid="CR340">2003</xref>). Yet, upon cancer progression, reactive oxygen species production is limited, protecting malignant cells from cell death (Sander et al. <xref ref-type="bibr" rid="CR340">2003</xref>; Durak et al. <xref ref-type="bibr" rid="CR91">1993</xref>; Portakal et al. <xref ref-type="bibr" rid="CR300">2000</xref>; Janssen et al. <xref ref-type="bibr" rid="CR168">2000</xref>). This redox harmony between antioxidant and pro-oxidant species is the main secret behind cancer progression. The type of tumor, the context of tumor’s microenvironment, and the nature of stimuli will determine if reactive oxygen species will shift the balance toward a pro-survival or pro-death response (Gentric et al. <xref ref-type="bibr" rid="CR127">2017</xref>; Costa et al. <xref ref-type="bibr" rid="CR70">2014</xref>).</p></sec><sec id="Sec17"><title>Chronic oxidative stress improves responses to anticancer treatment: underlying mechanisms identified in aggressive breast cancer and ovarian carcinomas</title><p id="Par49">Women patients affected by triple-negative breast cancers and ovarian high-grade serous carcinomas, the most aggressive form of breast and ovarian cancers, are generally treated with platinum- or taxane-based chemotherapy (e.g., cisplatin, paclitaxel), two powerful generators of both reactive oxygen species and consequent DNA damage (Alexandre et al. <xref ref-type="bibr" rid="CR6">2007</xref>). Interestingly, while chronic oxidative stress increases tumor growth and spread, recent studies have demonstrated that high basal reactive oxygen species levels in breast and ovarian adenocarcinoma cells also improve response to reactive oxygen species-producing chemotherapy (Gruosso et al. <xref ref-type="bibr" rid="CR135">2016</xref>; Mateescu et al. <xref ref-type="bibr" rid="CR247">2011</xref>). These beneficial effects are mediated by increased cancer cell apoptosis (Ramanathan et al. <xref ref-type="bibr" rid="CR310">2005</xref>; Mateescu et al. <xref ref-type="bibr" rid="CR247">2011</xref>; Batista et al. <xref ref-type="bibr" rid="CR21">2016</xref>), modulation of autophagy (Lefort et al. <xref ref-type="bibr" rid="CR224">2014</xref>), regulation of MEK pathway (Gruosso et al. <xref ref-type="bibr" rid="CR134">2015</xref>), and DNA damage response (Gruosso et al. <xref ref-type="bibr" rid="CR135">2016</xref>).</p><p id="Par50">In the last years, Mechta-Grigoriou’s research group identified the microRNA miR-200 family as a new molecular player linking chronic oxidative stress and chemosensitivity (Mateescu et al. <xref ref-type="bibr" rid="CR247">2011</xref>; Batista et al. <xref ref-type="bibr" rid="CR21">2016</xref>). Many adaptive mechanisms that modulate gene expression are activated in response to oxidative stress, including the p38α mitogen-activated protein kinase (MAPK) family, recognized to suppress tumorigenesis by blocking proliferation or promoting apoptosis (Hui et al. <xref ref-type="bibr" rid="CR164">2007</xref>; Wagner and Nebreda <xref ref-type="bibr" rid="CR408">2009</xref>). Interestingly, Mateescu and colleagues showed that the acute oxidative stress increases miR-200 family expression (miR-141 and miR-200a) in non-transformed cells, thus inhibiting p38α activity and promoting malignancy (Mateescu et al. <xref ref-type="bibr" rid="CR247">2011</xref>). However, while overexpression of miR-200a expression decreases p38α/MAPK14 protein in ovarian adenocarcinomas and promotes tumorigenesis, it enhances tumor cell death and slows tumor growth under treatment with paclitaxel (Taxane family group) (Mateescu et al. <xref ref-type="bibr" rid="CR247">2011</xref>). These observations demonstrate the tight relationship between miR-200 family members, oxidative stress, and cell apoptosis that has been validated by many other studies (Batista et al. <xref ref-type="bibr" rid="CR21">2016</xref>; Magenta et al. <xref ref-type="bibr" rid="CR237">2011</xref>; Xiao et al. <xref ref-type="bibr" rid="CR418">2015</xref>). It has been recently confirmed that miR-200c and miR-141 sensitize ovarian cancer cells to paclitaxel, but confer resistance to carboplatin (Brozovic et al. <xref ref-type="bibr" rid="CR48">2015</xref>). Interestingly, paclitaxel is a reactive oxygen species-producing chemotherapeutic agent and its efficacy has been directly linked to antioxidant defenses detected in patient blood (Ramanathan et al. <xref ref-type="bibr" rid="CR310">2005</xref>). Taken as a whole, these works emphasize the crosstalk between intracellular reactive oxygen species levels in tumors and levels of antioxidant defenses in response to reactive oxygen species-producing therapies, such as paclitaxel.</p><p id="Par51">More recently, Mechta-Grigoriou’s research group identified the histone variant H2AX, a key component in DNA repair, as being degraded by chemotherapy in Triple-Negative (TN) breast cancer patients (Gruosso et al. <xref ref-type="bibr" rid="CR135">2016</xref>). Importantly, H2AX decrease is a marker of chemotherapy efficiency. This study newly demonstrates that chronic oxidative stress, due to JunD−/Nrf2-deficiency, promotes degradation of H2AX by the E3 ubiquitin ligase RNF168. Gruosso and colleagues reported that cycles of chemotherapy (Adryamicin/Cyclophosphamide and Taxanes) given to TN breast cancer patients drives an Nrf2-antioxidant response. The extent of this antioxidant response in patients is linked to H2AX maintenance and resistance to chemotherapy. In tumor cells with low Nrf2-antioxidant response after treatment, the levels of reactive oxygen species remain high, H2AX is efficiently degraded, further reducing repair of DNA damage induced by the drug, tumor cell apoptosis is subsequently increased, and patient survival improved (Gruosso et al. <xref ref-type="bibr" rid="CR135">2016</xref>).</p></sec><sec id="Sec18"><title>Physical exercise and antioxidant supplementation to target reactive oxygen species in tumor: the need to individualize according to cancer grade</title><p id="Par52">During the last decade, studies investigating the impact of physical activity (PA) on cancer have increased exponentially giving birth to a new field named “exercise-oncology.” Mainly motivated by the evidence that PA could decrease cancer incidence, with a linear dose-response relationship in breast and colon cancer (Ballard-Barbash et al. <xref ref-type="bibr" rid="CR17">2012</xref>). Emerging data from breast, colon, and prostate cancer indicate that physically active patients exhibited less recurrence and mortality, highlighting a possible role for PA in the reduction of tumor growth (Meyerhardt et al. <xref ref-type="bibr" rid="CR256">2006</xref>; Friedenreich et al. <xref ref-type="bibr" rid="CR119">2016</xref>).</p><p id="Par53">The ability of exercise to mimic an antioxidant response has been suggested as a mechanism to counteract the role of reactive oxygen species in tumor growth (de Sousa et al. <xref ref-type="bibr" rid="CR83">2016</xref>). In a murine model of low-grade prostate cancer, Gueritat and colleagues demonstrated that regular physical training reduced prostate tumor growth (Gueritat et al. <xref ref-type="bibr" rid="CR137">2014</xref>). Although intratumoral protein carbonyls and lipid peroxidation breakdown products (i.e., 4-HNE) were unaffected, the levels of oxidatively generated DNA damage (i.e., 8-oxoGua) were significantly reduced by physical activity. These events were probably due to a decrease in intracellular reactive oxygen species in tumor, as the activation of the redox-sensitive kinase ERK1/2 was also attenuated. Accordingly, since ERK1/2 plays an important role in promoting tumor growth, its inhibition by exercise was positively reverberated on the rate of tumor cell proliferation (Gueritat et al. <xref ref-type="bibr" rid="CR137">2014</xref>).</p><p id="Par54">Based on the idea that exercise training acts as an antioxidant in tumors (Gueritat et al. <xref ref-type="bibr" rid="CR137">2014</xref>), exogenous antioxidants may induce similar effects and, therefore, could substitute physical exercise in advanced stages of cancer, when its use is not tolerated by the patient. Nutritional support, including antioxidant supplementation, is generally used to reduce the adverse side effects of anticancer therapies, like muscle wasting, mucositis, and fibrosis (Fig. <xref rid="Fig3" ref-type="fig">3</xref>) (Borek <xref ref-type="bibr" rid="CR36">2004</xref>).<fig id="Fig3"><label>Fig. 3</label><caption xml:lang="en"><p>Dual effects of antioxidant supplementation in cancer initiation and development. A combination of preclinical and clinical data provide support for the concept that intervention with nutritional antioxidants might be beneficial at early stages of cancer, but harmful in advanced stages. Early stages of cancer are associated with a decrease in antioxidant response contributing to increased reactive oxygen species (ROS) and consequent oxidative damage with malignant transformation. In this situation, supplementation with oral antioxidants might impede the pro-cancerous oxidant actions. During the progression of cancer, malignant cells enhance their metabolic activity to meet their increasing energetic needs, resulting in a higher generation of ROS. To subsist in such condition, cancerous cells activate signaling pathways to increase the intracellular pool of antioxidant systems and protect themselves against excessive oxidative damage. Consequently, in late stages of cancer, supplementation with antioxidants could actually strengthen tumor protection and help malignant growths avoid cell death</p></caption><graphic specific-use="web" mime-subtype="GIF" xlink:href="MediaObjects/11357_2017_2_Fig3_HTML.gif" id="MO3"/></fig></p><p id="Par55">However, recent preclinical and clinical findings showed antioxidant treatment for aggressive cancers was detrimental. The Swedish team of Martin Bergo demonstrated that vitamin E or N-acetylcysteine (NAC) reduced survival and accelerated lung cancer progression in mice (Sayin et al. <xref ref-type="bibr" rid="CR343">2014</xref>) and enhanced malignant melanoma metastasis to lymph nodes and lungs in mice with <italic>Braf</italic> and <italic>Pten</italic> mutations (Le Gal et al. <xref ref-type="bibr" rid="CR217">2015</xref>). Similarly, Piskounova et al. showed NAC increased the number of melanoma cells in blood and metastatic burden in NSG mice bearing aggressive melanoma xenografts from patients (Piskounova et al. <xref ref-type="bibr" rid="CR295">2015</xref>). Consistent with these findings, Assi and colleagues found that supplementation with an antioxidant mixture containing vitamins, oligoelements, and polyphenols reduced survival and enhanced C26 colon tumor growth in cachectic mice (Assi et al. <xref ref-type="bibr" rid="CR12">2016</xref>).</p><p id="Par56">On the contrary, studies using a low grade cancer model, antioxidant supplementation prevents tumorigenesis. Indeed, Gueritat and colleagues observed that natural antioxidants reduced the volume and delayed the growth of low-grade AT-1 prostate adenocarcinoma in rats (Gueritat et al. <xref ref-type="bibr" rid="CR137">2014</xref>). Similar findings occurred in mice bearing differentiated breast MCF-7 tumor (Liao et al. <xref ref-type="bibr" rid="CR228">1995</xref>) or Dalton’s lymphoma ascites (Sharma and Vinayak <xref ref-type="bibr" rid="CR353">2013</xref>). Clinically, histological studies found a decrease in the expression/activity of antioxidant enzymes in precancerous tissues (Bostwick et al. <xref ref-type="bibr" rid="CR38">2000</xref>; Cullen et al. <xref ref-type="bibr" rid="CR74">2003</xref>; Sander et al. <xref ref-type="bibr" rid="CR340">2003</xref>). In contrast, advanced grades of cancer showed increased expression/activity of antioxidant enzymes in tumor tissues (Sander et al. <xref ref-type="bibr" rid="CR340">2003</xref>; Durak et al. <xref ref-type="bibr" rid="CR91">1993</xref>; Portakal et al. <xref ref-type="bibr" rid="CR300">2000</xref>; Strzelczyk et al. <xref ref-type="bibr" rid="CR370">2012</xref>). The combination of preclinical and clinical data let us suppose that interventions with antioxidants could be plausible at early stages of cancer, but harmful in advanced stages.</p></sec><sec id="Sec19"><title>Oxidatively generated DNA damage: potential biomarkers for cancer progression monitoring which need to be correctly assessed</title><p id="Par57">The dose-dependent effects of physical exercise or antioxidant supplementation supports the idea that monitoring tumor redox status could be a promising therapeutic strategy in the care management of cancer patients. Among the different biomarkers that could be used to assess redox status of tumor cells, oxo-7,8-dihydro-2′-deoxyguanosine (8-oxodG) has gained much attention. However, its role as a reliable marker of cancer progression is still under debate, as its levels in blood, urine, or tumor tissues to predict survival and efficacy of anticancer treatment is still under debate (Sheridan et al. <xref ref-type="bibr" rid="CR355">2009</xref>; Crohns et al. <xref ref-type="bibr" rid="CR72">2009</xref>; Roszkowski et al. <xref ref-type="bibr" rid="CR328">2011</xref>; Roszkowski and Olinski <xref ref-type="bibr" rid="CR327">2012</xref>; Shen et al. <xref ref-type="bibr" rid="CR354">2007</xref>; Karihtala et al. <xref ref-type="bibr" rid="CR173">2011</xref>; Lee et al. <xref ref-type="bibr" rid="CR219">2010a</xref>).</p><p id="Par58">The difficulties to establish links between cancer progression and levels of oxidatively generated DNA damage is largely explained by inaccurate quantification of 8-oxodG. It is now well documented that several assays, including gas chromatography-mass spectrometry (GC-MS) and [<sup>32</sup>P]-postlabeling methods, suffer from major flaws during sample preparation (Cadet et al. <xref ref-type="bibr" rid="CR52">2011</xref>, <xref ref-type="bibr" rid="CR53">2012</xref>), leading to overestimation of 8-oxodG. In addition, immunoassays, which are still widely and improperly applied in clinical studies, are inaccurate due to antibody cross-reactivity (Lee et al. <xref ref-type="bibr" rid="CR219">2010a</xref>; Cadet et al. <xref ref-type="bibr" rid="CR52">2011</xref>). High performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry (HPLC-ESI-MS/MS) in the multiple reaction monitoring mode has become a relevant alternative thus providing unambiguous damage characterization and quantitative information (Lee et al. <xref ref-type="bibr" rid="CR219">2010a</xref>; Cadet et al. <xref ref-type="bibr" rid="CR52">2011</xref>). However assessing low variations in 8-oxodG levels by HPLC-ESI-MS/MS is still a challenge (Badouard et al. <xref ref-type="bibr" rid="CR15">2008</xref>). An additional alternative is the indirect detection of 8-oxodG or oxidized pyrimidine bases, mediated by either the comet assay or the alkaline elution technique, in association with DNA repair enzymes that convert base modifications into strand breaks (Klungland et al. <xref ref-type="bibr" rid="CR194">1999</xref>; Sauvaigo et al. <xref ref-type="bibr" rid="CR342">2002</xref>).</p><p id="Par59">The measurement of 8-oxodG and 8-oxoGua, the related nucleobase, in human fluids including urine, plasma, and saliva offers a non-invasive method to indirectly assess oxidatively generated damage in nuclear DNA (Cooke et al. <xref ref-type="bibr" rid="CR68">2008</xref>). However, the biological meaning of urinary 8-oxodG remains to be established since it was recently reported that the release of the oxidized nucleoside could not be accounted for by either the nucleotide excision repair from DNA or MTH1-mediated hydrolytic dephosphorylation of 8-oxo-7,8-dihydro-2′-deoxyguanosine 5′-triphosphate in nucleotide pools (Evans et al. <xref ref-type="bibr" rid="CR101">2016</xref>).</p><p id="Par60">These studies show that tumor redox status affects tumor development and impacts anticancer therapies. Physical exercise and antioxidant supplementation are proposed to optimize the effects of some specific agents, while being deleterious for Taxane family drugs. Future steps will require the identification of a patient’s tumor redox status. To achieve this goal requires the identification and validation of biological markers of oxidative stress to make the right diagnosis. As such, oxidatively DNA damage constitutes a promising biomarker, but requires an improved standardized and clinically relevant approach.</p></sec></sec><sec id="Sec20"><title>Neurological disorders and stroke</title><sec id="Sec21"><title>Stroke</title><p id="Par61">There is a long-standing link between neurodegenerative disorders, stroke, and oxidative stress. In general, the brain is particularly sensitive to oxygen overload and free radical generation, as it requires higher levels of oxygen and glucose than do other organs and tissues. Additionally, the brain’s high amounts of unsaturated fatty acids, with their easily oxidized double bonds, makes it highly susceptible to free radical attack (Butterfield et al. <xref ref-type="bibr" rid="CR50">2002</xref>). In strokes and the onset of cerebral ischemia, a decrease in oxygen levels removes controls over the free radicals generated by electron transport and leads to decreased levels of antioxidants, such as vitamins E and C, as they are consumed in the attempt to quench the increase in free radicals (Flamm et al. <xref ref-type="bibr" rid="CR111">1978</xref>). Even following the immediate danger of a stroke, free radicals continue to exert detrimental effects that lead to other complications such as brain edema, which can result from disruption of the blood brain barrier leading to fluid accumulation (Heo et al. <xref ref-type="bibr" rid="CR153">2005</xref>). There are some promising results suggesting that free radical scavengers may be beneficial in remediating post-stroke symptoms in a clinical setting (Toyoda et al. <xref ref-type="bibr" rid="CR386">2004</xref>), making antioxidant therapies a potentially promising avenue for treatment following strokes. Another type of stroke associated with oxidative damage is intracerebral hemorrhage or hemorrhagic stroke. In this type of stroke, free radicals are produced in two ways, the first is through the decomposition of blood that has rapidly accumulated in the brain, which in turn releases iron ions, heme, and thrombin that induce the production of free radicals. Second, the inflammatory response by cells such as microglia and neutrophils also generate free radicals. Together both sources of free radicals are leading causes of hemorrhagic brain tissue (Duan et al. <xref ref-type="bibr" rid="CR90">2016</xref>). These examples illustrate that often the events following a stroke are just as lethal with oxidatively generated damage playing a key role in the toxicity, making antioxidant therapies a promising treatment option.</p></sec><sec id="Sec22"><title>Alzheimer disease</title><p id="Par62">Neurological disorders such as Alzheimer’s disease, amyolotrophic lateral sclerosis (ALS), Multiple Sclerosis (MS), and Parkinson’s disease all include elements of redox imbalance (Uttara et al. <xref ref-type="bibr" rid="CR393">2009</xref>). Whether free radicals and oxidative stress are involved in both the initiation and the progression of (each of) these diseases, however, is not so clear. For example, Alzheimer disease is characterized by the accumulation of amyloid-<italic>β</italic> peptides to form amyloid plaques, which cause neuronal death (Butterfield et al. <xref ref-type="bibr" rid="CR50">2002</xref>). Evidence indicates that these aggregates then interact with redox metals to initiate the production of free radicals further promoting oxidative stress (Varadarajan et al. <xref ref-type="bibr" rid="CR404">2000</xref>). The inability to maintain a homeostatic balance between production of amyloid-<italic>β</italic> peptides and their degradation results in not only the elevation of oxidative stress but also the inhibition of proteasome-driven protein degradation (Bonet-Costa et al. <xref ref-type="bibr" rid="CR35">2016</xref>), which further contributes to the cascading effect of amyloid plaque formation. Exhibiting a similar neuropathology to Alzheimer disease is Down Syndrome (DS), a congenital birth defect that is the result of three copies of chromosome 21. Similar to Alzheimer disease, a redox imbalance likely has some role in the adverse effects of DS. One gene coded on chromosome 21, CuZn superoxide dismutase, has activity increased by 50% in DS. This enzyme is responsible for catalyzing the dismutation of superoxide to molecular oxygen and hydrogen peroxide, and increased activity of this enzyme may lead to greater production of hydrogen peroxide (Brugge et al. <xref ref-type="bibr" rid="CR49">1992</xref>). Additional similarity between DS and Alzheimer disease is found in the formation of amyloid plaques. In DS, the gene for amyloid A4 precursor is also located on chromosome 21 and is present at a rate 50% higher than normal (Rumble et al. <xref ref-type="bibr" rid="CR333">1989</xref>), which is potentially responsible for the amyloid plaque formed in DS. RCAN1, a regulator of calcineurin, has also been linked to both DS and Alzheimer disease as well as another neurological disorders. Paradoxically, RCAN1, specifically the isoform RCAN1-1L is neuroprotective against acute stress, but has detrimental effects when chronically up-regulated. RCAN1-1L is transiently elevated to defend against acute stress including oxidative stress; however, long-term elevation of RCAN1-1L is linked to DS and Alzheimer disease (Ermak and Davies <xref ref-type="bibr" rid="CR97">2013</xref>). In patients with Alzheimer disease, RCAN1-1L is expressed twice as much relative to non-Alzheimer disease controls suggesting that RCAN1-1L may have a role in Alzheimer disease (Ermak et al. <xref ref-type="bibr" rid="CR98">2001</xref>; Harris et al. <xref ref-type="bibr" rid="CR145">2007</xref>).</p><p id="Par63">For the individual, environment factors are major determinants of health across the lifespan. Further studies of ApoE alleles on ageing processes need also to consider environmental influences because the heritability of human lifespan is 30% or less (Finch and Tanzi <xref ref-type="bibr" rid="CR108">1997</xref>; Dato et al. <xref ref-type="bibr" rid="CR77">2017</xref>). The “bad” ApoE4 allele is associated with shorter lifespan and higher risk of Alzheimer disease and cardiovascular disease. Its life-shortening association was first reported in 1994 by Schächter and colleagues at the <italic>Centre d’Etudes du Polymorphisms Humain</italic> (Schächter et al. <xref ref-type="bibr" rid="CR344">1994</xref>).</p><p id="Par64">However, ApoE4 is protective in some environments with high exposure to pathogenic infections. In rural Ghana, ApoE4 had allele-dose benefits to survival of adults and children (van Exel et al. <xref ref-type="bibr" rid="CR397">2017</xref>). Moreover, the Tsimane of low-land Bolivia had better cognitive functions in ApoE4 carriers who also had blood indicators of a high parasite load (Trumble et al. <xref ref-type="bibr" rid="CR387">2017</xref>). Because ApoE4 is the most ancient allele (Fullerton et al. <xref ref-type="bibr" rid="CR120">2000</xref>), its persistence in human populations may represent its adaptive value under conditions of high pathogen exposure (Finch and Stanford <xref ref-type="bibr" rid="CR107">2004</xref>; Martin and Finch <xref ref-type="bibr" rid="CR245">2016</xref>). The lower risk of age-related macular degeneration (AMD) in ApoE4 carriers (Section 12.3) might be related to the increased UV exposure of early humans in the African savannah, where there is greater solar exposure than in the forest canopy of our great ape ancestors. UV-induced retinal damage is implicated in AMD (Kraljević Pavelić et al. <xref ref-type="bibr" rid="CR199">2015</xref>) (Section 10.4).</p><p id="Par65">In our highly polluted world, ApoE4 may increase the risk of Alzheimer disease. Based on epidemiological findings from the Womens’ Health Initiative Mental Study (WHIMS), it was shown that older women residing in elevated particle density (PM2.5, above EPA standards) had nearly double risk of dementia, with further doubling of risk in E4/E4 carriers (Cacciottolo et al. <xref ref-type="bibr" rid="CR51">2017</xref>). Correspondingly, EFAD mice carrying transgenes for ApoE alleles and familial Alzheimer disease had greater bran amyloid in the E4FAD carriers. Given the low heritability of human lifespan, it is timely to expand environmental studies in discussions of human ageing mechanisms<italic>.</italic> The human environment is being re-conceptualized in terms of the <italic>exposome</italic>, to identify external and internal influences on individual health and their synergies across the lifespan (of, N.A. and E. Sciences, and Medicine <xref ref-type="bibr" rid="CR270">2017</xref>; Vineis et al. <xref ref-type="bibr" rid="CR405">2017</xref>). The search for longevity associated gene variants might also consider environmental factors that contribute to life-shortening diseases.</p></sec><sec id="Sec23"><title>Huntington disease</title><p id="Par66">In contrast with high levels of RCAN1 expression in Alzheimer disease, depressed levels of RCAN1-1L are a hallmark of Huntington’s disease, a disease characterized by neuronal death caused by a mutant huntingtin protein (Ermak et al. <xref ref-type="bibr" rid="CR99">2009</xref>). RCAN1-1L has been shown to protect against toxic mutant huntingtin proteins in vitro by inhibiting calcineurin, which in turn increases phosphorylation of the mutant huntingtin protein. In Huntington disease, there are elevated levels of biomarkers for oxidative damage such as DNA damage and oxidized proteins, which is believed to be the cause of mitochondrial dysfunction and neuronal cell death. The association between oxidative stress and Huntington disease is well documented, and multiple studies and some clinical trials have shown antioxidant therapies to be a promising candidate for slowing progression and alleviating symptoms of Huntington disease (Gil-Mohapel et al. <xref ref-type="bibr" rid="CR131">2014</xref>).</p></sec><sec id="Sec24"><title>Multiple sclerosis</title><p id="Par67">MS is an auto-immune neuronal disorder that causes demyelination of the central nervous system (CNS). Due to the abundance of reactive oxygen species, it is arguably the disease source; however, the exact source of MS is still unknown. Analysis of MS plaques revealed elevated reactive oxygen species generation and decreased antioxidant levels (Langemann et al. <xref ref-type="bibr" rid="CR210">1992</xref>). Even though a cure to MS has yet to be developed, dietary modifications have shown promising results in delaying and easing symptoms of MS. A low fat diet has been shown to result in lower deterioration and death rates (Swank and Dugan <xref ref-type="bibr" rid="CR374">1990</xref>). Similarly, a low fat diet supplemented with the omega-3 fatty acids from fish oil has also been shown to decrease the severity of MS symptoms (Weinstock-Guttman et al. <xref ref-type="bibr" rid="CR414">2005</xref>). These studies show that diets high in antioxidants and low in oxidative strain have the potential to alleviate symptoms of MS and delay its progression through the sequestration of free radicals and restoring redox balance.</p></sec><sec id="Sec25"><title>Parkinson disease</title><p id="Par68">Parkinson disease is characterized by a neuronal loss, especially the nigral dopaminergic neurons and intraneuronal inclusions called Lewy bodies and constituted mainly of α-synuclein. This results in the underrepresentation of the neurotransmitter dopamine which is at origin of the cardinal motor symptoms of the disease: akinesia rigidity and tremor. The cause of neuronal loss is not fully known but includes aggregation of misfolded proteins (α-synuclein, tau), mitochondrial dysfunction (especially a loss of complex 1 activity), defective ubiquitine–proteasome proteolysis, and oxidative stress.</p><p id="Par69">Ultimately, dopamine neurons degenerate by an apoptotic process involving caspase 3 and 8 activation (Hartmann et al. <xref ref-type="bibr" rid="CR147">2000</xref>; Hartmann et al. <xref ref-type="bibr" rid="CR148">2001</xref>). In addition to these so-called cell autonomous mechanisms, non-cell autonomous mechanisms such as neuroinflammatory processes or dysregulation of trophic support also contribute to neuronal degeneration and self-perpetuation of degeneration (for review see (Hirsch and Hunot <xref ref-type="bibr" rid="CR157">2009</xref>)). This includes activation of microglial cells secreting pro-inflammatory cytokines and infiltration of CD4 and CD8 T lymphocytes as evidenced post-mortem in the substantia nigra of patients with Parkinson disease (McGeer et al. <xref ref-type="bibr" rid="CR250">1988</xref>; Brochard et al. <xref ref-type="bibr" rid="CR44">2009</xref>). Experimental models, mainly developed in mice using the parkinsonian drug MPTP, suggest the activation of both innate and adaptive immune response is involved in neuronal degeneration as blockade of these events prevents at least partially the loss of dopamine neurons.</p><p id="Par70">Several lines of evidence suggest oxidative stress plays a very special role in the degeneration of melanized dopamine in Parkinson disease, which are particularly sensitive to oxygen radicals (Hirsch et al. <xref ref-type="bibr" rid="CR158">1988</xref>). Within dopaminergic neurons, oxidative stress is due in part to a deficiency of complex-1 activity within mitochondria (Schapira et al. <xref ref-type="bibr" rid="CR345">1990</xref>). In line with this hypothesis, complex-1 inhibitors such as MPTP, rotenone, and the recently discovered annonacin can killed dopaminergic neurons in vitro and reproduce parkinsonism in animals (Lannuzel et al. <xref ref-type="bibr" rid="CR214">2008</xref>; Champy et al. <xref ref-type="bibr" rid="CR59">2004</xref>; Höglinger et al. <xref ref-type="bibr" rid="CR159">2003</xref>). Rotenone and annonacin are of great interest as they also produce α-synuclein and tau accumulations within the degenerating neurons. Post mortem analysis confirms that oxidative stress participates in neuronal degeneration through increased lipid peroxidation (Dexter et al. <xref ref-type="bibr" rid="CR86">1986</xref>), protein carbonylation (Alam et al. <xref ref-type="bibr" rid="CR2">1997a</xref>), and 8-hydroxyguanine formation (Alam et al. <xref ref-type="bibr" rid="CR3">1997b</xref>), all of which have been reported in the parkinsonian substantia nigra. Furthermore, oxidative stress is amplified by a rise in iron concentration (Hirsch et al. <xref ref-type="bibr" rid="CR158">1988</xref>; Sofic et al. <xref ref-type="bibr" rid="CR364">1988</xref>; Dexter et al. <xref ref-type="bibr" rid="CR87">1987</xref>). The origin of this increase in nigral iron is not fully understood but might be due to a dysregulation of iron transport within the cells. Indeed, the divalent metal transporter (DMT1) is over-expressed in Parkinson disease and animals with a mutated DMT1 (reducing its iron transport capacities) were less sensitive to parkinsonian toxins (Salazar et al. <xref ref-type="bibr" rid="CR337">2008</xref>). Altogether, multiple sources of evidence suggest oxidative stress, involving a rise in iron and the subsequent accumulation of misfolded proteins within dopaminergic neurons participate in the degenerative process. This raises the tantalizing hypothesis that reducing iron concentration in Parkinson disease might reduce the evolution of the disease. A recent clinical trial in France using the iron chelator deferiprone actually provided encouraging support for this hypothesis (Devos et al. <xref ref-type="bibr" rid="CR85">2014</xref>) which will be further tested (and hopefully confirmed) in an ongoing European clinical trial.</p><p id="Par71">There is also the possibility that diet and antioxidants may affect the incidence or progression of Parkinson disease. In Parkinson disease, protein damage and degradation mediated by reactive oxygen species and a positive feedback loop (Esteves et al. <xref ref-type="bibr" rid="CR100">2009</xref>) appear to contribute significantly to the loss of dopaminergic cells in the substantia nigra, leading to dopaminergic deficiency in the striatum, and alpha-synuclein oligomerization. Conversely, administration of antioxidants (GSH and coenzyme Q) decreased alpha-synuclein oligomerization and thus neurotoxicity (Esteves et al. <xref ref-type="bibr" rid="CR100">2009</xref>). Several studies have shown certain diets exhibited neuroprotective patterns against Parkinson disease. One study showed an inverse relationship with Parkinson disease and adherence to a Mediterranean-type diet (Alcalay et al. <xref ref-type="bibr" rid="CR5">2012</xref>), while other studies showed that high consumption rates of plant-based diet (such as fruits, vegetables, legumes, whole grains, nuts) with fish and poultry was inversely associated with Parkinson disease risk when compared with a standard Western diet characterized with more red meat, sweets, and fried foods (Gao et al. <xref ref-type="bibr" rid="CR124">2007</xref>). Similar to other neurological disorders covered, diet can play a large role in improving quality of life in patients with Parkinson disease and offer a promising avenue of further study.</p><sec id="Sec26"><title>Exercise enhances neuroplasticity by targeting synaptic energy metabolism and mitochondrial function in Parkinson disease patients</title><p id="Par72">Despite the brain’s high metabolic demand, it has little reserve when substrates are limited. Failure to supply neurons with energy can be severe, leading to neurotransmitter dysfunction and cell death. The analyses of brain tissues from a wide spectrum of neurodegenerative disorders all implicate deficits in the mitochondria. Consequently, mitochondria-targeted pharmacological therapeutics have been tested. However, none have translated into successful clinical treatments. Despite these challenges, energy metabolism remains a viable therapeutic target. By better understanding the underlying molecular and biochemical changes in glucose metabolism within the brain, including conditions of metabolic stress, such as transient hypoxia, acute and chronic injury, and degenerative diseases, may provide better direction of targeted therapies.</p><p id="Par73">Over the past several years, exercise has become attractive as a non-pharmacological and inexpensive treatment modality for many brain disorders. For example, many Parkinson disease patients incorporate aspects of physical activity in their standard of care. Small studies and patient reports support the benefits of exercise in improving quality of life, optimizing drug treatment, and possibly modifying disease progression. Research in animal models highlight the beneficial effects of exercise, and further our understanding of the underlying molecular mechanisms. Even in light of these major advancements, major gaps still exist.</p><p id="Par74">The following studies highlight the hypothesis that physical activity in the form of different types of exercise (aerobic versus skill-based) is beneficial due to its circuit specific effects on synaptic connectivity (a major component of neuroplasticity). Specifically, the effects of exercise on energy metabolism at the synapse, its ability to modulate synaptic mitochondrial function, glucose uptake, astrocyte-neuron coupling, and the mechanisms that link central nervous system (CNS) and peripheral (muscle) activity. Together, a greater understanding of these processes may improve pharmacological drug development, guide clinicians on patient-appropriate exercise, especially in treating motor deficits associated with Parkinson disease, and provide insight on long-term exercise for optimal brain function, including the later stages of ageing.</p></sec><sec id="Sec27"><title>Effects of exercise in an animal model of Parkinson’s disease</title><p id="Par75">Epidemiological studies have shown that exercise and other forms of physical activity reduce the incidence of Parkinson disease, Alzheimer disease, and mild cognitive impairment (MCI) (Chen et al. <xref ref-type="bibr" rid="CR61">2005</xref>; Ohman et al. <xref ref-type="bibr" rid="CR271">2016</xref>). Animal models utilizing the dopamine depleting agents MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and 6-OHDA (6-hydroxydopamine) have been instrumental in our understanding.</p><p id="Par76">However, a limitation of these studies is lack of consensus on exercise parameters employed in mouse studies, including duration, velocity, intensity, and level of skill. However, one common component is exercise introduced prior to or during the active phase of toxin-induced cell death protects against midbrain dopaminergic neuron cell death and the depletion of striatal dopamine. A number of mechanisms may mediate neuroprotection including (i) elevation of neurotrophic factors such as BDNF (brain-derived neurotrophic factor), (ii) increased resilience of mitochondria, (iii) reduced bioavailability of toxins due to alterations in peripheral processing (liver metabolism), transport across the blood brain barrier, uptake into dopaminergic neurons (through reduced expression of the dopamine transporter, DAT), or storage/sequestration via vesicular uptake through VMAT2 (vesicular monoamine transporter) into vesicles.</p><p id="Par77">Dopaminergic toxin-induced models can also be used to study neurorestoration: the effects of exercise on neuronal connectivity following toxin-induced cell death. One area of interest is understanding the underlying mechanism by which exercise, in the form of intensive treadmill running, leads to the restoration of motor behaviors in the MPTP-lesioned mouse model, collectively termed neuroplasticity (Fisher et al. <xref ref-type="bibr" rid="CR109">2004</xref>). In summary, exercise led to elevated striatal dopamine D2 receptor expression, reduced striatal DAT expression, elevated release of dorsolateral striatal dopamine, altered expression of the ionotropic glutamate receptor subunits GluA1 and GluA2, and restoration of dendritic spine density on striatal medium spiny neurons (MSNs) (Fisher et al. <xref ref-type="bibr" rid="CR109">2004</xref>; Petzinger et al. <xref ref-type="bibr" rid="CR285">2007</xref>; Toy et al. <xref ref-type="bibr" rid="CR385">2014</xref>; Kintz et al. <xref ref-type="bibr" rid="CR178">2013</xref>; VanLeeuwen et al. <xref ref-type="bibr" rid="CR401">2010</xref>). These results indicate circuit specific changes leading to improved motor behavior. The concept of circuit-specific changes is further supported by recent studies examining alterations in regional cerebral blood flow (rCBF) with exercise. Specifically, elevation in cortical rCBF in the PFC, with enhanced distribution upon skilled exercise compared to aerobic exercise (Wang et al. <xref ref-type="bibr" rid="CR411">2015</xref>).</p><p id="Par78">While exercise provides general brain health, we are interested in understanding how exercise can be targeted to specific brain circuits, especially those affected in neurological disorders like Parkinson disease. Moreover, different types of activity have variable effects. For example, types of exercise with greater skill and learning components, which engage cognitive circuits, show greater benefit than those which are purely aerobic and limited cognitive engagement (Voelcker-Rehage et al. <xref ref-type="bibr" rid="CR407">2011</xref>). This is important in patients with Parkinson disease where cognitive deficits are evident in the early stages of disease and may contribute to the degenerative process and lead to the progression of severe motor deficits. Interestingly, early synaptic changes with exercise in the MPTP-lesioned mouse model originate from cortical afferents, especially the corticostriatal circuit connecting the cerebral cortex with the striatum (caudate-putamen). These observations, along with the fact that deficits in cognition can interfere with gains in the benefits of exercise, highlight the importance of circuit specific targets that must be engaged to enhance improvements in motor behavior. In other words, mechanisms of neuroplasticity enhanced by activating cognitive circuits are critical for targeting improvement in motor circuits.</p><p id="Par79">Therefore, a major gap in our knowledge is the identity of the molecular mechanisms by which exercise, especially forms of exercise targeting corticostriatal afferents, lead to improved motor behaviors and modify disease progression. One attractive hypothesis is the role of metabolism as it links neuronal activity-induced changes in blood flow, breakdown of energetic substrates to the expression of genes and proteins involved in angiogenesis and synaptogenesis. Central to this hypothesis are the biosynthetic mechanisms involved in energy metabolism, mitochondrial function, and synaptic connectivity.</p></sec><sec id="Sec28"><title>Brain energy metabolism in Parkinson’s disease</title><p id="Par80">The brain is the most metabolically demanding organ in the human body (Attwell and Laughlin <xref ref-type="bibr" rid="CR13">2001</xref>). However, unlike most peripheral tissues, the brain has limited metabolic flexibility such that it relies almost exclusively on glucose (and under specific conditions, lactate) as its substrate for energy metabolism. This highlights the brain’s dependency on a continuously available exogenous fuel supply. In the brain, glucose is metabolized through four principle biochemical pathways: (i) glycolysis, (ii) oxidative phosphorylation (OXPHOS), (iii) the pentose phosphate pathway (PPP), and (iv) glycogenesis. Importantly, each of the different cell types within the brain (neurons, astrocytes, microglia, oligodendrocytes) has its own distinctive metabolic profile. For example, neurons have a high energy expenditure, due to the establishment and maintenance of the membrane resting potential. In addition, neuronal computation is extremely energetically demanding, with most energy consumption occurring at the synapse (Harris et al. <xref ref-type="bibr" rid="CR146">2012</xref>). This demand is reflected by the high number of mitochondria preferentially localized to the pre- and post-synaptic terminals, implicating the close relationship between energy production and its demand (Wong-Riley <xref ref-type="bibr" rid="CR417">1989</xref>). Mitochondria not only produce ATP, but are involved in other molecular functions, including buffering the cellular calcium influx and the generation of low levels of reactive oxygen species necessary for normal metabolic homeostasis.</p><p id="Par81">Loss of mitochondrial function at synapses can lead to synaptic deregulation and loss of brain connectivity. Historically, the study of neurodegenerative disorders has correlated alterations of mitochondrial function with synaptic changes. With respect to Parkinson disease, the discovery of MPTP-induced parkinsonism shed light on mitochondria as a contributor to disease process (Langston et al. <xref ref-type="bibr" rid="CR213">1983</xref>; Langston <xref ref-type="bibr" rid="CR212">2017</xref>). Since then, the involvement of mitochondria has been shown to be much more complex, with defect in: trafficking, biogenesis, mitophagy, activation of apoptosis, oxidative stress, and calcium buffering capacity (Mounsey and Teismann <xref ref-type="bibr" rid="CR259">2011</xref>).</p><p id="Par82">In addition, the mechanisms by which familial forms of Parkinson disease occur have increased our insight. These familial forms of Parkinson disease include genetic mutations in alpha-synuclein (SNCA), DJ-1, PINK1, Parkin, LRRK2, and UCH-L1. Many of these genes play key regulatory roles in mitochondrial function and synaptic health, especially those localized to the nigrostriatal and corticostriatal pathways. The PINK1/Parkin pathway acts as a mitochondrial “quality-control” pathway, due to its role in Drp1-mediated mitochondrial fission. Mutations in this genetic pathway are implicated in Parkinson disease characteristic dopaminergic degeneration (McWilliams and Muqit <xref ref-type="bibr" rid="CR253">2017</xref>). Similarly, loss of DJ-1 causes accumulation of dysfunctional mitochondria at the synapse by disrupting lysosomal homeostasis (Krebiehl et al. <xref ref-type="bibr" rid="CR201">2010</xref>). LRRK2 mutations act as an underlying cause of mtDNA damage in neural cells, the downstream effects impacting calcium imbalance, oxidative stress, and dendritic shortening. Alpha-synuclein impairs normal mitochondrial fission (biogenesis) (Xie and Chung <xref ref-type="bibr" rid="CR419">2012</xref>).</p><p id="Par83">Exercise is inherently associated with metabolism since increased metabolic expenditure demands require increased ATP. At the neuron, energy demands rise with increased firing of action potentials and increased synaptic neurotransmission. These metabolic challenges are addressed by enhanced delivery of glucose and lactate to meet the demands for greater ATP production. In addition, neuroprotective strategies are also activated through metabolic responses that help to protect neurons from acute bouts of oxidative stress; mitochondria can enter a state of senescence while alternative sources of energy production are activated—including aerobic glycolysis for the production of ATP (Barros <xref ref-type="bibr" rid="CR19">2013</xref>).</p><p id="Par84">In addition to increased energy requirements, the brain also engages in anabolic processes by which structural proteins and other macromolecules necessary for neuroplasticity including the synthesis of nascent receptors, axonal and dendritic scaffolding proteins, and other morphological changes are produced. The metabolic pathways, either directly or indirectly, contribute in shuttling small molecular substrates such as glucose, lactate, and other molecules like lipids and amino acids in supplying the needed structural components for neuroplasticity. Evidence is now emerging that exercise, specifically forms of exercise that target corticostriatal circuits, can promote metabolic changes that can harness neuroplasticity.</p><p id="Par85">Exercise activates specific circuits in the brain, including those involved in motor control, linking the cerebral cortex, basal ganglia, thalamus, and cerebellum. Enhanced neuronal activity is associated with increased metabolic demand and elevated levels of local cerebral glucose utilization. Consistent with this, several groups have reported increased expression of the glucose transporters GLUT1 (endothelial- and astrocyte-specific) and GLUT3 (neuron-specific) in motor control regions following treadmill exercise (Allen and Messier <xref ref-type="bibr" rid="CR7">2013</xref>; Takimoto and Hamada <xref ref-type="bibr" rid="CR380">2014</xref>; Kinni et al. <xref ref-type="bibr" rid="CR177">2011</xref>). Although there have been no reported changes in GLUT1 expression in the Parkinson disease brain, it has been shown that mitochondrial dysfunction and reactive oxygen species accumulation can impair cellular glucose uptake and an inadequate glucose supply can have deleterious effects on dendritic morphology and impair synaptic plasticity, which underlie aspects of Parkinson disease pathology (Gandhi et al. <xref ref-type="bibr" rid="CR123">2009</xref>). Therefore, by driving activation of circuits affected in Parkinson disease, exercise imposes a metabolic challenge, which is met by an adaptive upregulation of glucose transporters to improve glucose availability and to support synaptic function. In addition to changes in GLUT1 expression, there is also an activation of enzymes involved in energy production including dehydrogenases for lactate and glucose and others within the TCA cycle.</p><p id="Par86">In recent decades, lactate has emerged from largely being considered as a metabolic waste product to an important supplemental brain energy substrate and signaling molecule. At rest, blood-derived lactate (~ 1 mM) provides 8–10% of total brain energy requirements (Smith et al. <xref ref-type="bibr" rid="CR361">2003</xref>; Boumezbeur et al. <xref ref-type="bibr" rid="CR39">2010</xref>). Yet, during moderate-to-vigorous aerobic exercise, blood lactate levels can increase by up to 10-fold, supplementing brain energy requirements, up to 25% of the overall demand (van Hall et al. <xref ref-type="bibr" rid="CR398">2009</xref>). Complementing elevated blood lactate levels following bouts of aerobic exercise, specific regional up-regulation of lactate transporters have been found in the cortex, hippocampus, and hypothalamus, indicating a preferential utilization of peripheral lactate during supra-physiological conditions (Takimoto and Hamada <xref ref-type="bibr" rid="CR380">2014</xref>). Furthermore, it has been suggested that the immediate energy requirements of sustained synaptic activity are at least, in part, fueled by the complete oxidation of astrocyte-derived lactate (Hall et al. <xref ref-type="bibr" rid="CR142">2012</xref>). The potential central role of astrocytes in linking metabolism and neuroplasticity is highlighted in the next sections.</p></sec><sec id="Sec29"><title>Effects of exercise on brain mitochondrial function in Parkinson disease</title><p id="Par87">It has been well-established that aerobic exercise training is highly beneficial to muscle mitochondria efficiency. Surprisingly, much less is known about the effects of exercise on mitochondria in the brain, either in neurons or glia. As mentioned above, neuronal mitochondria are preferentially localized to the synapse and are responsible for supplying the energy demands of synaptic function in active neuronal circuits. In normal ageing and in neurodegenerative disorders such as Parkinson disease, there are a number of mitochondrial alterations that can result in their dysfunction, including the following: decreased activity of the ETC and other enzymatic proteins, including those involved in controlling oxidative stress and calcium buffering, accumulation of mtDNA mutations, altered biogenesis, and dysregulation of mitophagy (Schapira et al. <xref ref-type="bibr" rid="CR345">1990</xref>). Exercise represents a potentially important non-pharmacological approach to target mitochondrial function at the synapse with the goal to facilitate synaptic integrity and to promote synaptic plasticity.</p><p id="Par88">One means by which exercise can modulate brain mitochondria is through improved respiratory chain function. For example, regular physical activity has been reported to increase enzymatic activity of ETC Complexes I, III, and IV (Navarro et al. <xref ref-type="bibr" rid="CR265">2004</xref>). Furthermore, improved motor behaviors following exercise in the MPTP mouse model of Parkinson disease is associated with enhanced mitochondrial function (Lau et al. <xref ref-type="bibr" rid="CR216">2011</xref>). In addition to affecting mitochondrial ATP production efficiency, exercise can also regulate mitochondrial density at the synapse. Chronic physical exercise training, such as treadmill running, up-regulates the genes for silent information regulator 1 (SIRT1) and peroxisome proliferator-activated receptor-γ coactivator 1-alpha (PGC-1α). These proteins regulate mtDNA copy number in several brain regions including the PFC, striatum, and hippocampus, as well as cascades of enzymes involved in energy metabolism, biogenesis, regulation of oxidative stress, mitophagy, and apoptosis (Steiner et al. <xref ref-type="bibr" rid="CR367">2011</xref>; Gerhart-Hines et al. <xref ref-type="bibr" rid="CR129">2007</xref>). It is of interest to note that SIRT1 and PGC-1α are the focus of a number of pharmacological agents to enhance mitochondrial health and one can speculate that efficacy of any drug intervention may be enhanced with the synergistic application of exercise.</p></sec><sec id="Sec30"><title>Astrocytes, exercise, and neuroplasticity in Parkinson disease</title><p id="Par89">Astrocytes fulfill important tasks, including mediating brain vasculature, providing energetic substrates (such as lactate) for neighboring neurons, and recycling synaptic glutamate following neuronal activity. The latter activity, the glutamate-glutamine cycle, is a cornerstone of astrocyte-neuron coupling and serves as a key mediator of neuronal activation. With astrocytic processes enveloping neuronal synapses, the astrocytic excitatory amino acid transporter 1 and 2 (EAAT1 and 2) serve as sensors of neuronal activation (and subsequent glutamate release) and facilitate uptake of glutamate from the synaptic cleft (Rothstein et al. <xref ref-type="bibr" rid="CR329">1994</xref>). This glutamate is then converted into glutamine, which is subsequently recycled back to neurons for conversion into glutamate and repackaged into vesicles for future synaptic events. The uptake of glutamate is an ATP-dependent process, due to increased sodium-potassium-ATPase activity to meet ionic displacement during glutamate uptake (Khatri and Man <xref ref-type="bibr" rid="CR175">2013</xref>), thus inducing shifts in astrocytic metabolism to meet the neuroenergetics demands of glutamate-glutamine cycling.</p><p id="Par90">This example of astrocyte-neuron coupling forms the basis for the astrocyte-neuron lactate shuttle (ANLS) hypothesis which postulates that (i) excitatory neurotransmission at the glutamatergic synapse (glutamate/glutamine cycle) drives glucose uptake from the circulation via GLUT1 expressed in microvascular endothelial cells and astrocytes, (ii) glucose is preferentially metabolized via aerobic glycolysis in astrocytes to yield lactate, and (iii) lactate is shuttled from astrocytes to neurons via monocarboxylate transporters (MCTs) where it is converted back to pyruvate and enters the TCA cycle in mitochondria (Pellerin and Magistretti <xref ref-type="bibr" rid="CR281">1994</xref>). Astrocyte-specific metabolic changes during high levels of neuronal activity serve not only to provide energy to excitatory neurons through the ANLS, but also a necessary metabolic pivot to continue cycling glutamate.</p><p id="Par91">Important for the facilitation of exercise-induced neuroplasticity, the ANLS represents a model, which couples neuronal activity and the rapid delivery of energy substrates to the synapse. Preliminary data suggest that exercise may target synaptic metabolism by up-regulating the expression of ANLS components, such as lactate dehydrogenase and MCT2 (neuron specific lactate transporter), in the striatum, following a single bout of treadmill exercise (unpublished data, Halliday et al.). Interestingly, cell-specific overexpression of GLUT1 (in astrocytes) and MCT2 (in neurons) has been shown to be protective against glutamate excitotoxicity. Taken together, these findings suggest that exercise may improve astrocyte-neuron cooperation to facilitate lactate delivery required by active synapses in order to supplement the increased metabolic demand, and thus support synaptic function and plasticity. Disruption of astrocytic lactate impairs long-term memory formation and is rescued by administration of exogenous lactate, but not glucose (Suzuki et al. <xref ref-type="bibr" rid="CR372">2011</xref>). Intra-hippocampal infusions of lactate enhance working memory and blocking neuronal uptake of lactate impairs memory formation in rats (Newman et al. <xref ref-type="bibr" rid="CR267">2011</xref>). Further, neuronal uptake of lactate induces activation of immediate early genes (IEGs), including Zif-268, c-Fos, and Arc, implicating lactate in neuroplasticity processes (Yang et al. <xref ref-type="bibr" rid="CR427">2014</xref>). These findings, and others, demonstrate the critical role of astrocyte-derived lactate serving as an important energy substrate in synaptic plasticity.</p><p id="Par92">The close relationship between astrocytes and neurons and their health is paramount to adaptive neuroplasticity and synaptogenesis. In a number of neurodegenerative disorders, astrocytic activation has been well documented in terms of astrocyte morphology and elevated glia fibrillary acidic protein (GFAP) expression, a marker of astrocyte inflammation. Indeed, neuronal expression of lactate dehydrogenase subunit 1 (LDH-1) demonstrates a cell-specific ability to oxidize lactate (Bittar et al. <xref ref-type="bibr" rid="CR31">1996</xref>). An outcome that may prove beneficial in supplying high energetic demands during oxidative stress when glucose is selectively shunted toward the PPP to maintain neuronal antioxidant status. Additionally, overexpression of lactate dehydrogenase in vitro provided protection against amyloid-β exposure by shifting neuronal energetics from OXPHOS to aerobic glycolysis, ensuring cellular resistance (Newington et al. <xref ref-type="bibr" rid="CR266">2012</xref>). Dysfunctional astrocytes can have extensive molecular consequences including reduced lactate production to supply neurons, dysfunction of the BBB at astrocyte end feet, and diminished support through factors such as BDNF. Thus, astrocytic integrity may serve as an early indicator of brain disease and may emerge as an important therapeutic target.</p></sec><sec id="Sec31"><title>A potential role for hypoxia-inducible factor 1 in Parkinson disease</title><p id="Par93">When local metabolic demand through elevated neuronal activity exceeds that of available energy resources, highly conserved transcriptional programs are activated to increase oxygen delivery, optimize cellular metabolism, increase metabolic capacity, and establish homeostasis. The wide spectrum of molecular targets necessary for a successful response indicates the importance and complexity of changes that are necessary to survive challenges like metabolic demand. One such candidate is the hypoxia-inducible factor-1α (HIF-1α), a member of the HIF family of proteins. HIF-1α is a cytoplasmic multimeric protein that is constitutively expressed. Under normoxic conditions, HIF-1α is hydroxylated and subsequently ubiquitinated for targeted proteasome degradation. Under conditions of low oxygen, such as the transient hypoxia state during intensive exercise, HIF-1α is stabilized, and translocates into the nucleus, and in complex with the protein HIF-1β, forms an active transcription factor that binds to the hypoxia response element (HRE) found in the promoter region of a large number of genes including many responsible for glucose and lactate transport, energy metabolism, angiogenesis, mitochondria function, and synaptogenesis.</p><p id="Par94">It has been suggested that one of the potential benefits of exercise in the MPTP-lesioned mouse model is through the activation of HIF-1α (Smeyne et al. <xref ref-type="bibr" rid="CR359">2015</xref>). Thus, the role of HIF-1α in neural tissues is not restricted to the regulation of energy metabolism through oxygen sensing but has a potentially wider role in regulating complex molecular events including neurogenesis, angiogenesis, and mitochondrial function (biogenesis), which are important for exercise-induced neuroplasticity and synaptogenesis (Zhu et al. <xref ref-type="bibr" rid="CR435">2005</xref>; Shweiki et al. <xref ref-type="bibr" rid="CR357">1992</xref>; Correia et al. <xref ref-type="bibr" rid="CR69">2011</xref>; Petzinger et al. <xref ref-type="bibr" rid="CR286">2015</xref>). Therefore, one potential mechanism may be that exercise, through increased cellular metabolic energy demand, activates the HIF-1α transcriptional program, which in turn supports synaptic strength and connectivity during motor learning in the Parkinson disease brain (Fig. <xref rid="Fig4" ref-type="fig">4</xref>).<fig id="Fig4"><label>Fig. 4</label><caption xml:lang="en"><p>Changes in metabolism involving the corticostriatal pathway lead to improved circuit specific changes. The <italic>left panel</italic> highlights some of the features of the corticostriatal circuit in sedentary animals when synaptic activity is low. Glucose serves as the primary energy substrate in neurons catabolized to pyruvate by glycolysis and shuttled into mitochondria to the TCA cycle and ETC for oxidative phosphorylation. Mitochondria (small checkered ovals) generate ATP via oxidative phosphorylation. Expression of regulatory factors such as HIF is attenuated under normoxia. The <italic>right panel</italic> highlights changes in the corticostriatal circuit with exercise. Neuronal activation leads to significant metabolic changes at the synapse including reduced glucose and depletion of oxygen. Activation of astrocytes leads to an increase in aerobic glycolysis elevating levels of lactate from glucose substrates. Lactate is transported to neurons via the astrocyte neuron lactate shuttle (ANLS) for conversion to pyruvate providing an alternative substrate source for mitochondria energetics. Astrocytes located near synapses may have a unique function in neuroplasticity in that they can detect increased activity through changes in potassium release, glutamate neurotransmission, increased oxidative stress through ROS, and depletion of oxygen and glucose. It has yet to be established how these mechanisms may or may not differ from those astrocytes metabolically associated with neuron cell bodies for example. Changes in blood flow are both acute due to dilation by nitric oxide and prostaglandins and chronic due to increased expression of factors such as HIF-1α dependent VEGF. Increased blood flow and peripheral effects of exercise elevate blood glucose and lactate levels that can be transported to astrocytes and neurons via transporters including MCTs and GluTs</p></caption><graphic specific-use="web" mime-subtype="GIF" xlink:href="MediaObjects/11357_2017_2_Fig4_HTML.gif" id="MO4"/></fig></p><p id="Par95">It is interesting to note that transcription factors such as HIF-1α, which is tightly regulated by oxygen demand, are also regulated by other factors that can “sense” metabolic demand in neuronal circuits. These other factors include reactive oxygen species including superoxide, the glutamate-glutamine cycle, nitric oxide, and potassium levels all highlighting the potentially complex and important role played by such central regulators.</p><p id="Par96">It is well-established that exercise is beneficial in both treating and preventing many disorders in the diseased and ageing brain. It is necessary to identify the underlying molecular mechanism such that novel treatments can target specific disorders. In terms of Parkinson disease, evidence indicates that circuit specific pathways linking cognitive and motor circuits are critical in enhancing neuroplasticity to generate benefits in complex behavior like movement. These studies highlight the potential link between energy metabolism and neuroplasticity. Circuit specific activation of neuronal pathways leads to changes in glucose and lactate metabolism, altered mitochondria function, and activation of cascades including those through regulators like HIF-1α that can induce genes and proteins necessary for angiogenesis, synaptogenesis, and other components of neuroplasticity. While this may not represent a cure for disorders like Parkinson disease, it does implicate an important therapeutic target to complement pharmacological strategies and if implemented early may in fact modify disease progression.</p></sec></sec></sec><sec id="Sec32"><title>Joints and inflammation</title><sec id="Sec33"><title>Joints and mobility</title><p id="Par97">Freely movable diarthrosis or synovial joints have the greatest range of motion of any joint in the body. The six types of synovial joints are the pivot, hinge, saddle, planar, condyloid, and ball-and-socket joints. Pivot joints include the atlantoaxial joint between the atlas and axis of the neck. Hinge joints are found in the interphalangeal joints of fingers and toes. Saddle joints occur between the trapezium and metacarpal I–thumb joint. Planar joints are found between the navicular and second cuniform of the ankle. Condyloid (or gliding) joints occur between the radius, scaphoid, and lunate bones of the wrist. Ball-and-socket joints are found in the hips and shoulders.</p><p id="Par98">When diarthrosis or synovial joints are healthy, movement is smooth and painless. In contrast, when joints become inflamed and suffer damage to key components, movement becomes difficult and painful. Some common diseases or conditions that involve joint pain and inflammation are rheumatoid arthritis, systemic lupus erythematosus, and osteoarthritis, which are discussed below.</p></sec><sec id="Sec34"><title>Rheumatoid arthritis.</title><p id="Par99">Rheumatoid arthritis was first described in 1800. Initially it was felt to be a variant of gout, but this idea was proven wrong when excess uric acid was found to be involved in gout, but not in rheumatoid arthritis (Garrod <xref ref-type="bibr" rid="CR126">1859</xref>). Various theories have been postulated on the etiology of rheumatoid arthritis from pathogens including bacteria, as well as various viruses as potential triggers (Fox <xref ref-type="bibr" rid="CR113">2005</xref>); however, a direct link has yet to be determined. A genetic component clearly plays a role as there is a clear association between a group of major histocompatibility complex cell surface receptors and disease predilection (Reveille <xref ref-type="bibr" rid="CR318">1998</xref>). An increased level of reactive oxygen species formation and oxidative stress has also been found in rheumatoid arthritis. Intracellular formation of reactive oxygen species, lipid peroxidation, protein oxidation, and DNA damage have all been found in the blood of rheumatoid arthritis patients (Mateen et al. <xref ref-type="bibr" rid="CR246">2016</xref>; Chuang et al. <xref ref-type="bibr" rid="CR64">2012</xref>), so there is clear evidence that oxidative stress occurs in rheumatoid arthritis patients. Lunec et al. (Lunec et al. <xref ref-type="bibr" rid="CR234">1985</xref>) proposed that oxidative damage to IgG generated protein aggregates that can activate neutrophils and set up a “vicious cycle” (Halliwell <xref ref-type="bibr" rid="CR143">1995</xref>) of free radical production. A more recent clinical target to attempt to control rheumatoid arthritis is tumor necrosis factor (TNF). Kageyama et al. (Kageyama et al. <xref ref-type="bibr" rid="CR172">2008</xref>) have reported that treatment with infliximab, an anti-TNF biologic, played an essential role as an antioxidative agent against advanced glycation end-product (AGE) formation, oxidative DNA damage, and lipid peroxidation.</p></sec><sec id="Sec35"><title>Systemic lupus erythematosus</title><p id="Par100">Systemic lupus erythematosus is a complex inflammatory autoimmune disease whose etiology remains largely unknown. It involves many organs and presents in a varied way, mimicking many other diseases including malignancies and infections. Lupus typically presents with painful, swollen joints so that the disease is sometimes confused with arthritis. Lupus-related joint pain and stiffness are typically worse in the morning. In early stages of systemic lupus erythematosus, joint pain is typically mild, but then increases significantly as the disease progresses (Lahita <xref ref-type="bibr" rid="CR209">2011</xref>). The hallmark of systemic lupus erythematosus is the presence of diverse autoantibodies that are directed at a varied group of self-antigens (Boyd <xref ref-type="bibr" rid="CR40">1997</xref>). Many mechanisms have been implicated in its origin and disease progression. One of the mechanisms implicated is oxidative stress and free radicals. Uncontrolled oxidative stress is felt to contribute to modifications of cellular protein, lipid, and DNA. Biomarkers have been identified that may potentially be useful in measuring disease activity, and whose control could be an approach to diminish end-organ damage (Shah et al. <xref ref-type="bibr" rid="CR352">2014</xref>). Oxidative stress, for example, leads to lipid peroxidation these products have been implicated in the pathogenesis of systemic lupus erythematosus (Otaki et al. <xref ref-type="bibr" rid="CR274">2010</xref>). Autoantibodies are typically present several years prior to disease activity in systemic lupus erythematosus. Inflammation, infection, drugs, and environmental factors induce formation of neoantigens with involvement of reactive oxygen species. An attempt to determine how these factors trigger disease, in a subset of the population, is still under scrutiny. What is clear though is that oxidative damage is involved in diseases such as systemic lupus erythematosus. Formation of reactive oxygen species along with enzymatic and nonenzymatic control of these potentially harmful molecules becomes an ongoing process leading to disease (Kurien et al. <xref ref-type="bibr" rid="CR203">2012</xref>). Antioxidant enzymes may be the target of antibodies resulting in a loss of a delicate balance.</p></sec><sec id="Sec36"><title>Osteoarthritis</title><p id="Par101">Osteoarthritis (OA) is a major cause of severe joint pain, disability, and diminished quality of life in ageing populations. Breakdown of the extracellular matrix of the articular cartilage is a major factor in development and progression of osteoarthritis. The exact mechanisms leading to this cartilage change have not been defined, but loss of glucosamine and hyaluronic acid are early findings, which may be genetically determined. Other early observations include cell loss, elevated oxidative stress, and increased expression of inflammatory mediators. Chronic age-related conditions such as osteoarthritis demonstrate de-regulation of common molecular and cellular mechanisms (Ladislas <xref ref-type="bibr" rid="CR207">2000</xref>). Some of these changes involve impaired autophagy, diminished clearance of apoptotic bodies, protein misfolding, and oxidative stress which (in turn) can activate pro-inflammatory pathways that are felt to contribute to degeneration of articular cartilage. Elevated serum levels of pro-inflammatory cytokines such as IL-1, IL-6, IL-18, TNFα, and CRP have been shown to increase with ageing (Krabbe et al. <xref ref-type="bibr" rid="CR198">2004</xref>; Cesari et al. <xref ref-type="bibr" rid="CR56">2004</xref>). Elevated levels of damaged proteins, a result of the increased oxidative stress, have been found in synovial fluid and plasma of osteoarthritis patients, and have been used as biomarkers for disease progression (Ahmed et al. <xref ref-type="bibr" rid="CR1">2016</xref>). The articular cartilage is present in joints to support and distribute mechanical loads, allowing motion while avoiding erosion. Most of the articular cartilage consists of thick extracellular matrix, whereas chondrocytes, the only cell type in the articular cartilage, represent only 5% of the joint mass. Ageing results in cell senescence (Musumeci et al. <xref ref-type="bibr" rid="CR263">2015</xref>), loss of chondrocyte phenotype and thus abnormal remodeling of the extracellular matrix (Quintero et al. <xref ref-type="bibr" rid="CR306">1984</xref>; Lotz et al. <xref ref-type="bibr" rid="CR233">2010</xref>), and age-related changes in the extracellular matrix (Bhosale and Richardson <xref ref-type="bibr" rid="CR28">2008</xref>). The interaction of all of these changes is still poorly understood and further investigation needed to determine age-related therapeutic targets that may eventually lead to treatment and/or prevention of osteoarthritis in the elderly.</p></sec></sec><sec id="Sec37"><title>Bone and macrophages</title><p id="Par102">Bone is a dynamic structure dependent upon the constant activities of osteoblastic bone formation and osteoclastic bone resorption. If these two actions are not in balance, pathology ensues (Boyle et al. <xref ref-type="bibr" rid="CR42">2003</xref>; Nohl <xref ref-type="bibr" rid="CR269">1993</xref>; Wauquier et al. <xref ref-type="bibr" rid="CR412">2009</xref>; Vaananen et al. <xref ref-type="bibr" rid="CR394">2000</xref>). There is growing evidence indicating increased reactive oxygen species-derived oxidative stress, which increases with the onset of an inflammatory state or with ageing, can adversely affect bone (Wauquier et al. <xref ref-type="bibr" rid="CR412">2009</xref>; Altindag et al. <xref ref-type="bibr" rid="CR8">2008</xref>; Garrett et al. <xref ref-type="bibr" rid="CR125">1990</xref>; Ozgocmen et al. <xref ref-type="bibr" rid="CR275">2007</xref>). Abnormally high levels of oxidants and/or low levels or activity of antioxidants can specifically impair the osteoblastic/osteoclastic balance. Under physiological conditions, cells derived from bone marrow macrophages, coined osteoclasts, produce oxidant species that facilitate the destruction of calcified tissue, thus participating in bone remodeling (Silverton et al. <xref ref-type="bibr" rid="CR358">1995</xref>; Yang et al. <xref ref-type="bibr" rid="CR424">1998</xref>).</p><p id="Par103">Understanding which factors drive osteoclast activity and differentiation is important when studying diseases characterized by heightened bone resorption relative to formation, such as osteoporosis. In the last decade, studies have indicated that reactive oxygen species, including superoxide and hydrogen peroxide, are crucial components that regulate the differentiation process of osteoclasts.</p><sec id="Sec38"><title>Oxidative stress and osteoporosis</title><p id="Par104">A normal balance between oxidants and antioxidants is necessary for the correct equilibrium between osteoblast and osteoclast activities, respectively (Sheweita and Khoshhal <xref ref-type="bibr" rid="CR356">2007</xref>). In particular, when the production of reactive oxygen species by osteoclasts overwhelms the natural antioxidants defense mechanisms, the concomitant oxidant stress may lead to bone loss and hence to osteoporosis (Sheweita and Khoshhal <xref ref-type="bibr" rid="CR356">2007</xref>). However, the exact biochemical and cytological basis of the events finally responsible for bone resorption are still debated. It has been suggested that an enhanced osteoclastic activity may increase the superoxide anion generation and/or inhibit superoxide dismutase (SOD) and glutathione peroxidase activities with concomitant bone destruction (Sheweita and Khoshhal <xref ref-type="bibr" rid="CR356">2007</xref>). Indeed, early evidence for reactive oxygen species participation in bone reabsorption has been described (Garrett et al. <xref ref-type="bibr" rid="CR125">1990</xref>), wherein the addition of the superoxide-producing enzyme, xanthine oxidase, in vivo and in vitro, resulted in increased osteoclast numbers and activity. This effect was attenuated when SOD was added; however, no change was seen upon the addition of catalase, which scavenges H<sub>2</sub>O<sub>2</sub>. Therefore, the authors concluded that the superoxide radical rather than H<sub>2</sub>O<sub>2</sub> or ·OH was important in mediating the enhanced bone resorption. Subsequent studies also found that O<sub>2</sub><sup>·–</sup> production was present within the osteoclast and suggested that it may be derived from nicotinamide adenine dinucleotide phosphate (NADPH) oxidase localized to the bone–osteoclast interface within the osteoclast ruffled border (Key et al. <xref ref-type="bibr" rid="CR174">1994</xref>; Steinbeck et al. <xref ref-type="bibr" rid="CR366">1994</xref>). Blockage of NADPH oxidase by diphenylene iodonium resulted in decreased O<sub>2</sub><sup>·–</sup> production and bone resorption (Yang et al. <xref ref-type="bibr" rid="CR424">1998</xref>; Darden et al. <xref ref-type="bibr" rid="CR76">1996</xref>). Other studies, however, indicated that rather than O<sub>2</sub><sup>·–</sup>, H<sub>2</sub>O<sub>2</sub> was the primary culprit behind osteoclast formation and activity (Bax et al. <xref ref-type="bibr" rid="CR23">1992</xref>; Fraser et al. <xref ref-type="bibr" rid="CR115">1996</xref>; Kim et al. <xref ref-type="bibr" rid="CR176">2006</xref>).</p><p id="Par105">In a published case control study on 94 subjects aged &gt; 60 years (50 healthy and 44 with osteoporosis), where total antioxidant status, plasma lipid peroxides, SOD, and glutathione peroxidase (GPx) activities were measured, oxidative stress appeared as an independent risk factor for osteoporosis linked to the increase of SOD/GPx ratio (Sanchez-Rodriguez et al. <xref ref-type="bibr" rid="CR339">2007</xref>). Furthermore, since increased osteoclastic activity and decreased osteoblastic activity were shown to be associated with an imbalance between oxidant and antioxidant status plasma biomarkers in postmenopausal osteoporosis, antioxidant supplementation has been proposed as a novel therapeutic strategy in this disease (Altindag et al. <xref ref-type="bibr" rid="CR8">2008</xref>). In this context, α-lipoic acid inhibited osteoclast differentiation (Kim et al. <xref ref-type="bibr" rid="CR176">2006</xref>), while lycopene was shown to reduce either oxidative stress or levels of bone turnover markers in postmenopausal women, reducing the risk of osteoporosis (Rao et al. <xref ref-type="bibr" rid="CR311">2007</xref>). These findings highlight the importance of nutrition in the maintenance of healthy bones, in particular with the benefit of D-vitamin supplementation. Noticeably, since the lowest incidence of osteoporosis in European countries has been reported in the Mediterranean area, it may be that the “Mediterranean lifestyle” that implies the consumption of foods containing a complex array of naturally occurring bioactive molecules with antioxidant, anti-inflammatory, and alkalinizing properties, can contribute to a “bone-sparing” effect (Puel et al. <xref ref-type="bibr" rid="CR305">2007</xref>).</p></sec><sec id="Sec39"><title>Oxidative stress, NADPH oxidase activity, and osteoclast function</title><p id="Par106">Nox (NADPH oxidase) is a widely distributed enzyme in the body that catalyzes the generation of superoxide anion from molecular oxygen. This enzyme system can also generate O<sub>2</sub><sup>·–</sup> in osteoclasts (Yang et al. <xref ref-type="bibr" rid="CR424">1998</xref>; Steinbeck et al. <xref ref-type="bibr" rid="CR366">1994</xref>). One member of the Nox family, Nox4, is well expressed in kidneys, but is also abundant in the vascular system and in many other tissues and cells (Krause <xref ref-type="bibr" rid="CR200">2004</xref>), including osteoclasts (Yang et al. <xref ref-type="bibr" rid="CR426">2004</xref>), where its activity appears to be related to bone resorption. Abrogation of the normal level of Nox4 expression in osteoclasts inhibits both osteoclastic O<sub>2</sub><sup>·–</sup> production and bone resorption (Yang et al. <xref ref-type="bibr" rid="CR425">2001</xref>). An increase or decrease in superoxide anion production by osteoclasts is associated with, respectively, stimulated or inhibited osteoclastic bone resorption (Garrett et al. <xref ref-type="bibr" rid="CR125">1990</xref>; Berger et al. <xref ref-type="bibr" rid="CR27">2001</xref>; Ries et al. <xref ref-type="bibr" rid="CR322">1992</xref>).</p><p id="Par107">Of note, O<sub>2</sub><sup>·–</sup> produced by osteoclasts in an extracellular compartment and even in the absence of other enzymes is capable of degrading bone matrix proteins such as osteocalcin, which break up into small peptides post exposure (Key et al. <xref ref-type="bibr" rid="CR174">1994</xref>).</p></sec><sec id="Sec40"><title>Oxidative stress, nitric oxide and bone remodeling</title><p id="Par108">Nitric oxide (NO·) generated from arginine by NO synthase (NOS) is a free radical involved not only in vascular relaxation, platelet aggregation, neurotransmission, and immune system regulation (Moncada and Higgs <xref ref-type="bibr" rid="CR257">1993</xref>), but also in bone metabolism and function. Constitutive NOS (cNOS) is widely expressed in bone marrow stromal cells, osteoblasts, osteocytes, and osteoclasts (Helfrich et al. <xref ref-type="bibr" rid="CR151">1997</xref>), while inducible NOS (iNOS) has been observed in fetal bone (Hukkanen et al. <xref ref-type="bibr" rid="CR165">1999</xref>)—suggesting a role in skeletal development, but not constitutively in normal adult bone (Fox and Chow <xref ref-type="bibr" rid="CR114">1998</xref>). Osteoblasts stimulated with proinflammatory cytokines and/or endotoxin in vitro express iNOS (van't Hof and Ralston <xref ref-type="bibr" rid="CR402">1997</xref>), but it is still not clear whether osteoclasts express this enzyme. NO· can influence osteoblast or osteoclast activity and therefore bone remodeling.</p><p id="Par109">Osteoblasts and osteocytes under mechanical strain and shear stress conditions produce large amounts of iNOS-mediated NO· that may augment bone gain by inhibiting prostaglandin-induced bone resorption (Ralston and Grabowski <xref ref-type="bibr" rid="CR309">1996</xref>). It has also been reported that osteocytes show a greater increase in NO· production as a result of mechanical loading than osteoblasts. This supports the theory that osteocytes are the main sensors and effectors of mechanical stress in bone (van't Hof and Ralston <xref ref-type="bibr" rid="CR403">2001</xref>).</p><p id="Par110">Proinflammatory cytokines, such as IL-1 or TNF-α further increase NO· levels in bone tissues with subsequent potent inhibitory effects on osteoblast differentiation and growth. This may be eventually explained by the pro-apoptotic effects of NO· on osteoblasts (Armour et al. <xref ref-type="bibr" rid="CR10">2001</xref>), through a cGMP-dependent pathway (Mancini et al. <xref ref-type="bibr" rid="CR243">2000</xref>). This observation may explain the inhibitory effects of pro-inflammatory cytokines on bone formation.</p><p id="Par111">Since chronic inflammation is a hallmark of ageing, this parameter may play a role in bone healing by altering bone fitness. This may explain the high incidence of hip fracture in elderly patients. Indeed, with the ageing of the population, hip fractures are a growing issue. At least half of hip fracture patients never regain their previous function (Stevens and Olson <xref ref-type="bibr" rid="CR368">2000</xref>), and post-hip fracture mortality at 1 year remains as high as 33% (Roche et al. <xref ref-type="bibr" rid="CR325">2005</xref>). The factors influencing recovery from hip fracture are poorly understood although persistent inflammation related to oxidative stress is a common feature in these patients.</p><p id="Par112">When bone fracture occurs, the damaged tissues generate a remarkable amount of active radicals that are formed from the molecular interactions between embedded collagen strands and the mineral phase, and this phenomenon may facilitate bone healing (Symons <xref ref-type="bibr" rid="CR377">1996</xref>). As well, particular relationships between reactive oxygen species, hormones, and vitamins tie into bone metabolism. Estrogens, whose antioxidant activity is pivotal in protecting women of reproductive age from cardiovascular disease, stimulate osteoblastic activity through specific receptors, thus favoring bone growth. Therefore, primary estrogen deficiency in postmenopausal women can, through a loss of antioxidant potency, depress osteoblastic activity and indirectly enhance osteoclastic activity, leading to a reduction in skeletal mass and osteoporosis (Heaney et al. <xref ref-type="bibr" rid="CR149">1978</xref>; Raisz <xref ref-type="bibr" rid="CR308">1997</xref>). Another example, compensatory hyperparathyroidism, an unwanted consequence of chronic renal failure, can enhance osteoclastic activity and OCS generation, favoring bone resorption, which is characteristic of renal osteodystrophy (Freitag et al. <xref ref-type="bibr" rid="CR116">1978</xref>). The evidence suggests that OCS and antioxidants are involved in bone remodeling, although we cannot establish whether reactive species are the cause rather than the effect of the bone metabolic changes observed in many skeletal conditions and diseases.</p><p id="Par113">More recently, many studies are supporting a role for the gut and its microbiome in the regulation of bone density and health. Direct modulation of the quantity of bacteria present (through use of antibiotics), as well as addition of bacterial substrates (prebiotics) and addition of beneficial bacteria (probiotics) can affect measures of bone health and calcium metabolism (reviewed in McCabe L et al. (McCabe et al. <xref ref-type="bibr" rid="CR249">2015</xref>)). However, there is still much to learn regarding our understanding of the signaling pathways that link the microbiome and gut to skeletal health. Future studies should be performed to pinpoint the mechanisms by which the microbiome regulates osteoblast and osteoclast activities.</p><p id="Par114">In conclusion, oxidative stress is an important mediator of bone loss since increased free radical production overwhelms the natural antioxidants defense mechanisms, subjecting individuals to hyperoxidant stress and thus leading to osteoporosis or risk of hip fracture. Administration of antioxidants might protect bones from osteoporosis and help accelerating the healing of fractured bones.</p></sec></sec><sec id="Sec41"><title>Role of oxidation in skin photoaging</title><p id="Par115">Ageing is a multifactorial process characterized by metabolic, functional, and esthetic changes resulting from intrinsic genetically programmed processes and from environmental extrinsic factors (Helfrich et al. <xref ref-type="bibr" rid="CR152">2008</xref>; Thorin-Trescases et al. <xref ref-type="bibr" rid="CR384">2010</xref>). Photoaging is an accelerated form of ageing, specifically of the skin, resulting from exposure to ultraviolet (UV) light (Kligman <xref ref-type="bibr" rid="CR187">1989</xref>; Gilchrest <xref ref-type="bibr" rid="CR130">2013</xref>), causing the formation of deep wrinkles, loss of skin tone, dryness, elastic tissue clumping, pigmentary alteration, and exaggerated bruising (Yaar and Gilchrest <xref ref-type="bibr" rid="CR420">2012</xref>). Many of these clinical manifestations are a result of UV-induced changes in the dermis, the predominant target of UV radiation. Histopathological changes include alterations of elastin and the development of actinic elastosis, a hallmark of photoaging (Kligman <xref ref-type="bibr" rid="CR186">1969</xref>; Lewis et al. <xref ref-type="bibr" rid="CR227">2004</xref>). Actinic elastosis is characterized by an accumulation of elastotic material composed of abnormal elastin in addition to loss of fibrillar collagens and proteoglycans (Gilchrest <xref ref-type="bibr" rid="CR130">2013</xref>; El-Domyati et al. <xref ref-type="bibr" rid="CR96">2002</xref>; Sellheyer <xref ref-type="bibr" rid="CR350">2003</xref>; Weihermann et al. <xref ref-type="bibr" rid="CR413">2016</xref>). The key biological mechanism by which sun exposure leads to photoaging is the generation of reactive oxygen species (Gilchrest <xref ref-type="bibr" rid="CR130">2013</xref>; Yaar and Gilchrest <xref ref-type="bibr" rid="CR420">2012</xref>; Krutmann <xref ref-type="bibr" rid="CR202">2000</xref>)<italic>.</italic></p><p id="Par116">In the skin, reactive oxygen species can have deleterious effects on DNA, proteins, and lipids, particularly polyunsaturated fatty acids, leading to the formation of lipid oxidation products (LPO) which may contribute to dysfunction and skin damage (Vistoli et al. <xref ref-type="bibr" rid="CR406">2013</xref>). Ultraviolet A (UVA) is the largest source of reactive oxygen species, including the (non-radical oxidant) singlet oxygen (<sup>1</sup>O<sub>2</sub>) at the major contributor to photoaging. The skin has inherent defenses against UV-induced free radicals that include melanin, the pigment responsible for skin color, and constitutional repair processes present in damaged skin cells. Melanin is the first-line of defense against DNA damage at the surface of the skin. Pheomelanin, the melanin present in large quantities in red-haired individuals, is less protective than eumelanin, the melanin seen in blonde, brown, and black-haired individuals. However, melanin alone cannot entirely prevent skin damage even in those with very dark skin color. A second category of defense is repair processes which remove damaged biomolecules before they can accumulate and alter cell metabolism.</p><p id="Par117">Oxidative stress and subsequent tissue damage occurs when these lines of defense are overwhelmed. This point of saturation for the cell’s defense mechanisms may differ depending on the individual skin type and vulnerability (Battie et al. <xref ref-type="bibr" rid="CR22">2014</xref>; Rinnerthaler et al. <xref ref-type="bibr" rid="CR323">2015</xref>). Regardless, topical and oral antioxidants may combat photoaging by disrupting the molecular processes that promote reactive oxygen species generation. These antioxidant supplements are not FDA-regulated and consistency in recommendation is lacking.</p><sec id="Sec42"><title>Structure of the skin</title><p id="Par118">The skin is comprised of three main layers including the epidermis, dermis, and subcutaneous fat. The epidermis is the most superficial layer and is composed of stratified squamous cells or keratinocytes in addition to melanocytes and Langerhans cells, the immune cells of the epidermis. The dermis can be found just beneath the epidermis. This is the layer of the skin predominately targeted by the process of photoaging. The dermis is a flexible connective tissue network primarily comprised of collagen and elastin fibers embedded in a ground substance matrix that supports nerves, sensory receptors, lymphatic channels, and vasculature (Robinson <xref ref-type="bibr" rid="CR324">2015</xref>). Collagen comprises the majority of the dermis with collagen type I constituting 75% of this total. The predominant role of collagen is to impart strength and structure to the skin. Elastic fibers are synthesized by fibroblasts and keratinocytes and comprise approximately 3% of the dermis. The primary role of elastic fibers is to confer the skin with elasticity and resilience. The third component of the dermis is the ground substance. This material fills the spaces between collagen and elastin fibers and adds resilience to the skin. It is comprised of glycosaminoglycans (hyaluronic acid and dermatan sulfate) and glycoproteins (Robinson <xref ref-type="bibr" rid="CR324">2015</xref>).</p></sec><sec id="Sec43"><title>UV-induced production of reactive oxygen species</title><p id="Par119">Sunlight, the source of UV radiation, is divided into three main types based on wavelength. UVC (200–280 nm) is filtered by the ozone layer, UVB (280–320 nm) is mainly absorbed by the epidermis, and UVA (320–400 nm) deeply penetrates into the dermis. Aside from the direct reaction of UVB photons with DNA in the epidermis, an important consequence of skin irradiation by UVR (mainly UVA which represents more than 95% of solar radiation) is the generation of reactive oxygen species. This relationship between UV exposure and reactive oxygen species generation has been demonstrated by in vivo studies using markers of antioxidant activity such as ferritin. UVA exposure increases ferritin expression in basal and suprabasal keratinocytes in the epidermis and interstitial cells in the dermis suggesting an increase in oxidative stress induced by UVA exposure. Reactive oxygen species generation results from interactions between UV photons and endogenous photosensitizers (porphyrins, riboflavin, quinines, trans-urocanicacid) that become excited and react with O<sub>2</sub> to produce reactive oxygen species such as superoxide anion radical(O<sub>2</sub><sup>·–</sup>) and hydroxyl radical (·OH) non-radicals such as singlet oxygen (<sup>1</sup>O<sub>2</sub>) and hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) (Wenk et al. <xref ref-type="bibr" rid="CR415">2001</xref>; Panich et al. <xref ref-type="bibr" rid="CR276">2016</xref>). The singlet oxygen anion induces guanine moiety oxidation followed by structural rearrangement and 8-oxo-7,8-dihydroguanine (8-oxo-G) and 8-oxo-7,8-dihydro-2′-deoxyguanosine (8-oxo-dG) formation, which are biochemical markers of UVA-induced DNA damage (Panich et al. <xref ref-type="bibr" rid="CR276">2016</xref>). Protective pathways include both antioxidative and base excision repair (BER) pathways, but these pathways may become overwhelmed. In such instances, UVR-induced reactive oxygen species can lead to photoaging by varied mechanisms (Panich et al. <xref ref-type="bibr" rid="CR276">2016</xref>).</p></sec><sec id="Sec44"><title>Skin photoaging pathophysiology</title><p id="Par120">The skin is largely exposed to ambient UV-irradiation placing it at high risk for photooxidative damage. Oxidative stress leads to clinical signs of photoaging via a variety of different molecular mechanisms that converge on altered epidermal and dermal DNA, lipids, and proteins (Table <xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption xml:lang="en"><p>Contrast in histologic appearance of intrinsic ageing vs. photoaging (El-Domyati et al. <xref ref-type="bibr" rid="CR96">2002</xref>; Bosset et al. <xref ref-type="bibr" rid="CR37">2003</xref>)</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th><p>Intrinsic ageing</p></th><th><p>Photoaging</p></th></tr></thead><tbody><tr><td rowspan="2"><p>Epidermal basal layer</p></td><td><p>Single layer of cuboidal cells with 1 melanocyte per 5–10 basal keratinocytes intermixed with Merkel cells</p></td><td/></tr><tr><td><p>No apoptosis</p></td><td><p>Apoptosis of epidermal basal keratinocytes</p></td></tr><tr><td rowspan="7"><p>Cellular infiltrate</p></td><td><p>One layer of CD1a + cells found in lower epidermis</p></td><td/></tr><tr><td><p>Decreased Langerhans cell numbers</p></td><td/></tr><tr><td><p>Memory CD4+ T cells around superficial dermal blood vessels</p></td><td><p>CD1a+ cells distributed in two superposed layers in lower and mid-epidermis. CD1a+ cells more irregular and less dendritic</p></td></tr><tr><td><p>Increased number of CD1a+ and protein S100 (PS100)+ dendritic cells</p></td><td/></tr><tr><td><p>Increased mast cells and macrophages, especially in areas of elastosis</p></td><td/></tr><tr><td><p>Decreased Langerhans cell numbers</p></td><td/></tr><tr><td><p>Increased CD4+ T cells after acute drop in days following sun exposure</p></td><td/></tr><tr><td><p>Epidermal thickness</p></td><td><p>Minimal to no thinning: Approximately 0.1 mm (50–100 cell layers thick)</p></td><td><p>Atrophy/thickening</p></td></tr><tr><td><p>Dermal collagen</p></td><td><p>Decreased: diminished synthesis and/or increased degeneration (via abnormally increased expression of MMPs in aged skin)</p></td><td><p>Decreased: diminished synthesis and increased degeneration (via UV-induced up-regulation of MMPs)</p></td></tr><tr><td><p>Fibroblasts</p></td><td><p>Intact</p></td><td><p>Apoptotic in the upper dermis</p></td></tr><tr><td><p>Elastic fibers</p></td><td><p>Dark purple staining of elastic fibers. This correlates with loss of elastic tissue primarily in fine subepidermal elaunin network. In the reticular dermis, the elastic network may be irregularly thickened, fragmented, and disorganized</p></td><td><p>Solar elastosis: loss of eosin staining with resulting bluish color in upper dermis. This correlates with increased deposition of thickened, tangled, and granular amorphous elastic structures</p></td></tr></tbody></table></table-wrap></p><p id="Par121">Clinical features of photoaging include deep wrinkling, dyspigmentation, sallowness, telangiectasia, laxity, and a leathery appearance (Helfrich et al. <xref ref-type="bibr" rid="CR152">2008</xref>). These clinical changes are the result of UV-induced microscopic changes occurring across skin levels, but predominantly at the level of the dermis. There are also UV-induced mutations in keratinocytes and melanocytes and UV-induced apoptosis of the stem cells in the basal layer of the epidermis in addition to the hair bulge, which contributes to the clinical features of slow wound healing and dyspigmentation (Gilchrest <xref ref-type="bibr" rid="CR130">2013</xref>). Epidermal thickening or atrophy may also occur (Beckman and Ames <xref ref-type="bibr" rid="CR24">1998</xref>).</p><p id="Par122">In the dermis, there are a number of UV-induced changes that eventuate in, among others, skin wrinkling and loss of skin turgor and elasticity. Collagen degradation is accelerated with exposure to UV light. The decline in collagen with age is due at least in part to the increased activity of matrix metalloproteinases (MMPs), collagenase, 92 kd gelatinase, heme oxygenase-1, superoxide dismutase-2, and stromelysin (Battie et al. <xref ref-type="bibr" rid="CR22">2014</xref>). The activity of MMPs increases with exposure to UV light, increasing the destruction of existing collagen. There is also decreased production of de novo collagen. In vitro models report the disappearance of dermal fibroblasts in the upper part of the dermal equivalent within 48 h following UV exposure via an apoptotic process (Battie et al. <xref ref-type="bibr" rid="CR22">2014</xref>). The progressive loss of fibrillar collagen and collagen VII from the dermis leads to a large decrease in volume and strength with resultant wrinkling, easy bruising, and torpid wound healing (Gilchrest <xref ref-type="bibr" rid="CR130">2013</xref>).</p><p id="Par123">Elastosis, or the accumulation of partially degraded elastin fibers in the dermis, is another hallmark of photoaging (Gilchrest <xref ref-type="bibr" rid="CR130">2013</xref>). This is the result of UV-induction of destructive proteins such as lysosomal protease cathepsin K, the most potent of the elastin-degrading enzymes, increases in deposits of lysozyme, and alternative splicing (Gilchrest <xref ref-type="bibr" rid="CR130">2013</xref>). Lysozyme deposits on elastic fibers are seen in sun-damaged regions with the number of lysozyme-containing elastin fibers appearing to correlate with the degree of sun damage. It has been reported that lysozyme exerts its elastin-damaging effects by binding to fibers and inhibiting the proteolytic degradation of altered fibers by elastases (Battie et al. <xref ref-type="bibr" rid="CR22">2014</xref>). Thus, the occurrence of elastosis results from a reduction in functional elastin and an increase in non-functional elastin. In addition, UV radiation may induce altered splicing and expression of tropoelastin isoforms that contain exon 26A, which code for a highly lipophilic segment. These isoforms may alter the structural and biological properties of elastin and affect normal elastic fiber formation (Weihermann et al. <xref ref-type="bibr" rid="CR413">2016</xref>).</p><p id="Par124">Additional manifestations of UV-induced damage include detrimental DNA deletions. On average, skin cells exhibit some 4977 base pair deletions. In photoaged individuals, this deletion is up to 10-fold more prevalent. This compromises mitochondrial integrity and energy production, and increases mitochondrial superoxide production, which is believed to be related to the clinical signs of photoaging (Gilchrest <xref ref-type="bibr" rid="CR130">2013</xref>).</p><p id="Par125">The full extent of oxidative stress responses as experienced by different skin types remains unexplored, but clinical manifestations suggest that mechanisms for damage and repair may differ. Photoaging in more fair-skinned patients manifests with deep wrinkles and in darker-skinned patients manifests as dyspigmentation. This may result from racial variation in individual and aggregated melanosome distribution. For example, in Asians, there is a mix of individual (about 60%) and aggregated (about 40%) melanosomes that differs from European skin in which aggregated melanosomes are the majority at 85% (Battie et al. <xref ref-type="bibr" rid="CR22">2014</xref>). There appears to be a difference in the quantity of UV-induced DNA mutations in different skin tones with in vitro work demonstrating an inverse relationship between skin color and UV-induced skin response. There is a dose-dependent accumulation of DNA damage, throughout the entire epidermal layer and upper dermis of light, intermediate, and tan skin tones. In brown and dark skin tones, however, DNA damage is detected exclusively in suprabasal epidermal layers.</p><p id="Par126">Although variations in oxidative stress by skin type remain largely unexplored, the general mechanisms by which UV-induced oxidative stress leads to clinical signs of photoaging are more established. Oxidative stress incurred by human skin fibroblasts after UVR enhances expression of cell cycle inhibitors p16INK4A and p53/p21WAF1/CIP1, which eventually result in premature senescence of fibroblasts. These fibroblasts are not only key for collagen production, but also function as a key component of the skin microenvironment. This fibroblast dysfunction destabilizes the microenvironment vital for skin stem cells (Panich et al. <xref ref-type="bibr" rid="CR276">2016</xref>). UV-induced overexpression of c-Myc is correlated with depletion of epidermal stem cells, causing them to over proliferate, move out of their niche, and differentiate (Panich et al. <xref ref-type="bibr" rid="CR276">2016</xref>).</p><p id="Par127">Reactive oxygen species also activate signaling pathways in resident fibroblasts such as growth factor receptors, MAPK, or redox-sensitive transcription factors, leading to secretion of metalloproteases that degrade the proteins of extracellular matrix (ECM), including collagen. Reactive oxygen species indirectly provoke DNA oxidation and mutations, particularly the formation of 8 oxo-deoxyguanosine (8-oxo-dG) in guanine bases, which may be involved in skin cancer development (Wenk et al. <xref ref-type="bibr" rid="CR415">2001</xref>; Wang <xref ref-type="bibr" rid="CR409">2011</xref>). Reactive oxygen species may also activate the p53-p21 axis, Akt-MAPK, ATM pathways in addition to the forkhead homeobox type O (FOXO) transcription factors in various types of stem cells by influencing telomere length, thus accelerating the ageing process in skin cells (Panich et al. <xref ref-type="bibr" rid="CR276">2016</xref>). Furthermore, UV-radiation results in activation of cell surface receptors leading to the activation of MAP-kinase p38, c-Jun amino-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK) and the recruitment of c-Fos and c-Jun. This leads to the expression of MMP 3 and 9 in fibroblasts and keratinocytes (Rinnerthaler et al. <xref ref-type="bibr" rid="CR323">2015</xref>). Activator protein (AP)-1 inhibits transforming growth factor (TGF)-β responsible for collagen production and up-regulates the level of MMPs responsible for collagen degradation. AP-1 levels become elevated and remain elevated for at least 24 h following UV radiation. During this time frame, MMPs are up-regulated and collagen and ECM damage ensues (Helfrich et al. <xref ref-type="bibr" rid="CR152">2008</xref>).</p><p id="Par128">In addition to DNA, lipids are a predominant target of the reactive oxygen species oxidative attack, particularly polyunsaturated fatty acids (PUFA) that are present in the plasma membranes of fibroblasts. PUFA oxidation generates lipid oxidation products (LPO), including aldehydes such as 4-hydroxynonenal (HNE), malondialdehyde (MDA), acrolein, all of which form adducts on proteins, leading to progressive dysfunction and accumulation as modified material (carbonyl stress) (Vistoli et al. <xref ref-type="bibr" rid="CR406">2013</xref>). The role of carbonyl stress evoked by LPO in skin ageing is not yet clarified. However, aldehyde adducts (HNE-, acrolein-adducts) are detected in the lower epidermis and in the dermis, and could contribute to fibroblast dysfunction and ECM modification (Larroque-Cardoso et al. <xref ref-type="bibr" rid="CR215">2015</xref>).</p></sec><sec id="Sec45"><title>Preventing or minimizing photoaging</title><p id="Par129">Unlike the process of intrinsic ageing that cannot be halted, steps may be taken to reduce the damage from non-chronological factors. The cell has its own endogenous pathways to protect against oxidative damage. This includes enzymatic antioxidants such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione reductase, and thioredoxin reductase (Panich et al. <xref ref-type="bibr" rid="CR276">2016</xref>). Nuclear factor erythroid-2 related factor 2 (Nrf2) has also been implicated as a key regulator of redox homeostatic genes involved in skin adaptation to oxidative stress, with its depletion compromising the ability of a given cell to protect against photo-oxidative damage (Panich et al. <xref ref-type="bibr" rid="CR276">2016</xref>). When these pathways are functional and faced with low-level oxidative stress, the redox balance is maintained. However, extrinsic exposures may overwhelm endogenous protective mechanisms leading to oxidative tissue damage and thus photoaging.</p><p id="Par130">Supplemental topical and dietary antioxidants may offset the damage caused by an overwhelmed antioxidative system. Common examples of antioxidants include vitamin C (ascorbic acid), vitamin E (alpha-tocopherol), beta-carotenes, and a variety of phytochemicals, particularly polyphenols derived from plant-based foods and herbal products. Given their mechanism of action, however, effective antioxidants would need to have a very high antioxidative capacity and reactivity, to be present in extremely high concentrations, to be stable in their final formulation, and (if topical) to be able to penetrate the skin barrier (Wang et al. <xref ref-type="bibr" rid="CR410">2011</xref>).</p><p id="Par131">Vitamin C is a common, water-soluble, antioxidant found in the diet. It functions as a cofactor for many enzymatic reactions including the crosslinking of collagen. It also scavenges free radicals via donation of its electron and formation of a comparatively inert radical. It can then either be further reduced or can react further to become dehydroascorbic acid. Vitamin C may also be involved in a redox cycle that can re-reduce membrane-bound Vitamin E after it has been oxidized in acting as a chain-breaking antioxidant. Vitamin E is found in plant oils and has the ability to stop ongoing lipid peroxidation chain reactions via reduction of lipid peroxl radicals to hydroperoxides. In this process, it is itself transformed into a comparatively inert radical that may be further detoxified by ascorbate or glutathione. Topical application of vitamin E further works by decreasing MMP-1 transcription levels and pyrimidine dimer photoproduct formation (Rinnerthaler et al. <xref ref-type="bibr" rid="CR323">2015</xref>). Beta-carotene, a precursor to vitamin A, also works by scavenging radicals and inhibiting lipooxygenases capable of producing reactive oxygen species. The peroxyl radical is directly added to its backbone forming an epoxide that is later decomposed (Rinnerthaler et al. <xref ref-type="bibr" rid="CR323">2015</xref>).</p><p id="Par132">Protection from oxidatively induced damage is primarily via application of a broad-spectrum sunscreen with UVA and UVB protection. Particular emphasis for photoaging is placed on UVA (320 to 400 nm) protection given its central role in cutaneous reactive oxygen species production (Wang et al. <xref ref-type="bibr" rid="CR410">2011</xref>). UVB (290 to 320 nm) is characterized by superficial penetration and is primarily responsible for sunburns and direct DNA damage. While antioxidants do exist as standalone ingredients in oral and topical formulations, manufacturers have begun to include antioxidants in sunscreens with the claim of added oxidative damage protection (Wang et al. <xref ref-type="bibr" rid="CR410">2011</xref>). In theory, this provides two layers of protection: a “passive” layer and an “active” layer. The “passive” layer is comprised of UV filters that absorb or reflect UV rays and the “active” layer is comprised of antioxidants that neutralize any reactive oxygen species generated despite the passive layer. Whether such a system works upon application to the skin is unknown.</p><p id="Par133">Quantification of antioxidant effectiveness has many limitations and varied assays exist for such purpose. The technical application, uses, and limits of such assays have been described elsewhere (Pinti et al. <xref ref-type="bibr" rid="CR294">2016</xref>). There is no validated rating system or single assay used between and among products labeled as antioxidants and, thus, the ability of a consumer to draw conclusions about effectiveness is limited. A common assay is the radical skin protection factor (RSF). This is an ex vivo technique using porcine skin that directly measures protection against UVA-induced free radical formation. It is calculated from the ratio of free radicals in unprotected skin to those in protected skin with the radicals quantified using electron spin resonance (ESR) spectroscopy (Wang et al. <xref ref-type="bibr" rid="CR410">2011</xref>). The proportion of protection provided by antioxidants can be determined by the antioxidant power (AP) which compares oxidation protection provided by antioxidants versus UV filters. The AP value is generated in vitro utilizing an equation comprised of the constant reduction amplitude, the quantity of reduced free radicals, the characteristic weight of the antioxidant product, and the reduction time. The resulting value is expressed in antioxidative units (AU) with ascorbic acid utilized as the standard (Wang et al. <xref ref-type="bibr" rid="CR410">2011</xref>).</p><p id="Par134">Wang et al. used AP to determine the benefit of supplementing sunscreens with antioxidants and found low to zero AP units in many of the evaluated sunscreens indicating little additional protection from antioxidant additives. Of the 12 products tested, five products had an RSF over 15 (range 16.5–27). Of these five, the most common UV filters were octocrylene, titanium dioxide, and butyl methoxydibenzoylmethane. Ten of the 12 products had an antioxidant power of 0. Those with any measureable antioxidant power had multiple antioxidant additives and perhaps multiple combinations may offer better antioxidant protection. (Wang et al. <xref ref-type="bibr" rid="CR410">2011</xref>).</p><p id="Par135">Clinical studies have demonstrated an ability of sunscreens to minimize some features of photoaging. A study of 35 adults demonstrated solar elastosis was significantly decreased (<italic>p</italic> = 0.0001) by at least twice-daily application of a sunscreen consisting of 7% octylethoxycinnamate, 6% oxybenzone, and 5% octyl salicylate over 2 years (Boyd et al. <xref ref-type="bibr" rid="CR41">1995</xref>). Another study reported a highly photostable sunscreen (high UVA protection factor 22) was able to protect against multiple cellular markers of photoaging, sunburn cells, Langerhans cell depletion, cyclobutane pyrimidine dimer formation, and p53 expression. Clinical signs of photoaging from baseline to the end of the trial were reduced by 24% in the daily sunscreen group compared to the discretionary sunscreen group (relative odds 0.76, 95% confidence interval (0.59–0.98) (Young et al. <xref ref-type="bibr" rid="CR432">2016</xref>).</p><p id="Par136">Stand-alone antioxidants have been studied within various animal and human tissue models demonstrating benefit in certain markers of reactive oxygen species damage. However, the real life efficacy of these products may be dramatically different from those noted in these studies largely due to study designs which do not replicate real world conditions in regards to time and location of application.</p><p id="Par137">Photoaging is largely due to ultraviolet-induced reactive oxygen species and is distinct from intrinsic ageing. Intrinsic ageing is characterized by skin thinning, laxity, and fine wrinkling whereas photoaging is characterized by dryness, dyschromia, telangiectasia, and deep wrinkling. (Rui Yin and Hamblin <xref ref-type="bibr" rid="CR332">2015</xref>). UVA-radiation is primarily responsible for photoaging due to its deep penetration into the skin with effects on collagen, elastin, and the extracellular matrix. Topical and oral antioxidants have been utilized with the goal of quenching reactive oxygen species, but whether such products prevent photoaging in a clinically meaningful way remains unknown. Given the large role of UVA in photoaging, however, it is generally recommended that efforts at prevention of photoaging should incorporate use of a broad-spectrum sunscreen.</p></sec></sec><sec id="Sec46"><title>Cataracts</title><p id="Par138">The cause of cataracts, which is when the lens of the eye becomes clouded and impairs eyesight, stems from many different sources, yet many of these sources involve the unbalanced production of free radicals in common. In the eye lens, free radicals target the polyunsaturated fatty acids and lens crystallin proteins leading to the initiation of cataracts (Thiagarajan and Manikandan <xref ref-type="bibr" rid="CR383">2013</xref>). Studies examining whether dietary antioxidants offer protective effects against cataracts are promising, but generally show mixed results.</p><p id="Par139">Vitamin C (ascorbic acid) has strong antioxidant properties and has been shown to protect against DNA damage by quelling oxidative stress. Yet, in the presence of transition metals, vitamin C, paradoxically, contributes to DNA damage (Cai et al. <xref ref-type="bibr" rid="CR54">2001</xref>). Dietary supplementation of vitamin C has been associated with reduced risk of developing age-related cataracts (Yoshida et al. <xref ref-type="bibr" rid="CR430">2007</xref>; Jacques and Chylack <xref ref-type="bibr" rid="CR167">1991</xref>; Hankinson et al. <xref ref-type="bibr" rid="CR144">1992</xref>). Though its effectiveness is still up for debate, as other long-term studies showed that dietary supplementation of vitamin C had no effect on cataract development (Christen et al. <xref ref-type="bibr" rid="CR63">2010</xref>). Moreover, vitamin C has been shown to effectively protect against certain types of cataracts such as nuclear cataracts, but not others such as cortical or posterior subcapsular cataracts (Tan et al. <xref ref-type="bibr" rid="CR381">2008</xref>).</p><p id="Par140">Vitamin E is another dietary antioxidant, however clinical trials have shown that dietary supplementation of vitamin E did not prevent development or slow progression of age-related cataracts (McNeil et al. <xref ref-type="bibr" rid="CR252">2004</xref>) or did vitamin A (Chasan-Taber et al. <xref ref-type="bibr" rid="CR60">1999</xref>). Additionally, diet-derived carotenoids from fruits and vegetables showed a modest effect in decreasing the risk of cataracts over the course of an 8-year study (Brown et al. <xref ref-type="bibr" rid="CR46">1999</xref>) and 12-year study (Chasan-Taber et al. <xref ref-type="bibr" rid="CR60">1999</xref>). However, not all carotenoids confer protection against cataracts, only lutein and zeaxanthin had a measurable effect in both studies.</p></sec><sec id="Sec47"><title>Age-related macular degeneration</title><sec id="Sec48"><title>The APOE/cholesterol paradox of age-related macular degeneration</title><p id="Par141">Age-related macular degeneration (AMD) is a common, complex disease that results from interplay of genetic and environmental risk factors. Polymorphisms in the complement factor H (CFH) and in Apolipoprotein E (APOE) account for a large part of the genetic risks to AMD (Swaroop et al. <xref ref-type="bibr" rid="CR375">2007</xref>). Age, smoking, and obesity are the main environmental risk factors (Chakravarthy et al. <xref ref-type="bibr" rid="CR57">2010</xref>). The presence of large drusen, sizeable extracellular deposits of lipids and glycoproteins (Farkas et al. <xref ref-type="bibr" rid="CR103">1971</xref>) in Bruch’s membrane (BM), are a major risk factor for debilitating late AMD (Klein et al. <xref ref-type="bibr" rid="CR185">2004</xref>). Large drusen in the absence of vision loss is therefore considered the defining feature of intermediate AMD. Choroidal neovascularisation (wet AMD), or an extending lesion of the retinal pigment epithelium (RPE) and photoreceptors (geographic atrophy, GA) characterize late AMD (Sarks <xref ref-type="bibr" rid="CR341">1976</xref>). Intermediate AMD affects more than 150 million people worldwide and 10 million patients suffer from late AMD (Wong et al. <xref ref-type="bibr" rid="CR416">2014</xref>).</p><p id="Par142">Yet, our understanding about complex interactions of risk factors and AMD formation is relatively unknown. Early and late forms of AMD show chronic, non-resolving subretinal accumulation of mononuclear phagocytes (MP) (Levy et al. <xref ref-type="bibr" rid="CR225">2015a</xref>; Combadiere et al. <xref ref-type="bibr" rid="CR67">2007</xref>; Sennlaub et al. <xref ref-type="bibr" rid="CR351">2013</xref>; Lad et al. <xref ref-type="bibr" rid="CR206">2015</xref>; Gupta et al. <xref ref-type="bibr" rid="CR138">2003</xref>). MPs include monocytes (Mo), resident macrophages (rMφ) such as microglial cells (MC), and monocyte-derived inflammatory macrophages (iMφ) that arise during inflammation (Nathan and Ding <xref ref-type="bibr" rid="CR264">2010</xref>). While acute MP infiltration likely helps resolve large drusen (Klein et al. <xref ref-type="bibr" rid="CR183">2002</xref>; Smith et al. <xref ref-type="bibr" rid="CR362">2010</xref>), their chronic infiltration contributes significantly to the pathogenesis, as it can cause considerable collateral damage and fuel further inflammation (Nathan and Ding <xref ref-type="bibr" rid="CR264">2010</xref>). MPs plays a critical role in pathological choroidal neovascularisation (CNV) (Tsutsumi et al. <xref ref-type="bibr" rid="CR390">2003</xref>; Sakurai et al. <xref ref-type="bibr" rid="CR336">2003</xref>) and photoreceptor degeneration (Combadiere et al. <xref ref-type="bibr" rid="CR67">2007</xref>; Sennlaub et al. <xref ref-type="bibr" rid="CR351">2013</xref>; Rutar et al. <xref ref-type="bibr" rid="CR334">2012</xref>; Suzuki et al. <xref ref-type="bibr" rid="CR373">2012</xref>; Kohno et al. <xref ref-type="bibr" rid="CR195">2013</xref>; Cruz-Guilloty et al. <xref ref-type="bibr" rid="CR73">2013</xref>; Hu et al. <xref ref-type="bibr" rid="CR161">2015</xref>; Eandi et al. <xref ref-type="bibr" rid="CR93">2016</xref>) in advanced AMD (Moore and Tabas <xref ref-type="bibr" rid="CR258">2011</xref>).</p><p id="Par143">Large drusen and atherosclerotic lesions contain similar extracellular proteins (e.g., vitronectin, complement factors, and apolipoprotein E) and important amounts of cholesterol and cholesterol esters (Moore and Tabas <xref ref-type="bibr" rid="CR258">2011</xref>; Pikuleva and Curcio <xref ref-type="bibr" rid="CR289">2014</xref>; Hageman and Mullins <xref ref-type="bibr" rid="CR139">1999</xref>; Mullins et al. <xref ref-type="bibr" rid="CR261">2000</xref>; Curcio et al. <xref ref-type="bibr" rid="CR75">2001</xref>). These observations and experimental data led to the hypothesis that drusen lesions develop secondary to a deficit in the reverse cholesterol transport (RCT) similar to atherosclerotic plaques (Pikuleva and Curcio <xref ref-type="bibr" rid="CR289">2014</xref>; Malek et al. <xref ref-type="bibr" rid="CR241">2005</xref>; Ong et al. <xref ref-type="bibr" rid="CR272">2001</xref>). The RCT pathway directs excess cholesterol by high-density lipoproteins (HDL) to the liver for elimination, to avoid toxic overload of cholesterol in peripheral cells. Similarly, in atherosclerosis it is well established that low levels of HDL and high levels of non-HDL cholesterol participate in cholesterol accumulation and plaque formation (Moore and Tabas <xref ref-type="bibr" rid="CR258">2011</xref>). Accordingly, APOE<sup>−/−</sup> mice have extremely high lipid levels and massive amounts of cholesterol-rich β-VLDL and spontaneously develop atherosclerotic lesions (Meir and Leitersdorf <xref ref-type="bibr" rid="CR254">2004</xref>). Interestingly, macrophage APOE plays an important role in preventing the plaque formation (Van Eck et al. <xref ref-type="bibr" rid="CR396">1997</xref>; Fazio et al. <xref ref-type="bibr" rid="CR104">1997</xref>). APOE<sup>−/−</sup> mice also accumulate lipid debris in BM proposed to be similar to drusen (Ong et al. <xref ref-type="bibr" rid="CR272">2001</xref>), supporting the hypothesis that deficient RCT is also involved in drusen genesis.</p></sec><sec id="Sec49"><title>The AMD paradox</title><p id="Par144">Taken the similarities of large drusen and atherosclerotic plaques, one might expect a similar deregulation of the RCT with both diseases. Curiously, the reverse is the case: high levels of HDL, protective against atherosclerosis, are associated with AMD (Klein et al. <xref ref-type="bibr" rid="CR181">1993</xref>; Klein et al. <xref ref-type="bibr" rid="CR182">1997</xref>; Klein et al. <xref ref-type="bibr" rid="CR184">2003</xref>; Delcourt et al. <xref ref-type="bibr" rid="CR84">2001</xref>; van Leeuwen et al. <xref ref-type="bibr" rid="CR399">2004</xref>; Paun et al. <xref ref-type="bibr" rid="CR279">2015</xref>). A polymorphism of the ABCA1, linked with low HDL and impaired RCT, has been shown to be protective against advanced AMD (Chen et al. <xref ref-type="bibr" rid="CR62">2010</xref>). APOA-I levels are elevated (not decreased) in the vitreous (Koss et al. <xref ref-type="bibr" rid="CR197">2014</xref>) and serum (Paun et al. <xref ref-type="bibr" rid="CR279">2015</xref>) of AMD patients. Most importantly, the APOE<italic>4</italic>-isoform, associated with decreased APOE levels (Riddell et al. <xref ref-type="bibr" rid="CR321">2008</xref>; Bales et al. <xref ref-type="bibr" rid="CR16">2009</xref>; Sullivan et al. <xref ref-type="bibr" rid="CR371">2011</xref>; Levy et al. <xref ref-type="bibr" rid="CR226">2015b</xref>) (see below) and impaired reverse cholesterol transport (Heeren et al. <xref ref-type="bibr" rid="CR150">2004</xref>; Mahley et al. <xref ref-type="bibr" rid="CR239">2009</xref>), protects against AMD (McKay et al. <xref ref-type="bibr" rid="CR251">2011</xref>). In reference to the “French paradox” (that summarizes the apparently paradoxical epidemiological observation that the frequency of ischemic heart diseases in France is relatively moderate despite having a diet rich in cholesterol (Richard <xref ref-type="bibr" rid="CR320">1987</xref>)), one might therefore speak of an “AMD-paradox” describing the seemingly paradoxical association of markers of enhanced RCT with AMD, despite the obvious morphological and molecular similarities between cholesterol-rich drusen and atherosclerotic lesions.</p></sec><sec id="Sec50"><title>AMD and apolipoprotein E</title><p id="Par145">APOE is expressed in the liver and is the main lipoprotein of the brain and the retina (Mahley and Rall <xref ref-type="bibr" rid="CR238">2000</xref>; Anderson et al. <xref ref-type="bibr" rid="CR9">2001</xref>). It is strongly secreted by hepatocytes, but also in the RPE (Ishida et al. <xref ref-type="bibr" rid="CR166">2004</xref>) and in mononuclear phagocytes (MPs), such as Mφs and MCs (Levy et al. <xref ref-type="bibr" rid="CR225">2015a</xref>; Peri and Nusslein-Volhard <xref ref-type="bibr" rid="CR282">2008</xref>). As mentioned above, APOE plays a major role in macrophage lipid efflux and RCT in conjunction with APOA-I (Mahley et al. <xref ref-type="bibr" rid="CR239">2009</xref>; Mahley and Rall <xref ref-type="bibr" rid="CR238">2000</xref>; Peri and Nusslein-Volhard <xref ref-type="bibr" rid="CR282">2008</xref>). APOE, APOA-I, and cholesterol can also influence innate immunity. Cholesterol crystals can activate the innate immunity receptor cluster, formed by toll-like receptors (e.g., TLR2, TLR4) and obligate co-receptors (such as CD14) that activate Myd88, NFκB and induce inflammatory cytokines (CCL2, IL-6, TNFα, etc.). APOE and APOA-I can also bind and neutralize lipophilic TLR ligands (such as β-amyloid and LPS) and inhibit the induction of inflammatory cytokines (Azzam and Fessler <xref ref-type="bibr" rid="CR14">2012</xref>). But an excess of APOE and APOA-I can also activate the TLR2-TLR4-CD14-dependent IIRC, in the absence of extracellular ligands: Under physiological conditions, the different components of the IIRC of Mφs are separated from each other, as some elements cluster to cholesterol-rich membrane domains called lipid rafts (e.g., CD14) while others are located in the non-raft plasma membrane (e.g., TLR2 and TLR4) (Pfeiffer et al. <xref ref-type="bibr" rid="CR287">2001</xref>). IIRC ligands, such as bacterial lipopolysaccharides, overcome this separation, as they bind to the extracellular domains of both co-receptors (CD14 and TLRs), bringing the receptors and their intracellular domains closely together, which activates Myd88, NFκB and induces the transcription of inflammatory cytokines (Schmitz and Orso <xref ref-type="bibr" rid="CR346">2002</xref>). However, in the absence of IIRC ligands, excessive APOA-I and/or APOE can extract enough cholesterol from the lipid raft to lift the physiological separation of the IIRC co-receptors and trigger the intracellular signaling (Levy et al. <xref ref-type="bibr" rid="CR225">2015a</xref>; Smoak et al. <xref ref-type="bibr" rid="CR363">2010</xref>). In sterile inflammation, excessive APOA-I and APOE can thereby induce inflammatory cytokines such as IL-6 and CCL2 (Levy et al. <xref ref-type="bibr" rid="CR225">2015a</xref>; Smoak et al. <xref ref-type="bibr" rid="CR363">2010</xref>).</p><p id="Par146">In AMD, APOA-I levels are elevated in the vitreous (Koss et al. <xref ref-type="bibr" rid="CR197">2014</xref>) and serum (Paun et al. <xref ref-type="bibr" rid="CR279">2015</xref>) and APOE accumulates in drusen (Klaver et al. <xref ref-type="bibr" rid="CR180">1998</xref>) and is strongly expressed by subretinal MPs (Levy et al. <xref ref-type="bibr" rid="CR225">2015a</xref>). In mice, we showed that subretinal MPs of <italic>Cx3cr1</italic><sup><italic>GFP/GFP</italic></sup>-mice that develop subretinal inflammation and cardinal features of AMD (Combadiere et al. <xref ref-type="bibr" rid="CR67">2007</xref>) express similar high levels of APOE (Levy et al. <xref ref-type="bibr" rid="CR225">2015a</xref>), but also IL-6 (Levy et al. <xref ref-type="bibr" rid="CR225">2015a</xref>) and CCL2 (Sennlaub et al. <xref ref-type="bibr" rid="CR351">2013</xref>). Increased levels of CCL2 and IL6 are also observed in late AMD (Sennlaub et al. <xref ref-type="bibr" rid="CR351">2013</xref>; Jonas et al. <xref ref-type="bibr" rid="CR171">2010</xref>; Seddon et al. <xref ref-type="bibr" rid="CR348">2005</xref>; Chalam et al. <xref ref-type="bibr" rid="CR58">2014</xref>). <italic>ApoE</italic> deletion in <italic>Cx3cr1</italic><sup><italic>GFP/GFP</italic></sup>-mice nearly completely prevented age- and stress-induced pathogenic subretinal MP accumulation (Levy et al. <xref ref-type="bibr" rid="CR225">2015a</xref>). Mechanistically, APOE-induced IL-6 release from MPs represses RPE immune-suppression and prolongs subretinal MP survival and accumulation (Levy et al. <xref ref-type="bibr" rid="CR225">2015a</xref>). Additionally, APOE-dependent increase of CCL2 recruits pathogenic inflammatory CCR2<sup>+</sup> monocytes to the subretinal space (Sennlaub et al. <xref ref-type="bibr" rid="CR351">2013</xref>). Excessive APOE, and possibly APOA-I, can thereby induce chronic, pathogenic MP accumulation due to decreased MP elimination (IL-6) and increased MP recruitment (CCL2).</p><p id="Par147">In humans, the <italic>APOE</italic> gene has three common genetic variants (<italic>APOE2</italic>, <italic>APOE3</italic>, and <italic>APOE4</italic>) that lead to six possible diplotypes. <italic>APOE4</italic>, believed to be the ancestral form (Raichlen and Alexander <xref ref-type="bibr" rid="CR307">2014</xref>), evolved to <italic>APOE3</italic>, and <italic>APOE3</italic> to <italic>APOE2</italic> due to two polymorphisms (rs429358 and rs7412, respectively) that are imbedded in a well-defined CpG island, and lead to two cysteine-arginine interchanges at residues 112 and 158 (Yu et al. <xref ref-type="bibr" rid="CR433">2013</xref>). In most populations, <italic>APOE3</italic> is now the most common isoform (80% frequency) compared to <italic>APOE4</italic>- (14% frequency) and <italic>APOE2</italic>-isoforms (6% frequency). The <italic>APOE</italic> isoforms are associated with several common, age-related diseases. Notably, the <italic>APOE4</italic>-allele is the most important genetic risk factor for Alzheimer’s disease and a risk factor of atherosclerosis, while <italic>APOE2</italic> is protective for Alzheimer disease and atherosclerosis (except if associated with type III familial hyperlipiproteinemia) (Mahley et al. <xref ref-type="bibr" rid="CR239">2009</xref>; Herz and Beffert <xref ref-type="bibr" rid="CR154">2000</xref>; Davignon et al. <xref ref-type="bibr" rid="CR82">1988</xref>). Curiously, the association with AMD is inversed: <italic>APOE2</italic>-allele carriers are at increased risk for developing late AMD (OR = 1.83 for homozygote carriers), while the <italic>APOE4</italic>-allele protects for AMD (OR = 0.72 per haplotype) compared to the most common <italic>APOE3</italic>-allele recently confirmed in a worldwide study comprising 20,000 subjects (McKay et al. <xref ref-type="bibr" rid="CR251">2011</xref>). This association was found for both clinical forms of late AMD, but not for early/intermediate AMD (Paun et al. <xref ref-type="bibr" rid="CR279">2015</xref>), suggesting the APOE isoforms are not primarily implicated in the lipid accumulation in drusen genesis. Indeed, the targeted replacement mice expressing the human APOE4 (TRE4), and not APOE2 (TRE2), accumulate most lipids in Bruchs membrane compared to APOE3-expressing TRE3 mice (Malek et al. <xref ref-type="bibr" rid="CR241">2005</xref>), although <italic>APOE4-</italic>allele plays a protective role in human AMD (McKay et al. <xref ref-type="bibr" rid="CR251">2011</xref>). Similar, lipid deposits are also observed in APOE<sup>−/−</sup> mice (Ong et al. <xref ref-type="bibr" rid="CR272">2001</xref>), but AMD is associated with increased APOE immunoreactivity (Levy et al. <xref ref-type="bibr" rid="CR225">2015a</xref>; Anderson et al. <xref ref-type="bibr" rid="CR9">2001</xref>; Klaver et al. <xref ref-type="bibr" rid="CR180">1998</xref>) in the human disease. These results suggest that the reasons for the association of the APOE isoforms with AMD are not due to a decreased capacity to evacuate cholesterol from Bruchs membrane.</p><p id="Par148">The <italic>APOE</italic> isoforms are also associated with differences in APOE abundance: APOE plasma concentrations are significantly higher in homozygous <italic>APOE2</italic>-diplotype carriers and lower in <italic>APOE4</italic>-carriers compared to the <italic>APOE3</italic> homozygous diplotype (<italic>E2/E2</italic>: 13.8 mg/dl; <italic>E3/E2</italic>: 7.3 mg/dl; <italic>E4/E2</italic>: 6.7; <italic>E3/E3</italic>: 5.5 mg/dl; <italic>E3/E4</italic>: 5 mg/dl; <italic>E4/E4</italic>: 4.4 mg/dl) (Smit et al. <xref ref-type="bibr" rid="CR360">1988</xref>). The increased APOE concentrations associated with the <italic>APOE2</italic> isoform are likely due to its decreased affinity for the LDL receptor and impaired clearance (Mahley and Rall <xref ref-type="bibr" rid="CR238">2000</xref>), but also to increased transcription in certain cell types (astrocytes and Mφs), due to the loss of a CpG site present in the <italic>APOE3</italic>-alleles (Levy et al. <xref ref-type="bibr" rid="CR226">2015b</xref>; Yu et al. <xref ref-type="bibr" rid="CR433">2013</xref>). <italic>APOE2</italic>-carriers also display higher APOE concentrations in cerebrospinal fluid, brain tissue, and the retina (Riddell et al. <xref ref-type="bibr" rid="CR321">2008</xref>; Bales et al. <xref ref-type="bibr" rid="CR16">2009</xref>; Levy et al. <xref ref-type="bibr" rid="CR226">2015b</xref>). Compared to the <italic>APOE3</italic>-allele, the <italic>APOE4</italic>-allele is transcribed similarly in neurons, astrocytes, and Mφs (Levy et al. <xref ref-type="bibr" rid="CR226">2015b</xref>; Yu et al. <xref ref-type="bibr" rid="CR433">2013</xref>), but its protein concentration in plasma (see above), CSF, brain, and retina are decreased (Riddell et al. <xref ref-type="bibr" rid="CR321">2008</xref>; Bales et al. <xref ref-type="bibr" rid="CR16">2009</xref>; Sullivan et al. <xref ref-type="bibr" rid="CR371">2011</xref>; Levy et al. <xref ref-type="bibr" rid="CR226">2015b</xref>). The structural changes in the APOE4 protein also lead to diminished association with HDL (Dong and Weisgraber <xref ref-type="bibr" rid="CR88">1996</xref>) and impaired reverse cholesterol transport (Heeren et al. <xref ref-type="bibr" rid="CR150">2004</xref>; Mahley et al. <xref ref-type="bibr" rid="CR239">2009</xref>).</p><p id="Par149">Using the targeted replacement mice expressing the human APOE isoforms (TRE2, TRE3, and TRE4), we recently showed that the increased levels of APOE in MPs of <italic>TRE2</italic>-mice, activates the IIRC and induces IL-6, and CCL2 (Levy et al. <xref ref-type="bibr" rid="CR226">2015b</xref>) similar to <italic>Cx3cr1</italic><sup><italic>GFP/GFP</italic></sup>-mice (Levy et al. <xref ref-type="bibr" rid="CR225">2015a</xref>). As a consequence, <italic>TRE2</italic>-mice develop subretinal MP accumulation, photoreceptor degeneration, and exaggerated choroidal neovascularization akin to AMD (Levy et al. <xref ref-type="bibr" rid="CR226">2015b</xref>). In the context of APOE-dependent subretinal inflammation in <italic>Cx3cr1</italic><sup><italic>GFP/GFP</italic></sup>-mice, the <italic>APOE4</italic>-allele led to diminished APOE tissue levels and CCL2 levels and protected <italic>Cx3cr1</italic><sup><italic>GFP/GFP</italic></sup>-mice against harmful subretinal MP accumulation observed in <italic>Cx3cr1</italic><sup><italic>GFP/GFP</italic></sup><italic>TRE3</italic> mice (Levy et al. <xref ref-type="bibr" rid="CR226">2015b</xref>).</p><p id="Par150">A possible pathogenic role of excessive cholesterol extraction and IIRC activation in AMD is also supported by the observation of increased APOA-I levels in AMD patients (Paun et al. <xref ref-type="bibr" rid="CR279">2015</xref>; Koss et al. <xref ref-type="bibr" rid="CR197">2014</xref>), the protective effect of an ABCA1 polymorphism (associated with possibly impaired RCT) (Chen et al. <xref ref-type="bibr" rid="CR62">2010</xref>), and clinical studies showing that statins (that inhibit cholesterol synthesis) can accelerate the progression to late AMD (VanderBeek et al. <xref ref-type="bibr" rid="CR400">2013</xref>).</p><p id="Par151">Our study also sheds an interesting light on the puzzling differences of the APOE isoform association with AMD (McKay et al. <xref ref-type="bibr" rid="CR251">2011</xref>) and Alzheimer disease (Mahley and Rall <xref ref-type="bibr" rid="CR238">2000</xref>), two major age-related neurodegenerative diseases: In Alzheimer disease, the <italic>APOE4</italic>-allele is associated with greater β-amyloid burden, possibly due to decreased APOE tissue concentrations and reduced efficacy in clearance of β-amyloid clearance via multiple pathways (Bales et al. <xref ref-type="bibr" rid="CR16">2009</xref>; Mahley et al. <xref ref-type="bibr" rid="CR239">2009</xref>). Accordingly, Cx3cr1<sup>−/−</sup>mice that express increased amounts of APOE in MPs, including MCs (Levy et al. <xref ref-type="bibr" rid="CR225">2015a</xref>), are protected against beta-amyloid deposition in Alzheimer disease mouse models (Lee et al. <xref ref-type="bibr" rid="CR220">2010b</xref>).</p><p id="Par152">While a lack of APOE and RCT might play a pathogenic role due to reduced efficacy of cholesterol and β-amyloid clearance in atherosclerosis (Mahley et al. <xref ref-type="bibr" rid="CR239">2009</xref>) and Alzheimer disease (Bales et al. <xref ref-type="bibr" rid="CR16">2009</xref>; Mahley et al. <xref ref-type="bibr" rid="CR239">2009</xref>), excessive APOE and RCT might be responsible for IIRC activation and chronic inflammation in AMD. These fascinating differences might help explain the APOE/cholesterol paradox of age-related macular degeneration.</p></sec></sec><sec id="Sec51" sec-type="conclusions"><title>Conclusions</title><p id="Par153">This review explores the phenomenon of paradoxical relationships in biology, particularly as they relate to ageing and the etiology and/or progression of age-related diseases (Fig. <xref rid="Fig5" ref-type="fig">5</xref>).<fig id="Fig5"><label>Fig. 5</label><caption xml:lang="en"><p>Paradoxical relationships in the oxygen paradox and age-related, organ-based diseases. The figure points out just some of the paradoxical relationships between substances (free radicals, antioxidants) or gene products (RCAN1, HDL), oxygen itself, sunlight, fatty foods, hypoxia and reperfusion, etc. at low versus high concentrations, doses, or exposures that have been discussed in this review, and common age-related diseases of major organs. Please note that space limitations preclude a truly exhaustive listing or pictography</p></caption><graphic specific-use="web" mime-subtype="GIF" xlink:href="MediaObjects/11357_2017_2_Fig5_HTML.gif" id="MO5"/></fig></p><p id="Par154">Our particular focus is on the oxygen paradox as a means of exploring the potential underlying mechanisms responsible for the French paradox. We discuss adaptive homeostasis and how environmental signals, such as sub-toxic, non-damaging levels of oxidants can trigger the body’s defense mechanisms to confer protection against further assaults. We also examine how the decline of adaptive homeostasis associated with age brings with it a decreased ability to respond to stress. This review also discusses age-associated dysfunction in major human organs where we explore several mechanisms of defense and degeneration. The common theme in age-related oxidative damage is an imbalance in the redox state, accompanied with increased oxidative stress. For example, in bones oxidative stress is a major mediator of bone loss, as well as in the skin where reactive oxygen species damage is responsible for photoaging. Similarly, neurodegenerative diseases and ocular degeneration also have their roots in oxidatively generated damage.</p><p id="Par155">The oxygen paradox, specifically the dangers of imbalanced oxygen or oxygen radical levels is clearly illustrated in the lungs and heart. In the lungs, the oxygen paradox was clearly experienced during the early development of treatments for ARDS-related hypoxemia with high FIO2 volume ventilation used to try to regain normoxemia. It was quickly found, however, that a large influx of oxygen would often result in oxygen toxicity and lead to worsening of the lung injury. A balance was needed to find a “safe” and low FIO<sub>2</sub> level that would result in an effective treatment of ARDS. In the heart, the oxygen paradox is illustrated by the pathology of myocardial ischemia where blood flow is initially restricted, but then is quickly restored leading to reperfusion injury. During and after reperfusion is a time of considerable oxidative stress that leads to extensive cellular damage. However, should a myocardial infarction actually occur, treatment is most successful if administered in the small-time window pre-reperfusion. The detrimental reduction in available oxygen as a result of myocardial ischemia followed by the toxicity of high oxygen exposure after reperfusion is a prime (but unfortunate) example of the oxygen paradox in action.</p><p id="Par156">The potency of controlling redox balance is well illustrated in the context of cancer. On one hand, cancer cells increase reactive oxygen species and generate DNA damage, malignant transformation, and metabolic perturbations that provide the necessary resources for growth. On the other hand, cancer cells increase antioxidant activity during cancer progression to protect from excessive reactive oxygen species production, thus avoiding a toxic threshold. Disrupting this balance has been shown to have promising results in fighting certain breast and ovarian cancers, where chemotherapies involving high basal levels of reactive oxygen species have shown clinical promise. Exercise regimens also appear to initiate antioxidant mechanisms that may inhibit critical components essential to tumor growth. Nevertheless, these potential remedies must be applied cautiously because antioxidant supplementation has also been found to protect and encourage the grown of cancers. Identifying an individual’s redox status and applying oxidation/reduction-based therapies may 1 day prove to be a useful approach in cancer treatment.</p><p id="Par157">The treatment of many disease states and age-related outcomes all have commonalities in restoring or maintaining redox balance. Diet-derived antioxidants show some promise in preventing certain types of cataracts, while the contributing to bone health and repair. Exercise, which stimulates cognitive and motor function, has been shown to affect metabolism and, in turn, affect neuroplasticity. The Oxygen Paradox is a story of imbalance in the redox state, while the French Paradox is a potential illustration of robust mechanisms that allow for the maintenance of redox balance. This review highlights the consequences of redox state imbalances that affect the ageing process, as well as many age-related diseases.</p></sec></body><back><ack><title>Acknowledgements</title><p>This review was initiated as a result of the Paradox Workshop held at the Hospital of the Good Samaritan in Los Angeles, CA, USA, from October 13–16, 2016. The Workshop was organized by Drs. Joanna M. S. Davies, Kelvin J. A. Davies, Josiane Cillard, Bertrand Friguet, Enrique Cadenas, and Pierre Cillard. The Hospital of the Good Samaritan, through a generous gift from Mr. George Joseph, the Consulate of France in Los Angeles, and the Leonard Davis School of Gerontology of the University of Southern California were major sponsors of the Workshop. The organizers and the authors of this paper would particularly like to thank Mr. George Joseph, Mr. Andrew B. Leeka (President &amp; CEO of the Hospital of the Good Samaritan), Mr. Brian Thorne (Vice President for Fund Development at the Hospital of the Good Samaritan), M. Christophe Lemoine (Consul Général of France in Los Angeles), and M. Fabien Agenès and Dr. Jean Rosenbaum (both Attachés for Science &amp; Technology of the Office for Science and Technology of the Embassy of France in the United States) for their invaluable support, assistance, and encouragement.</p></ack><sec><title>Funding information</title><p>LCD Pomatto was supported by grant #DGE-1418060 of the USA National Science Foundation. HJ Forman was supported by grant #ES023864 from the National Institute of Environmental Health Sciences of the US National Institutes of Health. F Derbré and A. Rebillard thank the Region Bretagne, France for financial support of their research. F. Mechta-Grigoriou was supported by the Institut National de la Santé et de la Recherche Médicale (Inserm), the Institut Curie and the Ligue Nationale Contre le Cancer (Labelisation), France. CE Finch was supported by grant # AG-040753 from the National Institute on Aging of the US National Institutes of Health. CJ Pike was supported by grant # AG058068 from the National Institute on Aging of the US National Institutes of Health. M Mericksay was supported by Agence nationale de la recherche (NAD-Heart) and Fondation de France. AN Salvayre was supported by the Institut National pour la Santé et la Recherche Médicale” (INSERM) by the Centre National pour la Recherche Scientifique (CNRS) and by the Université Paul Sabatier, Toulouse, France. D Sauce and J. Capeau were supported by the Institut National pour la Santé et la Recherche Médicale (INSERM) and by the Université Pierre et Marie Curie (UPMC), France. B Friguet, J Mariani, Z Li, I Limon, and M Ruis were supported by INSERM, CNRS and the Université Pierre et Marie Curie (UPMC), France. C. Neri and J. Mariani were supported by a grant from Assistance Publique des Hopitaux de Paris (DHU Fight Aging &amp; Stress). P Cohen was supported by grant number DOD-PC160353U from the US Department of Defense, by grant # P01AG034906 and R01AG034430 from the National Institute on Aging of the US National Institutes of Health, by grant #R01ES020812 from the National Institute of Environmental Health Sciences of the US National Institutes of Health, and by a ‘BIG’ award from the American Foundation for Aging Research (AFAR). M Jakowec, G. Petzinger, MR Halliday, AJ Lindquist, and NA Jakowec were supported by grants from the Don Roberto Gonzalez and Family Foundation and from the National Parkinson Foundation. D Warburton was supported by grant #U01HL122681from the National Heart, Lung, and Blood Institute of the US National Institutes of Health; by grant #D43ES022862 from the National Institute of Environmental Health Sciences of the US National Institutes of Health; and by Philanthropic support from the Pasadena Guild, the Children’s Hospital Los Angeles, the Webb Foundation, and the Garland Foundation. KJA Davies wa<bold>s</bold> supported by grant #ES003598 from the National Institute of Environmental Health Sciences of the US National Institutes of Health. KJA Davies and PY Sun were supported by grant # AG052374 from the National Institute on Aging of the US National Institutes of Health.</p></sec><ref-list id="Bib1"><title>References</title><ref-list><ref id="CR1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>U</given-names></name><etal/></person-group><article-title xml:lang="en">Protein oxidation, nitration and glycation biomarkers for early-stage diagnosis of osteoarthritis of the knee and typing and progression of arthritic disease</article-title><source>Arthritis Res Ther</source><year>2016</year><volume>18</volume><issue>1</issue><fpage>250</fpage><pub-id pub-id-type="pmid">27788684</pub-id><pub-id pub-id-type="pmcid">5081671</pub-id><pub-id pub-id-type="doi">10.1186/s13075-016-1154-3</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXitVWksr%2FJ</pub-id></mixed-citation></ref><ref id="CR2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alam</surname><given-names>ZI</given-names></name><etal/></person-group><article-title xml:lang="en">A generalised increase in protein carbonyls in the brain in Parkinson’s but not incidental Lewy body disease</article-title><source>J Neurochem</source><year>1997</year><volume>69</volume><issue>3</issue><fpage>1326</fpage><lpage>1329</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK2sXls1Chu70%3D</pub-id><pub-id pub-id-type="pmid">9282961</pub-id><pub-id pub-id-type="doi">10.1046/j.1471-4159.1997.69031326.x</pub-id></mixed-citation></ref><ref id="CR3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alam</surname><given-names>ZI</given-names></name><etal/></person-group><article-title xml:lang="en">Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra</article-title><source>J Neurochem</source><year>1997</year><volume>69</volume><issue>3</issue><fpage>1196</fpage><lpage>1203</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK2sXls1Chtbs%3D</pub-id><pub-id pub-id-type="pmid">9282943</pub-id><pub-id pub-id-type="doi">10.1046/j.1471-4159.1997.69031196.x</pub-id></mixed-citation></ref><ref id="CR4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alberti</surname><given-names>KGM</given-names></name><name><surname>Zimmet</surname><given-names>P</given-names></name><name><surname>Shaw</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">The metabolic syndrome—a new worldwide definition</article-title><source>Lancet</source><year>2005</year><volume>366</volume><issue>9491</issue><fpage>1059</fpage><lpage>1062</lpage><pub-id pub-id-type="pmid">16182882</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(05)67402-8</pub-id></mixed-citation></ref><ref id="CR5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alcalay</surname><given-names>RN</given-names></name><etal/></person-group><article-title xml:lang="en">The association between Mediterranean diet adherence and Parkinson’s disease</article-title><source>Mov Disord</source><year>2012</year><volume>27</volume><issue>6</issue><fpage>771</fpage><lpage>774</lpage><pub-id pub-id-type="pmid">22314772</pub-id><pub-id pub-id-type="pmcid">3349773</pub-id><pub-id pub-id-type="doi">10.1002/mds.24918</pub-id></mixed-citation></ref><ref id="CR6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexandre</surname><given-names>J</given-names></name><etal/></person-group><article-title xml:lang="en">Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species</article-title><source>Cancer Res</source><year>2007</year><volume>67</volume><issue>8</issue><fpage>3512</fpage><lpage>3517</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2sXkt1Kjtb8%3D</pub-id><pub-id pub-id-type="pmid">17440056</pub-id><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-06-3914</pub-id></mixed-citation></ref><ref id="CR7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>A</given-names></name><name><surname>Messier</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">Plastic changes in the astrocyte GLUT1 glucose transporter and beta-tubulin microtubule protein following voluntary exercise in mice</article-title><source>Behav Brain Res</source><year>2013</year><volume>240</volume><fpage>95</fpage><lpage>102</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3sXnvFSksQ%3D%3D</pub-id><pub-id pub-id-type="pmid">23201358</pub-id><pub-id pub-id-type="doi">10.1016/j.bbr.2012.11.025</pub-id></mixed-citation></ref><ref id="CR8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altindag</surname><given-names>O</given-names></name><etal/></person-group><article-title xml:lang="en">Total oxidative/anti-oxidative status and relation to bone mineral density in osteoporosis</article-title><source>Rheumatol Int</source><year>2008</year><volume>28</volume><issue>4</issue><fpage>317</fpage><lpage>321</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD1cXjsFahsA%3D%3D</pub-id><pub-id pub-id-type="pmid">17823800</pub-id><pub-id pub-id-type="doi">10.1007/s00296-007-0452-0</pub-id></mixed-citation></ref><ref id="CR9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>DH</given-names></name><etal/></person-group><article-title xml:lang="en">Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation</article-title><source>Am J Ophthalmol</source><year>2001</year><volume>131</volume><issue>6</issue><fpage>767</fpage><lpage>781</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3MXjvFSitLw%3D</pub-id><pub-id pub-id-type="pmid">11384575</pub-id><pub-id pub-id-type="doi">10.1016/S0002-9394(00)00961-2</pub-id></mixed-citation></ref><ref id="CR10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armour</surname><given-names>KJ</given-names></name><etal/></person-group><article-title xml:lang="en">Activation of the inducible nitric oxide synthase pathway contributes to inflammation-induced osteoporosis by suppressing bone formation and causing osteoblast apoptosis</article-title><source>Arthritis Rheum</source><year>2001</year><volume>44</volume><issue>12</issue><fpage>2790</fpage><lpage>2796</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD38XislClsw%3D%3D</pub-id><pub-id pub-id-type="pmid">11762939</pub-id><pub-id pub-id-type="doi">10.1002/1529-0131(200112)44:12&lt;2790::AID-ART466&gt;3.0.CO;2-X</pub-id></mixed-citation></ref><ref id="CR11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnold</surname><given-names>JM</given-names></name><etal/></person-group><article-title xml:lang="en">Inotropic stimulation of reperfused myocardium with dopamine: effects on infarct size and myocardial function</article-title><source>J Am Coll Cardiol</source><year>1985</year><volume>6</volume><issue>5</issue><fpage>1026</fpage><lpage>1034</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaL28XhsFGksw%3D%3D</pub-id><pub-id pub-id-type="pmid">4045027</pub-id><pub-id pub-id-type="doi">10.1016/S0735-1097(85)80305-3</pub-id></mixed-citation></ref><ref id="CR12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Assi</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Antioxidant supplementation accelerates cachexia development by promoting tumor growth in C26 tumor-bearing mice</article-title><source>Free Radic Biol Med</source><year>2016</year><volume>91</volume><fpage>204</fpage><lpage>214</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXitVyqsrfJ</pub-id><pub-id pub-id-type="pmid">26708754</pub-id><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2015.12.019</pub-id></mixed-citation></ref><ref id="CR13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Attwell</surname><given-names>D</given-names></name><name><surname>Laughlin</surname><given-names>SB</given-names></name></person-group><article-title xml:lang="en">An energy budget for signaling in the grey matter of the brain</article-title><source>J Cereb Blood Flow Metab</source><year>2001</year><volume>21</volume><issue>10</issue><fpage>1133</fpage><lpage>1145</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3MXot1Ggsbc%3D</pub-id><pub-id pub-id-type="pmid">11598490</pub-id><pub-id pub-id-type="doi">10.1097/00004647-200110000-00001</pub-id></mixed-citation></ref><ref id="CR14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azzam</surname><given-names>KM</given-names></name><name><surname>Fessler</surname><given-names>MB</given-names></name></person-group><article-title xml:lang="en">Crosstalk between reverse cholesterol transport and innate immunity</article-title><source>Trends Endocrinol Metab</source><year>2012</year><volume>23</volume><issue>4</issue><fpage>169</fpage><lpage>178</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC38Xjs1Grtr8%3D</pub-id><pub-id pub-id-type="pmid">22406271</pub-id><pub-id pub-id-type="pmcid">3338129</pub-id><pub-id pub-id-type="doi">10.1016/j.tem.2012.02.001</pub-id></mixed-citation></ref><ref id="CR15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Badouard</surname><given-names>C</given-names></name><etal/></person-group><article-title xml:lang="en">Determination of new types of DNA lesions in human sperm</article-title><source>Zygote</source><year>2008</year><volume>16</volume><issue>1</issue><fpage>9</fpage><lpage>13</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD1cXhtVGmtrs%3D</pub-id><pub-id pub-id-type="pmid">18221576</pub-id><pub-id pub-id-type="doi">10.1017/S0967199407004340</pub-id></mixed-citation></ref><ref id="CR16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bales</surname><given-names>KR</given-names></name><etal/></person-group><article-title xml:lang="en">Human APOE isoform-dependent effects on brain beta-amyloid levels in PDAPP transgenic mice</article-title><source>J Neurosci</source><year>2009</year><volume>29</volume><issue>21</issue><fpage>6771</fpage><lpage>6779</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD1MXmvVGisrs%3D</pub-id><pub-id pub-id-type="pmid">19474305</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0887-09.2009</pub-id></mixed-citation></ref><ref id="CR17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ballard-Barbash</surname><given-names>R</given-names></name><etal/></person-group><article-title xml:lang="en">Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review</article-title><source>J Natl Cancer Inst</source><year>2012</year><volume>104</volume><issue>11</issue><fpage>815</fpage><lpage>840</lpage><pub-id pub-id-type="pmid">22570317</pub-id><pub-id pub-id-type="pmcid">3465697</pub-id><pub-id pub-id-type="doi">10.1093/jnci/djs207</pub-id></mixed-citation></ref><ref id="CR18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baraibar</surname><given-names>MA</given-names></name><name><surname>Friguet</surname><given-names>B</given-names></name></person-group><article-title xml:lang="en">Oxidative proteome modifications target specific cellular pathways during oxidative stress, cellular senescence and aging</article-title><source>Exp Gerontol</source><year>2013</year><volume>48</volume><issue>7</issue><fpage>620</fpage><lpage>625</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC38XhslyntrfM</pub-id><pub-id pub-id-type="pmid">23127722</pub-id><pub-id pub-id-type="doi">10.1016/j.exger.2012.10.007</pub-id></mixed-citation></ref><ref id="CR19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barros</surname><given-names>LF</given-names></name></person-group><article-title xml:lang="en">Metabolic signaling by lactate in the brain</article-title><source>Trends Neurosci</source><year>2013</year><volume>36</volume><issue>7</issue><fpage>396</fpage><lpage>404</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3sXmvVSqu7w%3D</pub-id><pub-id pub-id-type="pmid">23639382</pub-id><pub-id pub-id-type="doi">10.1016/j.tins.2013.04.002</pub-id></mixed-citation></ref><ref id="CR20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batista</surname><given-names>L</given-names></name><name><surname>Gruosso</surname><given-names>T</given-names></name><name><surname>Mechta-Grigoriou</surname><given-names>F</given-names></name></person-group><article-title xml:lang="en">Ovarian cancer emerging subtypes: role of oxidative stress and fibrosis in tumour development and response to treatment</article-title><source>Int J Biochem Cell Biol</source><year>2013</year><volume>45</volume><issue>6</issue><fpage>1092</fpage><lpage>1098</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3sXmt1Cltrc%3D</pub-id><pub-id pub-id-type="pmid">23500525</pub-id><pub-id pub-id-type="doi">10.1016/j.biocel.2013.03.001</pub-id></mixed-citation></ref><ref id="CR21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batista</surname><given-names>L</given-names></name><etal/></person-group><article-title xml:lang="en">Regulation of miR-200c/141 expression by intergenic DNA-looping and transcriptional read-through</article-title><source>Nat Commun</source><year>2016</year><volume>7</volume><fpage>8959</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28XjslSrtg%3D%3D</pub-id><pub-id pub-id-type="pmid">26725650</pub-id><pub-id pub-id-type="pmcid">4727242</pub-id><pub-id pub-id-type="doi">10.1038/ncomms9959</pub-id></mixed-citation></ref><ref id="CR22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Battie</surname><given-names>C</given-names></name><etal/></person-group><article-title xml:lang="en">New insights in photoaging, UVA induced damage and skin types</article-title><source>Exp Dermatol</source><year>2014</year><volume>23</volume><issue>Suppl 1</issue><fpage>7</fpage><lpage>12</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2cXhsF2ntbfO</pub-id><pub-id pub-id-type="pmid">25234829</pub-id><pub-id pub-id-type="doi">10.1111/exd.12388</pub-id></mixed-citation></ref><ref id="CR23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bax</surname><given-names>BE</given-names></name><etal/></person-group><article-title xml:lang="en">Stimulation of osteoclastic bone resorption by hydrogen peroxide</article-title><source>Biochem Biophys Res Commun</source><year>1992</year><volume>183</volume><issue>3</issue><fpage>1153</fpage><lpage>1158</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaK383jtFyktQ%3D%3D</pub-id><pub-id pub-id-type="pmid">1567393</pub-id><pub-id pub-id-type="doi">10.1016/S0006-291X(05)80311-0</pub-id></mixed-citation></ref><ref id="CR24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beckman</surname><given-names>KB</given-names></name><name><surname>Ames</surname><given-names>BN</given-names></name></person-group><article-title xml:lang="en">The free radical theory of aging matures</article-title><source>Physiol Rev</source><year>1998</year><volume>78</volume><issue>2</issue><fpage>547</fpage><lpage>581</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK1cXislakurg%3D</pub-id><pub-id pub-id-type="pmid">9562038</pub-id><pub-id pub-id-type="doi">10.1152/physrev.1998.78.2.547</pub-id></mixed-citation></ref><ref id="CR25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellamy</surname><given-names>V</given-names></name><etal/></person-group><article-title xml:lang="en">Long-term functional benefits of human embryonic stem cell-derived cardiac progenitors embedded into a fibrin scaffold</article-title><source>J Heart Lung Transplant</source><year>2015</year><volume>34</volume><issue>9</issue><fpage>1198</fpage><lpage>1207</lpage><pub-id pub-id-type="pmid">25534019</pub-id><pub-id pub-id-type="doi">10.1016/j.healun.2014.10.008</pub-id></mixed-citation></ref><ref id="CR26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellingan</surname><given-names>G</given-names></name><etal/></person-group><article-title xml:lang="en">The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study</article-title><source>Lancet Respir Med</source><year>2014</year><volume>2</volume><issue>2</issue><fpage>98</fpage><lpage>107</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2cXksleiurk%3D</pub-id><pub-id pub-id-type="pmid">24503265</pub-id><pub-id pub-id-type="doi">10.1016/S2213-2600(13)70259-5</pub-id></mixed-citation></ref><ref id="CR27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berger</surname><given-names>CE</given-names></name><etal/></person-group><article-title xml:lang="en">Scanning electrochemical microscopy at the surface of bone-resorbing osteoclasts: evidence for steady-state disposal and intracellular functional compartmentalization of calcium</article-title><source>J Bone Miner Res</source><year>2001</year><volume>16</volume><issue>11</issue><fpage>2092</fpage><lpage>2102</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3MXot12ltr4%3D</pub-id><pub-id pub-id-type="pmid">11697806</pub-id><pub-id pub-id-type="doi">10.1359/jbmr.2001.16.11.2092</pub-id></mixed-citation></ref><ref id="CR28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhosale</surname><given-names>AM</given-names></name><name><surname>Richardson</surname><given-names>JB</given-names></name></person-group><article-title xml:lang="en">Articular cartilage: structure, injuries and review of management</article-title><source>Br Med Bull</source><year>2008</year><volume>87</volume><fpage>77</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">18676397</pub-id><pub-id pub-id-type="doi">10.1093/bmb/ldn025</pub-id></mixed-citation></ref><ref id="CR29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bidault</surname><given-names>G</given-names></name><etal/></person-group><article-title xml:lang="en">Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2013</year><volume>33</volume><issue>9</issue><fpage>2162</fpage><lpage>2171</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3sXht1OqsbbK</pub-id><pub-id pub-id-type="pmid">23846499</pub-id><pub-id pub-id-type="doi">10.1161/ATVBAHA.113.301933</pub-id></mixed-citation></ref><ref id="CR30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birkenfeld</surname><given-names>AL</given-names></name><name><surname>Shulman</surname><given-names>GI</given-names></name></person-group><article-title xml:lang="en">Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes</article-title><source>Hepatology</source><year>2014</year><volume>59</volume><issue>2</issue><fpage>713</fpage><lpage>723</lpage><pub-id pub-id-type="pmid">23929732</pub-id><pub-id pub-id-type="pmcid">3946772</pub-id><pub-id pub-id-type="doi">10.1002/hep.26672</pub-id></mixed-citation></ref><ref id="CR31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bittar</surname><given-names>PG</given-names></name><etal/></person-group><article-title xml:lang="en">Selective distribution of lactate dehydrogenase isoenzymes in neurons and astrocytes of human brain</article-title><source>J Cereb Blood Flow Metab</source><year>1996</year><volume>16</volume><issue>6</issue><fpage>1079</fpage><lpage>1089</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK28XmvVCjsb0%3D</pub-id><pub-id pub-id-type="pmid">8898679</pub-id><pub-id pub-id-type="doi">10.1097/00004647-199611000-00001</pub-id></mixed-citation></ref><ref id="CR32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bizzarri</surname><given-names>C</given-names></name><etal/></person-group><article-title xml:lang="en">Requirements for the different cysteines in the chemotactic and desensitizing activity of human thioredoxin</article-title><source>Antioxid Redox Signal</source><year>2005</year><volume>7</volume><issue>9–10</issue><fpage>1189</fpage><lpage>1194</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2MXos1ertbs%3D</pub-id><pub-id pub-id-type="pmid">16115022</pub-id><pub-id pub-id-type="doi">10.1089/ars.2005.7.1189</pub-id></mixed-citation></ref><ref id="CR33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boden</surname><given-names>H</given-names></name><etal/></person-group><article-title xml:lang="en">Peak and fixed-time high-sensitive troponin for prediction of infarct size, impaired left ventricular function, and adverse outcomes in patients with first ST-segment elevation myocardial infarction receiving percutaneous coronary intervention</article-title><source>Am J Cardiol</source><year>2013</year><volume>111</volume><issue>10</issue><fpage>1387</fpage><lpage>1393</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3sXjtFSktb0%3D</pub-id><pub-id pub-id-type="pmid">23465094</pub-id><pub-id pub-id-type="doi">10.1016/j.amjcard.2013.01.284</pub-id></mixed-citation></ref><ref id="CR34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolli</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">Oxygen-derived free radicals and postischemic myocardial dysfunction (“stunned myocardium”)</article-title><source>J Am Coll Cardiol</source><year>1988</year><volume>12</volume><issue>1</issue><fpage>239</fpage><lpage>249</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaL1cXltVyhtbc%3D</pub-id><pub-id pub-id-type="pmid">3288676</pub-id><pub-id pub-id-type="doi">10.1016/0735-1097(88)90381-6</pub-id></mixed-citation></ref><ref id="CR35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonet-Costa</surname><given-names>V</given-names></name><name><surname>Pomatto</surname><given-names>LC</given-names></name><name><surname>Davies</surname><given-names>KJA</given-names></name></person-group><article-title xml:lang="en">The proteasome and oxidative stress in Alzheimer’s disease</article-title><source>Antioxid Redox Signal</source><year>2016</year><volume>25</volume><issue>16</issue><fpage>886</fpage><lpage>901</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28XhvFSmu7zK</pub-id><pub-id pub-id-type="pmid">27392670</pub-id><pub-id pub-id-type="pmcid">5124752</pub-id><pub-id pub-id-type="doi">10.1089/ars.2016.6802</pub-id></mixed-citation></ref><ref id="CR36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borek</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">Antioxidants and radiation therapy</article-title><source>J Nutr</source><year>2004</year><volume>134</volume><issue>11</issue><fpage>3207S</fpage><lpage>3209S</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2cXpvVGrsrw%3D</pub-id><pub-id pub-id-type="pmid">15514309</pub-id></mixed-citation></ref><ref id="CR37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosset</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">Photoageing shows histological features of chronic skin inflammation without clinical and molecular abnormalities</article-title><source>Br J Dermatol</source><year>2003</year><volume>149</volume><issue>4</issue><fpage>826</fpage><lpage>835</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3sXpsleisL4%3D</pub-id><pub-id pub-id-type="pmid">14616376</pub-id><pub-id pub-id-type="doi">10.1046/j.1365-2133.2003.05456.x</pub-id></mixed-citation></ref><ref id="CR38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bostwick</surname><given-names>DG</given-names></name><etal/></person-group><article-title xml:lang="en">Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer</article-title><source>Cancer</source><year>2000</year><volume>89</volume><issue>1</issue><fpage>123</fpage><lpage>134</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3cXltFKktrw%3D</pub-id><pub-id pub-id-type="pmid">10897009</pub-id><pub-id pub-id-type="doi">10.1002/1097-0142(20000701)89:1&lt;123::AID-CNCR17&gt;3.0.CO;2-9</pub-id></mixed-citation></ref><ref id="CR39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boumezbeur</surname><given-names>F</given-names></name><etal/></person-group><article-title xml:lang="en">The contribution of blood lactate to brain energy metabolism in humans measured by dynamic 13C nuclear magnetic resonance spectroscopy</article-title><source>J Neurosci</source><year>2010</year><volume>30</volume><issue>42</issue><fpage>13983</fpage><lpage>13991</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3cXhtlyqtLvM</pub-id><pub-id pub-id-type="pmid">20962220</pub-id><pub-id pub-id-type="pmcid">2996729</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2040-10.2010</pub-id></mixed-citation></ref><ref id="CR40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyd</surname><given-names>GW</given-names></name></person-group><article-title xml:lang="en">An evolution-based hypothesis on the origin and mechanisms of autoimmune disease</article-title><source>Immunol Cell Biol</source><year>1997</year><volume>75</volume><issue>5</issue><fpage>503</fpage><lpage>507</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaK1c%2FptFOgtw%3D%3D</pub-id><pub-id pub-id-type="pmid">9429900</pub-id><pub-id pub-id-type="doi">10.1038/icb.1997.78</pub-id></mixed-citation></ref><ref id="CR41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyd</surname><given-names>AS</given-names></name><etal/></person-group><article-title xml:lang="en">The effects of chronic sunscreen use on the histologic changes of dermatoheliosis</article-title><source>J Am Acad Dermatol</source><year>1995</year><volume>33</volume><issue>6</issue><fpage>941</fpage><lpage>946</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaK28%2FpsFWjtA%3D%3D</pub-id><pub-id pub-id-type="pmid">7490363</pub-id><pub-id pub-id-type="doi">10.1016/0190-9622(95)90284-8</pub-id></mixed-citation></ref><ref id="CR42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyle</surname><given-names>WJ</given-names></name><name><surname>Simonet</surname><given-names>WS</given-names></name><name><surname>Lacey</surname><given-names>DL</given-names></name></person-group><article-title xml:lang="en">Osteoclast differentiation and activation</article-title><source>Nature</source><year>2003</year><volume>423</volume><issue>6937</issue><fpage>337</fpage><lpage>342</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3sXjs1ynu7g%3D</pub-id><pub-id pub-id-type="pmid">12748652</pub-id><pub-id pub-id-type="doi">10.1038/nature01658</pub-id></mixed-citation></ref><ref id="CR43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braunwald</surname><given-names>E</given-names></name><name><surname>Kloner</surname><given-names>RA</given-names></name></person-group><article-title xml:lang="en">The stunned myocardium: prolonged, postischemic ventricular dysfunction</article-title><source>Circulation</source><year>1982</year><volume>66</volume><issue>6</issue><fpage>1146</fpage><lpage>1149</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaL3s%2FltFensg%3D%3D</pub-id><pub-id pub-id-type="pmid">6754130</pub-id><pub-id pub-id-type="doi">10.1161/01.CIR.66.6.1146</pub-id></mixed-citation></ref><ref id="CR44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brochard</surname><given-names>V</given-names></name><etal/></person-group><article-title xml:lang="en">Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease</article-title><source>J Clin Invest</source><year>2009</year><volume>119</volume><issue>1</issue><fpage>182</fpage><lpage>192</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD1MXmtFCgsA%3D%3D</pub-id><pub-id pub-id-type="pmid">19104149</pub-id></mixed-citation></ref><ref id="CR45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brower</surname><given-names>RG</given-names></name><etal/></person-group><article-title xml:lang="en">Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome</article-title><source>N Engl J Med</source><year>2000</year><volume>342</volume><issue>18</issue><fpage>1301</fpage><lpage>1308</lpage><pub-id pub-id-type="pmid">10793162</pub-id><pub-id pub-id-type="doi">10.1056/NEJM200005043421801</pub-id></mixed-citation></ref><ref id="CR46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>L</given-names></name><etal/></person-group><article-title xml:lang="en">A prospective study of carotenoid intake and risk of cataract extraction in US men</article-title><source>Am J Clin Nutr</source><year>1999</year><volume>70</volume><issue>4</issue><fpage>517</fpage><lpage>524</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK1MXmsFCgtbk%3D</pub-id><pub-id pub-id-type="pmid">10500021</pub-id></mixed-citation></ref><ref id="CR47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Browning</surname><given-names>JD</given-names></name><etal/></person-group><article-title xml:lang="en">Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity</article-title><source>Hepatology</source><year>2004</year><volume>40</volume><issue>6</issue><fpage>1387</fpage><lpage>1395</lpage><pub-id pub-id-type="pmid">15565570</pub-id><pub-id pub-id-type="doi">10.1002/hep.20466</pub-id></mixed-citation></ref><ref id="CR48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brozovic</surname><given-names>A</given-names></name><etal/></person-group><article-title xml:lang="en">The miR-200 family differentially regulates sensitivity to paclitaxel and carboplatin in human ovarian carcinoma OVCAR-3 and MES-OV cells</article-title><source>Mol Oncol</source><year>2015</year><volume>9</volume><issue>8</issue><fpage>1678</fpage><lpage>1693</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXoslCmtr0%3D</pub-id><pub-id pub-id-type="pmid">26025631</pub-id><pub-id pub-id-type="pmcid">4788969</pub-id><pub-id pub-id-type="doi">10.1016/j.molonc.2015.04.015</pub-id></mixed-citation></ref><ref id="CR49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brugge</surname><given-names>KL</given-names></name><etal/></person-group><article-title xml:lang="en">The role of alterations in free radical metabolism in mediating cognitive impairments in Down’s syndrome</article-title><source>EXS</source><year>1992</year><volume>62</volume><fpage>190</fpage><lpage>198</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK3sXhsVCnu74%3D</pub-id><pub-id pub-id-type="pmid">1450586</pub-id></mixed-citation></ref><ref id="CR50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butterfield</surname><given-names>DA</given-names></name><etal/></person-group><article-title xml:lang="en">Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death</article-title><source>Neurobiol Aging</source><year>2002</year><volume>23</volume><issue>5</issue><fpage>655</fpage><lpage>664</lpage><pub-id pub-id-type="pmid">12392766</pub-id><pub-id pub-id-type="doi">10.1016/S0197-4580(01)00340-2</pub-id></mixed-citation></ref><ref id="CR51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cacciottolo</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Particulate air pollutants, APOE alleles and their contributions to cognitive impairment in older women and to amyloidogenesis in experimental models</article-title><source>Transl Psychiatry</source><year>2017</year><volume>7</volume><issue>1</issue><fpage>e1022</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXhvV2itrs%3D</pub-id><pub-id pub-id-type="pmid">28140404</pub-id><pub-id pub-id-type="pmcid">5299391</pub-id><pub-id pub-id-type="doi">10.1038/tp.2016.280</pub-id></mixed-citation></ref><ref id="CR52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cadet</surname><given-names>J</given-names></name><name><surname>Douki</surname><given-names>T</given-names></name><name><surname>Ravanat</surname><given-names>JL</given-names></name></person-group><article-title xml:lang="en">Measurement of oxidatively generated base damage in cellular DNA</article-title><source>Mutat Res</source><year>2011</year><volume>711</volume><issue>1–2</issue><fpage>3</fpage><lpage>12</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3MXmsVGgs70%3D</pub-id><pub-id pub-id-type="pmid">21329709</pub-id><pub-id pub-id-type="doi">10.1016/j.mrfmmm.2011.02.004</pub-id></mixed-citation></ref><ref id="CR53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cadet</surname><given-names>J</given-names></name><etal/></person-group><article-title xml:lang="en">Measurement of oxidatively generated base damage to nucleic acids in cells: facts and artefacts</article-title><source>Bioanal Rev</source><year>2012</year><volume>4</volume><fpage>55</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1007/s12566-012-0029-6</pub-id></mixed-citation></ref><ref id="CR54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>L</given-names></name><name><surname>Koropatnick</surname><given-names>J</given-names></name><name><surname>Cherian</surname><given-names>MG</given-names></name></person-group><article-title xml:lang="en">Roles of vitamin C in radiation-induced DNA damage in presence and absence of copper</article-title><source>Chem Biol Interact</source><year>2001</year><volume>137</volume><issue>1</issue><fpage>75</fpage><lpage>88</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3MXmtV2nur0%3D</pub-id><pub-id pub-id-type="pmid">11518565</pub-id><pub-id pub-id-type="doi">10.1016/S0009-2797(01)00210-1</pub-id></mixed-citation></ref><ref id="CR55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catalgol</surname><given-names>B</given-names></name><etal/></person-group><article-title xml:lang="en">Resveratrol: French paradox revisited</article-title><source>Front Pharmacol</source><year>2012</year><volume>3</volume><fpage>141</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC38Xht1Sns7nP</pub-id><pub-id pub-id-type="pmid">22822401</pub-id><pub-id pub-id-type="pmcid">3398412</pub-id><pub-id pub-id-type="doi">10.3389/fphar.2012.00141</pub-id></mixed-citation></ref><ref id="CR56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cesari</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Inflammatory markers and physical performance in older persons: the InCHIANTI study</article-title><source>J Gerontol A Biol Sci Med Sci</source><year>2004</year><volume>59</volume><issue>3</issue><fpage>242</fpage><lpage>248</lpage><pub-id pub-id-type="pmid">15031308</pub-id><pub-id pub-id-type="doi">10.1093/gerona/59.3.M242</pub-id></mixed-citation></ref><ref id="CR57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakravarthy</surname><given-names>U</given-names></name><etal/></person-group><article-title xml:lang="en">Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis</article-title><source>BMC Ophthalmol</source><year>2010</year><volume>10</volume><fpage>31</fpage><pub-id pub-id-type="pmid">21144031</pub-id><pub-id pub-id-type="pmcid">3009619</pub-id><pub-id pub-id-type="doi">10.1186/1471-2415-10-31</pub-id></mixed-citation></ref><ref id="CR58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chalam</surname><given-names>KV</given-names></name><etal/></person-group><article-title xml:lang="en">Aqueous interleukin-6 levels are superior to vascular endothelial growth factor in predicting therapeutic response to bevacizumab in age-related macular degeneration</article-title><source>J Ophthalmol</source><year>2014</year><volume>2014</volume><fpage>502174</fpage><pub-id pub-id-type="pmid">25110587</pub-id><pub-id pub-id-type="pmcid">4121253</pub-id></mixed-citation></ref><ref id="CR59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Champy</surname><given-names>P</given-names></name><etal/></person-group><article-title xml:lang="en">Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe</article-title><source>J Neurochem</source><year>2004</year><volume>88</volume><issue>1</issue><fpage>63</fpage><lpage>69</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2cXktVyqtg%3D%3D</pub-id><pub-id pub-id-type="pmid">14675150</pub-id><pub-id pub-id-type="doi">10.1046/j.1471-4159.2003.02138.x</pub-id></mixed-citation></ref><ref id="CR60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chasan-Taber</surname><given-names>L</given-names></name><etal/></person-group><article-title xml:lang="en">A prospective study of carotenoid and vitamin A intakes and risk of cataract extraction in US women</article-title><source>Am J Clin Nutr</source><year>1999</year><volume>70</volume><issue>4</issue><fpage>509</fpage><lpage>516</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK1MXmsFCgtbg%3D</pub-id><pub-id pub-id-type="pmid">10500020</pub-id></mixed-citation></ref><ref id="CR61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name><etal/></person-group><article-title xml:lang="en">Physical activity and the risk of Parkinson disease</article-title><source>Neurology</source><year>2005</year><volume>64</volume><issue>4</issue><fpage>664</fpage><lpage>669</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DC%2BD2M%2FpvVyjtQ%3D%3D</pub-id><pub-id pub-id-type="pmid">15728289</pub-id><pub-id pub-id-type="doi">10.1212/01.WNL.0000151960.28687.93</pub-id></mixed-citation></ref><ref id="CR62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W</given-names></name><etal/></person-group><article-title xml:lang="en">Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration</article-title><source>Proc Natl Acad Sci U S A</source><year>2010</year><volume>107</volume><issue>16</issue><fpage>7401</fpage><lpage>7406</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3cXlsVynsbY%3D</pub-id><pub-id pub-id-type="pmid">20385819</pub-id><pub-id pub-id-type="pmcid">2867722</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0912702107</pub-id></mixed-citation></ref><ref id="CR63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christen</surname><given-names>WG</given-names></name><etal/></person-group><article-title xml:lang="en">Age-related cataract in a randomized trial of vitamins E and C in men</article-title><source>Arch Ophthalmol</source><year>2010</year><volume>128</volume><issue>11</issue><fpage>1397</fpage><lpage>1405</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3cXhsFOntr%2FK</pub-id><pub-id pub-id-type="pmid">21060040</pub-id><pub-id pub-id-type="pmcid">3051399</pub-id><pub-id pub-id-type="doi">10.1001/archophthalmol.2010.266</pub-id></mixed-citation></ref><ref id="CR64"><mixed-citation publication-type="other">Chuang W-C, Chen YL, Wei CC, Laio JW, Lu FJ (2012) Reactive oxygen species and antioxidant status in patients with rheumatoid arthritis. Free Radic Biol Med 53:S225–S226</mixed-citation></ref><ref id="CR65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clement</surname><given-names>N</given-names></name><etal/></person-group><article-title xml:lang="en">PGE2 amplifies the effects of IL-1beta on vascular smooth muscle cell de-differentiation: a consequence of the versatility of PGE2 receptors 3 due to the emerging expression of adenylyl cyclase 8</article-title><source>J Cell Physiol</source><year>2006</year><volume>208</volume><issue>3</issue><fpage>495</fpage><lpage>505</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD28XnvFWmsrw%3D</pub-id><pub-id pub-id-type="pmid">16741924</pub-id><pub-id pub-id-type="doi">10.1002/jcp.20673</pub-id></mixed-citation></ref><ref id="CR66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cobb</surname><given-names>LJ</given-names></name><etal/></person-group><article-title xml:lang="en">Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers</article-title><source>Aging (Albany NY)</source><year>2016</year><volume>8</volume><issue>4</issue><fpage>796</fpage><lpage>809</lpage><pub-id pub-id-type="doi">10.18632/aging.100943</pub-id></mixed-citation></ref><ref id="CR67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Combadiere</surname><given-names>C</given-names></name><etal/></person-group><article-title xml:lang="en">CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration</article-title><source>J Clin Invest</source><year>2007</year><volume>117</volume><issue>10</issue><fpage>2920</fpage><lpage>2928</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2sXhtFCnt7rK</pub-id><pub-id pub-id-type="pmid">17909628</pub-id><pub-id pub-id-type="pmcid">1994614</pub-id><pub-id pub-id-type="doi">10.1172/JCI31692</pub-id></mixed-citation></ref><ref id="CR68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooke</surname><given-names>MS</given-names></name><name><surname>Olinski</surname><given-names>R</given-names></name><name><surname>Loft</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">Measurement and meaning of oxidatively modified DNA lesions in urine</article-title><source>Cancer Epidemiol Biomark Prev</source><year>2008</year><volume>17</volume><issue>1</issue><fpage>3</fpage><lpage>14</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD1cXmt12gsQ%3D%3D</pub-id><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-07-0751</pub-id></mixed-citation></ref><ref id="CR69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Correia</surname><given-names>SC</given-names></name><etal/></person-group><article-title xml:lang="en">New insights into the mechanisms of mitochondrial preconditioning-triggered neuroprotection</article-title><source>Curr Pharm Des</source><year>2011</year><volume>17</volume><issue>31</issue><fpage>3381</fpage><lpage>3389</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC38XjtVGiuw%3D%3D</pub-id><pub-id pub-id-type="pmid">21902670</pub-id><pub-id pub-id-type="doi">10.2174/138161211798072490</pub-id></mixed-citation></ref><ref id="CR70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>A</given-names></name><name><surname>Scholer-Dahirel</surname><given-names>A</given-names></name><name><surname>Mechta-Grigoriou</surname><given-names>F</given-names></name></person-group><article-title xml:lang="en">The role of reactive oxygen species and metabolism on cancer cells and their microenvironment</article-title><source>Semin Cancer Biol</source><year>2014</year><volume>25</volume><fpage>23</fpage><lpage>32</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2cXht1KgsLs%3D</pub-id><pub-id pub-id-type="pmid">24406211</pub-id><pub-id pub-id-type="doi">10.1016/j.semcancer.2013.12.007</pub-id></mixed-citation></ref><ref id="CR71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Couchie</surname><given-names>D</given-names></name><etal/></person-group><article-title xml:lang="en">Human plasma thioredoxin-80 increases with age and in ApoE(−/−) mice induces inflammation, angiogenesis, and atherosclerosis</article-title><source>Circulation</source><year>2017</year><volume>136</volume><issue>5</issue><fpage>464</fpage><lpage>475</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXht1Clur%2FM</pub-id><pub-id pub-id-type="pmid">28473446</pub-id><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.117.027612</pub-id></mixed-citation></ref><ref id="CR72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crohns</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Impact of radiotherapy and chemotherapy on biomarkers of oxidative DNA damage in lung cancer patients</article-title><source>Clin Biochem</source><year>2009</year><volume>42</volume><issue>10–11</issue><fpage>1082</fpage><lpage>1090</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD1MXnt1emsLY%3D</pub-id><pub-id pub-id-type="pmid">19272366</pub-id><pub-id pub-id-type="doi">10.1016/j.clinbiochem.2009.02.022</pub-id></mixed-citation></ref><ref id="CR73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruz-Guilloty</surname><given-names>F</given-names></name><etal/></person-group><article-title xml:lang="en">Infiltration of proinflammatory m1 macrophages into the outer retina precedes damage in a mouse model of age-related macular degeneration</article-title><source>Int J Inflam</source><year>2013</year><volume>2013</volume><fpage>503725</fpage><pub-id pub-id-type="pmid">23533946</pub-id><pub-id pub-id-type="pmcid">3606733</pub-id><pub-id pub-id-type="doi">10.1155/2013/503725</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3sXktlygtro%3D</pub-id></mixed-citation></ref><ref id="CR74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cullen</surname><given-names>JJ</given-names></name><name><surname>Mitros</surname><given-names>FA</given-names></name><name><surname>Oberley</surname><given-names>LW</given-names></name></person-group><article-title xml:lang="en">Expression of antioxidant enzymes in diseases of the human pancreas: another link between chronic pancreatitis and pancreatic cancer</article-title><source>Pancreas</source><year>2003</year><volume>26</volume><issue>1</issue><fpage>23</fpage><lpage>27</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3sXns1SntL4%3D</pub-id><pub-id pub-id-type="pmid">12499913</pub-id><pub-id pub-id-type="doi">10.1097/00006676-200301000-00005</pub-id></mixed-citation></ref><ref id="CR75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curcio</surname><given-names>CA</given-names></name><etal/></person-group><article-title xml:lang="en">Accumulation of cholesterol with age in human Bruch’s membrane</article-title><source>Invest Ophthalmol Vis Sci</source><year>2001</year><volume>42</volume><issue>1</issue><fpage>265</fpage><lpage>274</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DC%2BD3M%2Fosl2iug%3D%3D</pub-id><pub-id pub-id-type="pmid">11133878</pub-id></mixed-citation></ref><ref id="CR76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darden</surname><given-names>AG</given-names></name><etal/></person-group><article-title xml:lang="en">Osteoclastic superoxide production and bone resorption: stimulation and inhibition by modulators of NADPH oxidase</article-title><source>J Bone Miner Res</source><year>1996</year><volume>11</volume><issue>5</issue><fpage>671</fpage><lpage>675</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK28XjtVGksrc%3D</pub-id><pub-id pub-id-type="pmid">9157782</pub-id><pub-id pub-id-type="doi">10.1002/jbmr.5650110515</pub-id></mixed-citation></ref><ref id="CR77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dato</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">The genetics of human longevity: an intricacy of genes, environment, culture and microbiome</article-title><source>Mech Ageing Dev</source><year>2017</year><volume>165</volume><issue>Pt B</issue><fpage>147</fpage><lpage>155</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXmtlSksLs%3D</pub-id><pub-id pub-id-type="pmid">28390822</pub-id><pub-id pub-id-type="doi">10.1016/j.mad.2017.03.011</pub-id></mixed-citation></ref><ref id="CR78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>KJA</given-names></name></person-group><article-title xml:lang="en">Oxidative stress: the paradox of aerobic life</article-title><source>Biochem Soc Symp</source><year>1995</year><volume>61</volume><fpage>1</fpage><lpage>31</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK28XjtlCjtb4%3D</pub-id><pub-id pub-id-type="pmid">8660387</pub-id><pub-id pub-id-type="doi">10.1042/bss0610001</pub-id></mixed-citation></ref><ref id="CR79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>KJA</given-names></name></person-group><article-title xml:lang="en">Adaptive homeostasis</article-title><source>Mol Asp Med</source><year>2016</year><volume>49</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.mam.2016.04.007</pub-id></mixed-citation></ref><ref id="CR80"><mixed-citation publication-type="other">Davies KJA, Ursini F (1995) The Oxygen Paradox: In the Honor of Paul Hochstein. CLEUP</mixed-citation></ref><ref id="CR81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>NJ</given-names></name><name><surname>Batehup</surname><given-names>L</given-names></name><name><surname>Thomas</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature</article-title><source>Br J Cancer</source><year>2011</year><volume>105</volume><issue>Suppl 1</issue><fpage>S52</fpage><lpage>S73</lpage><pub-id pub-id-type="pmid">22048034</pub-id><pub-id pub-id-type="pmcid">3251953</pub-id><pub-id pub-id-type="doi">10.1038/bjc.2011.423</pub-id></mixed-citation></ref><ref id="CR82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davignon</surname><given-names>J</given-names></name><name><surname>Gregg</surname><given-names>RE</given-names></name><name><surname>Sing</surname><given-names>CF</given-names></name></person-group><article-title xml:lang="en">Apolipoprotein E polymorphism and atherosclerosis</article-title><source>Arteriosclerosis</source><year>1988</year><volume>8</volume><issue>1</issue><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaL1cXht12gu7o%3D</pub-id><pub-id pub-id-type="pmid">3277611</pub-id><pub-id pub-id-type="doi">10.1161/01.ATV.8.1.1</pub-id></mixed-citation></ref><ref id="CR83"><mixed-citation publication-type="other">de Sousa CV et al (2016) The antioxidant effect of exercise: a systematic review and meta-analysis. Sports Med 47(2):277–293</mixed-citation></ref><ref id="CR84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delcourt</surname><given-names>C</given-names></name><etal/></person-group><article-title xml:lang="en">Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study</article-title><source>Ophthalmic Epidemiol</source><year>2001</year><volume>8</volume><issue>4</issue><fpage>237</fpage><lpage>249</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DC%2BD3MvitFGjtA%3D%3D</pub-id><pub-id pub-id-type="pmid">11471092</pub-id><pub-id pub-id-type="doi">10.1076/opep.8.4.237.1613</pub-id></mixed-citation></ref><ref id="CR85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devos</surname><given-names>D</given-names></name><etal/></person-group><article-title xml:lang="en">Targeting chelatable iron as a therapeutic modality in Parkinson’s disease</article-title><source>Antioxid Redox Signal</source><year>2014</year><volume>21</volume><issue>2</issue><fpage>195</fpage><lpage>210</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2cXpvVWmurk%3D</pub-id><pub-id pub-id-type="pmid">24251381</pub-id><pub-id pub-id-type="pmcid">4060813</pub-id><pub-id pub-id-type="doi">10.1089/ars.2013.5593</pub-id></mixed-citation></ref><ref id="CR86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dexter</surname><given-names>D</given-names></name><etal/></person-group><article-title xml:lang="en">Lipid peroxidation as cause of nigral cell death in Parkinson’s disease</article-title><source>Lancet</source><year>1986</year><volume>2</volume><issue>8507</issue><fpage>639</fpage><lpage>640</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaL28zgvFyrtQ%3D%3D</pub-id><pub-id pub-id-type="pmid">2875360</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(86)92471-2</pub-id></mixed-citation></ref><ref id="CR87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dexter</surname><given-names>DT</given-names></name><etal/></person-group><article-title xml:lang="en">Increased nigral iron content in postmortem parkinsonian brain</article-title><source>Lancet</source><year>1987</year><volume>2</volume><issue>8569</issue><fpage>1219</fpage><lpage>1220</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaL1c%2FmsVKgtA%3D%3D</pub-id><pub-id pub-id-type="pmid">2890848</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(87)91361-4</pub-id></mixed-citation></ref><ref id="CR88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>LM</given-names></name><name><surname>Weisgraber</surname><given-names>KH</given-names></name></person-group><article-title xml:lang="en">Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins</article-title><source>J Biol Chem</source><year>1996</year><volume>271</volume><issue>32</issue><fpage>19053</fpage><lpage>19057</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK28XkvFyns7g%3D</pub-id><pub-id pub-id-type="pmid">8702576</pub-id><pub-id pub-id-type="doi">10.1074/jbc.271.32.19053</pub-id></mixed-citation></ref><ref id="CR89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dow</surname><given-names>J</given-names></name><name><surname>Kloner</surname><given-names>RA</given-names></name></person-group><article-title xml:lang="en">Postconditioning does not reduce myocardial infarct size in an in vivo regional ischemia rodent model</article-title><source>J Cardiovasc Pharmacol Ther</source><year>2007</year><volume>12</volume><issue>2</issue><fpage>153</fpage><lpage>163</lpage><pub-id pub-id-type="pmid">17562786</pub-id><pub-id pub-id-type="doi">10.1177/1074248407300897</pub-id></mixed-citation></ref><ref id="CR90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>X</given-names></name><etal/></person-group><article-title xml:lang="en">Intracerebral hemorrhage, oxidative stress, and antioxidant therapy</article-title><source>Oxidative Med Cell Longev</source><year>2016</year><volume>2016</volume><fpage>1203285</fpage><pub-id pub-id-type="doi">10.1155/2016/1203285</pub-id></mixed-citation></ref><ref id="CR91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durak</surname><given-names>I</given-names></name><etal/></person-group><article-title xml:lang="en">Adenosine deaminase, 5′ nucleotidase, xanthine oxidase, superoxide dismutase, and catalase activities in cancerous and noncancerous human laryngeal tissues</article-title><source>Free Radic Biol Med</source><year>1993</year><volume>15</volume><issue>6</issue><fpage>681</fpage><lpage>684</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK2cXis1Kqtb8%3D</pub-id><pub-id pub-id-type="pmid">8138195</pub-id><pub-id pub-id-type="doi">10.1016/0891-5849(93)90174-S</pub-id></mixed-citation></ref><ref id="CR92"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dziaman</surname><given-names>T</given-names></name><etal/></person-group><article-title xml:lang="en">8-Oxo-7,8-dihydroguanine and uric acid as efficient predictors of survival in colon cancer patients</article-title><source>Int J Cancer</source><year>2014</year><volume>134</volume><issue>2</issue><fpage>376</fpage><lpage>383</lpage><pub-id pub-id-type="pmid">23832862</pub-id><pub-id pub-id-type="doi">10.1002/ijc.28374</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3sXht1SktLfM</pub-id></mixed-citation></ref><ref id="CR93"><mixed-citation publication-type="other">Eandi CM, Hugo CM, Augustin S, Dominguez E, Lavalette S, Forster V, Hu SJ, et al (2016) Subretinal mononuclear phagocytes induce cone segment loss via IL-1beta. elife 5(2016):e16490</mixed-citation></ref><ref id="CR94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisenberg</surname><given-names>T</given-names></name><etal/></person-group><article-title xml:lang="en">Cardioprotection and lifespan extension by the natural polyamine spermidine</article-title><source>Nat Med</source><year>2016</year><volume>22</volume><issue>12</issue><fpage>1428</fpage><lpage>1438</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28XhvVGgtL3O</pub-id><pub-id pub-id-type="pmid">27841876</pub-id><pub-id pub-id-type="doi">10.1038/nm.4222</pub-id></mixed-citation></ref><ref id="CR95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Hadri</surname><given-names>K</given-names></name><etal/></person-group><article-title xml:lang="en">Thioredoxin-1 promotes anti-inflammatory macrophages of the M2 phenotype and antagonizes atherosclerosis</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2012</year><volume>32</volume><issue>6</issue><fpage>1445</fpage><lpage>1452</lpage><pub-id pub-id-type="pmid">22516068</pub-id><pub-id pub-id-type="doi">10.1161/ATVBAHA.112.249334</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC38XmvF2lsbo%3D</pub-id></mixed-citation></ref><ref id="CR96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Domyati</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Intrinsic aging vs. photoaging: a comparative histopathological, immunohistochemical, and ultrastructural study of skin</article-title><source>Exp Dermatol</source><year>2002</year><volume>11</volume><issue>5</issue><fpage>398</fpage><lpage>405</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DC%2BD38nhtVKitw%3D%3D</pub-id><pub-id pub-id-type="pmid">12366692</pub-id><pub-id pub-id-type="doi">10.1034/j.1600-0625.2002.110502.x</pub-id></mixed-citation></ref><ref id="CR97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ermak</surname><given-names>G</given-names></name><name><surname>Davies</surname><given-names>KJA</given-names></name></person-group><article-title xml:lang="en">Chronic high levels of the RCAN1-1 protein may promote neurodegeneration and Alzheimer disease</article-title><source>Free Radic Biol Med</source><year>2013</year><volume>62</volume><fpage>47</fpage><lpage>51</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3sXis1Ohtro%3D</pub-id><pub-id pub-id-type="pmid">23369757</pub-id><pub-id pub-id-type="pmcid">4720382</pub-id><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2013.01.016</pub-id></mixed-citation></ref><ref id="CR98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ermak</surname><given-names>G</given-names></name><name><surname>Morgan</surname><given-names>TE</given-names></name><name><surname>Davies</surname><given-names>KJA</given-names></name></person-group><article-title xml:lang="en">Chronic overexpression of the calcineurin inhibitory gene DSCR1 (Adapt78) is associated with Alzheimer’s disease</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><issue>42</issue><fpage>38787</fpage><lpage>38794</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3MXnvVentb8%3D</pub-id><pub-id pub-id-type="pmid">11483593</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M102829200</pub-id></mixed-citation></ref><ref id="CR99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ermak</surname><given-names>G</given-names></name><etal/></person-group><article-title xml:lang="en">Regulator of calcineurin (RCAN1-1L) is deficient in Huntington disease and protective against mutant huntingtin toxicity in vitro</article-title><source>J Biol Chem</source><year>2009</year><volume>284</volume><issue>18</issue><fpage>11845</fpage><lpage>11853</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD1MXltVCmt7o%3D</pub-id><pub-id pub-id-type="pmid">19270310</pub-id><pub-id pub-id-type="pmcid">2673253</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M900639200</pub-id></mixed-citation></ref><ref id="CR100"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esteves</surname><given-names>AR</given-names></name><etal/></person-group><article-title xml:lang="en">Oxidative stress involvement in alpha-synuclein oligomerization in Parkinson’s disease cybrids</article-title><source>Antioxid Redox Signal</source><year>2009</year><volume>11</volume><issue>3</issue><fpage>439</fpage><lpage>448</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD1MXhtFOrsbs%3D</pub-id><pub-id pub-id-type="pmid">18717628</pub-id><pub-id pub-id-type="doi">10.1089/ars.2008.2247</pub-id></mixed-citation></ref><ref id="CR101"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>MD</given-names></name><etal/></person-group><article-title xml:lang="en">Nucleotide excision repair of oxidised genomic DNA is not a source of urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine</article-title><source>Free Radic Biol Med</source><year>2016</year><volume>99</volume><fpage>385</fpage><lpage>391</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28XhsVyjsr%2FP</pub-id><pub-id pub-id-type="pmid">27585947</pub-id><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2016.08.018</pub-id></mixed-citation></ref><ref id="CR102"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fabbrini</surname><given-names>E</given-names></name><name><surname>Sullivan</surname><given-names>S</given-names></name><name><surname>Klein</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications</article-title><source>Hepatology</source><year>2010</year><volume>51</volume><issue>2</issue><fpage>679</fpage><lpage>689</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3cXisVGnsrk%3D</pub-id><pub-id pub-id-type="pmid">20041406</pub-id><pub-id pub-id-type="pmcid">3575093</pub-id><pub-id pub-id-type="doi">10.1002/hep.23280</pub-id></mixed-citation></ref><ref id="CR103"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farkas</surname><given-names>TG</given-names></name><name><surname>Sylvester</surname><given-names>V</given-names></name><name><surname>Archer</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">The ultrastructure of drusen</article-title><source>Am J Ophthalmol</source><year>1971</year><volume>71</volume><issue>6</issue><fpage>1196</fpage><lpage>1205</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaE3M3jt1GhtQ%3D%3D</pub-id><pub-id pub-id-type="pmid">5091118</pub-id><pub-id pub-id-type="doi">10.1016/0002-9394(71)90963-9</pub-id></mixed-citation></ref><ref id="CR104"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fazio</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages</article-title><source>Proc Natl Acad Sci U S A</source><year>1997</year><volume>94</volume><issue>9</issue><fpage>4647</fpage><lpage>4652</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK2sXjtVyltbY%3D</pub-id><pub-id pub-id-type="pmid">9114045</pub-id><pub-id pub-id-type="pmcid">20778</pub-id><pub-id pub-id-type="doi">10.1073/pnas.94.9.4647</pub-id></mixed-citation></ref><ref id="CR105"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferlay</surname><given-names>J</given-names></name><etal/></person-group><article-title xml:lang="en">Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012</article-title><source>Int J Cancer</source><year>2015</year><volume>136</volume><issue>5</issue><fpage>E359</fpage><lpage>E386</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2cXitVyktbzI</pub-id><pub-id pub-id-type="pmid">25220842</pub-id><pub-id pub-id-type="doi">10.1002/ijc.29210</pub-id></mixed-citation></ref><ref id="CR106"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiamingo</surname><given-names>A</given-names></name><etal/></person-group><article-title xml:lang="en">Chitosan hydrogels for the regeneration of infarcted myocardium: preparation, physicochemical characterization, and biological evaluation</article-title><source>Biomacromolecules</source><year>2016</year><volume>17</volume><issue>5</issue><fpage>1662</fpage><lpage>1672</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28Xlslaqu7g%3D</pub-id><pub-id pub-id-type="pmid">27064341</pub-id><pub-id pub-id-type="doi">10.1021/acs.biomac.6b00075</pub-id></mixed-citation></ref><ref id="CR107"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finch</surname><given-names>CE</given-names></name><name><surname>Stanford</surname><given-names>CB</given-names></name></person-group><article-title xml:lang="en">Meat-adaptive genes and the evolution of slower aging in humans</article-title><source>Q Rev Biol</source><year>2004</year><volume>79</volume><issue>1</issue><fpage>3</fpage><lpage>50</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2cXjsVGisLY%3D</pub-id><pub-id pub-id-type="pmid">15101252</pub-id><pub-id pub-id-type="doi">10.1086/381662</pub-id></mixed-citation></ref><ref id="CR108"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finch</surname><given-names>CE</given-names></name><name><surname>Tanzi</surname><given-names>RE</given-names></name></person-group><article-title xml:lang="en">Genetics of aging</article-title><source>Science</source><year>1997</year><volume>278</volume><issue>5337</issue><fpage>407</fpage><lpage>411</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK2sXmslGltrc%3D</pub-id><pub-id pub-id-type="pmid">9334291</pub-id><pub-id pub-id-type="doi">10.1126/science.278.5337.407</pub-id></mixed-citation></ref><ref id="CR109"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>BE</given-names></name><etal/></person-group><article-title xml:lang="en">Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse basal ganglia</article-title><source>J Neurosci Res</source><year>2004</year><volume>77</volume><issue>3</issue><fpage>378</fpage><lpage>390</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2cXmslaitLg%3D</pub-id><pub-id pub-id-type="pmid">15248294</pub-id><pub-id pub-id-type="doi">10.1002/jnr.20162</pub-id></mixed-citation></ref><ref id="CR110"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flaherty</surname><given-names>JT</given-names></name><etal/></person-group><article-title xml:lang="en">Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction</article-title><source>Circulation</source><year>1994</year><volume>89</volume><issue>5</issue><fpage>1982</fpage><lpage>1991</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaK2c3js1OmtA%3D%3D</pub-id><pub-id pub-id-type="pmid">8181121</pub-id><pub-id pub-id-type="doi">10.1161/01.CIR.89.5.1982</pub-id></mixed-citation></ref><ref id="CR111"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flamm</surname><given-names>ES</given-names></name><etal/></person-group><article-title xml:lang="en">Free radicals in cerebral ischemia</article-title><source>Stroke</source><year>1978</year><volume>9</volume><issue>5</issue><fpage>445</fpage><lpage>447</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaE1cXlslOnu7Y%3D</pub-id><pub-id pub-id-type="pmid">705824</pub-id><pub-id pub-id-type="doi">10.1161/01.STR.9.5.445</pub-id></mixed-citation></ref><ref id="CR112"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forstermann</surname><given-names>U</given-names></name></person-group><article-title xml:lang="en">Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies</article-title><source>Nat Clin Pract Cardiovasc Med</source><year>2008</year><volume>5</volume><issue>6</issue><fpage>338</fpage><lpage>349</lpage><pub-id pub-id-type="pmid">18461048</pub-id><pub-id pub-id-type="doi">10.1038/ncpcardio1211</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD1cXmsVarsbg%3D</pub-id></mixed-citation></ref><ref id="CR113"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>DA</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Koopman</surname><given-names>WJ</given-names></name></person-group><article-title xml:lang="en">Etiology and pathogenesis of rheumatoid arthritis</article-title><source>Arthritis and Allied Conditions: A Textbook of Rheumatology</source><year>2005</year><edition>15</edition><publisher-loc>Philadelphia</publisher-loc><publisher-name>Lippincott Williams &amp; Wilkins</publisher-name></mixed-citation></ref><ref id="CR114"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>SW</given-names></name><name><surname>Chow</surname><given-names>JW</given-names></name></person-group><article-title xml:lang="en">Nitric oxide synthase expression in bone cells</article-title><source>Bone</source><year>1998</year><volume>23</volume><issue>1</issue><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK1cXksVygs7o%3D</pub-id><pub-id pub-id-type="pmid">9662123</pub-id><pub-id pub-id-type="doi">10.1016/S8756-3282(98)00070-2</pub-id></mixed-citation></ref><ref id="CR115"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fraser</surname><given-names>JH</given-names></name><etal/></person-group><article-title xml:lang="en">Hydrogen peroxide, but not superoxide, stimulates bone resorption in mouse calvariae</article-title><source>Bone</source><year>1996</year><volume>19</volume><issue>3</issue><fpage>223</fpage><lpage>226</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK28XlvFehtLk%3D</pub-id><pub-id pub-id-type="pmid">8873962</pub-id><pub-id pub-id-type="doi">10.1016/8756-3282(96)00177-9</pub-id></mixed-citation></ref><ref id="CR116"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freitag</surname><given-names>J</given-names></name><etal/></person-group><article-title xml:lang="en">Impaired parathyroid hormone metabolism in patients with chronic renal failure</article-title><source>N Engl J Med</source><year>1978</year><volume>298</volume><issue>1</issue><fpage>29</fpage><lpage>32</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaE1c%2FltFShsA%3D%3D</pub-id><pub-id pub-id-type="pmid">337145</pub-id><pub-id pub-id-type="doi">10.1056/NEJM197801052980107</pub-id></mixed-citation></ref><ref id="CR117"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freriksen</surname><given-names>JJ</given-names></name><etal/></person-group><article-title xml:lang="en">Genetic polymorphism 609C&gt;T in NAD(P)H:quinone oxidoreductase 1 enhances the risk of proximal colon cancer</article-title><source>J Hum Genet</source><year>2014</year><volume>59</volume><issue>7</issue><fpage>381</fpage><lpage>386</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2cXht1antLzO</pub-id><pub-id pub-id-type="pmid">24830960</pub-id><pub-id pub-id-type="doi">10.1038/jhg.2014.38</pub-id></mixed-citation></ref><ref id="CR118"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedenreich</surname><given-names>CM</given-names></name><name><surname>Neilson</surname><given-names>HK</given-names></name><name><surname>Lynch</surname><given-names>BM</given-names></name></person-group><article-title xml:lang="en">State of the epidemiological evidence on physical activity and cancer prevention</article-title><source>Eur J Cancer</source><year>2010</year><volume>46</volume><issue>14</issue><fpage>2593</fpage><lpage>2604</lpage><pub-id pub-id-type="pmid">20843488</pub-id><pub-id pub-id-type="doi">10.1016/j.ejca.2010.07.028</pub-id></mixed-citation></ref><ref id="CR119"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedenreich</surname><given-names>CM</given-names></name><etal/></person-group><article-title xml:lang="en">Physical activity and cancer outcomes<italic>:</italic> a precision medicine approach</article-title><source>Clin Cancer Res</source><year>2016</year><volume>22</volume><issue>19</issue><fpage>4766</fpage><lpage>4775</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28XhslOhsbrL</pub-id><pub-id pub-id-type="pmid">27407093</pub-id><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-16-0067</pub-id></mixed-citation></ref><ref id="CR120"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fullerton</surname><given-names>SM</given-names></name><etal/></person-group><article-title xml:lang="en">Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism</article-title><source>Am J Hum Genet</source><year>2000</year><volume>67</volume><issue>4</issue><fpage>881</fpage><lpage>900</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3cXnsVCgs7c%3D</pub-id><pub-id pub-id-type="pmid">10986041</pub-id><pub-id pub-id-type="pmcid">1287893</pub-id><pub-id pub-id-type="doi">10.1086/303070</pub-id></mixed-citation></ref><ref id="CR121"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galmiche</surname><given-names>G</given-names></name><etal/></person-group><article-title xml:lang="en">Inactivation of serum response factor contributes to decrease vascular muscular tone and arterial stiffness in mice</article-title><source>Circ Res</source><year>2013</year><volume>112</volume><issue>7</issue><fpage>1035</fpage><lpage>1045</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3sXkvVKjtbk%3D</pub-id><pub-id pub-id-type="pmid">23426017</pub-id><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.113.301076</pub-id></mixed-citation></ref><ref id="CR122"><mixed-citation publication-type="other">Gambini J, Inglés M, Olaso G, Lopez-Grueso R, Bonet-Costa V, Gimeno-Mallench L, Mas-Bargues C, Abdelaziz KM, Gomez-Cabrera MC, Vina J, Borras C (2015) Properties of resveratrol: in vitro and in vivo studies about metabolism, bioavailability, and biological effects in animal models and humans. Oxidative Med Cell Longev 2015:837042. <ext-link xlink:href="10.1155/2015/837042" ext-link-type="doi">https://doi.org/10.1155/2015/837042</ext-link></mixed-citation></ref><ref id="CR123"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gandhi</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">PINK1-associated Parkinson’s disease is caused by neuronal vulnerability to calcium-induced cell death</article-title><source>Mol Cell</source><year>2009</year><volume>33</volume><issue>5</issue><fpage>627</fpage><lpage>638</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD1MXltFSmsrY%3D</pub-id><pub-id pub-id-type="pmid">19285945</pub-id><pub-id pub-id-type="pmcid">2724101</pub-id><pub-id pub-id-type="doi">10.1016/j.molcel.2009.02.013</pub-id></mixed-citation></ref><ref id="CR124"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>X</given-names></name><etal/></person-group><article-title xml:lang="en">Prospective study of dietary pattern and risk of Parkinson disease</article-title><source>Am J Clin Nutr</source><year>2007</year><volume>86</volume><issue>5</issue><fpage>1486</fpage><lpage>1494</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2sXhtlWmsLzL</pub-id><pub-id pub-id-type="pmid">17991663</pub-id><pub-id pub-id-type="pmcid">2225168</pub-id></mixed-citation></ref><ref id="CR125"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrett</surname><given-names>IR</given-names></name><etal/></person-group><article-title xml:lang="en">Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo</article-title><source>J Clin Invest</source><year>1990</year><volume>85</volume><issue>3</issue><fpage>632</fpage><lpage>639</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK3cXhslaktrs%3D</pub-id><pub-id pub-id-type="pmid">2312718</pub-id><pub-id pub-id-type="pmcid">296476</pub-id><pub-id pub-id-type="doi">10.1172/JCI114485</pub-id></mixed-citation></ref><ref id="CR126"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Garrod</surname><given-names>AB</given-names></name></person-group><source>Treatise on nature of gout and rheumatic gout</source><year>1859</year><publisher-loc>London</publisher-loc><publisher-name>Walton and Maberly</publisher-name></mixed-citation></ref><ref id="CR127"><mixed-citation publication-type="other">Gentric G, Mieulet V, Mechta-Grigoriou F (2017) Heterogeneity in cancer metabolism: new concepts in an old field. Antioxid Redox Signal 26(9):462–485</mixed-citation></ref><ref id="CR128"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerczuk</surname><given-names>PZ</given-names></name><name><surname>Kloner</surname><given-names>RA</given-names></name></person-group><article-title xml:lang="en">An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials</article-title><source>J Am Coll Cardiol</source><year>2012</year><volume>59</volume><issue>11</issue><fpage>969</fpage><lpage>978</lpage><pub-id pub-id-type="pmid">22402067</pub-id><pub-id pub-id-type="doi">10.1016/j.jacc.2011.07.054</pub-id></mixed-citation></ref><ref id="CR129"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerhart-Hines</surname><given-names>Z</given-names></name><etal/></person-group><article-title xml:lang="en">Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha</article-title><source>EMBO J</source><year>2007</year><volume>26</volume><issue>7</issue><fpage>1913</fpage><lpage>1923</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2sXjslOmtLc%3D</pub-id><pub-id pub-id-type="pmid">17347648</pub-id><pub-id pub-id-type="pmcid">1847661</pub-id><pub-id pub-id-type="doi">10.1038/sj.emboj.7601633</pub-id></mixed-citation></ref><ref id="CR130"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilchrest</surname><given-names>BA</given-names></name></person-group><article-title xml:lang="en">Photoaging</article-title><source>J Invest Dermatol</source><year>2013</year><volume>133</volume><issue>E1</issue><fpage>E2</fpage><lpage>E6</lpage><pub-id pub-id-type="pmid">23820721</pub-id><pub-id pub-id-type="doi">10.1038/skinbio.2013.176</pub-id></mixed-citation></ref><ref id="CR131"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gil-Mohapel</surname><given-names>J</given-names></name><name><surname>Brocardo</surname><given-names>PS</given-names></name><name><surname>Christie</surname><given-names>BR</given-names></name></person-group><article-title xml:lang="en">The role of oxidative stress in Huntington’s disease: are antioxidants good therapeutic candidates?</article-title><source>Curr Drug Targets</source><year>2014</year><volume>15</volume><issue>4</issue><fpage>454</fpage><lpage>468</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2cXksFSnsLY%3D</pub-id><pub-id pub-id-type="pmid">24428525</pub-id><pub-id pub-id-type="doi">10.2174/1389450115666140115113734</pub-id></mixed-citation></ref><ref id="CR132"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glass</surname><given-names>CK</given-names></name><name><surname>Witztum</surname><given-names>JL</given-names></name></person-group><article-title xml:lang="en">Atherosclerosis. The road ahead</article-title><source>Cell</source><year>2001</year><volume>104</volume><issue>4</issue><fpage>503</fpage><lpage>516</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3MXis1Kksrc%3D</pub-id><pub-id pub-id-type="pmid">11239408</pub-id><pub-id pub-id-type="doi">10.1016/S0092-8674(01)00238-0</pub-id></mixed-citation></ref><ref id="CR133"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorrini</surname><given-names>C</given-names></name><name><surname>Harris</surname><given-names>IS</given-names></name><name><surname>Mak</surname><given-names>TW</given-names></name></person-group><article-title xml:lang="en">Modulation of oxidative stress as an anticancer strategy</article-title><source>Nat Rev Drug Discov</source><year>2013</year><volume>12</volume><issue>12</issue><fpage>931</fpage><lpage>947</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3sXhvVGqs7%2FI</pub-id><pub-id pub-id-type="pmid">24287781</pub-id><pub-id pub-id-type="doi">10.1038/nrd4002</pub-id></mixed-citation></ref><ref id="CR134"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gruosso</surname><given-names>T</given-names></name><etal/></person-group><article-title xml:lang="en">MAP3K8/TPL-2/COT is a potential predictive marker for MEK inhibitor treatment in high-grade serous ovarian carcinomas</article-title><source>Nat Commun</source><year>2015</year><volume>6</volume><fpage>8583</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXhs1Gks7bE</pub-id><pub-id pub-id-type="pmid">26456302</pub-id><pub-id pub-id-type="pmcid">4633961</pub-id><pub-id pub-id-type="doi">10.1038/ncomms9583</pub-id></mixed-citation></ref><ref id="CR135"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gruosso</surname><given-names>T</given-names></name><etal/></person-group><article-title xml:lang="en">Chronic oxidative stress promotes H2AX protein degradation and enhances chemosensitivity in breast cancer patients</article-title><source>EMBO Mol Med</source><year>2016</year><volume>8</volume><issue>5</issue><fpage>527</fpage><lpage>549</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28XksFCksbg%3D</pub-id><pub-id pub-id-type="pmid">27006338</pub-id><pub-id pub-id-type="pmcid">5123617</pub-id><pub-id pub-id-type="doi">10.15252/emmm.201505891</pub-id></mixed-citation></ref><ref id="CR136"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gueguen</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Implication of adenylyl cyclase 8 in pathological smooth muscle cell migration occurring in rat and human vascular remodelling</article-title><source>J Pathol</source><year>2010</year><volume>221</volume><issue>3</issue><fpage>331</fpage><lpage>342</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3cXptFymtb0%3D</pub-id><pub-id pub-id-type="pmid">20527026</pub-id><pub-id pub-id-type="doi">10.1002/path.2716</pub-id></mixed-citation></ref><ref id="CR137"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gueritat</surname><given-names>J</given-names></name><etal/></person-group><article-title xml:lang="en">Exercise training combined with antioxidant supplementation prevents the antiproliferative activity of their single treatment in prostate cancer through inhibition of redox adaptation</article-title><source>Free Radic Biol Med</source><year>2014</year><volume>77</volume><fpage>95</fpage><lpage>105</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2cXhslKjtrvN</pub-id><pub-id pub-id-type="pmid">25236740</pub-id><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2014.09.009</pub-id></mixed-citation></ref><ref id="CR138"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>N</given-names></name><name><surname>Brown</surname><given-names>KE</given-names></name><name><surname>Milam</surname><given-names>AH</given-names></name></person-group><article-title xml:lang="en">Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration</article-title><source>Exp Eye Res</source><year>2003</year><volume>76</volume><issue>4</issue><fpage>463</fpage><lpage>471</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3sXhvFeksrY%3D</pub-id><pub-id pub-id-type="pmid">12634111</pub-id><pub-id pub-id-type="doi">10.1016/S0014-4835(02)00332-9</pub-id></mixed-citation></ref><ref id="CR139"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hageman</surname><given-names>GS</given-names></name><name><surname>Mullins</surname><given-names>RF</given-names></name></person-group><article-title xml:lang="en">Molecular composition of drusen as related to substructural phenotype</article-title><source>Mol Vis</source><year>1999</year><volume>5</volume><fpage>28</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3cXlvFOhtQ%3D%3D</pub-id><pub-id pub-id-type="pmid">10562652</pub-id></mixed-citation></ref><ref id="CR140"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hale</surname><given-names>SL</given-names></name><name><surname>Dae</surname><given-names>MW</given-names></name><name><surname>Kloner</surname><given-names>RA</given-names></name></person-group><article-title xml:lang="en">Hypothermia during reperfusion limits ‘no-reflow’ injury in a rabbit model of acute myocardial infarction</article-title><source>Cardiovasc Res</source><year>2003</year><volume>59</volume><issue>3</issue><fpage>715</fpage><lpage>722</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3sXnt1Glu7s%3D</pub-id><pub-id pub-id-type="pmid">14499873</pub-id><pub-id pub-id-type="doi">10.1016/S0008-6363(03)00456-5</pub-id></mixed-citation></ref><ref id="CR141"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hale</surname><given-names>SL</given-names></name><name><surname>Herring</surname><given-names>MJ</given-names></name><name><surname>Kloner</surname><given-names>RA</given-names></name></person-group><article-title xml:lang="en">Delayed treatment with hypothermia protects against the no-reflow phenomenon despite failure to reduce infarct size</article-title><source>J Am Heart Assoc</source><year>2013</year><volume>2</volume><issue>1</issue><fpage>e004234</fpage><pub-id pub-id-type="pmid">23525431</pub-id><pub-id pub-id-type="pmcid">3603258</pub-id><pub-id pub-id-type="doi">10.1161/JAHA.112.004234</pub-id></mixed-citation></ref><ref id="CR142"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>CN</given-names></name><etal/></person-group><article-title xml:lang="en">Oxidative phosphorylation, not glycolysis, powers presynaptic and postsynaptic mechanisms underlying brain information processing</article-title><source>J Neurosci</source><year>2012</year><volume>32</volume><issue>26</issue><fpage>8940</fpage><lpage>8951</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC38XpvFOntr0%3D</pub-id><pub-id pub-id-type="pmid">22745494</pub-id><pub-id pub-id-type="pmcid">3390246</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0026-12.2012</pub-id></mixed-citation></ref><ref id="CR143"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halliwell</surname><given-names>B</given-names></name></person-group><article-title xml:lang="en">Oxygen radicals, nitric oxide and human inflammatory joint disease</article-title><source>Ann Rheum Dis</source><year>1995</year><volume>54</volume><issue>6</issue><fpage>505</fpage><lpage>510</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaK2MzlvVKnsw%3D%3D</pub-id><pub-id pub-id-type="pmid">7632097</pub-id><pub-id pub-id-type="pmcid">1009913</pub-id><pub-id pub-id-type="doi">10.1136/ard.54.6.505</pub-id></mixed-citation></ref><ref id="CR144"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hankinson</surname><given-names>SE</given-names></name><etal/></person-group><article-title xml:lang="en">Nutrient intake and cataract extraction in women: a prospective study</article-title><source>BMJ</source><year>1992</year><volume>305</volume><issue>6849</issue><fpage>335</fpage><lpage>339</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaK3s%2Fgs1ajsg%3D%3D</pub-id><pub-id pub-id-type="pmid">1392884</pub-id><pub-id pub-id-type="pmcid">1882980</pub-id><pub-id pub-id-type="doi">10.1136/bmj.305.6849.335</pub-id></mixed-citation></ref><ref id="CR145"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>CD</given-names></name><name><surname>Ermak</surname><given-names>G</given-names></name><name><surname>Davies</surname><given-names>KJA</given-names></name></person-group><article-title xml:lang="en">RCAN1-1L is overexpressed in neurons of Alzheimer’s disease patients</article-title><source>FEBS J</source><year>2007</year><volume>274</volume><issue>7</issue><fpage>1715</fpage><lpage>1724</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2sXksFSmu70%3D</pub-id><pub-id pub-id-type="pmid">17331188</pub-id><pub-id pub-id-type="doi">10.1111/j.1742-4658.2007.05717.x</pub-id></mixed-citation></ref><ref id="CR146"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>JJ</given-names></name><name><surname>Jolivet</surname><given-names>R</given-names></name><name><surname>Attwell</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">Synaptic energy use and supply</article-title><source>Neuron</source><year>2012</year><volume>75</volume><issue>5</issue><fpage>762</fpage><lpage>777</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC38XhtlSkurvN</pub-id><pub-id pub-id-type="pmid">22958818</pub-id><pub-id pub-id-type="doi">10.1016/j.neuron.2012.08.019</pub-id></mixed-citation></ref><ref id="CR147"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartmann</surname><given-names>A</given-names></name><etal/></person-group><article-title xml:lang="en">Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson’s disease</article-title><source>Proc Natl Acad Sci U S A</source><year>2000</year><volume>97</volume><issue>6</issue><fpage>2875</fpage><lpage>2880</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3cXitVahtrw%3D</pub-id><pub-id pub-id-type="pmid">10688892</pub-id><pub-id pub-id-type="pmcid">16023</pub-id><pub-id pub-id-type="doi">10.1073/pnas.040556597</pub-id></mixed-citation></ref><ref id="CR148"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartmann</surname><given-names>A</given-names></name><etal/></person-group><article-title xml:lang="en">Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson’s disease, but pathway inhibition results in neuronal necrosis</article-title><source>J Neurosci</source><year>2001</year><volume>21</volume><issue>7</issue><fpage>2247</fpage><lpage>2255</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3MXjslCmu7g%3D</pub-id><pub-id pub-id-type="pmid">11264300</pub-id></mixed-citation></ref><ref id="CR149"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heaney</surname><given-names>RP</given-names></name><name><surname>Recker</surname><given-names>RR</given-names></name><name><surname>Saville</surname><given-names>PD</given-names></name></person-group><article-title xml:lang="en">Menopausal changes in bone remodeling</article-title><source>J Lab Clin Med</source><year>1978</year><volume>92</volume><issue>6</issue><fpage>964</fpage><lpage>970</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaE1M7htVOqtA%3D%3D</pub-id><pub-id pub-id-type="pmid">739174</pub-id></mixed-citation></ref><ref id="CR150"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heeren</surname><given-names>J</given-names></name><etal/></person-group><article-title xml:lang="en">Impaired recycling of apolipoprotein E4 is associated with intracellular cholesterol accumulation</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><issue>53</issue><fpage>55483</fpage><lpage>55492</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2cXhtFeis7vF</pub-id><pub-id pub-id-type="pmid">15485881</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M409324200</pub-id></mixed-citation></ref><ref id="CR151"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helfrich</surname><given-names>MH</given-names></name><etal/></person-group><article-title xml:lang="en">Expression of nitric oxide synthase isoforms in bone and bone cell cultures</article-title><source>J Bone Miner Res</source><year>1997</year><volume>12</volume><issue>7</issue><fpage>1108</fpage><lpage>1115</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK2sXks1CjtrY%3D</pub-id><pub-id pub-id-type="pmid">9200011</pub-id><pub-id pub-id-type="doi">10.1359/jbmr.1997.12.7.1108</pub-id></mixed-citation></ref><ref id="CR152"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helfrich</surname><given-names>YR</given-names></name><name><surname>Sachs</surname><given-names>DL</given-names></name><name><surname>Voorhees</surname><given-names>JJ</given-names></name></person-group><article-title xml:lang="en">Overview of skin aging and photoaging</article-title><source>Dermatol Nurs</source><year>2008</year><volume>20</volume><issue>3</issue><fpage>177</fpage><lpage>183</lpage><pub-id pub-id-type="pmid">18649702</pub-id><comment>quiz 184</comment></mixed-citation></ref><ref id="CR153"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heo</surname><given-names>JH</given-names></name><name><surname>Han</surname><given-names>SW</given-names></name><name><surname>Lee</surname><given-names>SK</given-names></name></person-group><article-title xml:lang="en">Free radicals as triggers of brain edema formation after stroke</article-title><source>Free Radic Biol Med</source><year>2005</year><volume>39</volume><issue>1</issue><fpage>51</fpage><lpage>70</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2MXks1Wgtr4%3D</pub-id><pub-id pub-id-type="pmid">15925278</pub-id><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2005.03.035</pub-id></mixed-citation></ref><ref id="CR154"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herz</surname><given-names>J</given-names></name><name><surname>Beffert</surname><given-names>U</given-names></name></person-group><article-title xml:lang="en">Apolipoprotein E receptors: linking brain development and Alzheimer’s disease</article-title><source>Nat Rev Neurosci</source><year>2000</year><volume>1</volume><issue>1</issue><fpage>51</fpage><lpage>58</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3MXivVSjs74%3D</pub-id><pub-id pub-id-type="pmid">11252768</pub-id><pub-id pub-id-type="doi">10.1038/35036221</pub-id></mixed-citation></ref><ref id="CR155"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heyndrickx</surname><given-names>GR</given-names></name><etal/></person-group><article-title xml:lang="en">Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs</article-title><source>J Clin Invest</source><year>1975</year><volume>56</volume><issue>4</issue><fpage>978</fpage><lpage>985</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaE28%2Fgs1Wjtg%3D%3D</pub-id><pub-id pub-id-type="pmid">1159098</pub-id><pub-id pub-id-type="pmcid">301954</pub-id><pub-id pub-id-type="doi">10.1172/JCI108178</pub-id></mixed-citation></ref><ref id="CR156"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higinbotham</surname><given-names>KG</given-names></name><etal/></person-group><article-title xml:lang="en">GGT to GTT transversions in codon 12 of the K-ras oncogene in rat renal sarcomas induced with nickel subsulfide or nickel subsulfide/iron are consistent with oxidative damage to DNA</article-title><source>Cancer Res</source><year>1992</year><volume>52</volume><issue>17</issue><fpage>4747</fpage><lpage>4751</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK38XmtVKrtb4%3D</pub-id><pub-id pub-id-type="pmid">1511440</pub-id></mixed-citation></ref><ref id="CR157"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirsch</surname><given-names>EC</given-names></name><name><surname>Hunot</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">Neuroinflammation in Parkinson’s disease: a target for neuroprotection?</article-title><source>Lancet Neurol</source><year>2009</year><volume>8</volume><issue>4</issue><fpage>382</fpage><lpage>397</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD1MXks1Sis70%3D</pub-id><pub-id pub-id-type="pmid">19296921</pub-id><pub-id pub-id-type="doi">10.1016/S1474-4422(09)70062-6</pub-id></mixed-citation></ref><ref id="CR158"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirsch</surname><given-names>E</given-names></name><name><surname>Graybiel</surname><given-names>AM</given-names></name><name><surname>Agid</surname><given-names>YA</given-names></name></person-group><article-title xml:lang="en">Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson’s disease</article-title><source>Nature</source><year>1988</year><volume>334</volume><issue>6180</issue><fpage>345</fpage><lpage>348</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaL1cXltVyms78%3D</pub-id><pub-id pub-id-type="pmid">2899295</pub-id><pub-id pub-id-type="doi">10.1038/334345a0</pub-id></mixed-citation></ref><ref id="CR159"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Höglinger</surname><given-names>GU</given-names></name><etal/></person-group><article-title xml:lang="en">Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats</article-title><source>J Neurochem</source><year>2003</year><volume>84</volume><issue>3</issue><fpage>491</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">12558969</pub-id><pub-id pub-id-type="doi">10.1046/j.1471-4159.2003.01533.x</pub-id></mixed-citation></ref><ref id="CR160"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>CP</given-names></name><etal/></person-group><article-title xml:lang="en">The function of nicotinamide phosphoribosyltransferase in the heart</article-title><source>DNA Repair (Amst)</source><year>2014</year><volume>23</volume><fpage>64</fpage><lpage>68</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2cXhsFynsLvE</pub-id><pub-id pub-id-type="doi">10.1016/j.dnarep.2014.08.005</pub-id></mixed-citation></ref><ref id="CR161"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>SJ</given-names></name><etal/></person-group><article-title xml:lang="en">Upregulation of P2RX7 in Cx3cr1-deficient mononuclear phagocytes leads to increased interleukin-1beta secretion and photoreceptor neurodegeneration</article-title><source>J Neurosci</source><year>2015</year><volume>35</volume><issue>18</issue><fpage>6987</fpage><lpage>6996</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXos12ksb0%3D</pub-id><pub-id pub-id-type="pmid">25948251</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3955-14.2015</pub-id></mixed-citation></ref><ref id="CR162"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y</given-names></name><etal/></person-group><article-title xml:lang="en">An abundant dysfunctional apolipoprotein A1 in human atheroma</article-title><source>Nat Med</source><year>2014</year><volume>20</volume><issue>2</issue><fpage>193</fpage><lpage>203</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2cXht1ykurc%3D</pub-id><pub-id pub-id-type="pmid">24464187</pub-id><pub-id pub-id-type="pmcid">3923163</pub-id><pub-id pub-id-type="doi">10.1038/nm.3459</pub-id></mixed-citation></ref><ref id="CR163"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>CC</given-names></name><etal/></person-group><article-title xml:lang="en">Autophagy-regulated ROS from xanthine oxidase acts as an early effector for triggering late mitochondria-dependent apoptosis in Cathepsin S-targeted tumor cells</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><issue>6</issue><fpage>e0128045</fpage><pub-id pub-id-type="pmid">26029922</pub-id><pub-id pub-id-type="pmcid">4452096</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0128045</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28XhsVSgt7bL</pub-id></mixed-citation></ref><ref id="CR164"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hui</surname><given-names>L</given-names></name><etal/></person-group><article-title xml:lang="en">p38alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway</article-title><source>Nat Genet</source><year>2007</year><volume>39</volume><issue>6</issue><fpage>741</fpage><lpage>749</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2sXlvVSgt78%3D</pub-id><pub-id pub-id-type="pmid">17468757</pub-id><pub-id pub-id-type="doi">10.1038/ng2033</pub-id></mixed-citation></ref><ref id="CR165"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hukkanen</surname><given-names>MV</given-names></name><etal/></person-group><article-title xml:lang="en">Developmental regulation of nitric oxide synthase expression in rat skeletal bone</article-title><source>J Bone Miner Res</source><year>1999</year><volume>14</volume><issue>6</issue><fpage>868</fpage><lpage>877</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK1MXjvFKqtb4%3D</pub-id><pub-id pub-id-type="pmid">10352094</pub-id><pub-id pub-id-type="doi">10.1359/jbmr.1999.14.6.868</pub-id></mixed-citation></ref><ref id="CR166"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishida</surname><given-names>BY</given-names></name><etal/></person-group><article-title xml:lang="en">Regulated expression of apolipoprotein E by human retinal pigment epithelial cells</article-title><source>J Lipid Res</source><year>2004</year><volume>45</volume><issue>2</issue><fpage>263</fpage><lpage>271</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2cXhslOmtrg%3D</pub-id><pub-id pub-id-type="pmid">14594998</pub-id><pub-id pub-id-type="doi">10.1194/jlr.M300306-JLR200</pub-id></mixed-citation></ref><ref id="CR167"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacques</surname><given-names>PF</given-names></name><name><surname>Chylack</surname><given-names>LT</given-names></name></person-group><article-title xml:lang="en">Epidemiologic evidence of a role for the antioxidant vitamins and carotenoids in cataract prevention</article-title><source>Am J Clin Nutr</source><year>1991</year><volume>53</volume><issue>1</issue><fpage>352S</fpage><lpage>355S</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaK3M%2FptVSgtQ%3D%3D</pub-id><pub-id pub-id-type="pmid">1985409</pub-id></mixed-citation></ref><ref id="CR168"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janssen</surname><given-names>AM</given-names></name><etal/></person-group><article-title xml:lang="en">Superoxide dismutases in gastric and esophageal cancer and the prognostic impact in gastric cancer</article-title><source>Clin Cancer Res</source><year>2000</year><volume>6</volume><issue>8</issue><fpage>3183</fpage><lpage>3192</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3cXmsVOmtrY%3D</pub-id><pub-id pub-id-type="pmid">10955802</pub-id></mixed-citation></ref><ref id="CR169"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joanne</surname><given-names>P</given-names></name><etal/></person-group><article-title xml:lang="en">Nanofibrous clinical-grade collagen scaffolds seeded with human cardiomyocytes induces cardiac remodeling in dilated cardiomyopathy</article-title><source>Biomaterials</source><year>2016</year><volume>80</volume><fpage>157</fpage><lpage>168</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXhvF2murfP</pub-id><pub-id pub-id-type="pmid">26708641</pub-id><pub-id pub-id-type="doi">10.1016/j.biomaterials.2015.11.035</pub-id></mixed-citation></ref><ref id="CR170"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnston-Carey</surname><given-names>HK</given-names></name><name><surname>Pomatto</surname><given-names>LC</given-names></name><name><surname>Davies</surname><given-names>KJA</given-names></name></person-group><article-title xml:lang="en">The immunoproteasome in oxidative stress, aging, and disease</article-title><source>Crit Rev Biochem Mol Biol</source><year>2015</year><volume>51</volume><issue>4</issue><fpage>268</fpage><lpage>281</lpage><pub-id pub-id-type="pmid">27098648</pub-id><pub-id pub-id-type="doi">10.3109/10409238.2016.1172554</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28XmvFyktb4%3D</pub-id></mixed-citation></ref><ref id="CR171"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jonas</surname><given-names>JB</given-names></name><etal/></person-group><article-title xml:lang="en">Monocyte chemoattractant protein 1, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1 in exudative age-related macular degeneration</article-title><source>Arch Ophthalmol</source><year>2010</year><volume>128</volume><issue>10</issue><fpage>1281</fpage><lpage>1286</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3cXhtlyjt7rL</pub-id><pub-id pub-id-type="pmid">20937997</pub-id><pub-id pub-id-type="doi">10.1001/archophthalmol.2010.227</pub-id></mixed-citation></ref><ref id="CR172"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kageyama</surname><given-names>Y</given-names></name><etal/></person-group><article-title xml:lang="en">Reduction of oxidative stress marker levels by anti-TNF-alpha antibody, infliximab, in patients with rheumatoid arthritis</article-title><source>Clin Exp Rheumatol</source><year>2008</year><volume>26</volume><issue>1</issue><fpage>73</fpage><lpage>80</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DC%2BD1c7ntVegsg%3D%3D</pub-id><pub-id pub-id-type="pmid">18328150</pub-id></mixed-citation></ref><ref id="CR173"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karihtala</surname><given-names>P</given-names></name><etal/></person-group><article-title xml:lang="en">Divergent behaviour of oxidative stress markers 8-hydroxydeoxyguanosine (8-OHdG) and 4-hydroxy-2-nonenal (HNE) in breast carcinogenesis</article-title><source>Histopathology</source><year>2011</year><volume>58</volume><issue>6</issue><fpage>854</fpage><lpage>862</lpage><pub-id pub-id-type="pmid">21585424</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-2559.2011.03835.x</pub-id></mixed-citation></ref><ref id="CR174"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Key</surname><given-names>LL</given-names><suffix>Jr</suffix></name><etal/></person-group><article-title xml:lang="en">Superoxide and bone resorption</article-title><source>Bone</source><year>1994</year><volume>15</volume><issue>4</issue><fpage>431</fpage><lpage>436</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK2cXmt1Ojtrc%3D</pub-id><pub-id pub-id-type="pmid">7917583</pub-id><pub-id pub-id-type="doi">10.1016/8756-3282(94)90821-4</pub-id></mixed-citation></ref><ref id="CR175"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khatri</surname><given-names>N</given-names></name><name><surname>Man</surname><given-names>HY</given-names></name></person-group><article-title xml:lang="en">Synaptic activity and bioenergy homeostasis: implications in brain trauma and neurodegenerative diseases</article-title><source>Front Neurol</source><year>2013</year><volume>4</volume><fpage>199</fpage><pub-id pub-id-type="pmid">24376435</pub-id><pub-id pub-id-type="pmcid">3858785</pub-id><pub-id pub-id-type="doi">10.3389/fneur.2013.00199</pub-id></mixed-citation></ref><ref id="CR176"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H</given-names></name><etal/></person-group><article-title xml:lang="en">Bimodal actions of reactive oxygen species in the differentiation and bone-resorbing functions of osteoclasts</article-title><source>FEBS Lett</source><year>2006</year><volume>580</volume><issue>24</issue><fpage>5661</fpage><lpage>5665</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD28XhtVGisLbL</pub-id><pub-id pub-id-type="pmid">16996506</pub-id><pub-id pub-id-type="doi">10.1016/j.febslet.2006.09.015</pub-id></mixed-citation></ref><ref id="CR177"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinni</surname><given-names>H</given-names></name><etal/></person-group><article-title xml:lang="en">Cerebral metabolism after forced or voluntary physical exercise</article-title><source>Brain Res</source><year>2011</year><volume>1388</volume><fpage>48</fpage><lpage>55</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3MXkvVGgsbs%3D</pub-id><pub-id pub-id-type="pmid">21396919</pub-id><pub-id pub-id-type="doi">10.1016/j.brainres.2011.02.076</pub-id></mixed-citation></ref><ref id="CR178"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kintz</surname><given-names>N</given-names></name><etal/></person-group><article-title xml:lang="en">Exercise modifies alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor expression in striatopallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse</article-title><source>J Neurosci Res</source><year>2013</year><volume>91</volume><issue>11</issue><fpage>1492</fpage><lpage>1507</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3sXht1WrsbnP</pub-id><pub-id pub-id-type="pmid">23918451</pub-id><pub-id pub-id-type="doi">10.1002/jnr.23260</pub-id></mixed-citation></ref><ref id="CR179"><mixed-citation publication-type="other">Kitsara M, Agbulut O, Kontziampasis D, Chen Y, Menasché P (2016) Fibers for hearts: a critical review on electrospinning for cardiac tissue engineering. Acta Biomater 48:20–40</mixed-citation></ref><ref id="CR180"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klaver</surname><given-names>CC</given-names></name><etal/></person-group><article-title xml:lang="en">Genetic association of apolipoprotein E with age-related macular degeneration</article-title><source>Am J Hum Genet</source><year>1998</year><volume>63</volume><issue>1</issue><fpage>200</fpage><lpage>206</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK1cXnvFarsr0%3D</pub-id><pub-id pub-id-type="pmid">9634502</pub-id><pub-id pub-id-type="pmcid">1377225</pub-id><pub-id pub-id-type="doi">10.1086/301901</pub-id></mixed-citation></ref><ref id="CR181"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>R</given-names></name><name><surname>Klein</surname><given-names>BE</given-names></name><name><surname>Franke</surname><given-names>T</given-names></name></person-group><article-title xml:lang="en">The relationship of cardiovascular disease and its risk factors to age-related maculopathy<italic>.</italic> The Beaver Dam Eye Study</article-title><source>Ophthalmology</source><year>1993</year><volume>100</volume><issue>3</issue><fpage>406</fpage><lpage>414</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaK3s3htFKksw%3D%3D</pub-id><pub-id pub-id-type="pmid">8460013</pub-id><pub-id pub-id-type="doi">10.1016/S0161-6420(93)31634-9</pub-id></mixed-citation></ref><ref id="CR182"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>R</given-names></name><name><surname>Klein</surname><given-names>BE</given-names></name><name><surname>Jensen</surname><given-names>SC</given-names></name></person-group><article-title xml:lang="en">The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study</article-title><source>Ophthalmology</source><year>1997</year><volume>104</volume><issue>11</issue><fpage>1804</fpage><lpage>1812</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaK1c%2FjvV2ntQ%3D%3D</pub-id><pub-id pub-id-type="pmid">9373110</pub-id><pub-id pub-id-type="doi">10.1016/S0161-6420(97)30023-2</pub-id></mixed-citation></ref><ref id="CR183"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>R</given-names></name><etal/></person-group><article-title xml:lang="en">Ten-year incidence and progression of age-related maculopathy: the beaver dam eye study</article-title><source>Ophthalmology</source><year>2002</year><volume>109</volume><issue>10</issue><fpage>1767</fpage><lpage>1779</lpage><pub-id pub-id-type="pmid">12359593</pub-id><pub-id pub-id-type="doi">10.1016/S0161-6420(02)01146-6</pub-id></mixed-citation></ref><ref id="CR184"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>R</given-names></name><etal/></person-group><article-title xml:lang="en">The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study</article-title><source>Ophthalmology</source><year>2003</year><volume>110</volume><issue>6</issue><fpage>1273</fpage><lpage>1280</lpage><pub-id pub-id-type="pmid">12799274</pub-id><pub-id pub-id-type="doi">10.1016/S0161-6420(03)00599-2</pub-id></mixed-citation></ref><ref id="CR185"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>R</given-names></name><etal/></person-group><article-title xml:lang="en">The epidemiology of age-related macular degeneration</article-title><source>Am J Ophthalmol</source><year>2004</year><volume>137</volume><issue>3</issue><fpage>486</fpage><lpage>495</lpage><pub-id pub-id-type="pmid">15013873</pub-id><pub-id pub-id-type="doi">10.1016/j.ajo.2003.11.069</pub-id></mixed-citation></ref><ref id="CR186"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kligman</surname><given-names>AM</given-names></name></person-group><article-title xml:lang="en">Early destructive effect of sunlight on human skin</article-title><source>JAMA</source><year>1969</year><volume>210</volume><issue>13</issue><fpage>2377</fpage><lpage>2380</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaE3c%2Fmtleltw%3D%3D</pub-id><pub-id pub-id-type="pmid">5395389</pub-id><pub-id pub-id-type="doi">10.1001/jama.1969.03160390039008</pub-id></mixed-citation></ref><ref id="CR187"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kligman</surname><given-names>LH</given-names></name></person-group><article-title xml:lang="en">Photoaging. Manifestations, prevention, and treatment</article-title><source>Clin Geriatr Med</source><year>1989</year><volume>5</volume><issue>1</issue><fpage>235</fpage><lpage>251</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaL1M7ltFahuw%3D%3D</pub-id><pub-id pub-id-type="pmid">2646001</pub-id></mixed-citation></ref><ref id="CR188"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kloner</surname><given-names>RA</given-names></name></person-group><article-title xml:lang="en">No-reflow phenomenon: maintaining vascular integrity</article-title><source>J Cardiovasc Pharmacol Ther</source><year>2011</year><volume>16</volume><issue>3–4</issue><fpage>244</fpage><lpage>250</lpage><pub-id pub-id-type="pmid">21821523</pub-id><pub-id pub-id-type="doi">10.1177/1074248411405990</pub-id></mixed-citation></ref><ref id="CR189"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kloner</surname><given-names>RA</given-names></name><name><surname>Ganote</surname><given-names>CE</given-names></name><name><surname>Jennings</surname><given-names>RB</given-names></name></person-group><article-title xml:lang="en">The “no-reflow” phenomenon after temporary coronary occlusion in the dog</article-title><source>J Clin Invest</source><year>1974</year><volume>54</volume><issue>6</issue><fpage>1496</fpage><lpage>1508</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaE2M%2FmtVKrsA%3D%3D</pub-id><pub-id pub-id-type="pmid">4140198</pub-id><pub-id pub-id-type="pmcid">301706</pub-id><pub-id pub-id-type="doi">10.1172/JCI107898</pub-id></mixed-citation></ref><ref id="CR190"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kloner</surname><given-names>RA</given-names></name><etal/></person-group><article-title xml:lang="en">Studies of experimental coronary artery reperfusion. Effects on infarct size, myocardial function, biochemistry, ultrastructure and microvascular damage</article-title><source>Circulation</source><year>1983</year><volume>68</volume><issue>2 Pt 2</issue><fpage>I8</fpage><lpage>15</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaL3s3jtlajtw%3D%3D</pub-id><pub-id pub-id-type="pmid">6861331</pub-id></mixed-citation></ref><ref id="CR191"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kloner</surname><given-names>RA</given-names></name><name><surname>Dow</surname><given-names>JS</given-names></name><name><surname>Bhandari</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">First direct comparison of the late sodium current blocker ranolazine to established antiarrhythmic agents in an ischemia/reperfusion model</article-title><source>J Cardiovasc Pharmacol Ther</source><year>2011</year><volume>16</volume><issue>2</issue><fpage>192</fpage><lpage>196</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3MXnslOjsL0%3D</pub-id><pub-id pub-id-type="pmid">21193683</pub-id><pub-id pub-id-type="doi">10.1177/1074248410386485</pub-id></mixed-citation></ref><ref id="CR192"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kloner</surname><given-names>RA</given-names></name><etal/></person-group><article-title xml:lang="en">Reduction of ischemia/reperfusion injury with bendavia, a mitochondria-targeting cytoprotective peptide</article-title><source>J Am Heart Assoc</source><year>2012</year><volume>1</volume><issue>3</issue><fpage>e001644</fpage><pub-id pub-id-type="pmid">23130143</pub-id><pub-id pub-id-type="pmcid">3487333</pub-id><pub-id pub-id-type="doi">10.1161/JAHA.112.001644</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC38XhsVKjtbjI</pub-id></mixed-citation></ref><ref id="CR193"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kloner</surname><given-names>RA</given-names></name><etal/></person-group><article-title xml:lang="en">Cardioprotection: where to from here?</article-title><source>Cardiovasc Drugs Ther</source><year>2017</year><volume>31</volume><issue>1</issue><fpage>53</fpage><lpage>61</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28Xhs1GqsLzO</pub-id><pub-id pub-id-type="pmid">27714476</pub-id><pub-id pub-id-type="doi">10.1007/s10557-016-6691-0</pub-id></mixed-citation></ref><ref id="CR194"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klungland</surname><given-names>A</given-names></name><etal/></person-group><article-title xml:lang="en">Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage</article-title><source>Proc Natl Acad Sci U S A</source><year>1999</year><volume>96</volume><issue>23</issue><fpage>13300</fpage><lpage>13305</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK1MXns1Gmt7o%3D</pub-id><pub-id pub-id-type="pmid">10557315</pub-id><pub-id pub-id-type="pmcid">23942</pub-id><pub-id pub-id-type="doi">10.1073/pnas.96.23.13300</pub-id></mixed-citation></ref><ref id="CR195"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohno</surname><given-names>H</given-names></name><etal/></person-group><article-title xml:lang="en">Photoreceptor proteins initiate microglial activation via toll-like receptor 4 in retinal degeneration mediated by all-trans-retinal</article-title><source>J Biol Chem</source><year>2013</year><volume>288</volume><issue>21</issue><fpage>15326</fpage><lpage>15341</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3sXot1Wit7o%3D</pub-id><pub-id pub-id-type="pmid">23572532</pub-id><pub-id pub-id-type="pmcid">3663552</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M112.448712</pub-id></mixed-citation></ref><ref id="CR196"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kosova</surname><given-names>F</given-names></name><etal/></person-group><article-title xml:lang="en">Possible relations between oxidative damage and apoptosis in benign prostate hyperplasia and prostate cancer patients</article-title><source>Tumour Biol</source><year>2014</year><volume>35</volume><issue>5</issue><fpage>4295</fpage><lpage>4299</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2cXntlOkt7Y%3D</pub-id><pub-id pub-id-type="pmid">24375255</pub-id><pub-id pub-id-type="doi">10.1007/s13277-013-1560-y</pub-id></mixed-citation></ref><ref id="CR197"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koss</surname><given-names>MJ</given-names></name><etal/></person-group><article-title xml:lang="en">Proteomics of vitreous humor of patients with exudative age-related macular degeneration</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><issue>5</issue><fpage>e96895</fpage><pub-id pub-id-type="pmid">24828575</pub-id><pub-id pub-id-type="pmcid">4020801</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0096895</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2cXhvFKju7%2FE</pub-id></mixed-citation></ref><ref id="CR198"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krabbe</surname><given-names>KS</given-names></name><name><surname>Pedersen</surname><given-names>M</given-names></name><name><surname>Bruunsgaard</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Inflammatory mediators in the elderly</article-title><source>Exp Gerontol</source><year>2004</year><volume>39</volume><issue>5</issue><fpage>687</fpage><lpage>699</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2cXjvVahtbg%3D</pub-id><pub-id pub-id-type="pmid">15130663</pub-id><pub-id pub-id-type="doi">10.1016/j.exger.2004.01.009</pub-id></mixed-citation></ref><ref id="CR199"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kraljević Pavelić</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">UV-induced retinal proteome changes in the rat model of age-related macular degeneration</article-title><source>Biochim Biophys Acta</source><year>2015</year><volume>1852</volume><issue>9</issue><fpage>1833</fpage><lpage>1845</lpage><pub-id pub-id-type="pmid">26071645</pub-id><pub-id pub-id-type="doi">10.1016/j.bbadis.2015.06.006</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXhtVWru7fN</pub-id></mixed-citation></ref><ref id="CR200"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krause</surname><given-names>KH</given-names></name></person-group><article-title xml:lang="en">Tissue distribution and putative physiological function of NOX Family NADPH oxidases</article-title><source>Jpn J Infect Dis</source><year>2004</year><volume>57</volume><issue>5</issue><fpage>S28</fpage><lpage>S29</lpage><pub-id pub-id-type="pmid">15507765</pub-id></mixed-citation></ref><ref id="CR201"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krebiehl</surname><given-names>G</given-names></name><etal/></person-group><article-title xml:lang="en">Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson’s disease-associated protein DJ-1</article-title><source>PLoS One</source><year>2010</year><volume>5</volume><issue>2</issue><fpage>e9367</fpage><pub-id pub-id-type="pmid">20186336</pub-id><pub-id pub-id-type="pmcid">2826413</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0009367</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3cXis1Ggt7Y%3D</pub-id></mixed-citation></ref><ref id="CR202"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krutmann</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Ultraviolet a radiation-induced biological effects in human skin: relevance for photoaging and photodermatosis</article-title><source>J Dermatol Sci</source><year>2000</year><volume>23</volume><issue>Suppl 1</issue><fpage>S22</fpage><lpage>S26</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3cXovFGntL0%3D</pub-id><pub-id pub-id-type="pmid">10764987</pub-id><pub-id pub-id-type="doi">10.1016/S0923-1811(99)00077-8</pub-id></mixed-citation></ref><ref id="CR203"><mixed-citation publication-type="other">Kurien BT, Mohan C, Scofield H (2012) Mechanisms of tissue damage-free radicals and fibrosis. In: Wallace DJ (ed) Dubois’ Lupus Erythematosus and Related Syndromes E-Book: Expert Consult-Online, 8th edn. Elsevier Health Sciences, London, p 175–189</mixed-citation></ref><ref id="CR204"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lacolley</surname><given-names>P</given-names></name><etal/></person-group><article-title xml:lang="en">Mechanical properties and structure of carotid arteries in mice lacking desmin</article-title><source>Cardiovasc Res</source><year>2001</year><volume>51</volume><issue>1</issue><fpage>178</fpage><lpage>187</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3MXktVOisbc%3D</pub-id><pub-id pub-id-type="pmid">11399260</pub-id><pub-id pub-id-type="doi">10.1016/S0008-6363(01)00278-4</pub-id></mixed-citation></ref><ref id="CR205"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lacolley</surname><given-names>P</given-names></name><etal/></person-group><article-title xml:lang="en">The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles</article-title><source>Cardiovasc Res</source><year>2012</year><volume>95</volume><issue>2</issue><fpage>194</fpage><lpage>204</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC38XhtVSht77F</pub-id><pub-id pub-id-type="pmid">22467316</pub-id><pub-id pub-id-type="doi">10.1093/cvr/cvs135</pub-id></mixed-citation></ref><ref id="CR206"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lad</surname><given-names>EM</given-names></name><etal/></person-group><article-title xml:lang="en">Abundance of infiltrating CD163+ cells in the retina of postmortem eyes with dry and neovascular age-related macular degeneration</article-title><source>Graefes Arch Clin Exp Ophthalmol</source><year>2015</year><volume>253</volume><issue>11</issue><fpage>1941</fpage><lpage>1945</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXhtFOku7nP</pub-id><pub-id pub-id-type="pmid">26148801</pub-id><pub-id pub-id-type="pmcid">5203931</pub-id><pub-id pub-id-type="doi">10.1007/s00417-015-3094-z</pub-id></mixed-citation></ref><ref id="CR207"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ladislas</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">Cellular and molecular mechanisms of aging and age related diseases</article-title><source>Pathol Oncol Res</source><year>2000</year><volume>6</volume><issue>1</issue><fpage>3</fpage><lpage>9</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DC%2BD3c3htlKmsA%3D%3D</pub-id><pub-id pub-id-type="pmid">10749581</pub-id><pub-id pub-id-type="doi">10.1007/BF03032651</pub-id></mixed-citation></ref><ref id="CR208"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lagadu</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">8-oxo-7,8-dihydro-2′-deoxyguanosine as a biomarker of oxidative damage in oesophageal cancer patients: lack of association with antioxidant vitamins and polymorphism of hOGG1 and GST</article-title><source>J Exp Clin Cancer Res</source><year>2010</year><volume>29</volume><fpage>157</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3cXhsF2iu7vN</pub-id><pub-id pub-id-type="pmid">21134244</pub-id><pub-id pub-id-type="pmcid">3004823</pub-id><pub-id pub-id-type="doi">10.1186/1756-9966-29-157</pub-id></mixed-citation></ref><ref id="CR209"><mixed-citation publication-type="other">Lahita RG (2011) The clinical presentation of systemic lupus erythematosus. In Systemic Lupus Erythematosus, 5th edn. Elsevier, Amsterdam, p 525–539</mixed-citation></ref><ref id="CR210"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langemann</surname><given-names>H</given-names></name><name><surname>Kabiersch</surname><given-names>A</given-names></name><name><surname>Newcombe</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Measurement of low-molecular-weight antioxidants, uric acid, tyrosine and tryptophan in plaques and white matter from patients with multiple sclerosis</article-title><source>Eur Neurol</source><year>1992</year><volume>32</volume><issue>5</issue><fpage>248</fpage><lpage>252</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaK38zpsVWmtA%3D%3D</pub-id><pub-id pub-id-type="pmid">1521544</pub-id><pub-id pub-id-type="doi">10.1159/000116835</pub-id></mixed-citation></ref><ref id="CR211"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langlois</surname><given-names>B</given-names></name><etal/></person-group><article-title xml:lang="en">Vimentin knockout results in increased expression of sub-endothelial basement membrane components and carotid stiffness in mice</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><issue>1</issue><fpage>11628</fpage><pub-id pub-id-type="pmid">28912461</pub-id><pub-id pub-id-type="pmcid">5599644</pub-id><pub-id pub-id-type="doi">10.1038/s41598-017-12024-z</pub-id></mixed-citation></ref><ref id="CR212"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langston</surname><given-names>JW</given-names></name></person-group><article-title xml:lang="en">The MPTP story</article-title><source>J Park Dis</source><year>2017</year><volume>7</volume><issue>s1</issue><fpage>S11</fpage><lpage>s22</lpage><pub-id pub-id-type="doi">10.3233/JPD-179006</pub-id></mixed-citation></ref><ref id="CR213"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langston</surname><given-names>JW</given-names></name><etal/></person-group><article-title xml:lang="en">Chronic parkinsonism in humans due to a product of meperidine-analog synthesis</article-title><source>Science</source><year>1983</year><volume>219</volume><fpage>979</fpage><lpage>980</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaL3s7hvF2mtg%3D%3D</pub-id><pub-id pub-id-type="pmid">6823561</pub-id><pub-id pub-id-type="doi">10.1126/science.6823561</pub-id></mixed-citation></ref><ref id="CR214"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lannuzel</surname><given-names>A</given-names></name><name><surname>Ruberg</surname><given-names>M</given-names></name><name><surname>Michel</surname><given-names>PP</given-names></name></person-group><article-title xml:lang="en">Atypical parkinsonism in the Caribbean island of Guadeloupe: etiological role of the mitochondrial complex I inhibitor annonacin</article-title><source>Mov Disord</source><year>2008</year><volume>23</volume><issue>15</issue><fpage>2122</fpage><lpage>2128</lpage><pub-id pub-id-type="pmid">18816693</pub-id><pub-id pub-id-type="doi">10.1002/mds.22300</pub-id></mixed-citation></ref><ref id="CR215"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larroque-Cardoso</surname><given-names>P</given-names></name><etal/></person-group><article-title xml:lang="en">Elastin modification by 4-hydroxynonenal in hairless mice exposed to UV-A. Role in photoaging and actinic elastosis</article-title><source>J Invest Dermatol</source><year>2015</year><volume>135</volume><issue>7</issue><fpage>1873</fpage><lpage>1881</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXmt1SntLk%3D</pub-id><pub-id pub-id-type="pmid">25739050</pub-id><pub-id pub-id-type="doi">10.1038/jid.2015.84</pub-id></mixed-citation></ref><ref id="CR216"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>YS</given-names></name><etal/></person-group><article-title xml:lang="en">Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson’s disease with moderate neurodegeneration</article-title><source>Eur J Neurosci</source><year>2011</year><volume>33</volume><issue>7</issue><fpage>1264</fpage><lpage>1274</lpage><pub-id pub-id-type="pmid">21375602</pub-id><pub-id pub-id-type="pmcid">3079264</pub-id><pub-id pub-id-type="doi">10.1111/j.1460-9568.2011.07626.x</pub-id></mixed-citation></ref><ref id="CR217"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Gal</surname><given-names>K</given-names></name><etal/></person-group><article-title xml:lang="en">Antioxidants can increase melanoma metastasis in mice</article-title><source>Sci Transl Med</source><year>2015</year><volume>7</volume><issue>308</issue><fpage>308re8</fpage><pub-id pub-id-type="pmid">26446958</pub-id><pub-id pub-id-type="doi">10.1126/scitranslmed.aad3740</pub-id></mixed-citation></ref><ref id="CR218"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lebovics</surname><given-names>E</given-names></name><name><surname>Rubin</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Non-alcoholic fatty liver disease (NAFLD): why you should care, when you should worry, what you should do</article-title><source>Diabetes Metab Res Rev</source><year>2011</year><volume>27</volume><issue>5</issue><fpage>419</fpage><lpage>424</lpage><pub-id pub-id-type="pmid">21425426</pub-id><pub-id pub-id-type="doi">10.1002/dmrr.1198</pub-id></mixed-citation></ref><ref id="CR219"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KH</given-names></name><etal/></person-group><article-title xml:lang="en">Breast cancer and urinary biomarkers of polycyclic aromatic hydrocarbon and oxidative stress in the Shanghai Women’s Health Study</article-title><source>Cancer Epidemiol Biomark Prev</source><year>2010</year><volume>19</volume><issue>3</issue><fpage>877</fpage><lpage>883</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3cXivFegt7o%3D</pub-id><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-09-1098</pub-id></mixed-citation></ref><ref id="CR220"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer’s disease mouse models</article-title><source>Am J Pathol</source><year>2010</year><volume>177</volume><issue>5</issue><fpage>2549</fpage><lpage>2562</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3cXhsFWgsrzO</pub-id><pub-id pub-id-type="pmid">20864679</pub-id><pub-id pub-id-type="pmcid">2966811</pub-id><pub-id pub-id-type="doi">10.2353/ajpath.2010.100265</pub-id></mixed-citation></ref><ref id="CR221"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Kim</surname><given-names>KH</given-names></name><name><surname>Cohen</surname><given-names>P</given-names></name></person-group><article-title xml:lang="en">MOTS-c: a novel mitochondrial-derived peptide regulating muscle and fat metabolism</article-title><source>Free Radic Biol Med</source><year>2016</year><volume>100</volume><fpage>182</fpage><lpage>187</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28XptVSltr4%3D</pub-id><pub-id pub-id-type="pmid">27216708</pub-id><pub-id pub-id-type="pmcid">5116416</pub-id><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2016.05.015</pub-id></mixed-citation></ref><ref id="CR222"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>CF</given-names></name><etal/></person-group><article-title xml:lang="en">Normalization of NAD+ redox balance as a therapy for heart failure</article-title><source>Circulation</source><year>2016</year><volume>134</volume><issue>12</issue><fpage>883</fpage><lpage>894</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28XhsFGku7zM</pub-id><pub-id pub-id-type="pmid">27489254</pub-id><pub-id pub-id-type="pmcid">5193133</pub-id><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.116.022495</pub-id></mixed-citation></ref><ref id="CR223"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefèvre</surname><given-names>C</given-names></name><etal/></person-group><article-title xml:lang="en">Premature senescence of vascular cells is induced by HIV protease inhibitors: implication of prelamin A and reversion by statin</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2010</year><volume>30</volume><issue>12</issue><fpage>2611</fpage><lpage>2620</lpage><pub-id pub-id-type="pmid">20884875</pub-id><pub-id pub-id-type="doi">10.1161/ATVBAHA.110.213603</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3cXhsVCksbrO</pub-id></mixed-citation></ref><ref id="CR224"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefort</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancers</article-title><source>Autophagy</source><year>2014</year><volume>10</volume><issue>12</issue><fpage>2122</fpage><lpage>2142</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXmtlSns7o%3D</pub-id><pub-id pub-id-type="pmid">25427136</pub-id><pub-id pub-id-type="doi">10.4161/15548627.2014.981788</pub-id></mixed-citation></ref><ref id="CR225"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>O</given-names></name><etal/></person-group><article-title xml:lang="en">Apolipoprotein E promotes subretinal mononuclear phagocyte survival and chronic inflammation in age-related macular degeneration</article-title><source>EMBO Mol Med</source><year>2015</year><volume>7</volume><issue>2</issue><fpage>211</fpage><lpage>226</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXhsl2gtbs%3D</pub-id><pub-id pub-id-type="pmid">25604058</pub-id><pub-id pub-id-type="pmcid">4328649</pub-id><pub-id pub-id-type="doi">10.15252/emmm.201404524</pub-id></mixed-citation></ref><ref id="CR226"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>O</given-names></name><etal/></person-group><article-title xml:lang="en">APOE-isoforms control pathogenic subretinal inflammation in age related macular degeneration</article-title><source>J Neurosci</source><year>2015</year><volume>35</volume><issue>40</issue><fpage>13568</fpage><lpage>13576</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28Xjt1Kgtbc%3D</pub-id><pub-id pub-id-type="pmid">26446211</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2468-15.2015</pub-id></mixed-citation></ref><ref id="CR227"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>KG</given-names></name><etal/></person-group><article-title xml:lang="en">Acquired disorders of elastic tissue: part I. Increased elastic tissue and solar elastotic syndromes</article-title><source>J Am Acad Dermatol</source><year>2004</year><volume>51</volume><issue>1</issue><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">15243519</pub-id><pub-id pub-id-type="doi">10.1016/j.jaad.2004.03.013</pub-id><comment>quiz 22-4</comment></mixed-citation></ref><ref id="CR228"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate</article-title><source>Cancer Lett</source><year>1995</year><volume>96</volume><issue>2</issue><fpage>239</fpage><lpage>243</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK2MXos1Ggt74%3D</pub-id><pub-id pub-id-type="pmid">7585463</pub-id><pub-id pub-id-type="doi">10.1016/0304-3835(95)03948-V</pub-id></mixed-citation></ref><ref id="CR229"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livnat-Levanon</surname><given-names>N</given-names></name><etal/></person-group><article-title xml:lang="en">Reversible 26S proteasome disassembly upon mitochondrial stress</article-title><source>Cell Rep</source><year>2014</year><volume>7</volume><issue>5</issue><fpage>1371</fpage><lpage>1380</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2cXoslyitr0%3D</pub-id><pub-id pub-id-type="pmid">24857655</pub-id><pub-id pub-id-type="doi">10.1016/j.celrep.2014.04.030</pub-id></mixed-citation></ref><ref id="CR230"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo</surname><given-names>HM</given-names></name><name><surname>Kloner</surname><given-names>RA</given-names></name><name><surname>Braunwald</surname><given-names>E</given-names></name></person-group><article-title xml:lang="en">Effect of intracoronary verapamil on infarct size in the ischemic, reperfused canine heart: critical importance of the timing of treatment</article-title><source>Am J Cardiol</source><year>1985</year><volume>56</volume><issue>10</issue><fpage>672</fpage><lpage>677</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaL2MXlvV2msLk%3D</pub-id><pub-id pub-id-type="pmid">4050705</pub-id><pub-id pub-id-type="doi">10.1016/0002-9149(85)91033-1</pub-id></mixed-citation></ref><ref id="CR231"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loft</surname><given-names>S</given-names></name><name><surname>Poulsen</surname><given-names>HE</given-names></name></person-group><article-title xml:lang="en">Cancer risk and oxidative DNA damage in man</article-title><source>J Mol Med (Berl)</source><year>1996</year><volume>74</volume><issue>6</issue><fpage>297</fpage><lpage>312</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK28XjvFWnsLY%3D</pub-id><pub-id pub-id-type="doi">10.1007/BF00207507</pub-id></mixed-citation></ref><ref id="CR232"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lomeli</surname><given-names>N</given-names></name><name><surname>Bota</surname><given-names>DA</given-names></name><name><surname>Davies</surname><given-names>KJA</given-names></name></person-group><article-title xml:lang="en">Diminished stress resistance and defective adaptive homeostasis in age-related diseases</article-title><source>Clin Sci (Lond)</source><year>2017</year><volume>131</volume><issue>21</issue><fpage>2573</fpage><lpage>2599</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXhvV2gsbfI</pub-id><pub-id pub-id-type="doi">10.1042/CS20160982</pub-id></mixed-citation></ref><ref id="CR233"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lotz</surname><given-names>MK</given-names></name><etal/></person-group><article-title xml:lang="en">Cartilage cell clusters</article-title><source>Arthritis Rheum</source><year>2010</year><volume>62</volume><issue>8</issue><fpage>2206</fpage><lpage>2218</lpage><pub-id pub-id-type="pmid">20506158</pub-id><pub-id pub-id-type="pmcid">2921934</pub-id><pub-id pub-id-type="doi">10.1002/art.27528</pub-id></mixed-citation></ref><ref id="CR234"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lunec</surname><given-names>J</given-names></name><etal/></person-group><article-title xml:lang="en">Self-perpetuating mechanisms of immunoglobulin G aggregation in rheumatoid inflammation</article-title><source>J Clin Invest</source><year>1985</year><volume>76</volume><issue>6</issue><fpage>2084</fpage><lpage>2090</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaL28Xos1OhsA%3D%3D</pub-id><pub-id pub-id-type="pmid">3001140</pub-id><pub-id pub-id-type="pmcid">424314</pub-id><pub-id pub-id-type="doi">10.1172/JCI112212</pub-id></mixed-citation></ref><ref id="CR235"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>J</given-names></name><name><surname>Solimini</surname><given-names>NL</given-names></name><name><surname>Elledge</surname><given-names>SJ</given-names></name></person-group><article-title xml:lang="en">Principles of cancer therapy: oncogene and non-oncogene addiction</article-title><source>Cell</source><year>2009</year><volume>136</volume><issue>5</issue><fpage>823</fpage><lpage>837</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD1MXltFSnsLw%3D</pub-id><pub-id pub-id-type="pmid">19269363</pub-id><pub-id pub-id-type="pmcid">2894612</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2009.02.024</pub-id></mixed-citation></ref><ref id="CR236"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madamanchi</surname><given-names>NR</given-names></name><name><surname>Hakim</surname><given-names>ZS</given-names></name><name><surname>Runge</surname><given-names>MS</given-names></name></person-group><article-title xml:lang="en">Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes</article-title><source>J Thromb Haemost</source><year>2005</year><volume>3</volume><issue>2</issue><fpage>254</fpage><lpage>267</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2MXitlSqsr0%3D</pub-id><pub-id pub-id-type="pmid">15670030</pub-id><pub-id pub-id-type="doi">10.1111/j.1538-7836.2004.01085.x</pub-id></mixed-citation></ref><ref id="CR237"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magenta</surname><given-names>A</given-names></name><etal/></person-group><article-title xml:lang="en">miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition</article-title><source>Cell Death Differ</source><year>2011</year><volume>18</volume><issue>10</issue><fpage>1628</fpage><lpage>1639</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3MXhtFKrtr3L</pub-id><pub-id pub-id-type="pmid">21527937</pub-id><pub-id pub-id-type="pmcid">3172120</pub-id><pub-id pub-id-type="doi">10.1038/cdd.2011.42</pub-id></mixed-citation></ref><ref id="CR238"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahley</surname><given-names>RW</given-names></name><name><surname>Rall</surname><given-names>SC</given-names><suffix>Jr</suffix></name></person-group><article-title xml:lang="en">Apolipoprotein E: far more than a lipid transport protein</article-title><source>Annu Rev Genomics Hum Genet</source><year>2000</year><volume>1</volume><fpage>507</fpage><lpage>537</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3cXnsVarsrY%3D</pub-id><pub-id pub-id-type="pmid">11701639</pub-id><pub-id pub-id-type="doi">10.1146/annurev.genom.1.1.507</pub-id></mixed-citation></ref><ref id="CR239"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahley</surname><given-names>RW</given-names></name><name><surname>Weisgraber</surname><given-names>KH</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer’s disease to AIDS</article-title><source>J Lipid Res</source><year>2009</year><volume>50</volume><issue>Suppl</issue><fpage>S183</fpage><lpage>S188</lpage><pub-id pub-id-type="pmid">19106071</pub-id><pub-id pub-id-type="pmcid">2674716</pub-id><pub-id pub-id-type="doi">10.1194/jlr.R800069-JLR200</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD1MXks1Wiur8%3D</pub-id></mixed-citation></ref><ref id="CR240"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahmood</surname><given-names>DF</given-names></name><etal/></person-group><article-title xml:lang="en">Truncated thioredoxin (Trx-80) promotes pro-inflammatory macrophages of the M1 phenotype and enhances atherosclerosis</article-title><source>J Cell Physiol</source><year>2013</year><volume>228</volume><issue>7</issue><fpage>1577</fpage><lpage>1583</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3sXktleqsrk%3D</pub-id><pub-id pub-id-type="pmid">23335265</pub-id><pub-id pub-id-type="doi">10.1002/jcp.24319</pub-id></mixed-citation></ref><ref id="CR241"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malek</surname><given-names>G</given-names></name><etal/></person-group><article-title xml:lang="en">Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration</article-title><source>Proc Natl Acad Sci U S A</source><year>2005</year><volume>102</volume><issue>33</issue><fpage>11900</fpage><lpage>11905</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2MXpsFGgurg%3D</pub-id><pub-id pub-id-type="pmid">16079201</pub-id><pub-id pub-id-type="pmcid">1187976</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0503015102</pub-id></mixed-citation></ref><ref id="CR242"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mancebo</surname><given-names>SE</given-names></name><name><surname>Wang</surname><given-names>SQ</given-names></name></person-group><article-title xml:lang="en">Recognizing the impact of ambient air pollution on skin health</article-title><source>J Eur Acad Dermatol Venereol</source><year>2015</year><volume>29</volume><issue>12</issue><fpage>2326</fpage><lpage>2332</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DC%2BC287ksVelsQ%3D%3D</pub-id><pub-id pub-id-type="pmid">26289769</pub-id><pub-id pub-id-type="doi">10.1111/jdv.13250</pub-id></mixed-citation></ref><ref id="CR243"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mancini</surname><given-names>L</given-names></name><etal/></person-group><article-title xml:lang="en">The biphasic effects of nitric oxide in primary rat osteoblasts are cGMP dependent</article-title><source>Biochem Biophys Res Commun</source><year>2000</year><volume>274</volume><issue>2</issue><fpage>477</fpage><lpage>481</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3cXltVOktrs%3D</pub-id><pub-id pub-id-type="pmid">10913363</pub-id><pub-id pub-id-type="doi">10.1006/bbrc.2000.3164</pub-id></mixed-citation></ref><ref id="CR244"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marrero</surname><given-names>JA</given-names></name><etal/></person-group><article-title xml:lang="en">NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States</article-title><source>Hepatology</source><year>2002</year><volume>36</volume><issue>6</issue><fpage>1349</fpage><lpage>1354</lpage><pub-id pub-id-type="pmid">12447858</pub-id><pub-id pub-id-type="doi">10.1002/hep.1840360609</pub-id></mixed-citation></ref><ref id="CR245"><mixed-citation publication-type="other">Martin GM, Finch CE (2016) Dementias of the Alzheimer type: views through the lens of evolutionary biology suggest amyloid-driven brain aging is a trade-off with host defence. In: Alvergne A, Jenkinson C, Faurie C (eds) Evolutionary thinking in medicine: from research to policy and practice. Springer International Publishing, Cham, p 277–298. <ext-link xlink:href="10.1007/978-3-319-29716-3_19" ext-link-type="doi">https://doi.org/10.1007/978-3-319-29716-3_19</ext-link></mixed-citation></ref><ref id="CR246"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mateen</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">Increased reactive oxygen species formation and oxidative stress in rheumatoid arthritis</article-title><source>PLoS One</source><year>2016</year><volume>11</volume><issue>4</issue><fpage>e0152925</fpage><pub-id pub-id-type="pmid">27043143</pub-id><pub-id pub-id-type="pmcid">4820274</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0152925</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28Xhs12qtL7O</pub-id></mixed-citation></ref><ref id="CR247"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mateescu</surname><given-names>B</given-names></name><etal/></person-group><article-title xml:lang="en">miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response</article-title><source>Nat Med</source><year>2011</year><volume>17</volume><issue>12</issue><fpage>1627</fpage><lpage>1635</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3MXhsV2gt7%2FK</pub-id><pub-id pub-id-type="pmid">22101765</pub-id><pub-id pub-id-type="doi">10.1038/nm.2512</pub-id></mixed-citation></ref><ref id="CR248"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsushima</surname><given-names>S</given-names></name><name><surname>Zablocki</surname><given-names>D</given-names></name><name><surname>Sadoshima</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Application of recombinant thioredoxin1 for treatment of heart disease</article-title><source>J Mol Cell Cardiol</source><year>2011</year><volume>51</volume><issue>4</issue><fpage>570</fpage><lpage>573</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3MXhtFymt7jJ</pub-id><pub-id pub-id-type="pmid">20955713</pub-id><pub-id pub-id-type="doi">10.1016/j.yjmcc.2010.09.020</pub-id></mixed-citation></ref><ref id="CR249"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCabe</surname><given-names>L</given-names></name><name><surname>Britton</surname><given-names>RA</given-names></name><name><surname>Parameswaran</surname><given-names>N</given-names></name></person-group><article-title xml:lang="en">Prebiotic and probiotic regulation of bone health: role of the intestine and its microbiome</article-title><source>Curr Osteoporos Rep</source><year>2015</year><volume>13</volume><issue>6</issue><fpage>363</fpage><lpage>371</lpage><pub-id pub-id-type="pmid">26419466</pub-id><pub-id pub-id-type="pmcid">4623939</pub-id><pub-id pub-id-type="doi">10.1007/s11914-015-0292-x</pub-id></mixed-citation></ref><ref id="CR250"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGeer</surname><given-names>PL</given-names></name><etal/></person-group><article-title xml:lang="en">Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson’s and Alzheimer’s disease brains</article-title><source>Neurology</source><year>1988</year><volume>38</volume><issue>8</issue><fpage>1285</fpage><lpage>1291</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaL1c3ovVKkuw%3D%3D</pub-id><pub-id pub-id-type="pmid">3399080</pub-id><pub-id pub-id-type="doi">10.1212/WNL.38.8.1285</pub-id></mixed-citation></ref><ref id="CR251"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKay</surname><given-names>GJ</given-names></name><etal/></person-group><article-title xml:lang="en">Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies</article-title><source>Hum Mutat</source><year>2011</year><volume>32</volume><issue>12</issue><fpage>1407</fpage><lpage>1416</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3MXhsVKgs7vM</pub-id><pub-id pub-id-type="pmid">21882290</pub-id><pub-id pub-id-type="pmcid">3217135</pub-id><pub-id pub-id-type="doi">10.1002/humu.21577</pub-id></mixed-citation></ref><ref id="CR252"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNeil</surname><given-names>JJ</given-names></name><etal/></person-group><article-title xml:lang="en">Vitamin E supplementation and cataract: randomized controlled trial</article-title><source>Ophthalmology</source><year>2004</year><volume>111</volume><issue>1</issue><fpage>75</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">14711717</pub-id><pub-id pub-id-type="doi">10.1016/j.ophtha.2003.04.009</pub-id></mixed-citation></ref><ref id="CR253"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McWilliams</surname><given-names>TG</given-names></name><name><surname>Muqit</surname><given-names>MM</given-names></name></person-group><article-title xml:lang="en">PINK1 and Parkin: emerging themes in mitochondrial homeostasis</article-title><source>Curr Opin Cell Biol</source><year>2017</year><volume>45</volume><fpage>83</fpage><lpage>91</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXmtFOhsrs%3D</pub-id><pub-id pub-id-type="pmid">28437683</pub-id><pub-id pub-id-type="doi">10.1016/j.ceb.2017.03.013</pub-id></mixed-citation></ref><ref id="CR254"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meir</surname><given-names>KS</given-names></name><name><surname>Leitersdorf</surname><given-names>E</given-names></name></person-group><article-title xml:lang="en">Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2004</year><volume>24</volume><issue>6</issue><fpage>1006</fpage><lpage>1014</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2cXkt1Ogsbk%3D</pub-id><pub-id pub-id-type="pmid">15087308</pub-id><pub-id pub-id-type="doi">10.1161/01.ATV.0000128849.12617.f4</pub-id></mixed-citation></ref><ref id="CR255"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mericskay</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Nicotinamide adenine dinucleotide homeostasis and signalling in heart disease: pathophysiological implications and therapeutic potential</article-title><source>Arch Cardiovasc Dis</source><year>2016</year><volume>109</volume><issue>3</issue><fpage>207</fpage><lpage>215</lpage><pub-id pub-id-type="pmid">26707577</pub-id><pub-id pub-id-type="doi">10.1016/j.acvd.2015.10.004</pub-id></mixed-citation></ref><ref id="CR256"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyerhardt</surname><given-names>JA</given-names></name><etal/></person-group><article-title xml:lang="en">Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803</article-title><source>J Clin Oncol</source><year>2006</year><volume>24</volume><issue>22</issue><fpage>3535</fpage><lpage>3541</lpage><pub-id pub-id-type="pmid">16822843</pub-id><pub-id pub-id-type="doi">10.1200/JCO.2006.06.0863</pub-id></mixed-citation></ref><ref id="CR257"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moncada</surname><given-names>S</given-names></name><name><surname>Higgs</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">The L-arginine-nitric oxide pathway</article-title><source>N Engl J Med</source><year>1993</year><volume>329</volume><issue>27</issue><fpage>2002</fpage><lpage>2012</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK2cXhsF2ntrw%3D</pub-id><pub-id pub-id-type="pmid">7504210</pub-id><pub-id pub-id-type="doi">10.1056/NEJM199312303292706</pub-id></mixed-citation></ref><ref id="CR258"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>KJ</given-names></name><name><surname>Tabas</surname><given-names>I</given-names></name></person-group><article-title xml:lang="en">Macrophages in the pathogenesis of atherosclerosis</article-title><source>Cell</source><year>2011</year><volume>145</volume><issue>3</issue><fpage>341</fpage><lpage>355</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3MXlsFSiu7c%3D</pub-id><pub-id pub-id-type="pmid">21529710</pub-id><pub-id pub-id-type="pmcid">3111065</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2011.04.005</pub-id></mixed-citation></ref><ref id="CR259"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mounsey</surname><given-names>RB</given-names></name><name><surname>Teismann</surname><given-names>P</given-names></name></person-group><article-title xml:lang="en">Mitochondrial dysfunction in Parkinson’s disease: pathogenesis and neuroprotection</article-title><source>Park Dis</source><year>2011</year><volume>2011</volume><fpage>617472</fpage></mixed-citation></ref><ref id="CR260"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mozaffarian</surname><given-names>D</given-names></name><etal/></person-group><article-title xml:lang="en">Heart disease and stroke statistics—2015 update: a report from the American Heart Association</article-title><source>Circulation</source><year>2015</year><volume>131</volume><issue>4</issue><fpage>e29</fpage><lpage>322</lpage><pub-id pub-id-type="pmid">25520374</pub-id><pub-id pub-id-type="doi">10.1161/CIR.0000000000000152</pub-id></mixed-citation></ref><ref id="CR261"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullins</surname><given-names>RF</given-names></name><etal/></person-group><article-title xml:lang="en">Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease</article-title><source>FASEB J</source><year>2000</year><volume>14</volume><issue>7</issue><fpage>835</fpage><lpage>846</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3cXjtVejtb0%3D</pub-id><pub-id pub-id-type="pmid">10783137</pub-id></mixed-citation></ref><ref id="CR262"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musso</surname><given-names>G</given-names></name><etal/></person-group><article-title xml:lang="en">Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity</article-title><source>Ann Med</source><year>2011</year><volume>43</volume><issue>8</issue><fpage>617</fpage><lpage>649</lpage><pub-id pub-id-type="pmid">21039302</pub-id><pub-id pub-id-type="doi">10.3109/07853890.2010.518623</pub-id></mixed-citation></ref><ref id="CR263"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musumeci</surname><given-names>G</given-names></name><name><surname>Szychlinska</surname><given-names>MA</given-names></name><name><surname>Mobasheri</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Age-related degeneration of articular cartilage in the pathogenesis of osteoarthritis: molecular markers of senescent chondrocytes</article-title><source>Histol Histopathol</source><year>2015</year><volume>30</volume><issue>1</issue><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXmsV2ktrw%3D</pub-id><pub-id pub-id-type="pmid">25010513</pub-id></mixed-citation></ref><ref id="CR264"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nathan</surname><given-names>C</given-names></name><name><surname>Ding</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Nonresolving inflammation</article-title><source>Cell</source><year>2010</year><volume>140</volume><issue>6</issue><fpage>871</fpage><lpage>882</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3cXlsVSgu7s%3D</pub-id><pub-id pub-id-type="pmid">20303877</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2010.02.029</pub-id></mixed-citation></ref><ref id="CR265"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarro</surname><given-names>A</given-names></name><etal/></person-group><article-title xml:lang="en">Beneficial effects of moderate exercise on mice aging: survival, behavior, oxidative stress, and mitochondrial electron transfer</article-title><source>Am J Physiol Regul Integr Comp Physiol</source><year>2004</year><volume>286</volume><issue>3</issue><fpage>R505</fpage><lpage>R511</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2cXitlShtLo%3D</pub-id><pub-id pub-id-type="pmid">14615275</pub-id><pub-id pub-id-type="doi">10.1152/ajpregu.00208.2003</pub-id></mixed-citation></ref><ref id="CR266"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newington</surname><given-names>JT</given-names></name><etal/></person-group><article-title xml:lang="en">Overexpression of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a in nerve cells confers resistance to amyloid beta and other toxins by decreasing mitochondrial respiration and reactive oxygen species production</article-title><source>J Biol Chem</source><year>2012</year><volume>287</volume><issue>44</issue><fpage>37245</fpage><lpage>37258</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC38XhsFOqs7%2FF</pub-id><pub-id pub-id-type="pmid">22948140</pub-id><pub-id pub-id-type="pmcid">3481323</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M112.366195</pub-id></mixed-citation></ref><ref id="CR267"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>LA</given-names></name><name><surname>Korol</surname><given-names>DL</given-names></name><name><surname>Gold</surname><given-names>PE</given-names></name></person-group><article-title xml:lang="en">Lactate produced by glycogenolysis in astrocytes regulates memory processing</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><issue>12</issue><fpage>e28427</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC38XhsFWqtw%3D%3D</pub-id><pub-id pub-id-type="pmid">22180782</pub-id><pub-id pub-id-type="pmcid">3236748</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0028427</pub-id></mixed-citation></ref><ref id="CR268"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ngo</surname><given-names>JK</given-names></name><name><surname>Pomatto</surname><given-names>LC</given-names></name><name><surname>Davies</surname><given-names>KJA</given-names></name></person-group><article-title xml:lang="en">Upregulation of the mitochondrial Lon protease allows adaptation to acute oxidative stress but dysregulation is associated with chronic stress, disease, and aging</article-title><source>Redox Biol</source><year>2013</year><volume>1</volume><fpage>258</fpage><lpage>264</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2cXptFGmuw%3D%3D</pub-id><pub-id pub-id-type="pmid">24024159</pub-id><pub-id pub-id-type="pmcid">3757690</pub-id><pub-id pub-id-type="doi">10.1016/j.redox.2013.01.015</pub-id></mixed-citation></ref><ref id="CR269"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nohl</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Involvement of free radicals in ageing: a consequence or cause of senescence</article-title><source>Br Med Bull</source><year>1993</year><volume>49</volume><issue>3</issue><fpage>653</fpage><lpage>667</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK2cXltFantw%3D%3D</pub-id><pub-id pub-id-type="pmid">8221030</pub-id><pub-id pub-id-type="doi">10.1093/oxfordjournals.bmb.a072638</pub-id></mixed-citation></ref><ref id="CR270"><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>of, N.A. and E. Sciences, and Medicine</collab></person-group><source>Using 21st century science to improve risk-related evaluations</source><year>2017</year><publisher-loc>Washington, DC</publisher-loc><publisher-name>The National Academies Pres</publisher-name></mixed-citation></ref><ref id="CR271"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohman</surname><given-names>H</given-names></name><etal/></person-group><article-title xml:lang="en">Effects of exercise on cognition: the Finnish Alzheimer disease exercise trial: a randomized, Controlled Trial</article-title><source>J Am Geriatr Soc</source><year>2016</year><volume>64</volume><issue>4</issue><fpage>731</fpage><lpage>738</lpage><pub-id pub-id-type="pmid">27037872</pub-id><pub-id pub-id-type="doi">10.1111/jgs.14059</pub-id></mixed-citation></ref><ref id="CR272"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ong</surname><given-names>JM</given-names></name><etal/></person-group><article-title xml:lang="en">Effects of cholesterol and apolipoprotein E on retinal abnormalities in ApoE-deficient mice</article-title><source>Invest Ophthalmol Vis Sci</source><year>2001</year><volume>42</volume><issue>8</issue><fpage>1891</fpage><lpage>1900</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DC%2BD3MznsVOhsA%3D%3D</pub-id><pub-id pub-id-type="pmid">11431458</pub-id></mixed-citation></ref><ref id="CR273"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ong</surname><given-names>JP</given-names></name><name><surname>Pitts</surname><given-names>A</given-names></name><name><surname>Younossi</surname><given-names>ZM</given-names></name></person-group><article-title xml:lang="en">Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease</article-title><source>J Hepatol</source><year>2008</year><volume>49</volume><issue>4</issue><fpage>608</fpage><lpage>612</lpage><pub-id pub-id-type="pmid">18682312</pub-id><pub-id pub-id-type="doi">10.1016/j.jhep.2008.06.018</pub-id></mixed-citation></ref><ref id="CR274"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otaki</surname><given-names>N</given-names></name><etal/></person-group><article-title xml:lang="en">Identification of a lipid peroxidation product as the source of oxidation-specific epitopes recognized by anti-DNA autoantibodies</article-title><source>J Biol Chem</source><year>2010</year><volume>285</volume><issue>44</issue><fpage>33834</fpage><lpage>33842</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3cXhtlWktrvI</pub-id><pub-id pub-id-type="pmid">20736172</pub-id><pub-id pub-id-type="pmcid">2962483</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M110.165175</pub-id></mixed-citation></ref><ref id="CR275"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozgocmen</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">Role of antioxidant systems, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis</article-title><source>Mol Cell Biochem</source><year>2007</year><volume>295</volume><issue>1–2</issue><fpage>45</fpage><lpage>52</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2sXosFKjtw%3D%3D</pub-id><pub-id pub-id-type="pmid">16841180</pub-id><pub-id pub-id-type="doi">10.1007/s11010-006-9270-z</pub-id></mixed-citation></ref><ref id="CR276"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panich</surname><given-names>U</given-names></name><etal/></person-group><article-title xml:lang="en">Ultraviolet radiation-induced skin aging: the role of DNA damage and oxidative stress in epidermal stem cell damage mediated skin aging</article-title><source>Stem Cells Int</source><year>2016</year><volume>2016</volume><fpage>7370642</fpage><pub-id pub-id-type="pmid">27148370</pub-id><pub-id pub-id-type="pmcid">4842382</pub-id><pub-id pub-id-type="doi">10.1155/2016/7370642</pub-id></mixed-citation></ref><ref id="CR277"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panieri</surname><given-names>E</given-names></name><name><surname>Santoro</surname><given-names>MM</given-names></name></person-group><article-title xml:lang="en">ROS homeostasis and metabolism: a dangerous liason in cancer cells</article-title><source>Cell Death Dis</source><year>2016</year><volume>7</volume><issue>6</issue><fpage>e2253</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28XmvFChsLo%3D</pub-id><pub-id pub-id-type="pmid">27277675</pub-id><pub-id pub-id-type="pmcid">5143371</pub-id><pub-id pub-id-type="doi">10.1038/cddis.2016.105</pub-id></mixed-citation></ref><ref id="CR278"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>B</given-names></name><etal/></person-group><article-title xml:lang="en">Postischemic myocardial “stunning”: a clinically relevant phenomenon</article-title><source>Ann Intern Med</source><year>1988</year><volume>108</volume><issue>4</issue><fpage>626</fpage><lpage>628</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaL1c7mtF2juw%3D%3D</pub-id><pub-id pub-id-type="pmid">3279896</pub-id><pub-id pub-id-type="doi">10.7326/0003-4819-108-4-626</pub-id></mixed-citation></ref><ref id="CR279"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paun</surname><given-names>CC</given-names></name><etal/></person-group><article-title xml:lang="en">Genetic variants and systemic complement activation levels are associated with serum lipoprotein levels in age-related macular degeneration</article-title><source>Invest Ophthalmol Vis Sci</source><year>2015</year><volume>56</volume><issue>13</issue><fpage>7766</fpage><lpage>7773</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28XitFWktL%2FO</pub-id><pub-id pub-id-type="pmid">26641553</pub-id><pub-id pub-id-type="doi">10.1167/iovs.15-17035</pub-id></mixed-citation></ref><ref id="CR280"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pekkari</surname><given-names>K</given-names></name><name><surname>Holmgren</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Truncated thioredoxin: physiological functions and mechanism</article-title><source>Antioxid Redox Signal</source><year>2004</year><volume>6</volume><issue>1</issue><fpage>53</fpage><lpage>61</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2cXhs1entg%3D%3D</pub-id><pub-id pub-id-type="pmid">14713335</pub-id><pub-id pub-id-type="doi">10.1089/152308604771978345</pub-id></mixed-citation></ref><ref id="CR281"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pellerin</surname><given-names>L</given-names></name><name><surname>Magistretti</surname><given-names>PJ</given-names></name></person-group><article-title xml:lang="en">Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization</article-title><source>Proc Natl Acad Sci U S A</source><year>1994</year><volume>91</volume><issue>22</issue><fpage>10625</fpage><lpage>10629</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK2cXmvFentr8%3D</pub-id><pub-id pub-id-type="pmid">7938003</pub-id><pub-id pub-id-type="pmcid">45074</pub-id><pub-id pub-id-type="doi">10.1073/pnas.91.22.10625</pub-id></mixed-citation></ref><ref id="CR282"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peri</surname><given-names>F</given-names></name><name><surname>Nusslein-Volhard</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">Live imaging of neuronal degradation by microglia reveals a role for v0-ATPase a1 in phagosomal fusion in vivo</article-title><source>Cell</source><year>2008</year><volume>133</volume><issue>5</issue><fpage>916</fpage><lpage>927</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD1cXntFalt7k%3D</pub-id><pub-id pub-id-type="pmid">18510934</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2008.04.037</pub-id></mixed-citation></ref><ref id="CR283"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petropoulos</surname><given-names>I</given-names></name><name><surname>Friguet</surname><given-names>B</given-names></name></person-group><article-title xml:lang="en">Maintenance of proteins and aging: the role of oxidized protein repair</article-title><source>Free Radic Res</source><year>2006</year><volume>40</volume><issue>12</issue><fpage>1269</fpage><lpage>1276</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD28XhtlGqs7nN</pub-id><pub-id pub-id-type="pmid">17090416</pub-id><pub-id pub-id-type="doi">10.1080/10715760600917144</pub-id></mixed-citation></ref><ref id="CR284"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petty</surname><given-names>TL</given-names></name><name><surname>Ashbaugh</surname><given-names>DG</given-names></name></person-group><article-title xml:lang="en">The adult respiratory distress syndrome. Clinical features, factors influencing prognosis and principles of management</article-title><source>Chest</source><year>1971</year><volume>60</volume><issue>3</issue><fpage>233</fpage><lpage>239</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaE38%2FgtFamsg%3D%3D</pub-id><pub-id pub-id-type="pmid">4937358</pub-id><pub-id pub-id-type="doi">10.1378/chest.60.3.233</pub-id></mixed-citation></ref><ref id="CR285"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petzinger</surname><given-names>GM</given-names></name><etal/></person-group><article-title xml:lang="en">Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury</article-title><source>J Neurosci</source><year>2007</year><volume>27</volume><issue>20</issue><fpage>5291</fpage><lpage>5300</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2sXlvFGiu7Y%3D</pub-id><pub-id pub-id-type="pmid">17507552</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1069-07.2007</pub-id></mixed-citation></ref><ref id="CR286"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petzinger</surname><given-names>GM</given-names></name><etal/></person-group><article-title xml:lang="en">The effects of exercise on dopamine neurotransmission in Parkinson’s disease: targeting neuroplasticity to modulate basal ganglia circuitry</article-title><source>Brain Plast</source><year>2015</year><volume>1</volume><issue>1</issue><fpage>29</fpage><lpage>39</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DC%2BC2srjvVCgtg%3D%3D</pub-id><pub-id pub-id-type="pmid">26512345</pub-id><pub-id pub-id-type="pmcid">4621077</pub-id><pub-id pub-id-type="doi">10.3233/BPL-150021</pub-id></mixed-citation></ref><ref id="CR287"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeiffer</surname><given-names>A</given-names></name><etal/></person-group><article-title xml:lang="en">Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in rafts</article-title><source>Eur J Immunol</source><year>2001</year><volume>31</volume><issue>11</issue><fpage>3153</fpage><lpage>3164</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3MXosl2qur4%3D</pub-id><pub-id pub-id-type="pmid">11745332</pub-id><pub-id pub-id-type="doi">10.1002/1521-4141(200111)31:11&lt;3153::AID-IMMU3153&gt;3.0.CO;2-0</pub-id></mixed-citation></ref><ref id="CR288"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierson</surname><given-names>DJ</given-names></name></person-group><article-title xml:lang="en">Oxygen in respiratory care: a personal perspective from 40 years in the field</article-title><source>Respir Care</source><year>2013</year><volume>58</volume><issue>1</issue><fpage>196</fpage><lpage>204</lpage><pub-id pub-id-type="pmid">23271829</pub-id><pub-id pub-id-type="doi">10.4187/respcare.02239</pub-id></mixed-citation></ref><ref id="CR289"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pikuleva</surname><given-names>IA</given-names></name><name><surname>Curcio</surname><given-names>CA</given-names></name></person-group><article-title xml:lang="en">Cholesterol in the retina: the best is yet to come</article-title><source>Prog Retin Eye Res</source><year>2014</year><volume>41</volume><fpage>64</fpage><lpage>89</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2cXntlOqsbw%3D</pub-id><pub-id pub-id-type="pmid">24704580</pub-id><pub-id pub-id-type="doi">10.1016/j.preteyeres.2014.03.002</pub-id></mixed-citation></ref><ref id="CR290"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pillai</surname><given-names>JB</given-names></name><etal/></person-group><article-title xml:lang="en">Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2alpha deacetylase activity</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><issue>52</issue><fpage>43121</fpage><lpage>43130</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2MXhtlCmsbzJ</pub-id><pub-id pub-id-type="pmid">16207712</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M506162200</pub-id></mixed-citation></ref><ref id="CR291"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinti</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Upregulation of nuclear-encoded mitochondrial LON protease in HAART-treated HIV-positive patients with lipodystrophy: implications for the pathogenesis of the disease</article-title><source>AIDS</source><year>2010</year><volume>24</volume><issue>6</issue><fpage>841</fpage><lpage>850</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3cXjt1Kisbo%3D</pub-id><pub-id pub-id-type="pmid">20168207</pub-id><pub-id pub-id-type="doi">10.1097/QAD.0b013e32833779a3</pub-id></mixed-citation></ref><ref id="CR292"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinti</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Functional characterization of the promoter of the human Lon protease gene</article-title><source>Mitochondrion</source><year>2011</year><volume>11</volume><issue>1</issue><fpage>200</fpage><lpage>206</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3cXhsFGhtrnI</pub-id><pub-id pub-id-type="pmid">20933102</pub-id><pub-id pub-id-type="doi">10.1016/j.mito.2010.09.010</pub-id></mixed-citation></ref><ref id="CR293"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinti</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Mitochondrial Lon protease at the crossroads of oxidative stress, ageing and cancer</article-title><source>Cell Mol Life Sci</source><year>2015</year><volume>72</volume><issue>24</issue><fpage>4807</fpage><lpage>4824</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXhsFSiurbE</pub-id><pub-id pub-id-type="pmid">26363553</pub-id><pub-id pub-id-type="doi">10.1007/s00018-015-2039-3</pub-id></mixed-citation></ref><ref id="CR294"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinti</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Emerging role of Lon protease as a master regulator of mitochondrial functions</article-title><source>Biochim Biophys Acta</source><year>2016</year><volume>1857</volume><issue>8</issue><fpage>1300</fpage><lpage>1306</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28Xls1OjsLw%3D</pub-id><pub-id pub-id-type="pmid">27033304</pub-id><pub-id pub-id-type="doi">10.1016/j.bbabio.2016.03.025</pub-id></mixed-citation></ref><ref id="CR295"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piskounova</surname><given-names>E</given-names></name><etal/></person-group><article-title xml:lang="en">Oxidative stress inhibits distant metastasis by human melanoma cells</article-title><source>Nature</source><year>2015</year><volume>527</volume><issue>7577</issue><fpage>186</fpage><lpage>191</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXhslOrtLfL</pub-id><pub-id pub-id-type="pmid">26466563</pub-id><pub-id pub-id-type="pmcid">4644103</pub-id><pub-id pub-id-type="doi">10.1038/nature15726</pub-id></mixed-citation></ref><ref id="CR296"><mixed-citation publication-type="other">Pomatto LCD, Davies KJA (2017) The role of declining adaptive homeostasis in ageing. J Physiol. <ext-link xlink:href="10.1113/JP275072" ext-link-type="doi">https://doi.org/10.1113/JP275072</ext-link></mixed-citation></ref><ref id="CR297"><mixed-citation publication-type="other">Pomatto LCD, Tower J, Davies KJA (2017a) Sexual dimorphism and aging differentially regulate adaptive homeostasis<italic>.</italic> J Gerontol A Biol Sci Med Sci</mixed-citation></ref><ref id="CR298"><mixed-citation publication-type="other">Pomatto LC et al (2017b) The age-and sex-specific decline of the 20s proteasome and the Nrf2/CncC signal transduction pathway in adaption and resistance to oxidative stress in <italic>Drosophila melanogaster</italic>. Aging (Albany NY) 9(4):1153–1185</mixed-citation></ref><ref id="CR299"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pomatto</surname><given-names>LC</given-names></name><etal/></person-group><article-title xml:lang="en">The mitochondrial Lon protease is required for age-specific and sex-specific adaptation to oxidative stress</article-title><source>Curr Biol</source><year>2017</year><volume>27</volume><issue>1</issue><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28XhvF2gtr7O</pub-id><pub-id pub-id-type="pmid">27916526</pub-id><pub-id pub-id-type="doi">10.1016/j.cub.2016.10.044</pub-id></mixed-citation></ref><ref id="CR300"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Portakal</surname><given-names>O</given-names></name><etal/></person-group><article-title xml:lang="en">Coenzyme Q10 concentrations and antioxidant status in tissues of breast cancer patients</article-title><source>Clin Biochem</source><year>2000</year><volume>33</volume><issue>4</issue><fpage>279</fpage><lpage>284</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3cXmvVelsb0%3D</pub-id><pub-id pub-id-type="pmid">10936586</pub-id><pub-id pub-id-type="doi">10.1016/S0009-9120(00)00067-9</pub-id></mixed-citation></ref><ref id="CR301"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Przyklenk</surname><given-names>K</given-names></name><name><surname>Kloner</surname><given-names>RA</given-names></name></person-group><article-title xml:lang="en">Superoxide dismutase plus catalase improve contractile function in the canine model of the “stunned myocardium”</article-title><source>Circ Res</source><year>1986</year><volume>58</volume><issue>1</issue><fpage>148</fpage><lpage>156</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaL28XmtFyiuw%3D%3D</pub-id><pub-id pub-id-type="pmid">3943152</pub-id><pub-id pub-id-type="doi">10.1161/01.RES.58.1.148</pub-id></mixed-citation></ref><ref id="CR302"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Przyklenk</surname><given-names>K</given-names></name><name><surname>Kloner</surname><given-names>RA</given-names></name></person-group><article-title xml:lang="en">“Reperfusion injury” by oxygen-derived free radicals? Effect of superoxide dismutase plus catalase, given at the time of reperfusion, on myocardial infarct size, contractile function, coronary microvasculature, and regional myocardial blood flow</article-title><source>Circ Res</source><year>1989</year><volume>64</volume><issue>1</issue><fpage>86</fpage><lpage>96</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaL1MXpt12itw%3D%3D</pub-id><pub-id pub-id-type="pmid">2909304</pub-id><pub-id pub-id-type="doi">10.1161/01.RES.64.1.86</pub-id></mixed-citation></ref><ref id="CR303"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Przyklenk</surname><given-names>K</given-names></name><etal/></person-group><article-title xml:lang="en">Nifedipine administered after reperfusion ablates systolic contractile dysfunction of postischemic “stunned” myocardium</article-title><source>J Am Coll Cardiol</source><year>1989</year><volume>13</volume><issue>5</issue><fpage>1176</fpage><lpage>1183</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaL1MXitVGgsbk%3D</pub-id><pub-id pub-id-type="pmid">2926068</pub-id><pub-id pub-id-type="doi">10.1016/0735-1097(89)90281-7</pub-id></mixed-citation></ref><ref id="CR304"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Przyklenk</surname><given-names>K</given-names></name><etal/></person-group><article-title xml:lang="en">Regional ischemic ‘preconditioning’ protects remote virgin myocardium from subsequent sustained coronary occlusion</article-title><source>Circulation</source><year>1993</year><volume>87</volume><issue>3</issue><fpage>893</fpage><lpage>899</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaK3s7osFahtQ%3D%3D</pub-id><pub-id pub-id-type="pmid">7680290</pub-id><pub-id pub-id-type="doi">10.1161/01.CIR.87.3.893</pub-id></mixed-citation></ref><ref id="CR305"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puel</surname><given-names>C</given-names></name><name><surname>Coxam</surname><given-names>V</given-names></name><name><surname>Davicco</surname><given-names>MJ</given-names></name></person-group><article-title xml:lang="en">Mediterranean diet and osteoporosis prevention</article-title><source>Med Sci (Paris)</source><year>2007</year><volume>23</volume><issue>8–9</issue><fpage>756</fpage><lpage>760</lpage><pub-id pub-id-type="doi">10.1051/medsci/20072389756</pub-id></mixed-citation></ref><ref id="CR306"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quintero</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Cellular aspects of the aging of the articular cartilage. II. Condylar cartilage with fissured surface taken from normal and arthritic knees</article-title><source>Rev Rhum Mal Osteoartic</source><year>1984</year><volume>51</volume><issue>9</issue><fpage>445</fpage><lpage>449</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaL2M%2FmsFGlsQ%3D%3D</pub-id><pub-id pub-id-type="pmid">6505594</pub-id></mixed-citation></ref><ref id="CR307"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raichlen</surname><given-names>DA</given-names></name><name><surname>Alexander</surname><given-names>GE</given-names></name></person-group><article-title xml:lang="en">Exercise, APOE genotype, and the evolution of the human lifespan</article-title><source>Trends Neurosci</source><year>2014</year><volume>37</volume><issue>5</issue><fpage>247</fpage><lpage>255</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2cXlt1Cjsrs%3D</pub-id><pub-id pub-id-type="pmid">24690272</pub-id><pub-id pub-id-type="pmcid">4066890</pub-id><pub-id pub-id-type="doi">10.1016/j.tins.2014.03.001</pub-id></mixed-citation></ref><ref id="CR308"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raisz</surname><given-names>LG</given-names></name></person-group><article-title xml:lang="en">The osteoporosis revolution</article-title><source>Ann Intern Med</source><year>1997</year><volume>126</volume><issue>6</issue><fpage>458</fpage><lpage>462</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaK2s3gvVOnsQ%3D%3D</pub-id><pub-id pub-id-type="pmid">9072932</pub-id><pub-id pub-id-type="doi">10.7326/0003-4819-126-6-199703150-00007</pub-id></mixed-citation></ref><ref id="CR309"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ralston</surname><given-names>SH</given-names></name><name><surname>Grabowski</surname><given-names>PS</given-names></name></person-group><article-title xml:lang="en">Mechanisms of cytokine induced bone resorption: role of nitric oxide, cyclic guanosine monophosphate, and prostaglandins</article-title><source>Bone</source><year>1996</year><volume>19</volume><issue>1</issue><fpage>29</fpage><lpage>33</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK28XkvFShtLc%3D</pub-id><pub-id pub-id-type="pmid">8830984</pub-id><pub-id pub-id-type="doi">10.1016/8756-3282(96)00101-9</pub-id></mixed-citation></ref><ref id="CR310"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramanathan</surname><given-names>B</given-names></name><etal/></person-group><article-title xml:lang="en">Resistance to paclitaxel is proportional to cellular total antioxidant capacity</article-title><source>Cancer Res</source><year>2005</year><volume>65</volume><issue>18</issue><fpage>8455</fpage><lpage>8460</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2MXhtVShsbbL</pub-id><pub-id pub-id-type="pmid">16166325</pub-id><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-1162</pub-id></mixed-citation></ref><ref id="CR311"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>LG</given-names></name><etal/></person-group><article-title xml:lang="en">Lycopene consumption decreases oxidative stress and bone resorption markers in postmenopausal women</article-title><source>Osteoporos Int</source><year>2007</year><volume>18</volume><issue>1</issue><fpage>109</fpage><lpage>115</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD28Xht1OhtrfN</pub-id><pub-id pub-id-type="pmid">16941193</pub-id><pub-id pub-id-type="doi">10.1007/s00198-006-0205-z</pub-id></mixed-citation></ref><ref id="CR312"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasmussen</surname><given-names>MM</given-names></name><etal/></person-group><article-title xml:lang="en">Infarct size reduction by propranolol before and after coronary ligation in dogs</article-title><source>Circulation</source><year>1977</year><volume>56</volume><issue>5</issue><fpage>794</fpage><lpage>798</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaE1c%2Fit1yjug%3D%3D</pub-id><pub-id pub-id-type="pmid">912840</pub-id><pub-id pub-id-type="doi">10.1161/01.CIR.56.5.794</pub-id></mixed-citation></ref><ref id="CR313"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Rattan</surname><given-names>S</given-names></name><name><surname>Le Bourg</surname><given-names>E</given-names></name></person-group><source>Hormesis in health and disease</source><year>2014</year><publisher-loc>Boca Raton</publisher-loc><publisher-name>CRC Press</publisher-name><pub-id pub-id-type="doi">10.1201/b17042</pub-id></mixed-citation></ref><ref id="CR314"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rebillard</surname><given-names>A</given-names></name><etal/></person-group><article-title xml:lang="en">Prostate cancer and physical activity: adaptive response to oxidative stress</article-title><source>Free Radic Biol Med</source><year>2013</year><volume>60</volume><fpage>115</fpage><lpage>124</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3sXnsFWjsLo%3D</pub-id><pub-id pub-id-type="pmid">23462616</pub-id><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2013.02.009</pub-id></mixed-citation></ref><ref id="CR315"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reffelmann</surname><given-names>T</given-names></name><name><surname>Kloner</surname><given-names>RA</given-names></name></person-group><article-title xml:lang="en">Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2002</year><volume>283</volume><issue>3</issue><fpage>H1099</fpage><lpage>H1107</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD38XntFOguro%3D</pub-id><pub-id pub-id-type="pmid">12181140</pub-id><pub-id pub-id-type="doi">10.1152/ajpheart.00270.2002</pub-id></mixed-citation></ref><ref id="CR316"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reffelmann</surname><given-names>T</given-names></name><etal/></person-group><article-title xml:lang="en">No-reflow phenomenon persists long-term after ischemia/reperfusion in the rat and predicts infarct expansion</article-title><source>Circulation</source><year>2003</year><volume>108</volume><issue>23</issue><fpage>2911</fpage><lpage>2917</lpage><pub-id pub-id-type="pmid">14656914</pub-id><pub-id pub-id-type="doi">10.1161/01.CIR.0000101917.80668.E1</pub-id></mixed-citation></ref><ref id="CR317"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renaud</surname><given-names>S</given-names></name><name><surname>de Lorgeril</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Wine, alcohol, platelets, and the French paradox for coronary heart disease</article-title><source>Lancet</source><year>1992</year><volume>339</volume><issue>8808</issue><fpage>1523</fpage><lpage>1526</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaK383pt1ygtA%3D%3D</pub-id><pub-id pub-id-type="pmid">1351198</pub-id><pub-id pub-id-type="doi">10.1016/0140-6736(92)91277-F</pub-id></mixed-citation></ref><ref id="CR318"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reveille</surname><given-names>JD</given-names></name></person-group><article-title xml:lang="en">The genetic contribution to the pathogenesis of rheumatoid arthritis</article-title><source>Curr Opin Rheumatol</source><year>1998</year><volume>10</volume><issue>3</issue><fpage>187</fpage><lpage>200</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK1cXjvVCrsL0%3D</pub-id><pub-id pub-id-type="pmid">9608321</pub-id><pub-id pub-id-type="doi">10.1097/00002281-199805000-00007</pub-id></mixed-citation></ref><ref id="CR319"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rezkalla</surname><given-names>SH</given-names></name><etal/></person-group><article-title xml:lang="en">No-reflow phenomenon following percutaneous coronary intervention for acute myocardial infarction: incidence, outcome, and effect of pharmacologic therapy</article-title><source>J Interv Cardiol</source><year>2010</year><volume>23</volume><issue>5</issue><fpage>429</fpage><lpage>436</lpage><pub-id pub-id-type="pmid">20819117</pub-id><pub-id pub-id-type="doi">10.1111/j.1540-8183.2010.00561.x</pub-id></mixed-citation></ref><ref id="CR320"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richard</surname><given-names>JL</given-names></name></person-group><article-title xml:lang="en">Coronary risk factors. The French paradox</article-title><source>Arch Mal Coeur Vaiss</source><year>1987</year><volume>80</volume><fpage>17</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">3113393</pub-id></mixed-citation></ref><ref id="CR321"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riddell</surname><given-names>DR</given-names></name><etal/></person-group><article-title xml:lang="en">Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels</article-title><source>J Neurosci</source><year>2008</year><volume>28</volume><issue>45</issue><fpage>11445</fpage><lpage>11453</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD1cXhtlOgtrfK</pub-id><pub-id pub-id-type="pmid">18987181</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1972-08.2008</pub-id></mixed-citation></ref><ref id="CR322"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ries</surname><given-names>WL</given-names></name><name><surname>Key</surname><given-names>LL</given-names><suffix>Jr</suffix></name><name><surname>Rodriguiz</surname><given-names>RM</given-names></name></person-group><article-title xml:lang="en">Nitroblue tetrazolium reduction and bone resorption by osteoclasts in vitro inhibited by a manganese-based superoxide dismutase mimic</article-title><source>J Bone Miner Res</source><year>1992</year><volume>7</volume><issue>8</issue><fpage>931</fpage><lpage>939</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK38XmtV2lt7k%3D</pub-id><pub-id pub-id-type="pmid">1442207</pub-id><pub-id pub-id-type="doi">10.1002/jbmr.5650070810</pub-id></mixed-citation></ref><ref id="CR323"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rinnerthaler</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Oxidative stress in aging human skin</article-title><source>Biomol Ther</source><year>2015</year><volume>5</volume><issue>2</issue><fpage>545</fpage><lpage>589</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXhtFyhurrK</pub-id></mixed-citation></ref><ref id="CR324"><mixed-citation publication-type="other">Robinson JK (2015) Anatomy for procedural dermatology, in Surgery of the skin, p 1–27</mixed-citation></ref><ref id="CR325"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roche</surname><given-names>JJ</given-names></name><etal/></person-group><article-title xml:lang="en">Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study</article-title><source>BMJ</source><year>2005</year><volume>331</volume><issue>7529</issue><fpage>1374</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DC%2BD2MnlsFOhtQ%3D%3D</pub-id><pub-id pub-id-type="pmid">16299013</pub-id><pub-id pub-id-type="pmcid">1309645</pub-id><pub-id pub-id-type="doi">10.1136/bmj.38643.663843.55</pub-id></mixed-citation></ref><ref id="CR326"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenzweig</surname><given-names>T</given-names></name><etal/></person-group><article-title xml:lang="en">Red wine and wine pomace reduced the development of insulin resistance and liver steatosis in HFD-fed mice</article-title><source>J Funct Foods</source><year>2017</year><volume>34</volume><fpage>379</fpage><lpage>389</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXnsFent7s%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.jff.2017.04.043</pub-id></mixed-citation></ref><ref id="CR327"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roszkowski</surname><given-names>K</given-names></name><name><surname>Olinski</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">Urinary 8-oxoguanine as a predictor of survival in patients undergoing radiotherapy</article-title><source>Cancer Epidemiol Biomark Prev</source><year>2012</year><volume>21</volume><issue>4</issue><fpage>629</fpage><lpage>634</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC38XkvVCjtbc%3D</pub-id><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-11-0981</pub-id></mixed-citation></ref><ref id="CR328"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roszkowski</surname><given-names>K</given-names></name><etal/></person-group><article-title xml:lang="en">Oxidative damage DNA: 8-oxoGua and 8-oxodG as molecular markers of cancer</article-title><source>Med Sci Monit</source><year>2011</year><volume>17</volume><issue>6</issue><fpage>CR329</fpage><lpage>CR333</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3MXhtFWjtr3O</pub-id><pub-id pub-id-type="pmid">21629187</pub-id><pub-id pub-id-type="pmcid">3539537</pub-id><pub-id pub-id-type="doi">10.12659/MSM.881805</pub-id></mixed-citation></ref><ref id="CR329"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothstein</surname><given-names>JD</given-names></name><name><surname>Martin</surname><given-names>L</given-names></name><name><surname>Levey</surname><given-names>AI</given-names></name><name><surname>Dykes-Hoberg</surname><given-names>M</given-names></name><name><surname>Jin</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Nash</surname><given-names>N</given-names></name><name><surname>Kuncl</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">Localization of neuronal and glial glutamate transporters</article-title><source>Neuron</source><year>1994</year><volume>13</volume><fpage>713</fpage><lpage>725</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK2MXhtVCktb0%3D</pub-id><pub-id pub-id-type="pmid">7917301</pub-id><pub-id pub-id-type="doi">10.1016/0896-6273(94)90038-8</pub-id></mixed-citation></ref><ref id="CR330"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Rouiller</surname><given-names>C</given-names></name></person-group><source>The liver: morphology, biochemistry, physiology</source><year>2013</year><publisher-loc>Cambridge</publisher-loc><publisher-name>Academic</publisher-name></mixed-citation></ref><ref id="CR331"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>K</given-names></name><etal/></person-group><article-title xml:lang="en">NADPH oxidases and cancer</article-title><source>Clin Sci (Lond)</source><year>2015</year><volume>128</volume><issue>12</issue><fpage>863</fpage><lpage>875</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXlsl2rsbw%3D</pub-id><pub-id pub-id-type="doi">10.1042/CS20140542</pub-id></mixed-citation></ref><ref id="CR332"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Rui Yin</surname><given-names>QC</given-names></name><name><surname>Hamblin</surname><given-names>MR</given-names></name></person-group><source>Skin aging and photoaging, in Skin photoaging</source><year>2015</year><publisher-loc>San Rafael</publisher-loc><publisher-name>Morgan &amp; Claypool</publisher-name><fpage>1</fpage><lpage>4</lpage></mixed-citation></ref><ref id="CR333"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rumble</surname><given-names>B</given-names></name><etal/></person-group><article-title xml:lang="en">Amyloid A4 protein and its precursor in Down’s syndrome and Alzheimer’s disease</article-title><source>N Engl J Med</source><year>1989</year><volume>320</volume><issue>22</issue><fpage>1446</fpage><lpage>1452</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaL1M3jvVCrtg%3D%3D</pub-id><pub-id pub-id-type="pmid">2566117</pub-id><pub-id pub-id-type="doi">10.1056/NEJM198906013202203</pub-id></mixed-citation></ref><ref id="CR334"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rutar</surname><given-names>M</given-names></name><name><surname>Natoli</surname><given-names>R</given-names></name><name><surname>Provis</surname><given-names>JM</given-names></name></person-group><article-title xml:lang="en">Small interfering RNA-mediated suppression of Ccl2 in Muller cells attenuates microglial recruitment and photoreceptor death following retinal degeneration</article-title><source>J Neuroinflammation</source><year>2012</year><volume>9</volume><fpage>221</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3sXitlSmsLk%3D</pub-id><pub-id pub-id-type="pmid">22992301</pub-id><pub-id pub-id-type="pmcid">3546872</pub-id></mixed-citation></ref><ref id="CR335"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sainz</surname><given-names>RM</given-names></name><name><surname>Lombo</surname><given-names>F</given-names></name><name><surname>Mayo</surname><given-names>JC</given-names></name></person-group><article-title xml:lang="en">Radical decisions in cancer: redox control of cell growth and death</article-title><source>Cancers (Basel)</source><year>2012</year><volume>4</volume><issue>2</issue><fpage>442</fpage><lpage>474</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC38XnvFWqsLc%3D</pub-id><pub-id pub-id-type="doi">10.3390/cancers4020442</pub-id></mixed-citation></ref><ref id="CR336"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakurai</surname><given-names>E</given-names></name><etal/></person-group><article-title xml:lang="en">Macrophage depletion inhibits experimental choroidal neovascularization</article-title><source>Invest Ophthalmol Vis Sci</source><year>2003</year><volume>44</volume><issue>8</issue><fpage>3578</fpage><lpage>3585</lpage><pub-id pub-id-type="pmid">12882810</pub-id><pub-id pub-id-type="doi">10.1167/iovs.03-0097</pub-id></mixed-citation></ref><ref id="CR337"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salazar</surname><given-names>J</given-names></name><etal/></person-group><article-title xml:lang="en">Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson’s disease</article-title><source>Proc Natl Acad Sci U S A</source><year>2008</year><volume>105</volume><issue>47</issue><fpage>18578</fpage><lpage>18583</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD1cXhsVOltLzN</pub-id><pub-id pub-id-type="pmid">19011085</pub-id><pub-id pub-id-type="pmcid">2587621</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0804373105</pub-id></mixed-citation></ref><ref id="CR338"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samuel</surname><given-names>VT</given-names></name><etal/></person-group><article-title xml:lang="en">Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><issue>31</issue><fpage>32345</fpage><lpage>32353</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2cXmtVChsL0%3D</pub-id><pub-id pub-id-type="pmid">15166226</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M313478200</pub-id></mixed-citation></ref><ref id="CR339"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez-Rodriguez</surname><given-names>MA</given-names></name><etal/></person-group><article-title xml:lang="en">Oxidative stress as a risk factor for osteoporosis in elderly Mexicans as characterized by antioxidant enzymes</article-title><source>BMC Musculoskelet Disord</source><year>2007</year><volume>8</volume><fpage>124</fpage><pub-id pub-id-type="pmid">18088440</pub-id><pub-id pub-id-type="pmcid">2225394</pub-id><pub-id pub-id-type="doi">10.1186/1471-2474-8-124</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD1cXnslWqsw%3D%3D</pub-id></mixed-citation></ref><ref id="CR340"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sander</surname><given-names>CS</given-names></name><etal/></person-group><article-title xml:lang="en">Oxidative stress in malignant melanoma and non-melanoma skin cancer</article-title><source>Br J Dermatol</source><year>2003</year><volume>148</volume><issue>5</issue><fpage>913</fpage><lpage>922</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3sXlslarsL8%3D</pub-id><pub-id pub-id-type="pmid">12786821</pub-id><pub-id pub-id-type="doi">10.1046/j.1365-2133.2003.05303.x</pub-id></mixed-citation></ref><ref id="CR341"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarks</surname><given-names>SH</given-names></name></person-group><article-title xml:lang="en">Ageing and degeneration in the macular region: a clinico-pathological study</article-title><source>Br J Ophthalmol</source><year>1976</year><volume>60</volume><issue>5</issue><fpage>324</fpage><lpage>341</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaE283ltlChtQ%3D%3D</pub-id><pub-id pub-id-type="pmid">952802</pub-id><pub-id pub-id-type="pmcid">1042725</pub-id><pub-id pub-id-type="doi">10.1136/bjo.60.5.324</pub-id></mixed-citation></ref><ref id="CR342"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sauvaigo</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">Comet assay coupled to repair enzymes for the detection of oxidative damage to DNA induced by low doses of gamma-radiation: use of YOYO-1, low-background slides, and optimized electrophoresis conditions</article-title><source>Anal Biochem</source><year>2002</year><volume>303</volume><issue>1</issue><fpage>107</fpage><lpage>109</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD38XitFeisLw%3D</pub-id><pub-id pub-id-type="pmid">11906159</pub-id><pub-id pub-id-type="doi">10.1006/abio.2001.5559</pub-id></mixed-citation></ref><ref id="CR343"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sayin</surname><given-names>VI</given-names></name><etal/></person-group><article-title xml:lang="en">Antioxidants accelerate lung cancer progression in mice</article-title><source>Sci Transl Med</source><year>2014</year><volume>6</volume><issue>221</issue><fpage>221ra15</fpage><pub-id pub-id-type="pmid">24477002</pub-id><pub-id pub-id-type="doi">10.1126/scitranslmed.3007653</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2cXptV2gsbc%3D</pub-id></mixed-citation></ref><ref id="CR344"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schächter</surname><given-names>F</given-names></name><etal/></person-group><article-title xml:lang="en">Genetic associations with human longevity at the APOE and ACE loci</article-title><source>Nat Genet</source><year>1994</year><volume>6</volume><issue>1</issue><fpage>29</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">8136829</pub-id><pub-id pub-id-type="doi">10.1038/ng0194-29</pub-id></mixed-citation></ref><ref id="CR345"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schapira</surname><given-names>AH</given-names></name><etal/></person-group><article-title xml:lang="en">Mitochondrial complex I deficiency in Parkinson’s disease</article-title><source>J Neurochem</source><year>1990</year><volume>54</volume><issue>3</issue><fpage>823</fpage><lpage>827</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK3cXhsFKiur4%3D</pub-id><pub-id pub-id-type="pmid">2154550</pub-id><pub-id pub-id-type="doi">10.1111/j.1471-4159.1990.tb02325.x</pub-id></mixed-citation></ref><ref id="CR346"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitz</surname><given-names>G</given-names></name><name><surname>Orso</surname><given-names>E</given-names></name></person-group><article-title xml:lang="en">CD14 signalling in lipid rafts: new ligands and co-receptors</article-title><source>Curr Opin Lipidol</source><year>2002</year><volume>13</volume><issue>5</issue><fpage>513</fpage><lpage>521</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD38Xntl2isrg%3D</pub-id><pub-id pub-id-type="pmid">12352015</pub-id><pub-id pub-id-type="doi">10.1097/00041433-200210000-00007</pub-id></mixed-citation></ref><ref id="CR347"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitz</surname><given-names>G</given-names></name><name><surname>Liebisch</surname><given-names>G</given-names></name><name><surname>Langmann</surname><given-names>T</given-names></name></person-group><article-title xml:lang="en">Lipidomic strategies to study structural and functional defects of ABC-transporters in cellular lipid trafficking</article-title><source>FEBS Lett</source><year>2006</year><volume>580</volume><issue>23</issue><fpage>5597</fpage><lpage>5610</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD28XhtVajsrzO</pub-id><pub-id pub-id-type="pmid">16934254</pub-id><pub-id pub-id-type="doi">10.1016/j.febslet.2006.08.014</pub-id></mixed-citation></ref><ref id="CR348"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seddon</surname><given-names>JM</given-names></name><etal/></person-group><article-title xml:lang="en">Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers</article-title><source>Arch Ophthalmol</source><year>2005</year><volume>123</volume><issue>6</issue><fpage>774</fpage><lpage>782</lpage><pub-id pub-id-type="pmid">15955978</pub-id><pub-id pub-id-type="doi">10.1001/archopht.123.6.774</pub-id></mixed-citation></ref><ref id="CR349"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sehgel</surname><given-names>NL</given-names></name><name><surname>Vatner</surname><given-names>SF</given-names></name><name><surname>Meininger</surname><given-names>GA</given-names></name></person-group><article-title xml:lang="en">“Smooth muscle cell stiffness syndrome”—revisiting the structural basis of arterial stiffness</article-title><source>Front Physiol</source><year>2015</year><volume>6</volume><fpage>335</fpage><pub-id pub-id-type="pmid">26635621</pub-id><pub-id pub-id-type="pmcid">4649054</pub-id><pub-id pub-id-type="doi">10.3389/fphys.2015.00335</pub-id></mixed-citation></ref><ref id="CR350"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sellheyer</surname><given-names>K</given-names></name></person-group><article-title xml:lang="en">Pathogenesis of solar elastosis: synthesis or degradation?</article-title><source>J Cutan Pathol</source><year>2003</year><volume>30</volume><issue>2</issue><fpage>123</fpage><lpage>127</lpage><pub-id pub-id-type="pmid">12641791</pub-id><pub-id pub-id-type="doi">10.1034/j.1600-0560.2003.00018.x</pub-id></mixed-citation></ref><ref id="CR351"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sennlaub</surname><given-names>F</given-names></name><etal/></person-group><article-title xml:lang="en">CCR2(+) monocytes infiltrate atrophic lesions in age-related macular disease and mediate photoreceptor degeneration in experimental subretinal inflammation in Cx3cr1 deficient mice</article-title><source>EMBO Mol Med</source><year>2013</year><volume>5</volume><issue>11</issue><fpage>1775</fpage><lpage>1793</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3sXhslWms73P</pub-id><pub-id pub-id-type="pmid">24142887</pub-id><pub-id pub-id-type="pmcid">3840491</pub-id><pub-id pub-id-type="doi">10.1002/emmm.201302692</pub-id></mixed-citation></ref><ref id="CR352"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>D</given-names></name><etal/></person-group><article-title xml:lang="en">Oxidative stress and its biomarkers in systemic lupus erythematosus</article-title><source>J Biomed Sci</source><year>2014</year><volume>21</volume><fpage>23</fpage><pub-id pub-id-type="pmid">24636579</pub-id><pub-id pub-id-type="pmcid">3995422</pub-id><pub-id pub-id-type="doi">10.1186/1423-0127-21-23</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXjtFyjtbk%3D</pub-id></mixed-citation></ref><ref id="CR353"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>R</given-names></name><name><surname>Vinayak</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Alpha-tocopherol prevents lymphoma by improving antioxidant defence system of mice</article-title><source>Mol Biol Rep</source><year>2013</year><volume>40</volume><issue>2</issue><fpage>839</fpage><lpage>849</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3sXjvVKkug%3D%3D</pub-id><pub-id pub-id-type="pmid">23065278</pub-id><pub-id pub-id-type="doi">10.1007/s11033-012-2123-9</pub-id></mixed-citation></ref><ref id="CR354"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>J</given-names></name><etal/></person-group><article-title xml:lang="en">8-Hydroxy-2′-deoxyguanosine (8-OH-dG) as a potential survival biomarker in patients with nonsmall-cell lung cancer</article-title><source>Cancer</source><year>2007</year><volume>109</volume><issue>3</issue><fpage>574</fpage><lpage>580</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2sXitV2it74%3D</pub-id><pub-id pub-id-type="pmid">17154177</pub-id><pub-id pub-id-type="doi">10.1002/cncr.22417</pub-id></mixed-citation></ref><ref id="CR355"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheridan</surname><given-names>J</given-names></name><etal/></person-group><article-title xml:lang="en">Nuclear oxidative damage correlates with poor survival in colorectal cancer</article-title><source>Br J Cancer</source><year>2009</year><volume>100</volume><issue>2</issue><fpage>381</fpage><lpage>388</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD1MXpsVWjsQ%3D%3D</pub-id><pub-id pub-id-type="pmid">19066606</pub-id><pub-id pub-id-type="doi">10.1038/sj.bjc.6604821</pub-id></mixed-citation></ref><ref id="CR356"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheweita</surname><given-names>SA</given-names></name><name><surname>Khoshhal</surname><given-names>KI</given-names></name></person-group><article-title xml:lang="en">Calcium metabolism and oxidative stress in bone fractures: role of antioxidants</article-title><source>Curr Drug Metab</source><year>2007</year><volume>8</volume><issue>5</issue><fpage>519</fpage><lpage>525</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2sXnsl2jtLg%3D</pub-id><pub-id pub-id-type="pmid">17584023</pub-id><pub-id pub-id-type="doi">10.2174/138920007780866852</pub-id></mixed-citation></ref><ref id="CR357"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shweiki</surname><given-names>D</given-names></name><etal/></person-group><article-title xml:lang="en">Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis</article-title><source>Nature</source><year>1992</year><volume>359</volume><issue>6398</issue><fpage>843</fpage><lpage>845</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK38XmsV2gsb4%3D</pub-id><pub-id pub-id-type="pmid">1279431</pub-id><pub-id pub-id-type="doi">10.1038/359843a0</pub-id></mixed-citation></ref><ref id="CR358"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silverton</surname><given-names>SF</given-names></name><etal/></person-group><article-title xml:lang="en">Osteoclast radical interactions: NADPH causes pulsatile release of NO and stimulates superoxide production</article-title><source>Endocrinology</source><year>1995</year><volume>136</volume><issue>11</issue><fpage>5244</fpage><lpage>5247</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK2MXovFOlurw%3D</pub-id><pub-id pub-id-type="pmid">7588266</pub-id><pub-id pub-id-type="doi">10.1210/endo.136.11.7588266</pub-id></mixed-citation></ref><ref id="CR359"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smeyne</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">HIF1alpha is necessary for exercise-induced neuroprotection while HIF2alpha is needed for dopaminergic neuron survival in the substantia nigra pars compacta</article-title><source>Neuroscience</source><year>2015</year><volume>295</volume><fpage>23</fpage><lpage>38</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXkvF2qur4%3D</pub-id><pub-id pub-id-type="pmid">25796140</pub-id><pub-id pub-id-type="pmcid">4524512</pub-id><pub-id pub-id-type="doi">10.1016/j.neuroscience.2015.03.015</pub-id></mixed-citation></ref><ref id="CR360"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smit</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Apolipoprotein E polymorphism in The Netherlands and its effect on plasma lipid and apolipoprotein levels</article-title><source>Hum Genet</source><year>1988</year><volume>80</volume><issue>3</issue><fpage>287</fpage><lpage>292</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaL1MXlsV2rsg%3D%3D</pub-id><pub-id pub-id-type="pmid">3192216</pub-id><pub-id pub-id-type="doi">10.1007/BF01790099</pub-id></mixed-citation></ref><ref id="CR361"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>D</given-names></name><etal/></person-group><article-title xml:lang="en">Lactate: a preferred fuel for human brain metabolism in vivo</article-title><source>J Cereb Blood Flow Metab</source><year>2003</year><volume>23</volume><issue>6</issue><fpage>658</fpage><lpage>664</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3sXks1yqsLg%3D</pub-id><pub-id pub-id-type="pmid">12796713</pub-id><pub-id pub-id-type="doi">10.1097/01.WCB.0000063991.19746.11</pub-id></mixed-citation></ref><ref id="CR362"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>RT</given-names></name><etal/></person-group><article-title xml:lang="en">Dynamic soft drusen remodelling in age-related macular degeneration</article-title><source>Br J Ophthalmol</source><year>2010</year><volume>94</volume><issue>12</issue><fpage>1618</fpage><lpage>1623</lpage><pub-id pub-id-type="pmid">20530179</pub-id><pub-id pub-id-type="pmcid">2948612</pub-id><pub-id pub-id-type="doi">10.1136/bjo.2009.166843</pub-id></mixed-citation></ref><ref id="CR363"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smoak</surname><given-names>KA</given-names></name><etal/></person-group><article-title xml:lang="en">Myeloid differentiation primary response protein 88 couples reverse cholesterol transport to inflammation</article-title><source>Cell Metab</source><year>2010</year><volume>11</volume><issue>6</issue><fpage>493</fpage><lpage>502</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3cXnsFyitrk%3D</pub-id><pub-id pub-id-type="pmid">20519121</pub-id><pub-id pub-id-type="pmcid">3091482</pub-id><pub-id pub-id-type="doi">10.1016/j.cmet.2010.04.006</pub-id></mixed-citation></ref><ref id="CR364"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sofic</surname><given-names>E</given-names></name><etal/></person-group><article-title xml:lang="en">Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain</article-title><source>J Neural Transm</source><year>1988</year><volume>74</volume><issue>3</issue><fpage>199</fpage><lpage>205</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaL1M%2FpsVegsQ%3D%3D</pub-id><pub-id pub-id-type="pmid">3210014</pub-id><pub-id pub-id-type="doi">10.1007/BF01244786</pub-id></mixed-citation></ref><ref id="CR365"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stadtman</surname><given-names>ER</given-names></name><name><surname>Berlett</surname><given-names>BS</given-names></name></person-group><article-title xml:lang="en">Reactive oxygen-mediated protein oxidation in aging and disease</article-title><source>Chem Res Toxicol</source><year>1997</year><volume>10</volume><issue>5</issue><fpage>485</fpage><lpage>494</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK2sXjs1WgtbY%3D</pub-id><pub-id pub-id-type="pmid">9168245</pub-id><pub-id pub-id-type="doi">10.1021/tx960133r</pub-id></mixed-citation></ref><ref id="CR366"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinbeck</surname><given-names>MJ</given-names></name><etal/></person-group><article-title xml:lang="en">NADPH-oxidase expression and in situ production of superoxide by osteoclasts actively resorbing bone</article-title><source>J Cell Biol</source><year>1994</year><volume>126</volume><issue>3</issue><fpage>765</fpage><lpage>772</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK2cXltVGjs74%3D</pub-id><pub-id pub-id-type="pmid">8045939</pub-id><pub-id pub-id-type="doi">10.1083/jcb.126.3.765</pub-id></mixed-citation></ref><ref id="CR367"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steiner</surname><given-names>JL</given-names></name><etal/></person-group><article-title xml:lang="en">Exercise training increases mitochondrial biogenesis in the brain</article-title><source>J Appl Physiol (1985)</source><year>2011</year><volume>111</volume><issue>4</issue><fpage>1066</fpage><lpage>1071</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3MXhtl2ru7rM</pub-id><pub-id pub-id-type="doi">10.1152/japplphysiol.00343.2011</pub-id></mixed-citation></ref><ref id="CR368"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevens</surname><given-names>JA</given-names></name><name><surname>Olson</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">Reducing falls and resulting hip fractures among older women</article-title><source>Home Care Provid</source><year>2000</year><volume>5</volume><issue>4</issue><fpage>134</fpage><lpage>139</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DC%2BD383pslamtA%3D%3D</pub-id><pub-id pub-id-type="pmid">10931397</pub-id><pub-id pub-id-type="doi">10.1067/mhc.2000.109232</pub-id><comment>quiz 140-1</comment></mixed-citation></ref><ref id="CR369"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>B</given-names></name><name><surname>Wild</surname><given-names>C</given-names></name></person-group><source>World Cancer Report 2014</source><year>2014</year><publisher-loc>Lyon</publisher-loc><publisher-name>IARC Publications</publisher-name></mixed-citation></ref><ref id="CR370"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strzelczyk</surname><given-names>JK</given-names></name><etal/></person-group><article-title xml:lang="en">The activity of antioxidant enzymes in colorectal adenocarcinoma and corresponding normal mucosa</article-title><source>Acta Biochim Pol</source><year>2012</year><volume>59</volume><issue>4</issue><fpage>549</fpage><lpage>556</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3sXjsVSisb8%3D</pub-id><pub-id pub-id-type="pmid">23189274</pub-id></mixed-citation></ref><ref id="CR371"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>PM</given-names></name><etal/></person-group><article-title xml:lang="en">Reduced levels of human apoE4 protein in an animal model of cognitive impairment</article-title><source>Neurobiol Aging</source><year>2011</year><volume>32</volume><issue>5</issue><fpage>791</fpage><lpage>801</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3MXkvVWmsro%3D</pub-id><pub-id pub-id-type="pmid">19577821</pub-id><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2009.05.011</pub-id></mixed-citation></ref><ref id="CR372"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>A</given-names></name><etal/></person-group><article-title xml:lang="en">Astrocyte-neuron lactate transport is required for long-term memory formation</article-title><source>Cell</source><year>2011</year><volume>144</volume><issue>5</issue><fpage>810</fpage><lpage>823</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3MXjsFeqt7Y%3D</pub-id><pub-id pub-id-type="pmid">21376239</pub-id><pub-id pub-id-type="pmcid">3073831</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2011.02.018</pub-id></mixed-citation></ref><ref id="CR373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Chronic photo-oxidative stress and subsequent MCP-1 activation as causative factors for age-related macular degeneration</article-title><source>J Cell Sci</source><year>2012</year><volume>125</volume><issue>Pt 10</issue><fpage>2407</fpage><lpage>2415</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC38XhtFehurrP</pub-id><pub-id pub-id-type="pmid">22357958</pub-id><pub-id pub-id-type="pmcid">3383257</pub-id><pub-id pub-id-type="doi">10.1242/jcs.097683</pub-id></mixed-citation></ref><ref id="CR374"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swank</surname><given-names>RL</given-names></name><name><surname>Dugan</surname><given-names>BB</given-names></name></person-group><article-title xml:lang="en">Effect of low saturated fat diet in early and late cases of multiple sclerosis</article-title><source>Lancet</source><year>1990</year><volume>336</volume><issue>8706</issue><fpage>37</fpage><lpage>39</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DyaK3czgvFCktQ%3D%3D</pub-id><pub-id pub-id-type="pmid">1973220</pub-id><pub-id pub-id-type="doi">10.1016/0140-6736(90)91533-G</pub-id></mixed-citation></ref><ref id="CR375"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swaroop</surname><given-names>A</given-names></name><etal/></person-group><article-title xml:lang="en">Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits</article-title><source>Hum Mol Genet</source><year>2007</year><volume>16</volume><issue>2</issue><fpage>R174</fpage><lpage>R182</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2sXht1KntLfM</pub-id><pub-id pub-id-type="pmid">17911160</pub-id><pub-id pub-id-type="doi">10.1093/hmg/ddm212</pub-id></mixed-citation></ref><ref id="CR376"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sykiotis</surname><given-names>GP</given-names></name><name><surname>Bohmann</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">Keap1/Nrf2 signaling regulates oxidative stress tolerance and lifespan in <italic>Drosophila</italic></article-title><source>Dev Cell</source><year>2008</year><volume>14</volume><issue>1</issue><fpage>76</fpage><lpage>85</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD1cXhtFyjtL0%3D</pub-id><pub-id pub-id-type="pmid">18194654</pub-id><pub-id pub-id-type="pmcid">2257869</pub-id><pub-id pub-id-type="doi">10.1016/j.devcel.2007.12.002</pub-id></mixed-citation></ref><ref id="CR377"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Symons</surname><given-names>MC</given-names></name></person-group><article-title xml:lang="en">Radicals generated by bone cutting and fracture</article-title><source>Free Radic Biol Med</source><year>1996</year><volume>20</volume><issue>6</issue><fpage>831</fpage><lpage>835</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK28XisFCrsro%3D</pub-id><pub-id pub-id-type="pmid">8728031</pub-id><pub-id pub-id-type="doi">10.1016/0891-5849(95)02174-4</pub-id></mixed-citation></ref><ref id="CR378"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szatrowski</surname><given-names>TP</given-names></name><name><surname>Nathan</surname><given-names>CF</given-names></name></person-group><article-title xml:lang="en">Production of large amounts of hydrogen peroxide by human tumor cells</article-title><source>Cancer Res</source><year>1991</year><volume>51</volume><issue>3</issue><fpage>794</fpage><lpage>798</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK3MXpvFagsw%3D%3D</pub-id><pub-id pub-id-type="pmid">1846317</pub-id></mixed-citation></ref><ref id="CR379"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabas</surname><given-names>I</given-names></name></person-group><article-title xml:lang="en">Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2005</year><volume>25</volume><issue>11</issue><fpage>2255</fpage><lpage>2264</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2MXhtFCisbfM</pub-id><pub-id pub-id-type="pmid">16141399</pub-id><pub-id pub-id-type="doi">10.1161/01.ATV.0000184783.04864.9f</pub-id></mixed-citation></ref><ref id="CR380"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takimoto</surname><given-names>M</given-names></name><name><surname>Hamada</surname><given-names>T</given-names></name></person-group><article-title xml:lang="en">Acute exercise increases brain region-specific expression of MCT1, MCT2, MCT4, GLUT1, and COX IV proteins</article-title><source>J Appl Physiol (1985)</source><year>2014</year><volume>116</volume><issue>9</issue><fpage>1238</fpage><lpage>1250</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2cXhtFKkt7fO</pub-id><pub-id pub-id-type="doi">10.1152/japplphysiol.01288.2013</pub-id></mixed-citation></ref><ref id="CR381"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>AG</given-names></name><etal/></person-group><article-title xml:lang="en">Antioxidant nutrient intake and the long-term incidence of age-related cataract: the Blue Mountains Eye Study</article-title><source>Am J Clin Nutr</source><year>2008</year><volume>87</volume><issue>6</issue><fpage>1899</fpage><lpage>1905</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD1cXnslWqu78%3D</pub-id><pub-id pub-id-type="pmid">18541583</pub-id></mixed-citation></ref><ref id="CR382"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Targher</surname><given-names>G</given-names></name><etal/></person-group><article-title xml:lang="en">Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients</article-title><source>Diabetes Care</source><year>2007</year><volume>30</volume><issue>5</issue><fpage>1212</fpage><lpage>1218</lpage><pub-id pub-id-type="pmid">17277038</pub-id><pub-id pub-id-type="doi">10.2337/dc06-2247</pub-id></mixed-citation></ref><ref id="CR383"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thiagarajan</surname><given-names>R</given-names></name><name><surname>Manikandan</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">Antioxidants and cataract</article-title><source>Free Radic Res</source><year>2013</year><volume>47</volume><issue>5</issue><fpage>337</fpage><lpage>345</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3sXlslyku7Y%3D</pub-id><pub-id pub-id-type="pmid">23438873</pub-id><pub-id pub-id-type="doi">10.3109/10715762.2013.777155</pub-id></mixed-citation></ref><ref id="CR384"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorin-Trescases</surname><given-names>N</given-names></name><etal/></person-group><article-title xml:lang="en">Age-dependent oxidative stress: toward an irreversible failure in endothelial maintenance</article-title><source>Med Sci (Paris)</source><year>2010</year><volume>26</volume><issue>10</issue><fpage>875</fpage><lpage>880</lpage><pub-id pub-id-type="doi">10.1051/medsci/20102610875</pub-id></mixed-citation></ref><ref id="CR385"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toy</surname><given-names>WA</given-names></name><etal/></person-group><article-title xml:lang="en">Treadmill exercise reverses dendritic spine loss in direct and indirect striatal medium spiny neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson’s disease</article-title><source>Neurobiol Dis</source><year>2014</year><volume>63</volume><fpage>201</fpage><lpage>209</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2cXhtFOlsrs%3D</pub-id><pub-id pub-id-type="pmid">24316165</pub-id><pub-id pub-id-type="doi">10.1016/j.nbd.2013.11.017</pub-id></mixed-citation></ref><ref id="CR386"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toyoda</surname><given-names>K</given-names></name><etal/></person-group><article-title xml:lang="en">Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion</article-title><source>J Neurol Sci</source><year>2004</year><volume>221</volume><issue>1–2</issue><fpage>11</fpage><lpage>17</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2cXks1Cjsb8%3D</pub-id><pub-id pub-id-type="pmid">15178207</pub-id><pub-id pub-id-type="doi">10.1016/j.jns.2004.03.002</pub-id></mixed-citation></ref><ref id="CR387"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trumble</surname><given-names>BC</given-names></name><etal/></person-group><article-title xml:lang="en">Apolipoprotein E4 is associated with improved cognitive function in Amazonian forager-horticulturalists with a high parasite burden</article-title><source>FASEB J</source><year>2017</year><volume>31</volume><issue>4</issue><fpage>1508</fpage><lpage>1515</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXhtFOhsrfN</pub-id><pub-id pub-id-type="pmid">28031319</pub-id><pub-id pub-id-type="doi">10.1096/fj.201601084R</pub-id></mixed-citation></ref><ref id="CR388"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsakiri</surname><given-names>EN</given-names></name><etal/></person-group><article-title xml:lang="en">Differential regulation of proteasome functionality in reproductive vs. somatic tissues of <italic>Drosophila</italic> during aging or oxidative stress</article-title><source>FASEB J</source><year>2013</year><volume>27</volume><issue>6</issue><fpage>2407</fpage><lpage>2420</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3sXpt1yhsLk%3D</pub-id><pub-id pub-id-type="pmid">23457214</pub-id><pub-id pub-id-type="pmcid">4050428</pub-id><pub-id pub-id-type="doi">10.1096/fj.12-221408</pub-id></mixed-citation></ref><ref id="CR389"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsakiri</surname><given-names>EN</given-names></name><etal/></person-group><article-title xml:lang="en">Proteasome dysfunction in <italic>Drosophila</italic> signals to an Nrf2-dependent regulatory circuit aiming to restore proteostasis and prevent premature aging</article-title><source>Aging Cell</source><year>2013</year><volume>12</volume><issue>5</issue><fpage>802</fpage><lpage>813</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3sXhsVektrrI</pub-id><pub-id pub-id-type="pmid">23738891</pub-id><pub-id pub-id-type="pmcid">4096703</pub-id><pub-id pub-id-type="doi">10.1111/acel.12111</pub-id></mixed-citation></ref><ref id="CR390"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsutsumi</surname><given-names>C</given-names></name><etal/></person-group><article-title xml:lang="en">The critical role of ocular-infiltrating macrophages in the development of choroidal neovascularization</article-title><source>J Leukoc Biol</source><year>2003</year><volume>74</volume><issue>1</issue><fpage>25</fpage><lpage>32</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3sXlsVeqt7w%3D</pub-id><pub-id pub-id-type="pmid">12832439</pub-id><pub-id pub-id-type="doi">10.1189/jlb.0902436</pub-id></mixed-citation></ref><ref id="CR391"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turer</surname><given-names>AT</given-names></name><etal/></person-group><article-title xml:lang="en">Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarction</article-title><source>Curr Control Trials Cardiovasc Med</source><year>2005</year><volume>6</volume><fpage>12</fpage><pub-id pub-id-type="pmid">16115321</pub-id><pub-id pub-id-type="pmcid">1236947</pub-id><pub-id pub-id-type="doi">10.1186/1468-6708-6-12</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2MXhtVChtLvM</pub-id></mixed-citation></ref><ref id="CR392"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turoczi</surname><given-names>T</given-names></name><etal/></person-group><article-title xml:lang="en">Thioredoxin redox signaling in the ischemic heart: an insight with transgenic mice overexpressing Trx1</article-title><source>J Mol Cell Cardiol</source><year>2003</year><volume>35</volume><issue>6</issue><fpage>695</fpage><lpage>704</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3sXkt1Gku7s%3D</pub-id><pub-id pub-id-type="pmid">12788387</pub-id><pub-id pub-id-type="doi">10.1016/S0022-2828(03)00117-2</pub-id></mixed-citation></ref><ref id="CR393"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uttara</surname><given-names>B</given-names></name><etal/></person-group><article-title xml:lang="en">Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options</article-title><source>Curr Neuropharmacol</source><year>2009</year><volume>7</volume><issue>1</issue><fpage>65</fpage><lpage>74</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD1MXhtVWqsrfN</pub-id><pub-id pub-id-type="pmid">19721819</pub-id><pub-id pub-id-type="pmcid">2724665</pub-id><pub-id pub-id-type="doi">10.2174/157015909787602823</pub-id></mixed-citation></ref><ref id="CR394"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaananen</surname><given-names>HK</given-names></name><etal/></person-group><article-title xml:lang="en">The cell biology of osteoclast function</article-title><source>J Cell Sci</source><year>2000</year><volume>113</volume><issue>Pt 3</issue><fpage>377</fpage><lpage>381</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3cXhsFCqsLw%3D</pub-id><pub-id pub-id-type="pmid">10639325</pub-id></mixed-citation></ref><ref id="CR395"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valacchi</surname><given-names>G</given-names></name><etal/></person-group><article-title xml:lang="en">Cutaneous responses to environmental stressors</article-title><source>Ann N Y Acad Sci</source><year>2012</year><volume>1271</volume><fpage>75</fpage><lpage>81</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC38XhvVeks7%2FI</pub-id><pub-id pub-id-type="pmid">23050967</pub-id><pub-id pub-id-type="pmcid">3495295</pub-id><pub-id pub-id-type="doi">10.1111/j.1749-6632.2012.06724.x</pub-id></mixed-citation></ref><ref id="CR396"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Eck</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Bone marrow transplantation in apolipoprotein E-deficient mice. Effect of ApoE gene dosage on serum lipid concentrations, (beta)VLDL catabolism, and atherosclerosis</article-title><source>Arterioscler Thromb Vasc Biol</source><year>1997</year><volume>17</volume><issue>11</issue><fpage>3117</fpage><lpage>3126</lpage><pub-id pub-id-type="pmid">9409301</pub-id><pub-id pub-id-type="doi">10.1161/01.ATV.17.11.3117</pub-id></mixed-citation></ref><ref id="CR397"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Exel</surname><given-names>E</given-names></name><etal/></person-group><article-title xml:lang="en">Effect of APOE ε4 allele on survival and fertility in an adverse environment</article-title><source>PLoS One</source><year>2017</year><volume>12</volume><issue>7</issue><fpage>e0179497</fpage><pub-id pub-id-type="pmid">28683096</pub-id><pub-id pub-id-type="pmcid">5500260</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0179497</pub-id></mixed-citation></ref><ref id="CR398"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Hall</surname><given-names>G</given-names></name><etal/></person-group><article-title xml:lang="en">Blood lactate is an important energy source for the human brain</article-title><source>J Cereb Blood Flow Metab</source><year>2009</year><volume>29</volume><issue>6</issue><fpage>1121</fpage><lpage>1129</lpage><pub-id pub-id-type="pmid">19337275</pub-id><pub-id pub-id-type="doi">10.1038/jcbfm.2009.35</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD1MXntVyku7o%3D</pub-id></mixed-citation></ref><ref id="CR399"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Leeuwen</surname><given-names>R</given-names></name><etal/></person-group><article-title xml:lang="en">Cholesterol and age-related macular degeneration: is there a link?</article-title><source>Am J Ophthalmol</source><year>2004</year><volume>137</volume><issue>4</issue><fpage>750</fpage><lpage>752</lpage><pub-id pub-id-type="pmid">15059717</pub-id><pub-id pub-id-type="doi">10.1016/j.ajo.2003.09.015</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2cXisl2ru7k%3D</pub-id></mixed-citation></ref><ref id="CR400"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>VanderBeek</surname><given-names>BL</given-names></name><etal/></person-group><article-title xml:lang="en">Role of statins in the development and progression of age-related macular degeneration</article-title><source>Retina</source><year>2013</year><volume>33</volume><issue>2</issue><fpage>414</fpage><lpage>422</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3sXjsVKntr0%3D</pub-id><pub-id pub-id-type="pmid">23314233</pub-id><pub-id pub-id-type="pmcid">3939714</pub-id><pub-id pub-id-type="doi">10.1097/IAE.0b013e318276e0cf</pub-id></mixed-citation></ref><ref id="CR401"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>VanLeeuwen</surname><given-names>JE</given-names></name><etal/></person-group><article-title xml:lang="en">Altered AMPA receptor expression with treadmill exercise in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury</article-title><source>J Neurosci Res</source><year>2010</year><volume>88</volume><issue>3</issue><fpage>650</fpage><lpage>668</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3cXkvFCkug%3D%3D</pub-id><pub-id pub-id-type="pmid">19746427</pub-id></mixed-citation></ref><ref id="CR402"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van't Hof</surname><given-names>RJ</given-names></name><name><surname>Ralston</surname><given-names>SH</given-names></name></person-group><article-title xml:lang="en">Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity</article-title><source>J Bone Miner Res</source><year>1997</year><volume>12</volume><issue>11</issue><fpage>1797</fpage><lpage>1804</lpage><pub-id pub-id-type="doi">10.1359/jbmr.1997.12.11.1797</pub-id></mixed-citation></ref><ref id="CR403"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van't Hof</surname><given-names>RJ</given-names></name><name><surname>Ralston</surname><given-names>SH</given-names></name></person-group><article-title xml:lang="en">Nitric oxide and bone</article-title><source>Immunology</source><year>2001</year><volume>103</volume><issue>3</issue><fpage>255</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2567.2001.01261.x</pub-id></mixed-citation></ref><ref id="CR404"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varadarajan</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">Review: Alzheimer’s amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity</article-title><source>J Struct Biol</source><year>2000</year><volume>130</volume><issue>2–3</issue><fpage>184</fpage><lpage>208</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3cXls1anu7w%3D</pub-id><pub-id pub-id-type="pmid">10940225</pub-id><pub-id pub-id-type="doi">10.1006/jsbi.2000.4274</pub-id></mixed-citation></ref><ref id="CR405"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vineis</surname><given-names>P</given-names></name><etal/></person-group><article-title xml:lang="en">The exposome in practice: design of the EXPOsOMICS project</article-title><source>Int J Hyg Environ Health</source><year>2017</year><volume>220</volume><issue>2 Pt A</issue><fpage>142</fpage><lpage>151</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:STN:280:DC%2BC2szlvFOkug%3D%3D</pub-id><pub-id pub-id-type="pmid">27576363</pub-id><pub-id pub-id-type="doi">10.1016/j.ijheh.2016.08.001</pub-id></mixed-citation></ref><ref id="CR406"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vistoli</surname><given-names>G</given-names></name><etal/></person-group><article-title xml:lang="en">Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation</article-title><source>Free Radic Res</source><year>2013</year><volume>47</volume><issue>Suppl 1</issue><fpage>3</fpage><lpage>27</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3sXht1Witr%2FP</pub-id><pub-id pub-id-type="pmid">23767955</pub-id><pub-id pub-id-type="doi">10.3109/10715762.2013.815348</pub-id></mixed-citation></ref><ref id="CR407"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voelcker-Rehage</surname><given-names>C</given-names></name><name><surname>Godde</surname><given-names>B</given-names></name><name><surname>Staudinger</surname><given-names>UM</given-names></name></person-group><article-title xml:lang="en">Cardiovascular and coordination training differentially improve cognitive performance and neural processing in older adults</article-title><source>Front Hum Neurosci</source><year>2011</year><volume>5</volume><fpage>26</fpage><pub-id pub-id-type="pmid">21441997</pub-id><pub-id pub-id-type="pmcid">3062100</pub-id><pub-id pub-id-type="doi">10.3389/fnhum.2011.00026</pub-id></mixed-citation></ref><ref id="CR408"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>EF</given-names></name><name><surname>Nebreda</surname><given-names>AR</given-names></name></person-group><article-title xml:lang="en">Signal integration by JNK and p38 MAPK pathways in cancer development</article-title><source>Nat Rev Cancer</source><year>2009</year><volume>9</volume><issue>8</issue><fpage>537</fpage><lpage>549</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD1MXovFymu7w%3D</pub-id><pub-id pub-id-type="pmid">19629069</pub-id><pub-id pub-id-type="doi">10.1038/nrc2694</pub-id></mixed-citation></ref><ref id="CR409"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>B</given-names></name></person-group><article-title xml:lang="en">Photoaging: a review of current concepts of pathogenesis</article-title><source>J Cutan Med Surg</source><year>2011</year><volume>15</volume><issue>Suppl 1</issue><fpage>S374</fpage><lpage>S377</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC38XisFWju7Y%3D</pub-id><pub-id pub-id-type="pmid">22469204</pub-id></mixed-citation></ref><ref id="CR410"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>SQ</given-names></name><name><surname>Osterwalder</surname><given-names>U</given-names></name><name><surname>Jung</surname><given-names>K</given-names></name></person-group><article-title xml:lang="en">Ex vivo evaluation of radical sun protection factor in popular sunscreens with antioxidants</article-title><source>J Am Acad Dermatol</source><year>2011</year><volume>65</volume><issue>3</issue><fpage>525</fpage><lpage>530</lpage><pub-id pub-id-type="pmid">21624700</pub-id><pub-id pub-id-type="doi">10.1016/j.jaad.2010.07.009</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3MXhtVais7nJ</pub-id></mixed-citation></ref><ref id="CR411"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><etal/></person-group><article-title xml:lang="en">Recruitment of the prefrontal cortex and cerebellum in parkinsonian rats following skilled aerobic exercise</article-title><source>Neurobiol Dis</source><year>2015</year><volume>77</volume><fpage>71</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">25747184</pub-id><pub-id pub-id-type="pmcid">4402279</pub-id><pub-id pub-id-type="doi">10.1016/j.nbd.2015.02.020</pub-id></mixed-citation></ref><ref id="CR412"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wauquier</surname><given-names>F</given-names></name><etal/></person-group><article-title xml:lang="en">Oxidative stress in bone remodelling and disease</article-title><source>Trends Mol Med</source><year>2009</year><volume>15</volume><issue>10</issue><fpage>468</fpage><lpage>477</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD1MXhtlWhsb3K</pub-id><pub-id pub-id-type="pmid">19811952</pub-id><pub-id pub-id-type="doi">10.1016/j.molmed.2009.08.004</pub-id></mixed-citation></ref><ref id="CR413"><mixed-citation publication-type="other">Weihermann AC et al (2016) Elastin structure and its involvement in skin photoageing<italic>.</italic> Int J Cosmet Sci 39(3):241–247</mixed-citation></ref><ref id="CR414"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinstock-Guttman</surname><given-names>B</given-names></name><etal/></person-group><article-title xml:lang="en">Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients</article-title><source>Prostaglandins Leukot Essent Fatty Acids</source><year>2005</year><volume>73</volume><issue>5</issue><fpage>397</fpage><lpage>404</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2MXhtVKjsLvK</pub-id><pub-id pub-id-type="pmid">16099630</pub-id><pub-id pub-id-type="doi">10.1016/j.plefa.2005.05.024</pub-id></mixed-citation></ref><ref id="CR415"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wenk</surname><given-names>J</given-names></name><etal/></person-group><article-title xml:lang="en">UV-induced oxidative stress and photoaging</article-title><source>Curr Probl Dermatol</source><year>2001</year><volume>29</volume><fpage>83</fpage><lpage>94</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3MXkvV2qsw%3D%3D</pub-id><pub-id pub-id-type="pmid">11225204</pub-id><pub-id pub-id-type="doi">10.1159/000060656</pub-id></mixed-citation></ref><ref id="CR416"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>WL</given-names></name><etal/></person-group><article-title xml:lang="en">Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis</article-title><source>Lancet Glob Health</source><year>2014</year><volume>2</volume><issue>2</issue><fpage>e106</fpage><lpage>e116</lpage><pub-id pub-id-type="pmid">25104651</pub-id><pub-id pub-id-type="doi">10.1016/S2214-109X(13)70145-1</pub-id></mixed-citation></ref><ref id="CR417"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong-Riley</surname><given-names>MT</given-names></name></person-group><article-title xml:lang="en">Cytochrome oxidase: an endogenous metabolic marker for neuronal activity</article-title><source>Trends Neurosci</source><year>1989</year><volume>12</volume><issue>3</issue><fpage>94</fpage><lpage>101</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaL1MXitV2lurc%3D</pub-id><pub-id pub-id-type="pmid">2469224</pub-id><pub-id pub-id-type="doi">10.1016/0166-2236(89)90165-3</pub-id></mixed-citation></ref><ref id="CR418"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>Y</given-names></name><etal/></person-group><article-title xml:lang="en">p38/p53/miR-200a-3p feedback loop promotes oxidative stress-mediated liver cell death</article-title><source>Cell Cycle</source><year>2015</year><volume>14</volume><issue>10</issue><fpage>1548</fpage><lpage>1558</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28XjvVyqs7o%3D</pub-id><pub-id pub-id-type="pmid">25789565</pub-id><pub-id pub-id-type="pmcid">4615042</pub-id><pub-id pub-id-type="doi">10.1080/15384101.2015.1026491</pub-id></mixed-citation></ref><ref id="CR419"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>W</given-names></name><name><surname>Chung</surname><given-names>KK</given-names></name></person-group><article-title xml:lang="en">Alpha-synuclein impairs normal dynamics of mitochondria in cell and animal models of Parkinson’s disease</article-title><source>J Neurochem</source><year>2012</year><volume>122</volume><issue>2</issue><fpage>404</fpage><lpage>414</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC38XhtFeisbrE</pub-id><pub-id pub-id-type="pmid">22537068</pub-id><pub-id pub-id-type="doi">10.1111/j.1471-4159.2012.07769.x</pub-id></mixed-citation></ref><ref id="CR420"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Yaar</surname><given-names>M</given-names></name><name><surname>Gilchrest</surname><given-names>BA</given-names></name></person-group><source>Aging of the skin, in Fitspatrick’s dermatology in general medicine</source><year>2012</year><publisher-loc>New York</publisher-loc><publisher-name>McGraw Hill</publisher-name><fpage>1213</fpage><lpage>1211</lpage></mixed-citation></ref><ref id="CR421"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy</article-title><source>J Clin Invest</source><year>2003</year><volume>112</volume><issue>9</issue><fpage>1395</fpage><lpage>1406</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3sXovVGqs7g%3D</pub-id><pub-id pub-id-type="pmid">14597765</pub-id><pub-id pub-id-type="pmcid">228400</pub-id><pub-id pub-id-type="doi">10.1172/JCI200317700</pub-id></mixed-citation></ref><ref id="CR422"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>T</given-names></name><etal/></person-group><article-title xml:lang="en">Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><issue>6</issue><fpage>e98972</fpage><pub-id pub-id-type="pmid">24905194</pub-id><pub-id pub-id-type="pmcid">4048236</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0098972</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2cXhsVKhu7nN</pub-id></mixed-citation></ref><ref id="CR423"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>SJ</given-names></name><name><surname>Lim</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation</article-title><source>Metabolism</source><year>2014</year><volume>63</volume><issue>5</issue><fpage>693</fpage><lpage>701</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2cXkt1Snu7s%3D</pub-id><pub-id pub-id-type="pmid">24629563</pub-id><pub-id pub-id-type="doi">10.1016/j.metabol.2014.02.003</pub-id></mixed-citation></ref><ref id="CR424"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Ries</surname><given-names>WL</given-names></name><name><surname>Key</surname><given-names>LL</given-names><suffix>Jr</suffix></name></person-group><article-title xml:lang="en">Nicotinamide adenine dinucleotide phosphate oxidase in the formation of superoxide in osteoclasts</article-title><source>Calcif Tissue Int</source><year>1998</year><volume>63</volume><issue>4</issue><fpage>346</fpage><lpage>350</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK1cXmsVegsrg%3D</pub-id><pub-id pub-id-type="pmid">9744995</pub-id><pub-id pub-id-type="doi">10.1007/s002239900538</pub-id></mixed-citation></ref><ref id="CR425"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">A new superoxide-generating oxidase in murine osteoclasts</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><issue>8</issue><fpage>5452</fpage><lpage>5458</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3MXhs1Kms70%3D</pub-id><pub-id pub-id-type="pmid">11098048</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M001004200</pub-id></mixed-citation></ref><ref id="CR426"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">Expression of Nox4 in osteoclasts</article-title><source>J Cell Biochem</source><year>2004</year><volume>92</volume><issue>2</issue><fpage>238</fpage><lpage>248</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2cXjvVaqsL4%3D</pub-id><pub-id pub-id-type="pmid">15108351</pub-id><pub-id pub-id-type="doi">10.1002/jcb.20048</pub-id></mixed-citation></ref><ref id="CR427"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J</given-names></name><etal/></person-group><article-title xml:lang="en">Lactate promotes plasticity gene expression by potentiating NMDA signaling in neurons</article-title><source>Proc Natl Acad Sci U S A</source><year>2014</year><volume>111</volume><issue>33</issue><fpage>12228</fpage><lpage>12233</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2cXht1amsLnN</pub-id><pub-id pub-id-type="pmid">25071212</pub-id><pub-id pub-id-type="pmcid">4143009</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1322912111</pub-id></mixed-citation></ref><ref id="CR428"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yellon</surname><given-names>DM</given-names></name><name><surname>Hausenloy</surname><given-names>DJ</given-names></name></person-group><article-title xml:lang="en">Myocardial reperfusion injury</article-title><source>N Engl J Med</source><year>2007</year><volume>357</volume><issue>11</issue><fpage>1121</fpage><lpage>1135</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2sXhtVKgtLzF</pub-id><pub-id pub-id-type="pmid">17855673</pub-id><pub-id pub-id-type="doi">10.1056/NEJMra071667</pub-id></mixed-citation></ref><ref id="CR429"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yen</surname><given-names>K</given-names></name><etal/></person-group><article-title xml:lang="en">The emerging role of the mitochondrial-derived peptide humanin in stress resistance</article-title><source>J Mol Endocrinol</source><year>2013</year><volume>50</volume><issue>1</issue><fpage>R11</fpage><lpage>R19</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3sXjsFansr8%3D</pub-id><pub-id pub-id-type="pmid">23239898</pub-id><pub-id pub-id-type="pmcid">3705736</pub-id><pub-id pub-id-type="doi">10.1530/JME-12-0203</pub-id></mixed-citation></ref><ref id="CR430"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Prospective study showing that dietary vitamin C reduced the risk of age-related cataracts in a middle-aged Japanese population</article-title><source>Eur J Nutr</source><year>2007</year><volume>46</volume><issue>2</issue><fpage>118</fpage><lpage>124</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2sXkt1Sqsrg%3D</pub-id><pub-id pub-id-type="pmid">17265171</pub-id><pub-id pub-id-type="doi">10.1007/s00394-006-0641-8</pub-id></mixed-citation></ref><ref id="CR431"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>O</given-names></name><etal/></person-group><article-title xml:lang="en">Levels of oxidative damage and lipid peroxidation in thyroid neoplasia</article-title><source>Head Neck</source><year>2010</year><volume>32</volume><issue>6</issue><fpage>750</fpage><lpage>756</lpage><pub-id pub-id-type="pmid">19998441</pub-id></mixed-citation></ref><ref id="CR432"><mixed-citation publication-type="other">Young AR, Claveau J, Rossi AB (2016) Ultraviolet radiation and the skin: photobiology and sunscreen photoprotection. J Am Acad Dermatol 76(3):S100–S109</mixed-citation></ref><ref id="CR433"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>CE</given-names></name><etal/></person-group><article-title xml:lang="en">Epigenetic signature and enhancer activity of the human APOE gene</article-title><source>Hum Mol Genet</source><year>2013</year><volume>22</volume><issue>24</issue><fpage>5036</fpage><lpage>5047</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3sXhvVamsbnM</pub-id><pub-id pub-id-type="pmid">23892237</pub-id><pub-id pub-id-type="pmcid">3836480</pub-id><pub-id pub-id-type="doi">10.1093/hmg/ddt354</pub-id></mixed-citation></ref><ref id="CR434"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name><etal/></person-group><article-title xml:lang="en">Nrf2-regulated phase II enzymes are induced by chronic ambient nanoparticle exposure in young mice with age-related impairments</article-title><source>Free Radic Biol Med</source><year>2012</year><volume>52</volume><issue>9</issue><fpage>2038</fpage><lpage>2046</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC38XlsFGjt74%3D</pub-id><pub-id pub-id-type="pmid">22401859</pub-id><pub-id pub-id-type="pmcid">3342863</pub-id><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2012.02.042</pub-id></mixed-citation></ref><ref id="CR435"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>LL</given-names></name><etal/></person-group><article-title xml:lang="en">Neurogenesis in the adult rat brain after intermittent hypoxia</article-title><source>Brain Res</source><year>2005</year><volume>1055</volume><issue>1–2</issue><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2MXpvV2ktLo%3D</pub-id><pub-id pub-id-type="pmid">16098951</pub-id><pub-id pub-id-type="doi">10.1016/j.brainres.2005.04.075</pub-id></mixed-citation></ref><ref id="CR436"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zweier</surname><given-names>JL</given-names></name><name><surname>Flaherty</surname><given-names>JT</given-names></name><name><surname>Weisfeldt</surname><given-names>ML</given-names></name></person-group><article-title xml:lang="en">Direct measurement of free radical generation following reperfusion of ischemic myocardium</article-title><source>Proc Natl Acad Sci U S A</source><year>1987</year><volume>84</volume><issue>5</issue><fpage>1404</fpage><lpage>1407</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaL2sXitFWrtL8%3D</pub-id><pub-id pub-id-type="pmid">3029779</pub-id><pub-id pub-id-type="pmcid">304438</pub-id><pub-id pub-id-type="doi">10.1073/pnas.84.5.1404</pub-id></mixed-citation></ref></ref-list></ref-list></back></article></records><facets><facet name="subject"><facet-value count="1">Cell Biology</facet-value><facet-value count="1">Geriatrics/Gerontology</facet-value><facet-value count="1">Life Sciences</facet-value><facet-value count="1">Molecular Medicine</facet-value></facet><facet name="keyword"><facet-value count="1">Adaptive Homeostasis</facet-value><facet-value count="1">Age-related diseases</facet-value><facet-value count="1">Ageing</facet-value><facet-value count="1">French Paradox</facet-value><facet-value count="1">Healthspan</facet-value><facet-value count="1">Oxidative stress</facet-value><facet-value count="1">Oxygen Paradox</facet-value><facet-value count="1">Proteostasis</facet-value></facet><facet name="pub"><facet-value count="1">GeroScience</facet-value></facet><facet name="year"><facet-value count="1">2017</facet-value></facet><facet name="country"><facet-value count="1">Canada</facet-value><facet-value count="1">France</facet-value><facet-value count="1">Italy</facet-value><facet-value count="1">United States</facet-value></facet><facet name="type"><facet-value count="1">Journal</facet-value></facet></facets></response>
